WorldWideScience

Sample records for allergic rhinitis websites

  1. Japanese Guideline for Allergic Rhinitis

    OpenAIRE

    Kimihiro Okubo; Yuichi Kurono; Shigeharu Fujieda; Satoshi Ogino; Eiichi Uchio; Hiroshi Odajima; Hiroshi Takenaka; Kohtaro Baba

    2011-01-01

    Like asthma and atopic dermatitis, allergic rhinitis is an allergic disease, but of the three, it is the only type I allergic disease. Allergic rhinitis includes pollinosis, which is intractable and reduces quality of life (QOL) when it becomes severe. A guideline is needed to understand allergic rhinitis and to use this knowledge to develop a treatment plan. In Japan, the first guideline was prepared after a symposium held by the Japanese Society of Allergology in 1993. The current 6th editi...

  2. Pediatric allergic conjunctivitis and allergic rhinitis

    Institute of Scientific and Technical Information of China (English)

    Tong Qiao; Yizhen Hu; Zhinan Wang

    2008-01-01

    Objective: To assess the relationship between allergic conjunctivitis(AC) and allergic rhinitis(AR) in pediatric ophthalmology and E.N.T outpatient clinic. Methods:Eight hundred and ninety two patients were enrolled in survey during Mar. 2005~Jan. 2007, 407 allergic conjunctivitis cases were placed in the ophthalmology clinic group and 485 allergic rhinitis cases were from the E.N.T clinic.The comorbid disorders, histories, symptoms, signs of patients were recorded. Type 1 allergy was tested in 479 cases by a specific IgE antibody blood test. Eosinophils were detected in superficial conjunctival scrapings of the superior tarsal conjunctiva and mucosa surface scrapings of middle nasal meatus in 88 cases with both diseases. Results:302(74%), 374(92%), 116(29%) in 407 cases with allergic conjunctivitis had concomitant eczema, rhinitis and asthma, respectively; 334(69%), 430(89%), 145(30%) in 485 cases with allergic rhinitis had concomitant eczema, allergic conjunctivitis and asthma, respectively. The prevalence of allergic conjunctivitis concomitant allergic rhinitis and allergic rhinitis concomitant allergic conjunctivitis had no significant difference(x2=2.6, P>0.05). The prevalence of allergic conjunctivitis and allergic rhinitis concomitant eczema and asthma also had no significant difference (x2=3.08; x2=0.21, P>0.05). The degree of severity of two kinds of disease symptoms is not parallel, in the patients with seasonal allergic conjuctivitis(SAC) and perennial allergic conjunctivitis(PAC), the clinical signs of AR were always severer(x2=258.2, P<0.05)than those of AC. However, the results coincided with the cases with vernal keratoconjuctivitis(VKC)(x2=66.5, P<0.05); Eosinophils were revealed in 50(57%) conjunctival scrapings and nasal mucosa scrapings(x2=1.5, P>0.05), 47(53%) cases had positive results in both scrapings. The main aeroallergens were house dust mites, house dust and fungi, and the main food-allergens were fish, crab and shrimp

  3. Allergic Rhinitis in Childhood - Review

    Directory of Open Access Journals (Sweden)

    Arzu Babayiğit

    2010-12-01

    Full Text Available Allergic rhinitis, an immunoglobulin E mediated disease, is the most common chronic allergic childhood disease. The disease is characterized by nasal sneezing, rhinorrhea, palate and eye itchiness, and congestion and it can significantly impact children’s health. It causes uncomfortable symptoms, impairs quality of life and can predispose to the development of comorbidities such as asthma. Etiological diagnosis is based on cutaneous prick tests, which have a high sensitivity and specificity rate and which can be easily applied to young children. Treatment initially involves avoidance measures and, when necessary, pharmacotherapy or immunotherapy. Pharmacotherapy generally involves antihistamines and/or nasal corticosteroids, but leukotriene antagonists have also demonstrated effectiveness in treating allergic rhinitis symptoms. In this article, the symptoms, diagnosis and treatment of allergic rhinitis in childhood are discussed. (Journal of Current Pediatrics 2010; 8: 105-12

  4. Japanese Guideline for Allergic Rhinitis 2014

    OpenAIRE

    Kimihiro Okubo; Yuichi Kurono; Shigeharu Fujieda; Satoshi Ogino; Eiichi Uchio; Hiroshi Odajima; Hiroshi Takenaka

    2014-01-01

    Like asthma and atopic dermatitis, allergic rhinitis is an allergic disease, but of the three, it is the only type I allergic disease. Allergic rhinitis includes pollinosis, which is intractable and reduces quality of life (QOL) when it becomes severe. A guideline is needed to understand allergic rhinitis and to use this knowledge to develop a treatment plan. In Japan, the first guideline was prepared after a symposium held by the Japanese Society of Allergology in 1993. The current 7th editi...

  5. Remission of allergic rhinitis

    DEFF Research Database (Denmark)

    Bødtger, Uffe; Linneberg, Allan

    2004-01-01

    months and s-IgE levels of class 2 or greater against pollen (birch, grass, or mugwort). This was similar for AR to animals (cat or dog) or house dust mites (HDMs). Remission of AR was defined as AR at baseline but no rhinitis symptoms at follow-up and sensitization (s-IgE level class > or =2 at baseline...

  6. Allergic Rhinitis: Mechanisms and Treatment.

    Science.gov (United States)

    Bernstein, David I; Schwartz, Gene; Bernstein, Jonathan A

    2016-05-01

    The prevalence of allergic rhinitis (AR) has been estimated at 10% to 40%, and its economic burden is substantial. AR patients develop specific immunoglobulin E (IgE) antibody responses to indoor and outdoor environmental allergens with exposure over time. These specific IgE antibodies bind to high-affinity IgE receptors on mast cells and basophils. Key outcome measures of therapeutic interventions include rhinitis symptom control, rescue medication requirements, and quality-of-life measures. A comprehensive multiple modality treatment plan customized to the individual patient can optimize outcomes.

  7. Current management of allergic rhinitis in children

    NARCIS (Netherlands)

    C. Georgalas; I. Terreehorst; W. Fokkens

    2010-01-01

    Over the last 20 years, there has been significant progress in our understanding of the pathophysiology of allergic rhinitis, including the discovery of new inflammatory mediators, the link between asthma and allergic rhinitis ('one airway-one disease' concept) and the introduction of novel therapeu

  8. Treating allergic rhinitis in pregnancy.

    Science.gov (United States)

    Piette, Vincent; Daures, Jean-Pierre; Demoly, Pascal

    2006-05-01

    Numerous pregnant women suffer from allergic rhinitis, and particular attention is required when prescribing drugs to these patients. In addition, physiologic changes associated with pregnancy could affect the upper airways. Evidence-based guidelines on the management of allergic rhinitis have been published. Medication can be prescribed during pregnancy when the apparent benefit of the drug is greater than the apparent risk. Usually, there is at least one "safe" drug from each major class used to control symptoms. All glucocorticosteroids are teratogenic in animals but, when the indication is clear (for diseases possibly associated, such as severe asthma exacerbation), the benefit of the drug is far greater than the risk. Inhaled glucocorticosteroids (eg, beclomethasone or budesonide) have not been incriminated as teratogens in humans and are used by pregnant women who have asthma. A few H1-antihistamines can safely be used as well. Most oral decongestants (except pseudoephedrine) are teratogenic in animals. There are no such data available for intranasal decongestants. Finally, pregnancy is not considered to be a contraindication for the continuation of immunotherapy.

  9. [Definition and clinic of the allergic rhinitis].

    Science.gov (United States)

    Spielhaupter, Magdalena

    2016-03-01

    The allergic rhinitis is the most common immune disorder with a lifetime prevalence of 24% and one of the most common chronic diseases at all--with tendency to rise. It occurs in childhood and influences the patients' social life, school performance and labour productivity. Furthermore the allergic rhinitis is accompanied by a lot of comorbidities, including conjunctivitis, asthma bronchiale, food allergy, neurodermatitis and sinusitis. For example the risk for asthma is 3.2-fold higher for adults with allergic rhinitis than for healthy people.

  10. Japanese guidelines for allergic rhinitis 2017

    Directory of Open Access Journals (Sweden)

    Kimihiro Okubo

    2017-04-01

    To incorporate evidence based medicine (EBM introduced from abroad, the most recent collection of evidence/literature was supplemented to the Practical Guideline for the Management of Allergic Rhinitis in Japan 2016. The revised guideline includes assessment of diagnosis/treatment and prescriptions for children and pregnant women, for broad clinical applications. An evidence-based step-by-step strategy for treatment is also described. In addition, the QOL concept and cost benefit analyses are also addressed. Along with Allergic Rhinitis and its Impact of Asthma (ARIA, this guideline is widely used for various clinical purposes, such as measures for patients with sinusitis, childhood allergic rhinitis, oral allergy syndrome, and anaphylaxis and for pregnant women. A Q&A section regarding allergic rhinitis in Japan was added to the end of this guideline.

  11. The effects of spirulina on allergic rhinitis.

    Science.gov (United States)

    Cingi, Cemal; Conk-Dalay, Meltem; Cakli, Hamdi; Bal, Cengiz

    2008-10-01

    The prevalence of allergic rhinitis is increasing globally due to various causes. It affects the quality life of a large group of people in all around the world. Allergic rhinitis still remains inadequately controlled with present medical means. The need of continuous medical therapy makes individuals anxious about the side effects of the drugs. So there is a need for an alternative strategy. Effects of spirulina, tinospora cordifolia and butterbur were investigated recently on allergic rhinitis in just very few investigations. Spirulina represents a blue-green alga that is produced and commercialized as a dietary supplement for modulating immune functions, as well as ameliorating a variety of diseases. This double blind, placebo controlled study, evaluated the effectiveness and tolerability of spirulina for treating patients with allergic rhinitis. Spirulina consumption significantly improved the symptoms and physical findings compared with placebo (P Spirulina is clinically effective on allergic rhinitis when compared with placebo. Further studies should be performed in order to clarify the mechanism of this effect.

  12. Aetiology of allergic rhinitis in Hong Kong

    Directory of Open Access Journals (Sweden)

    Christopher W.K. Lam

    1998-01-01

    Full Text Available In a 1993 survey, allergic rhinitis was identified as the most common allergic disease in Hong Kong, affecting 29.1% of schoolchildren. Recently (1995, the International Study of Asthma and Allergies in Childhood (ISAAC also reported 44.5% current rhinitis among Hong Kong teenagers. Our objective was to study the aetiology of allergic rhinitis in Hong Kong using serological tests of allergen sensitization. In 57 allergic rhinitis patients and in the same number of age- and sex-matched controls the following were measured: serum total IgE, mixed aeroallergen IgE (Phadiatop™ and specific IgE versus house dust mite (HDM, cockroach, cat and dog dander, mould mixture (Penicillium, Cladosporium, Aspergillus and Alternaria species and four local pollens (Bermuda grass, Timothy, ragweed and mugwort. Compared with controls, allergic rhinitis patients (26 males, 31 females; mean (± SD age 25 ±11 years had a significantly elevated serum total IgE concentration (mean ± SEM: 496 ± 88 vs 179 ± 38 kU/L and an increased proportion of positive Phadiatop (95 vs 33% and specific IgE tests versus HDM (90 vs 44% and cockroach (42 vs 9%; Mann-Whitney U-test and χ2 tests all P < 0.005. There was no significant difference in sensitization to other allergens tested. House dust mite and cockroach are ubiquitous in Hong Kong with a warm, humid climate and crowded living conditions. Their identification as aetiological agents of allergic rhinitis should help in the development of environmental strategies for reducing the inhalant allergen load to prevent and control this prevalent and costly health problem in our community.

  13. Nasal hyperreactivity and inflammation in allergic rhinitis

    Directory of Open Access Journals (Sweden)

    I. M. Garrelds

    1996-01-01

    Full Text Available The history of allergic disease goes back to 1819, when Bostock described his own ‘periodical affection of the eyes and chest’, which he called ‘summer catarrh’. Since they thought it was produced by the effluvium of new hay, this condition was also called hay fever. Later, in 1873, Blackley established that pollen played an important role in the causation of hay fever. Nowadays, the definition of allergy is ‘An untoward physiologic event mediated by a variety of different immunologic reactions’. In this review, the term allergy will be restricted to the IgE-dependent reactions. The most important clinical manifestations of IgE-dependent reactions are allergic conjunctivitis, allergic rhinitis, allergic asthma and atopic dermatitis. However, this review will be restricted to allergic rhinitis. The histopathological features of allergic inflammation involve an increase in blood flow and vascular permeability, leading to plasma exudation and the formation of oedema. In addition, a cascade of events occurs which involves a variety of inflammatory cells. These inflammatory cells migrate under the influence of chemotactic agents to the site of injury and induce the process of repair. Several types of inflammatory cells have been implicated in the pathogenesis of allergic rhinitis. After specific or nonspecific stimuli, inflammatory mediators are generated from cells normally found in the nose, such as mast cells, antigen-presenting cells and epithelial cells (primary effector cells and from cells recruited into the nose, such as basophils, eosinophils, lymphocytes, platelets and neutrophils (secondary effector cells. This review describes the identification of each of the inflammatory cells and their mediators which play a role in the perennial allergic processes in the nose of rhinitis patients.

  14. Links between allergic rhinitis and asthma

    Institute of Scientific and Technical Information of China (English)

    2006-01-01

    @@ Allergic diseases of the airway, which include seasonal rhinitis, chronic perennial rhinitis and asthma, are recognized as inflammatory disorders of the airway mucosa,1-3 but differ in the location of the inflammatory reaction and clinical manifestations of the disease. Asthma and allergic rhinitis frequently coexist in the same patient and are thought to share common predisposing genetic factors which interact with the environmental influences. Both diseases have increased in prevalence over recent decades4,5 particularly in westernized countries. This increase has been largely attributed to environmental factors such as exposure to aerial pollutants,4,6 and early life events, including the degree of exposure to infectious agents which might affect IgE production,5,7 since there has been insufficient time for a significant change in the gene pool.

  15. Allergic rhinitis management pocket reference 2008.

    NARCIS (Netherlands)

    Bousquet, J.; Reid, J.; Weel, C. van; Cagnani, C. Baena; Canonica, G.W.; Demoly, P.; Denburg, J.; Fokkens, W.J.; Grouse, L.; Mullol, K.; Ohta, K.; Schermer, T.; Valovirta, E.; Zhong, N.; Zuberbier, T.

    2008-01-01

    Allergic rhinitis is a major chronic respiratory disease because of its prevalence, impacts on quality of life and work/school performance, economic burden, and links with asthma. Family doctors (also known as 'primary care physicians' or 'general practitioners') play a major role in the management

  16. Treatment of allergic rhinitis during pregnancy.

    Science.gov (United States)

    Demoly, Pascal; Piette, Vincent; Daures, Jean-Pierre

    2003-01-01

    Allergic rhinitis is a frequent problem during pregnancy. In addition, physiological changes associated with pregnancy can affect the upper airways. Evidence-based guidelines on the management of allergic rhinitis have recently been published, the most recent being the Allergic Rhinitis and its Impact on Asthma (ARIA)--World Health Organization consensus. Many pregnant women experience allergic rhinitis and particular attention is required when prescribing drugs to these patients. Medication can be prescribed during pregnancy when the apparent benefit of the drug is greater than the apparent risk. Usually, there is at least one drug from each major class that can be safely utilised to control symptoms. All glucocorticosteroids are teratogenic in animals but, when the indication is clear (for diseases possibly associated, such as severe asthma exacerbation), the benefit of the drug is far greater than the risk. Inhaled glucocorticosteroids (e.g. beclomethasone or budesonide) have not been incriminated as teratogens in humans and are used by pregnant women who have asthma. A few histamine H(1)-receptor antagonists (H(1)-antihistamines) can safely be used as well. Most oral decongestants (except pseudoephedrine) are teratogenic in animals. There are no such data available for intra-nasal decongestants. Finally, pregnancy is not considered as a contraindication for the continuation of allergen specific immunotherapy.

  17. Steroids vs immunotherapy for allergic rhinitis

    DEFF Research Database (Denmark)

    Aasbjerg, Kristian; Backer, Vibeke

    2014-01-01

    Treatment for seasonal allergic rhinitis induced by airborne allergens can be divided into two major groups: symptom-dampening drugs, such as antihistamines and corticosteroids, and disease-modifying drugs in the form of immunotherapy. It has been speculated that depot-injection corticosteroids g...

  18. Allergic Rhinitis and its Impact on Asthma (ARIA)

    DEFF Research Database (Denmark)

    Bousquet, J; Schünemann, H J; Samolinski, B;

    2012-01-01

    Allergic rhinitis (AR) and asthma represent global health problems for all age groups. Asthma and rhinitis frequently coexist in the same subjects. Allergic Rhinitis and its Impact on Asthma (ARIA) was initiated during a World Health Organization workshop in 1999 (published in 2001). ARIA has rec...

  19. Upper and lower airway pathology in young children with allergic- and non-allergic rhinitis

    DEFF Research Database (Denmark)

    Chawes, Bo Lk

    2011-01-01

    Allergic- and non-allergic rhinitis are very common diseases in childhood in industrialized countries. Although these conditions are widely trivialized by both parents and physicians they induce a major impact on quality of life for the affected children and a substantial drainage of health care...... symptom in both allergic- and non-allergic rhinitis, and eosinophilic inflammation is a hallmark of the allergic diseases. In paper I, we studied nasal eosinophilia and nasal airway patency assessed by acoustic rhinometry in children with allergic rhinitis, non-allergic rhinitis and healthy controls...... nasal eosinophilia albeit less than children with allergic rhinitis. These findings suggest different pathology in allergic- and non-allergic rhinitis which may have important clinical implications for early pharmacological treatment of rhinitis in young children. In paper II, we utilized the nasal...

  20. Bilastine: in allergic rhinitis and urticaria.

    Science.gov (United States)

    Carter, Natalie J

    2012-06-18

    Bilastine is an orally administered, second-generation antihistamine used in the symptomatic treatment of seasonal or perennial allergic rhinoconjunctivitis and urticaria. In two well designed phase III trials, 14 days' treatment with bilastine was associated with a significantly lower area under the effect curve (AUEC) for the reflective total symptom score (TSS) than placebo in patients with symptomatic seasonal allergic rhinitis. Additionally, reflective nasal symptom scores were significantly lower in bilastine than placebo recipients in patients with a history of seasonal allergic rhinitis who were challenged with grass pollen allergen in a single-centre, phase II study. Neither bilastine nor cetirizine was effective in the treatment of perennial allergic rhinitis with regard to the mean AUEC for reflective TSS in another well designed phase III trial. However, results may have been altered by differences in some baseline characteristics and placebo responses between study countries. In another well designed phase III trial, compared with placebo, bilastine was associated with a significantly greater change from baseline to day 28 in the mean reflective daily urticaria symptom score in patients with chronic urticaria. There were no significant differences in primary endpoint results between bilastine and any of the active comparators used in these trials (i.e. cetirizine, levocetirizine and desloratadine). Bilastine was generally well tolerated, with a tolerability profile that was generally similar to that of the other second-generation antihistamines included in phase III clinical trials.

  1. Benzaldehyde suppresses murine allergic asthma and rhinitis.

    Science.gov (United States)

    Jang, Tae Young; Park, Chang-Shin; Kim, Kyu-Sung; Heo, Min-Jeong; Kim, Young Hyo

    2014-10-01

    To evaluate the antiallergic effects of oral benzaldehyde in a murine model of allergic asthma and rhinitis, we divided 20 female BALB/c mice aged 8-10 weeks into nonallergic (intraperitoneally sensitized and intranasally challenged to normal saline), allergic (intraperitoneally sensitized and intranasally challenged to ovalbumin), and 200- and 400-mg/kg benzaldehyde (allergic but treated) groups. The number of nose-scratching events in 10 min, levels of total and ovalbumin-specific IgE in serum, differential counts of inflammatory cells in bronchoalveolar lavage (BAL) fluid, titers of Th2 cytokines (IL-4, IL-5, IL-13) in BAL fluid, histopathologic findings of lung and nasal tissues, and expressions of proteins involved in apoptosis (Bcl-2, Bax, caspase-3), inflammation (COX-2), antioxidation (extracellular SOD, HO-1), and hypoxia (HIF-1α, VEGF) in lung tissue were evaluated. The treated mice had significantly fewer nose-scratching events, less inflammatory cell infiltration in lung and nasal tissues, and lower HIF-1α and VEGF expressions in lung tissue than the allergic group. The number of eosinophils and neutrophils and Th2 cytokine titers in BAL fluid significantly decreased after the treatment (Pbenzaldehyde exerts antiallergic effects in murine allergic asthma and rhinitis, possibly through inhibition of HIF-1α and VEGF.

  2. Allergic and non-allergic rhinitis: relationship with nasal polyposis, asthma and family history.

    Science.gov (United States)

    Gelardi, M; Iannuzzi, L; Tafuri, S; Passalacqua, G; Quaranta, N

    2014-02-01

    Rhinitis and rhinosinusitis (with/without polyposis), either allergic or non-allergic, represent a major medical problem. Their associated comorbidities and relationship with family history have so far been poorly investigated. We assessed these aspects in a large population of patients suffering from rhinosinusal diseases. Clinical history, nasal cytology, allergy testing and direct nasal examination were performed in all patients referred for rhinitis/rhinosinusitis. Fibre optic nasal endoscopy, CT scan and nasal challenge were used for diagnosis, when indicated. A total of 455 patients (60.7% male, age range 4-84 years) were studied; 108 (23.7%) had allergic rhinitis, 128 (28.1%) rhinosinusitis with polyposis, 107 (23.5%) non-allergic rhinitis (negative skin test); 112 patients had associated allergic and non-allergic rhinitis, the majority with eosinophilia. There was a significant association between non-allergic rhinitis and family history of nasal polyposis (OR = 4.45; 95%CI = 1.70-11.61; p = 0.0019), whereas this association was no longer present when allergic rhinitis was also included. Asthma was equally frequent in non-allergic and allergic rhinitis, but more frequent in patients with polyposis. Aspirin sensitivity was more frequent in nasal polyposis, independent of the allergic (p = 0.03) or non-allergic (p = 0.01) nature of rhinitis. Nasal polyposis is significantly associated with asthma and positive family history of asthma, partially independent of the allergic aetiology of rhinitis.

  3. Children with allergic and nonallergic rhinitis have a similar risk of asthma

    DEFF Research Database (Denmark)

    Chawes, Bo Lund Krogsgaard; Bønnelykke, Klaus; Kreiner-Møller, Eskil;

    2010-01-01

    Both allergic and nonallergic rhinitis have been associated with increased prevalence of asthma.......Both allergic and nonallergic rhinitis have been associated with increased prevalence of asthma....

  4. STUDY OF PREVALENCE OF EOSINOPHILIA IN ALLERGIC RHINITIS

    Directory of Open Access Journals (Sweden)

    Ravi Kumar

    2015-10-01

    Full Text Available BACKGROUND: Allergic rhinitis is a common condition, though not life threatening, causes significant morbidity in terms of quality of life. Confirmation of allergen as etiological agent is cumbersome. Hence need for a simple test is vital and eosinophil parameters were looked at to answer the quest. AIM: To find out the prevalence of e osinophilia in Allergic rhinitis . To assess the value of nasal cytogram as an alternative investigation in diagnosing allergic rhinitis . MATERIALS & METHODS: Prospective study of 200 cases divided into two groups of 100 each was done. One group clinically with allergic rhinitis and other without. All cases had clinical examination after history was taken, Blood Absolute eosinophil count, Nasal smear for eosinophils done and assessed. RESULTS: Of the 200 patients examined in two groups of 100 each, mean age of allergic rhinitis patients was 26.22 years . Allergic rhinitis was more common in males than females. Prevalence of nasal eosinophilia was 61%.and blood eosinophilia was 57% in allergic rhinitis patients. Nasal smear sensitivity was 61% and specificity w as 87% . CONCLUSION: Nasal smear eosinophilia is a valid test, can be quickly and easily performed and read. Being an in - expensive test can be used to screen the patients of allergic rhinitis

  5. Expression of Pendrin Periostin in Allergic Rhinitis Chronic Rhinosinusitis

    Directory of Open Access Journals (Sweden)

    Akihiro Ishida

    2012-01-01

    Conclusions: : Production of pendrin and periostin is upregulated in allergic rhinitis, chronic rhinosinusitis with nasal polyps, and aspirin-induced asthma. These findings suggest that pendrin can induce mucus production and that periostin can induce tissue fibrosis and remodeling in the nasal mucosa. Therefore, these mediators may be therapeutic target candidates for allergic rhinitis, chronic rhinosinusitis with nasal polyps, and aspirin- induced asthma.

  6. Upper and lower airway pathology in young children with allergic- and non-allergic rhinitis

    DEFF Research Database (Denmark)

    Chawes, Bo Lk

    2011-01-01

    Allergic- and non-allergic rhinitis are very common diseases in childhood in industrialized countries. Although these conditions are widely trivialized by both parents and physicians they induce a major impact on quality of life for the affected children and a substantial drainage of health care...... symptom in both allergic- and non-allergic rhinitis, and eosinophilic inflammation is a hallmark of the allergic diseases. In paper I, we studied nasal eosinophilia and nasal airway patency assessed by acoustic rhinometry in children with allergic rhinitis, non-allergic rhinitis and healthy controls...... or asthma should be considered inflamed in the entire respiratory tract. In paper III, we aimed to describe asthma and intermediary asthma end-points associated with allergic- and non-allergic rhinitis in preschool-aged children. At age 7 years, we evaluated prevalence of asthma, eczema, food sensitization...

  7. The Current Management at Diagnosis and Treatment of Allergic Rhinitis

    Directory of Open Access Journals (Sweden)

    Ozgur Tarkan

    2009-06-01

    Full Text Available Allergic rhinitis is a common disease with a remarkable social impact. The semptoms of allerjic rhinitis include itching, nasal discharge and sneezing. Similar to lethargy, fatigue, somnolence, decreased cognition, difficulty in concentration and decreased sleep and appetite is commonly seen besides physical symptoms. The treatment of allergic rhinitis consists of allergen avoidance, pharmacotherapy and immunotherapy. [Archives Medical Review Journal 2009; 18(3.000: 156-170

  8. Is Allergic Rhinitis a Factor That Affects Success of Tympanoplasty?

    Directory of Open Access Journals (Sweden)

    Elif Ersoy Callioglu

    2016-04-01

    Full Text Available Objective: The aim of the present study was to investigate the effect of allergic rhinitis on the success of the operation in chronic otitis surgery by using score for allergic rhinitis (SFAR. Materials and Methods: In the present study; 121 patients, who underwent type 1 tympanoplasty were examined retrospectively. SFAR of all patients were recorded. The graft success rates of 26 patients with allergic rhinitis (AR and 95 patients with no allergic rhinitis group (NAR were compared. Results: While the graft success rate in NAR group was 89.5%, this rate was 80.8% in the AR group. However, the difference between groups was not statistically significant (p = 0.311. Conclusion: These findings suggest that allergic rhinitis decreases the graft success rate of the pathologies occurring in eustachian tube, middle ear and mastoid although statistically significant difference wasn’t found. Prospective studies with larger patient groups are required in order to evaluate this pathology.

  9. Number of siblings and allergic rhinitis in children

    Directory of Open Access Journals (Sweden)

    Soewira Sastra

    2016-05-01

    Full Text Available Background Allergic rhinitis is one of the most common chronic diseases of childhood. Recent studies have suggested that having fewer siblings was associated with allergic rhinitis and atopic diseases in children. Previous studies also indicated that older siblings was associated with higher incidence of allergic rhinitis.Objectives To assess for a possible association between number of siblings and allergic rhinitis and to assess for an effect of birth order on allergic rhinitis in children.Methods We performed a cross-sectional study among school children aged 7 to 15 years, in the West Medan District from July to August 2011. Children with moderate or high risk of allergy were included. Subjects were divided into two groups, those with <3 siblings or ≥3 siblings. Children with acute respiratory tract infections, septal deviation, choanal atresia, nasal polyps, nasal tumors, or nasal foreign body were excluded. Risk of allergy was determined using the Indonesian Pediatrics Allergy Immunology Working Group trace card scoring system. Identification of allergic rhinitis and evaluation of its severity were done by use of the International Study of Asthma and Allergies in Childhood (ISAAC core questionnaire. Allergic rhinitis was diagnosed based on history, physical examination, and anterior rhinoscopy.Results A total of 78 subjects were enrolled. Allergic rhinitis was significantly higher in children with <3 siblings than those with ≥3 siblings (OR 10.33; 95%CI 3.569 to 29.916. Furthermore, allergic rhinitis was significantly higher in first-born children than in their younger siblings (P=0.0001.Conclusion Larger number of siblings and non-first-born children are associated with lower incidence of allergic rhinitis in children.

  10. Number of siblings and allergic rhinitis in children

    Directory of Open Access Journals (Sweden)

    Soewira Sastra

    2016-01-01

    Full Text Available Background Allergic rhinitis is one of the most common chronic diseases of childhood. Recent studies have suggested that having fewer siblings was associated with allergic rhinitis and atopic diseases in children. Previous studies also indicated that older siblings was associated with higher incidence of allergic rhinitis. Objectives To assess for a possible association between number of siblings and allergic rhinitis and to assess for an effect of birth order on allergic rhinitis in children. Methods We performed a cross-sectional study among school children aged 7 to 15 years, in the West Medan District from July to August 2011. Children with moderate or high risk of allergy were included. Subjects were divided into two groups, those with <3 siblings or ≥3 siblings. Children with acute respiratory tract infections, septal deviation, choanal atresia, nasal polyps, nasal tumors, or nasal foreign body were excluded. Risk of allergy was determined using the Indonesian Pediatrics Allergy Immunology Working Group trace card scoring system. Identification of aller-allergic rhinitis and evaluation of its severity were done by use of the International Study of Asthma and Allergies in Childhood (ISAAC core questionnaire. Allergic rhinitis was diagnosed based on history, physical examination, and anterior rhinoscopy. Results A total of 78 subjects were enrolled. Allergic rhinitis was significantly higher in children with <3 siblings than those with ≥3 siblings (OR 10.33; 95%CI 3.569 to 29.916. Furthermore, allergic rhinitis was significantly higher in first-born children than in their younger siblings (P=0.0001. Conclusion Larger number of siblings and non-first-born children are associated with lower incidence of allergic rhinitis in children.

  11. Poor reproducibility of allergic rhinitis SNP associations.

    Directory of Open Access Journals (Sweden)

    Daniel Nilsson

    Full Text Available Replication of reported associations is crucial to the investigation of complex disease. More than 100 SNPs have previously been reported as associated with allergic rhinitis (AR, but few of these have been replicated successfully. To investigate the general reproducibility of reported AR-associations in candidate gene studies, one Swedish (352 AR-cases, 709 controls and one Singapore Chinese population (948 AR-cases, 580 controls were analyzed using 49 AR-associated SNPs. The overall pattern of P-values indicated that very few of the investigated SNPs were associated with AR. Given published odds ratios (ORs most SNPs showed high power to detect an association, but no correlations were found between the ORs of the two study populations or with published ORs. None of the association signals were in common to the two genome-wide association studies published in AR, indicating that the associations represent false positives or have much lower effect-sizes than reported.

  12. Heart Rate Variability Analysis in Patients with Allergic Rhinitis

    Directory of Open Access Journals (Sweden)

    Ming-Ying Lan

    2013-01-01

    Full Text Available Background. Very few studies investigate the role of the autonomic nervous system in allergic rhinitis. In this study, we evaluated the autonomic nervous system in allergic rhinitis patients using heart rate variability (HRV analysis. Methods. Eleven patients with allergic rhinitis and 13 healthy controls, aged between 19 and 40 years old, were enrolled in the study. Diagnosis of allergic rhinitis was based on clinical history, symptoms, and positive Phadiatop test. Electrocardiographic recordings on the sitting and supine positions were obtained for HRV analysis. Results. In the supine position, there were no significant statistical differences in very-low-frequency power (VLF, ≤0.04 Hz, low-frequency power (LF, 0.04–0.15 Hz, high-frequency power (HF, 0.15–0.40 Hz, and the ratio of LF to HF (LF/HF between the patient and control groups. The mean RR intervals significantly increased, while LF% and LF/HF significantly decreased in the patient group in the sitting position. Moreover, mean RR intervals, LF, and LF/HF, which were significantly different between the two positions in the control group, did not show a significant change with the posture change in the patient group. Conclusion. These suggest that patients with allergic rhinitis may have poor sympathetic modulation in the sitting position. Autonomic dysfunction may therefore play a role in the pathophysiology of allergic rhinitis.

  13. Prevalence of Aeroallergens in Allergic Rhinitis in Shiraz

    Directory of Open Access Journals (Sweden)

    Sara Kashef

    2003-12-01

    Full Text Available Allergic rhinitis is an extremely common disease worldwide. Aeroallergens are very often involved in allergic rhinitis and their prevalence may vary in differ¬ent regions. The causative allergens of allergic rhinitis in our area are unknown.The purpose of this study was to determine the prevalence of skin reactivity to different aeroallergens in patients with allergic rhinitis in the city of Shiraz, Iran.A total of 212 patients who were referred to Motahari Allergy Clinic with chronic rhinitis were subjected to skin prick test (SPT with a series of common allergenic extracts including grasses, weeds, trees, house dust mites and moulds.One hundred and thirty two subjects (62.2% had positive SPT to at least one aeroallergen. Male to female ratio was 1.2 and mean age was 18.2 years. The prevalence rates for allergen groups were: pollens (92.4%, mites (22.7% and moulds (8.3%. Among 122 patients reactive to pollens, 92 (75.4% showed skin reactivity to weeds, 78 (63.9% to grasses and 68 (55.7% to trees. Polysensitization was common, with 75.7% of all sensitized patients being posi¬tive to more than one aeroallergen.Pollens are the main sensitizing allergens among patients with allergic rhinitis in Shiraz. This pattern of prevalence was expected based on herbal geography, climate and also found to be compatible with the results from studies carried out in places with the same habitat.

  14. Treatment of 67 Cases of Seasonal Allergic Rhinitis by Acupuncture

    Institute of Scientific and Technical Information of China (English)

    王旭; 张利; 王鹰雷; 黄国琪

    2010-01-01

    @@ Seasonal allergic rhinitis refers to a seasonal and regional allergic disease induced mainly by botanical pollen,also termed "Hay Fever" and "Pollinosis",clinically manifested by the main symptoms of itching sensation in the nose,nasal obstruction,sneezing,watery nasal discharge,conjunctival congestion,itching in the eyes,lacrimation,and asthma developed from an incessant cough in some people,or manifested by the gastrointestinal symptoms of nausea,vomiting,abdominal pain,and diarrhea,and skin eczema,urticaria,pruritus vulvae,vaginitis.The author treated 67 cases of seasonal allergic rhinitis by acupuncture from 2002 to 2004.Now,the result is summarized as follows.

  15. Non-allergic rhinitis in children: Epidemiological aspects, pathological features, diagnostic methodology and clinical management.

    Science.gov (United States)

    Poddighe, Dimitri; Gelardi, Matteo; Licari, Amelia; Del Giudice, Michele Miraglia; Marseglia, Gian Luigi

    2016-12-26

    Chronic rhinitis is a very common disease, as the prevalence in the general population resulted to be 40%. Allergic rhinitis has been considered to be the most frequent form of chronic rhinitis, as non-allergic rhinitis has been estimated to account for 25%. However, several evidences suggested that non-allergic rhinitis have been underrated, especially in children. In pediatrics, the diagnostic definition of non-allergic rhinitis has been often limited to the exclusion of an allergic sensitization. Actually, local allergic rhinitis has been often misdiagnosed as well as mixed rhinitis has not been recognized in most cases. Nasal cytology is a diagnostic procedure being suitable for routine clinical practice with children and could be a very useful tool to characterize and diagnose non-allergic rhinitis, providing important clues for epidemiological analysis and clinical management.

  16. Olfaction in allergic rhinitis: A systematic review.

    Science.gov (United States)

    Stuck, Boris A; Hummel, Thomas

    2015-12-01

    Olfactory dysfunction is a key symptom in patients with allergic rhinitis (AR). Despite the implications for quality of life, relatively few articles have tested olfactory function in their investigations. The current systematic review aimed to investigate the following 2 questions: (1) What does AR do to human olfaction? (2) How effective is the treatment of AR in restoring the sense of smell? A comprehensive literature search was performed, and human studies of any design were included. A total of 420 articles were identified, and 36 articles were considered relevant. Data indicate that the frequency of olfactory dysfunction increases with the duration of the disorder, and most studies report a frequency in the range of 20% to 40%. Although olfactory dysfunction does not appear to be very severe in patients with AR, its presence seems to increase with the severity of the disease. There is very limited evidence that antihistamines improve olfactory function. In addition, there is limited evidence that topical steroids improve the sense of smell, especially in patients with seasonal AR. This is also the case for specific immunotherapy. However, many questions remain unanswered because randomized controlled trials are infrequent and only a few studies rely on quantitative measurement of olfactory function.

  17. Treatment of 82 Cases of Allergic Rhinitis with Aconite Cake-partitioned Moxibustion

    Institute of Scientific and Technical Information of China (English)

    胡志平; 李小军; 黄克伟; 洪珏

    2010-01-01

    @@ Allergic rhinitis is mainly characterized by recurrent sneezing and runny nose.The author has treated 82 cases of allergic rhinitis with aconite cake-partitioned moxibustion and now it is reported as follows.

  18. Treatment of allergic rhinitis is associated with improved attention performance in children: the Allergic Rhinitis Cohort Study for Kids (ARCO-Kids.

    Directory of Open Access Journals (Sweden)

    Dong-Kyu Kim

    Full Text Available BACKGROUND: It has been well known that pediatric allergic rhinitis was associated with poor performance at school due to attention deficit. However, there were no cohort studies for the effect of treatment of allergic rhinitis on attention performance in pediatric population. Thus, the aim of this study was to investigate whether attention performance was improved after treatment in children with allergic rhinitis. METHODS: In this ARCO-Kids (Allergic Rhinitis Cohort Study for Kids, consecutive pediatric patients with rhinitis symptoms underwent a skin prick test and computerized comprehensive attention test. According to the skin prick test results, the children were diagnosed as allergic rhinitis or non- allergic rhinitis. All of the patients were regularly followed up and treated with oral medication or intranasal corticosteroid sprays. The comprehensive attention tests consisted of sustained and divided attention tasks. Each of the tasks was assessed by the attention score which was calculated by the number of omission and commission errors. The comprehension attention test was repeated after 1 year. RESULTS: A total of 797 children with allergic rhinitis and 239 children with non-allergic rhinitis were included. Initially, the attention scores of omission and commission errors on divided attention task were significantly lower in children with allergic rhinitis than in children with non-allergic rhinitis. After 1 year of treatment, children with allergic rhinitis showed improvement in attention: commission error of sustained (95.6±17.0 vs 97.0±16.6 and divided attention task (99.1±15.8 vs 91.8±23.5. Meanwhile, there was no significant difference of attention scores in children with non-allergic rhinitis. CONCLUSIONS: Our study showed that management of allergic rhinitis might be associated with improvement of attention.

  19. Upper and lower airway pathology in young children with allergic- and non-allergic rhinitis

    DEFF Research Database (Denmark)

    Chawes, Bo

    2011-01-01

    Allergic- and non-allergic rhinitis are very common diseases in childhood in industrialized countries. Although these conditions are widely trivialized by both parents and physicians they induce a major impact on quality of life for the affected children and a substantial drainage of health care...... understood and there is a paucity of data objectivizing this association in young children. The aim of this thesis was to describe pathology in the upper and lower airways in young children from the COPSAC birth cohort with investigator-diagnosed allergic- and non-allergic rhinitis. Nasal congestion is a key...... children may contribute to the discovery of new mechanisms involved in pathogenesis and help direct future research to develop correctly timed preventive measures as well as adequate monitoring and treatment of children with rhinitis. Asthma is a common comorbidity in subjects with allergic rhinitis...

  20. MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis) : the new generation guideline implementation

    OpenAIRE

    Bousquet, J.; Schunemann, H J; Fonseca, J.; B. Samolinski; Bachert, C; Canonica, G. W.; Casale, T; Cruz, A A; P. Demoly; Hellings, P; Valiulis, A.; Wickman, M.; Zuberbier, T.; Bosnic-Anticevitch, S; Bedbrook, A.

    2015-01-01

    Several unmet needs have been identified in allergic rhinitis: identification of the time of onset of the pollen season, optimal control of rhinitis and comorbidities, patient stratification, multidisciplinary team for integrated care pathways, innovation in clinical trials and, above all, patient empowerment. MASK-rhinitis (MACVIA-ARIA Sentinel NetworK for allergic rhinitis) is a simple system centred around the patient which was devised to fill many of these gaps using Information and Commu...

  1. House dust mite induced allergic rhinitis in children in primary care : Epidemiology and Management

    NARCIS (Netherlands)

    C.M.A. de Bot (Cindy)

    2012-01-01

    textabstractAllergic rhinitis (AR) is an allergen-induced, upper-airway inflammatory disease. The characteristic symptoms of allergic rhinitis are a runny nose, sneezing, congestion, redness of the eyes, watering eyes, and itching of the eyes, nose and throat. Previously, allergic rhinitis was subdi

  2. Clinical Experience in Acupuncture Treatment of Allergic Rhinitis

    Institute of Scientific and Technical Information of China (English)

    ZHANG Yan-qiu

    2009-01-01

    Objective:To observe the clinical effects of acupuncture for allergic rhinitis.Methods:The body acupuncture, auricular seed-embedding and microwave irradiation were adopted for treatment of allergic rhinitis due to various causative factors, such as cold and insufficiency of the lung-qi weakening the body resistance, insufficiency of the spleen-qi with lucid yang failing to rise, insufficiency of the kidney-yang failing to warm the body surface, and the heat accumulated in the lung channels giving invading the nose.Results:After treatment, the symptoms and signs disappeared in all illustrative cases, with no recurrence found after a one-year follow-up.Conclusion:Acupuncture may help to improve the blood rheology indexes with an increased volume of blood flow, and regulate the immunological function of the human body, thus giving therapeutic effects for allergic rhinitis.

  3. [Therapy of allergic rhinitis: the preferences of specialists].

    Science.gov (United States)

    Danilova, K V; Razdorskaia, I M

    2014-01-01

    The objective of the present work was to study the stereotypes of addressing such a serious medical problem as the treatment of allergic rhinitis by practicing physicians and the development of criteria for the priority choice of pharmaceutical products to be prescribed to the patients presenting with this pathology. This pharmacoepidemiological investigation was designed to elucidate the preferences shown by specialists dealing with this disease. The special questionnaire was developed to collect and analyse the opinions of otorhinolaryngologists and allergologists. The study has demonstrated that both therapy of allergic rhinitis and preferences of specialists conform with the respective international standards. However, the study revealed the lack of the adequate communicative and informational interactions between two basic components of the healthcare system, viz. doctors and pharmacists. The authors emphasize the necessity to optimize professional approaches to the management of allergic rhinitis.

  4. Association between allergic rhinitis and migraine

    Directory of Open Access Journals (Sweden)

    Alia Saberi

    2012-01-01

    Full Text Available Background: Migraine and allergic rhinitis (AR are two common causes of headache and facial pain that inflammatory mediators with vasoactive function play important roles in both of them. The aim of this research was to determine the prevalence of migraine in AR patients. Materials and Methods: In a cross-sectional comparative study performed from June to December 2010 in patients with AR sign and symptoms referred to ear, nose, throat (ENT clinic of a university hospital in Iran-Rasht, 46 patients with positive skin prick test were compared with 60 subject without AR signs and symptoms and with negative skin test. In both the groups, history of migraine according to IHS (International Headache Society criteria were investigated. Analysis of data was performed by chi-sqaure and Fisher exact test by using SPSS16. Odds ratio were estimated for determining the chance of migraine in AR. Results: In case group (14 male, 37 female; mean age: 31.17 ± 8.31 years and control group (23 male, 32 female; mean age: 37.58 ± 12.63 years, the prevalence of migraine was 37% and 5%, respectively. The differences in prevalence of migraine and migraine without aura between cases and controls were significant (P = 0.001. The chance of migraine in AR was 8.227 folds (95% CI: 2.38-28.42. In subjects older than 40 years old, the difference of prevalence of migraine was significant, contrary to subjects younger than 30 years old and between 30 and 39 years old. Conclusions: There is a correlation between migraine especially without aura and AR and this correlation is more powerful with increasing age.

  5. Frequency of Mold Allergens in Allergic Rhinitis Patients

    Directory of Open Access Journals (Sweden)

    Bonyadi, MR. (PhD

    2014-06-01

    Full Text Available Background and Objective: Allergic rhinitis can be stimulated by several allergens. Molds are among these allergens and it is important to assess their frequency in different geographic area. Hence, we aimed at determining the frequency of mold allergens in allergic rhinitis patients referred to specialized clinics of Tabriz Imam Reza hospital, 2011. Material and Methods: This cross-sectional study was conducted on the serums of 90 rhinitis patients diagnosed by specialized physician. Using Immunoblotting method, the level of specific IgE against four molds including Penicillium, Aspergillus, Alternaria and Cladosporium were investigated. Results: Of 90 Patients, 40 were men (44.4% and 50 were women (55.6%. The participants were between 6 to 53 years and the most were 28-31years. The allergy was related to Penicillium (3.3%, Aspergillus (5.6%, Alternaria (13.3% and Cladosporium (4.4%. There was a significant statistical relation between age and allergic rhinitis to Alternaria (P=0.011. Conclusion: Molds can grow and proliferate in very humid environments. Because of low humidity climate in Tabriz (in the northwest of Iran, allergy to molds is relatively low in this region. Key words: Rhinitis Allergic; Mold; Allergy

  6. From IgE to clinical trials of allergic rhinitis.

    Science.gov (United States)

    Ciprandi, Giorgio; Marseglia, Gian Luigi; Castagnoli, Riccardo; Valsecchi, Chiara; Tagliacarne, Carlotta; Caimmi, Silvia; Licari, Amelia

    2015-01-01

    The current scientific research is continuously aiming at identifying new therapeutic targets with the purpose of modifying the immune response to allergens. The evolution in immunological methods has led to the identification of immunoglobulin E (IgE) as both a diagnostic biomarker and potential therapeutic target in allergic diseases, such as allergic rhinitis. Allergen immunotherapy has been used for more than 100 years to treat allergic diseases and it is today considered the only disease-modifying treatment capable of inducing a long-lasting immunological and clinical tolerance toward the causal allergen. During the past 20 years, major advances have been made in understanding the molecular and cellular mechanisms of allergen tolerance in humans. Moreover, there has been considerable progress in allergen extract modifications and additions to standard extracts. The recognition that IgE plays a pivotal role in basic regulatory mechanisms of allergic inflammation has recently stimulated research into the therapeutic potential of directly targeting this antibody. Omalizumab, the most advanced humanized anti-IgE monoclonal antibody, is currently approved for the treatment of uncontrolled allergic asthma and chronic spontaneous urticaria. Interesting results also arise from studies in which omalizumab was administered in patients with allergic rhinitis. The aim of this review is to provide an update on current findings on immunological and clinical effects of allergen immunotherapy and anti-IgE therapy, which have been shown to have synergistic modes of action for the treatment of allergic rhinitis.

  7. Allergic Sensitization, Rhinitis and Tobacco Smoke Exposure in US Adults.

    Directory of Open Access Journals (Sweden)

    Josef Shargorodsky

    Full Text Available Tobacco exposure has been linked with sinonasal pathology and may be associated with allergic sensitization. This study evaluates the association between exposure to active smoking or secondhand smoke (SHS and the prevalence of rhinitis and allergic sensitization in the US adult population.Cross-sectional study in 4,339 adults aged 20-85 in the National Health and Nutrition Examination Survey, 2005-2006. Never smoking was defined as reported lifetime smoking less than 100 cigarettes and serum cotinine levels 10 ng/mL. Self-reported rhinitis was based on symptoms during the past 12 months, and allergen sensitization was defined as a positive response to any of the 19 specific IgE antigens tested.Almost half of the population (43% had detectable levels of IgE specific to at least one inhaled allergen and 32% reported a history of rhinitis. After multivariate adjustment, there was a statistically significant association between the highest serum cotinine tertile and rhinitis in active smokers (OR 1.42; 95%CI 1.00-2.00. The association between active smoking and rhinitis was stronger in individuals without allergic sensitization (OR 2.47; 95%CI 1.44-4.23. There was a statistically significant association between increasing cotinine tertiles and decreased odds of inhaled allergen sensitization (p-trend <.01.Tobacco smoke exposure was associated with increased prevalence of rhinitis symptoms, but not with allergic sensitization. The results indicate that the relationship between tobacco smoke exposure and sinonasal pathology in adults may be independent of allergic sensitization.

  8. Disturbed sleep: linking allergic rhinitis, mood and suicidal behavior.

    Science.gov (United States)

    Fang, Beverly J; Tonelli, Leonardo H; Soriano, Joseph J; Postolache, Teodor T

    2010-01-01

    Allergic inflammation is associated with mood disorders, exacerbation of depression, and suicidal behavior. Mediators of inflammation modulate sleep , with Th1 cytokines promoting NREM sleep and increasing sleepiness and Th2 cytokines (produced during allergic inflammation) impairing sleep. As sleep impairment is a rapidly modifiable suicide risk factor strongly associated with mood disorders, we review the literature leading to the hypothesis that allergic rhinitis leads to mood and anxiety disorders and an increased risk of suicide via sleep impairment. Specifically, allergic rhinitis can impair sleep through mechanical (obstructive) and molecular (cytokine production) processes. The high prevalence of mood and anxiety disorders and allergy, the nonabating suicide incidence, the currently available treatment modalities to treat sleep impairment and the need for novel therapeutic targets for mood and anxiety disorders, justify multilevel efforts to explore disturbance of sleep as a pathophysiological link.

  9. The Prevalence of Allergic Rhinitis in Patients with Chronic Rhinosinusitis

    Directory of Open Access Journals (Sweden)

    Mehdi Bakhshaee

    2014-10-01

    Full Text Available Introduction: Chronic rhinosinusitis (CRS is a multifactorial disease. Allergies are considered a predisposing factor to CRS; however, this remains controversial. The objective of this research was to investigate the prevalence of co-morbidities and allergic reaction, and to specify the most common allergens in patients with confirmed CRS.   Materials and Methods: One hundred patients with signs and symptoms of CRS who met the diagnostic endoscopic and radiologic criteria of chronic rhinosinusitis were selected. They filled out a questionnaire and underwent a skin prick test for the common inhalant allergens. Allergic rhinitis was diagnosed according to the history and positive skin prick tests.   Results: The mean age of patients was 34. Males were slightly more involved (54%. The prevalence of polypoid and none-polypoid rhinosinusitis was 54% and 46% respectively. The patients’ most common symptoms were nasal discharge (95%, blockage (94%, smell disorders (63%, cough (45%, halitosis (41%, lethargy (37%, and aural fullness (36%. Allergy to at least one allergen was noted in 64% of the CRS patients which is higher than general population in Mashhad, Iran with allergic rhinitis (22.4%. Salsola was the most common allergen. There was no significant difference in allergic reactions between polypoid and non-polypoid CRS patients.   Conclusion:  Allergic reactions was found in Iranian CRS patients with or without polyposis to be much higher than general population in Mashhad with allergic rhinitis alone.

  10. Observation on Therapeutic Effects of Cupping Therapy for Allergic Rhinitis

    Institute of Scientific and Technical Information of China (English)

    许荣正; 朱雪兰; 吴国民; 黄国琪

    2010-01-01

    @@ Allergic rhinitis is mainly characterized by the symptoms of sneezing,tickling sensation in the nose,runny nose,and nasal obstruction,and often occurs after invasion of pathogenic wind and cold.The author has treated 50 cases of this disease by applying cupping therapy on Shenque (CV 8).Now,the report is given as follows.

  11. Advances in pharmacotherapy for the treatment of allergic rhinitis

    DEFF Research Database (Denmark)

    Bousquet, Jean; Bachert, Claus; Bernstein, Jonathan;

    2015-01-01

    INTRODUCTION: Effective pharmacologic treatment exists for most patients suffering from allergic rhinitis (AR). However, both in clinical trials and in real-life studies, many patients are dissatisfied with treatment. Physicians often use multiple therapies, in an attempt to improve symptom contr...

  12. Relation between air pollution and allergic rhinitis in Taiwanese schoolchildren

    Directory of Open Access Journals (Sweden)

    Lee Yung-Ling

    2006-02-01

    Full Text Available Abstract Background Recent findings suggest that exposure to outdoor air pollutants may increase the risk of allergic rhinitis. The results of these studies are inconsistent, but warrant further attention. The objective of the study was to assess the effect of relation between exposure to urban air pollution and the prevalence allergic rhinitis among school children. Methods We conducted a nationwide cross-sectional study of 32,143 Taiwanese school children. We obtained routine air-pollution monitoring data for sulphur dioxide (SO2, nitrogen oxides (NOx, ozone (O3, carbon monoxide (CO, and particles with an aerodynamic diameter of 10 μm or less (PM10. A parent-administered questionnaire provided information on individual characteristics and indoor environments (response rate 92%. Municipal-level exposure was calculated using the mean of the 2000 monthly averages. The effect estimates were presented as odds ratios (ORs per 10 ppb change for SO2, NOx, and O3, 100 ppb change for CO, and 10 μg/m3 change for PM10. Results In two-stage hierarchical model adjusting for confounding, the prevalence of allergic rhinitis was significantly associated with SO2 (adjusted odds ratio (OR = 1.43, 95% confidence interval (CI: 1.25, 1.64, CO (aOR = 1.05, 95% CI: 1.04, 1.07, and NOx (aOR = 1.11, 95% CI: 1.08, 1.15. Contrary to our hypothesis, the prevalence of allergic rhinitis was weakly or not related to O3 (aOR = 1.05, 95% CI: 0.98, 1.12 and PM10 (aOR = 1.00, 95% CI: 0.99, 1.02. Conclusion Persistent exposure to NOx, CO, and SO2 may increase the prevalence of allergic rhinitis in children.

  13. Allergic Rhinitis and its Impact on Asthma (ARIA) : Achievements in 10 years and future needs

    NARCIS (Netherlands)

    Bousquet, J.; Schuenemann, H. J.; Samolinski, B.; Demoly, P.; Baena-Cagnani, C. E.; Bachert, C.; Bonini, S.; Boulet, L. P.; Bousquet, P. J.; Brozek, J. L.; Canonica, G. W.; Casale, T. B.; Cruz, A. A.; Fokkens, W. J.; Fonseca, J. A.; van Wijk, R. Gerth; Grouse, L.; Haahtela, T.; Khaltaev, N.; Kuna, P.; Lockey, R. F.; Carlsen, K. C. Lodrup; Mullol, J.; Naclerio, R.; O'Hehir, R. E.; Ohta, K.; Palkonen, S.; Papadopoulos, N. G.; Passalacqua, G.; Pawankar, R.; Price, D.; Ryan, D.; Simons, F. E. R.; Togias, A.; Williams, D.; Yorgancioglu, A.; Yusuf, O. M.; Aberer, W.; Adachi, M.; Agache, I.; Ait-Khaled, N.; Akdis, C. A.; Andrianarisoa, A.; Annesi-Maesano, I.; Ansotegui, I. J.; Baiardini, I.; Bateman, E. D.; Bedbrook, A.; Beghe, B.; Beji, M.; Bel, E. H.; Ben Kheder, A.; Bennoor, K. S.; Bergmann, K. C.; Berrissoul, F.; Bieber, T.; Jensen, C. Bindslev; Blaiss, M. S.; Boner, A. L.; Bouchard, J.; Braido, F.; Brightling, C. E.; Bush, A.; Caballero, F.; Calderon, M. A.; Calvo, M. A.; Camargos, P. A. M.; Caraballo, L. R.; Carlsen, K. H.; Carr, W.; Cepeda, A. M.; Cesario, A.; Chavannes, N. H.; Chen, Y. Z.; Chiriac, A. M.; Chivato Perez, T.; Chkhartishvili, E.; Ciprandi, G.; Costa, D. J.; Cox, L.; Custovic, A.; Dahl, R.; Darsow, U.; De Blay, F.; Deleanu, D.; Denburg, J. A.; Devillier, P.; Didi, T.; Dokic, D.; Dolen, W. K.; Douagui, H.; Dubakiene, R.; Durham, S. R.; Dykewicz, M. S.; El-Gamal, Y.; El-Meziane, A.; Emuzyte, R.; Fiocchi, A.; Fletcher, M.; Fukuda, T.; Gamkrelidze, A.; Gereda, J. E.; Gonzalez Diaz, S.; Gotua, M.; Guzman, M. A.; Hellings, P. W.; Hellquist-Dahl, B.; Horak, F.; Hourihane, J. O'B.; Howarth, P.; Humbert, M.; Ivancevich, J. C.; Jackson, C.; Just, J.; Kalayci, O.; Kaliner, M. A.; Kalyoncu, A. F.; Keil, T.; Keith, P. K.; Khayat, G.; Kim, Y. Y.; N'Goran, B. Koffi; Koppelman, G. H.; Kowalski, M. L.; Kull, I.; Kvedariene, V.; Larenas-Linnemann, D.; Le, L. T.; Lemiere, C.; Li, J.; Lieberman, P.; Lipworth, B.; Mahboub, B.; Makela, M. J.; Martin, F.; Marshall, G. D.; Martinez, F. D.; Masjedi, M. R.; Maurer, M.; Mavale-Manuel, S.; Mazon, A.; Melen, E.; Meltzer, E. O.; Mendez, N. H.; Merk, H.; Mihaltan, F.; Mohammad, Y.; Morais-Almeida, M.; Muraro, A.; Nafti, S.; Namazova-Baranova, L.; Nekam, K.; Neou, A.; Niggemann, B.; Nizankowska-Mogilnicka, E.; Nyembue, T. D.; Okamoto, Y.; Okubo, K.; Orru, M. P.; Ouedraogo, S.; Ozdemir, C.; Panzner, P.; Pali-Schoell, I.; Park, H. S.; Pigearias, B.; Pohl, W.; Popov, T. A.; Postma, D. S.; Potter, P.; Rabe, K. F.; Ratomaharo, J.; Reitamo, S.; Ring, J.; Roberts, R.; Rogala, B.; Romano, A.; Rodriguez, M. Roman; Rosado-Pinto, J.; Rosenwasser, L.; Rottem, M.; Sanchez-Borges, M.; Scadding, G. K.; Schmid-Grendelmeier, P.; Sheikh, A.; Sisul, J. C.; Sole, D.; Sooronbaev, T.; Spicak, V.; Spranger, O.; Stein, R. T.; Stoloff, S. W.; Sunyer, J.; Szczeklik, A.; Todo-Bom, A.; Toskala, E.; Tremblay, Y.; Valenta, R.; Valero, A. L.; Valeyre, D.; Valiulis, A.; Valovirta, E.; Van Cauwenberge, P.; Vandenplas, O.; van weel, C.; Vichyanond, P.; Viegi, G.; Wang, D. Y.; Wickman, M.; Woehrl, S.; Wright, J.; Yawn, B. P.; Yiallouros, P. K.; Zar, H. J.; Zernotti, M. E.; Zhong, N.; Zidarn, M.; Zuberbier, T.

    2012-01-01

    Allergic rhinitis (AR) and asthma represent global health problems for all age groups. Asthma and rhinitis frequently coexist in the same subjects. Allergic Rhinitis and its Impact on Asthma (ARIA) was initiated during a World Health Organization workshop in 1999 (published in 2001). ARIA has reclas

  14. Allergic Rhinitis and its Impact on Asthma (ARIA): Achievements in 10 years and future needs

    NARCIS (Netherlands)

    Bousquet, J.; Schunemann, H.J.; Samolinski, B.; Demoly, P.; Baena-Cagnani, C.E.; Bachert, C.; Bonini, S.; Boulet, L.P.; Bousquet, P.J.; Brozek, J.L.; Canonica, G.W.; Casale, T.B.; Cruz, A.A.; Fokkens, W.J.; Fonseca, J.A.; Wijk, R.G. van; Grouse, L.; Haahtela, T.; Khaltaev, N.; Kuna, P.; Lockey, R.F.; Lodrup Carlsen, K.C.; Mullol, J.; Naclerio, R.; O'Hehir, R.E.; Ohta, K.; Palkonen, S.; Papadopoulos, N.G.; Passalacqua, G.; Pawankar, R.; Price, D.; Ryan, D.; Simons, F.E.; Togias, A.; Williams, D.; Yorgancioglu, A.; Yusuf, O.M.; Aberer, W.; Adachi, M.; Agache, I.; Ait-Khaled, N.; Akdis, C.A.; Andrianarisoa, A.; Annesi-Maesano, I.; Ansotegui, I.J.; Baiardini, I.; Bateman, E.D.; Bedbrook, A.; Beghe, B.; Beji, M.; Bel, E.H.; Ben Kheder, A.; Bennoor, K.S.; Bergmann, K.C.; Berrissoul, F.; Bieber, T.; Bindslev Jensen, C.; Blaiss, M.S.; Boner, A.L.; Bouchard, J.; Braido, F.; Brightling, C.E.; Bush, A.; Caballero, F.; Calderon, M.A.; Calvo, M.A.; Camargos, P.A.; Caraballo, L.R.; Carlsen, K.H.; Carr, W.; Cepeda, A.M.; Cesario, A.; Chavannes, N.H.; Chen, Y.Z.; Chiriac, A.M.; Chivato Perez, T.; Chkhartishvili, E.; Ciprandi, G.; Costa, D.J.; Cox, L.; Custovic, A.; Dahl, R.; Darsow, U.; Blay, F. de; Deleanu, D.; Denburg, J.A.; Devillier, P.; Didi, T.; Dokic, D.; Dolen, W.K.; Douagui, H.; Dubakiene, R.; Durham, S.R.; Dykewicz, M.S.; El-Gamal, Y.; El-Meziane, A.; Emuzyte, R.; Fiocchi, A.; Fletcher, M.; Fukuda, T.; Weel, C. van

    2012-01-01

    Allergic rhinitis (AR) and asthma represent global health problems for all age groups. Asthma and rhinitis frequently coexist in the same subjects. Allergic Rhinitis and its Impact on Asthma (ARIA) was initiated during a World Health Organization workshop in 1999 (published in 2001). ARIA has reclas

  15. Role of Predatory Mites in Persistent Nonoccupational Allergic Rhinitis

    Science.gov (United States)

    Poza Guedes, Paloma; Sánchez Machín, Inmaculada; Matheu, Víctor; Iraola, Víctor

    2016-01-01

    Mites can sensitize and induce atopic disease in predisposed individuals and are an important deteriorating factor in patients with allergic rhinitis, asthma, and atopic dermatitis. Although Pyroglyphidae mites have been extensively studied, very scarce reports are available on Cheyletidae spp. especially regarding human respiratory pathology. The main objective of the present study is to investigate the clinical role of this predator mite (Cheyletus eruditus) as a respiratory antigen in a selected sensitized human population. Fifty-two adult patients were recruited from the outpatient allergy clinic to assess their eligibility for the study. The thirty-seven subjects with persistent allergic rhinitis (PAR) who fulfilled the ARIA criteria had a positive IgE response confirmed by skin prick test (SPT) to C. eruditus. Only those individuals (37/47) with a positive SPT to C. eruditus showed a positive nasal provocation test (NPT), while 10 patients with nonallergic mild-to-moderate persistent rhinitis, control group, had a negative NPT with C. eruditus. The present paper describes a new role for the predator mite Cheyletus eruditus as a respiratory allergen in a selected subset of patients in a subtropical environment afflicted with persistent nonoccupational allergic rhinitis. PMID:27445552

  16. Role of Predatory Mites in Persistent Nonoccupational Allergic Rhinitis

    Directory of Open Access Journals (Sweden)

    Paloma Poza Guedes

    2016-01-01

    Full Text Available Mites can sensitize and induce atopic disease in predisposed individuals and are an important deteriorating factor in patients with allergic rhinitis, asthma, and atopic dermatitis. Although Pyroglyphidae mites have been extensively studied, very scarce reports are available on Cheyletidae spp. especially regarding human respiratory pathology. The main objective of the present study is to investigate the clinical role of this predator mite (Cheyletus eruditus as a respiratory antigen in a selected sensitized human population. Fifty-two adult patients were recruited from the outpatient allergy clinic to assess their eligibility for the study. The thirty-seven subjects with persistent allergic rhinitis (PAR who fulfilled the ARIA criteria had a positive IgE response confirmed by skin prick test (SPT to C. eruditus. Only those individuals (37/47 with a positive SPT to C. eruditus showed a positive nasal provocation test (NPT, while 10 patients with nonallergic mild-to-moderate persistent rhinitis, control group, had a negative NPT with C. eruditus. The present paper describes a new role for the predator mite Cheyletus eruditus as a respiratory allergen in a selected subset of patients in a subtropical environment afflicted with persistent nonoccupational allergic rhinitis.

  17. Local Nasal Specific Immunotherapy for Allergic Rhinitis

    Directory of Open Access Journals (Sweden)

    Passalacqua Giovanni

    2006-09-01

    Full Text Available Abstract The possibility of producing local hyposensitization by administering allergens via mucosal routes was envisaged at the beginning of 1900, and local nasal immunotherapy has been extensively studied since the 1970s. Presently, there are 21 randomized controlled trials being conducted with the most common allergens, consistently showing the clinical efficacy of local nasal immunotherapy for rhinitis. Other advantages are that it has an optimal safety profile and can be self-administered at home by the patient. Moreover, there are several data from animal models and from humans that confirm the immunomodulatory effect of intranasally administered antigens. On the other hand, local nasal immunotherapy seems to be effective only on rhinitis symptoms and requires a particular technique of administration. For these reasons, its clinical use is progressively declining in favour of the sublingual route although nasal immunotherapy is validated in official documents and remains a viable alternative to injection.

  18. Sleep disturbances in allergic rhinitis: disease and/or the drug?

    OpenAIRE

    Anant D. Patil

    2013-01-01

    Allergic rhinitis is a common chronic disease in adults as well as children. Allergic rhinitis has negative impact on sleep and quality of life of the patient. Antihistamines are widely used in the management of allergic rhinitis. First generation antihistamines cause sedation and drowsiness. Second generation antihistamines cause minimal or no sedation. There is difference in propensity to cause sedation amongst second generation antihistamines. As sleep is important for physical as well as ...

  19. Subcutaneous Immunotherapy Improves the Symptomatology of Allergic Rhinitis

    Directory of Open Access Journals (Sweden)

    Lourenço, Edmir Américo

    2015-10-01

    Full Text Available Introduction The relevance of allergic rhinitis is unquestionable. This condition affects people's quality of life and its incidence has increased over the last years. Objective Thus, this study aims to analyze the effectiveness of subcutaneous injectable immunotherapy in cases of nasal itching, sneeze, rhinorrhea and nasal congestion in allergic rhinitis patients. Methods In the present study, the same researcher analyzed the records of 281 patients. Furthermore, the researchers identified allergens through puncture cutaneous tests using standardized extracts containing acari, fungi, pet hair, flower pollen, and feathers. Then, the patients underwent treatment with subcutaneous specific immunotherapy, using four vaccine vials for desensitization, associated with environmental hygiene. The authors analyzed conditions of nasal itching, sneeze, rhinorrhea, and nasal congestion throughout the treatment, and assigned them with a score ranging from zero (0, meaning absence of these symptoms to three (3, for severe cases. The symptoms were statistically compared in the beginning, during, and after treatment. Results In this study, authors analyzed the cases distribution according to age and the evolution of symptomatology according to the scores, comparing all phases of treatment. The average score for the entire population studied was 2.08 before treatment and 0.44 at the end. These results represent an overall improvement of ∼79% in symptomatology of allergic rhinitis in the studied population. Conclusion The subcutaneous immunotherapy as treatment of allergic rhinitis led to a reduction in all symptoms studied, improving the quality of life of patients, proving itself as an important therapeutic tool for these pathological conditions.

  20. Sleep disturbances in allergic rhinitis: disease and/or the drug?

    Directory of Open Access Journals (Sweden)

    Anant D. Patil

    2013-12-01

    Full Text Available Allergic rhinitis is a common chronic disease in adults as well as children. Allergic rhinitis has negative impact on sleep and quality of life of the patient. Antihistamines are widely used in the management of allergic rhinitis. First generation antihistamines cause sedation and drowsiness. Second generation antihistamines cause minimal or no sedation. There is difference in propensity to cause sedation amongst second generation antihistamines. As sleep is important for physical as well as mental health, present article reviews impact of allergic rhinitis and antihistamines on sleep. [Int J Basic Clin Pharmacol 2013; 2(6.000: 668-670

  1. Trichuris suis ova therapy for allergic rhinitis

    DEFF Research Database (Denmark)

    Bager, Peter; Arnved, John; Rønborg, Steen;

    2010-01-01

    Parasitic helminth infections can protect against allergic airway inflammation in experimental models and have been associated with a reduced risk of atopy and a reduced course of asthma in some observational studies. Although no clinical evidence exists to support the use of helminth therapy...

  2. MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis)

    DEFF Research Database (Denmark)

    Bousquet, J; Schunemann, H J; Fonseca, J;

    2015-01-01

    -based daily visual analogue scale (VAS) assessment of disease control, CARAT (Control of Allergic Rhinitis and Asthma Test) and e-Allergy screening (premedical system of early diagnosis of allergy and asthma based on online tools). These tools are combined with a clinical decision support system (CDSS......) and are available in many languages. An e-CRF and an e-learning tool complete MASK. MASK is flexible and other tools can be added. It appears to be an advanced, global and integrated ICT answer for many unmet needs in allergic diseases which will improve policies and standards....

  3. MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis) : the new generation guideline implementation

    NARCIS (Netherlands)

    Bousquet, J.; Schunemann, H. J.; Fonseca, J.; Samolinski, B.; Bachert, C.; Canonica, G. W.; Casale, T.; Cruz, A. A.; Demoly, P.; Hellings, P.; Valiulis, A.; Wickman, M.; Zuberbier, T.; Bosnic-Anticevitch, S.; Bedbrook, A.; Bergmann, K. C.; Caimmi, D.; Dahl, R.; Fokkens, W. J.; Grisle, I.; Lodrup Carlsen, K.; Mullol, J.; Muraro, A.; Palkonen, S.; Papadopoulos, N.; Passalacqua, G.; Ryan, D.; Valovirta, E.; Yorgancioglu, A.; Aberer, W.; Agache, I.; Adachi, M.; Akdis, C. A.; Akdis, M.; Annesi-Maesano, I.; Ansotegui, I. J.; Anto, J. M.; Arnavielhe, S.; Arshad, H.; Baiardini, I.; Baigenzhin, A. K.; Barbara, C.; Bateman, E. D.; Beghe, B.; Bel, E. H.; Ben Kheder, A.; Bennoor, K. S.; Benson, M.; Bewick, M.; Bieber, T.; Bindslev-Jensen, C.; Bjermer, L.; Blain, H.; Boner, A. L.; Boulet, L. P.; Bonini, M.; Bonini, S.; Bosse, I.; Bourret, R.; Bousquet, P. J.; Braido, F.; Briggs, A. H.; Brightling, C. E.; Brozek, J.; Buhl, R.; Burney, P. G.; Bush, A.; Caballero-Fonseca, F.; Calderon, M. A.; Camargos, P. A. M.; Camuzat, T.; Carlsen, K. H.; Carr, W.; Sarabia, A. M. Cepeda; Chavannes, N. H.; Chatzi, L.; Chen, Y. Z.; Chiron, R.; Chkhartishvili, E.; Chuchalin, A. G.; Ciprandi, G.; Cirule, I.; Correia de Sousa, J.; Cox, L.; Crooks, G.; Costa, D. J.; Custovic, A.; Dahlen, S. E.; Darsow, U.; De Carlo, G.; De Blay, F.; Dedeu, T.; Deleanu, D.; Denburg, J. A.; Devillier, P.; Didier, A.; Dinh-Xuan, A. T.; Dokic, D.; Douagui, H.; Dray, G.; Dubakiene, R.; Durham, S. R.; Dykewicz, M. S.; El-Gamal, Y.; Emuzyte, R.; Wagner, A. Fink; Fletcher, M.; Fiocchi, A.; Forastiere, F.; Gamkrelidze, A.; Gemicioglu, B.; Gereda, J. E.; Gonzalez Diaz, S.; Gotua, M.; Grouse, L.; Guzman, M. A.; Haahtela, T.; Hellquist-Dahl, B.; Heinrich, J.; Horak, F.; Hourihane, J. O. B.; Howarth, P.; Humbert, M.; Hyland, M. E.; Ivancevich, J. C.; Jares, E. J.; Johnston, S. L.; Joos, G.; Jonquet, O.; Jung, K. S.; Just, J.; Kaidashev, I.; Kalayci, O.; Kalyoncu, A. F.; Keil, T.; Keith, P. K.; Khaltaev, N.; Klimek, L.; N'Goran, B. Koffi; Kolek, V.; Koppelman, G. H.; Kowalski, M. L.; Kull, I.; Kuna, P.; Kvedariene, V.; Lambrecht, B.; Lau, S.; Larenas-Linnemann, D.; Laune, D.; Le, L. T. T.; Lieberman, P.; Lipworth, B.; Li, J.; Louis, R.; Magard, Y.; Magnan, A.; Mahboub, B.; Majer, I.; Makela, M. J.; Manning, P.; De Manuel Keenoy, E.; Marshall, G. D.; Masjedi, M. R.; Maurer, M.; Mavale-Manuel, S.; Melen, E.; Melo-Gomes, E.; Meltzer, E. O.; Merk, H.; Miculinic, N.; Mihaltan, F.; Milenkovic, B.; Mohammad, Y.; Molimard, M.; Momas, I.; Montilla-Santana, A.; Morais-Almeida, M.; Moesges, R.; Namazova-Baranova, L.; Naclerio, R.; Neou, A.; Neffen, H.; Nekam, K.; Niggemann, B.; Nyembue, T. D.; O'Hehir, R. E.; Ohta, K.; Okamoto, Y.; Okubo, K.; Ouedraogo, S.; Paggiaro, P.; Pali-Schoell, I.; Palmer, S.; Panzner, P.; Papi, A.; Park, H. S.; Pavord, I.; Pawankar, R.; Pfaar, O.; Picard, R.; Pigearias, B.; Pin, I.; Plavec, D.; Pohl, W.; Popov, T. A.; Portejoie, F.; Postma, D.; Potter, P.; Price, D.; Rabe, K. F.; Raciborski, F.; Pontal, F. Radier; Repka-Ramirez, S.; Robalo-Cordeiro, C.; Rolland, C.; Rosado-Pinto, J.; Reitamo, S.; Rodenas, F.; Roman Rodriguez, M.; Romano, A.; Rosario, N.; Rosenwasser, L.; Rottem, M.; Sanchez-Borges, M.; Scadding, G. K.; Serrano, E.; Schmid-Grendelmeier, P.; Sheikh, A.; Simons, F. E. R.; Sisul, J. C.; Skrindo, I.; Smit, H. A.; Sole, D.; Sooronbaev, T.; Spranger, O.; Stelmach, R.; Strandberg, T.; Sunyer, J.; Thijs, C.; Todo-Bom, A.; Triggiani, M.; Valenta, R.; Valero, A. L.; van Hage, M.; Vandenplas, O.; Vezzani, G.; Vichyanond, P.; Viegi, G.; Wagenmann, M.; Walker, S.; Wang, D. Y.; Wahn, U.; Williams, D. M.; Wright, J.; Yawn, B. P.; Yiallouros, P. K.; Yusuf, O. M.; Zar, H. J.; Zernotti, M. E.; Zhang, L.; Zhong, N.; Zidarn, M.; Mercier, J.

    2015-01-01

    Several unmet needs have been identified in allergic rhinitis: identification of the time of onset of the pollen season, optimal control of rhinitis and comorbidities, patient stratification, multidisciplinary team for integrated care pathways, innovation in clinical trials and, above all, patient e

  4. The impact of allergic rhinitis and asthma on human nasal and bronchial epithelial gene expression.

    Directory of Open Access Journals (Sweden)

    Ariane H Wagener

    Full Text Available BACKGROUND: The link between upper and lower airways in patients with both asthma and allergic rhinitis is still poorly understood. As the biological complexity of these disorders can be captured by gene expression profiling we hypothesized that the clinical expression of rhinitis and/or asthma is related to differential gene expression between upper and lower airways epithelium. OBJECTIVE: Defining gene expression profiles of primary nasal and bronchial epithelial cells from the same individuals and examining the impact of allergic rhinitis with and without concomitant allergic asthma on expression profiles. METHODS: This cross-sectional study included 18 subjects (6 allergic asthma and allergic rhinitis; 6 allergic rhinitis; 6 healthy controls. The estimated false discovery rate comparing 6 subjects per group was approximately 5%. RNA was extracted from isolated and cultured epithelial cells from bronchial brushings and nasal biopsies, and analyzed by microarray (Affymetrix U133+ PM Genechip Array. Data were analysed using R and Bioconductor Limma package. For gene ontology GeneSpring GX12 was used. RESULTS: The study was successfully completed by 17 subjects (6 allergic asthma and allergic rhinitis; 5 allergic rhinitis; 6 healthy controls. Using correction for multiple testing, 1988 genes were differentially expressed between healthy lower and upper airway epithelium, whereas in allergic rhinitis with or without asthma this was only 40 and 301 genes, respectively. Genes influenced by allergic rhinitis with or without asthma were linked to lung development, remodeling, regulation of peptidases and normal epithelial barrier functions. CONCLUSIONS: Differences in epithelial gene expression between the upper and lower airway epithelium, as observed in healthy subjects, largely disappear in patients with allergic rhinitis with or without asthma, whilst new differences emerge. The present data identify several pathways and genes that might be

  5. Control of Allergic Rhinitis and Asthma Test (CARAT) : dissemination and applications in primary care

    NARCIS (Netherlands)

    Azevedo, Pedro; Correia-de-Sousa, Jaime; Bousquet, Jean; Bugalho-Almeida, Antonio; Del Giacco, Stefano R.; Demoly, Pascal; Haahtela, Tari; Jacinto, Tiago; Garcia-Larsen, Vanessa; van der Molen, Thys; Morais-Almeida, Mario; Nogueira-Silva, Luis; Pereira, Ana M.; Roman-Rodrigues, Miguel; Silva, Barbara G.; Tsiligianni, Ioanna G.; Yaman, Hakan; Yawn, Barbara; Fonseca, Joao A.

    2013-01-01

    Asthma frequently occurs in association with allergic rhinitis and a combined management approach has been suggested. The Control of Allergic Rhinitis and Asthma Test (CARAT) is the first questionnaire to assess control of both diseases concurrently. However, to have an impact on healthcare it needs

  6. Efficacy of desloratadine in persistent allergic rhinitis - a GA²LEN study

    DEFF Research Database (Denmark)

    Bousquet, Jean; Bachert, Claus; Canonica, Giorgio W;

    2010-01-01

    The ARIA (Allergic Rhinitis and its Impact on Asthma) guidelines proposed a classification for allergic rhinitis based on the duration of symptoms (intermittent or persistent) rather than on the time of allergen exposure (seasonal or perennial). There had been no placebo-controlled, randomized, c...

  7. The pathogenesis of allergic rhinitis : cellular aspects with special emphasis on Langerhans cells

    NARCIS (Netherlands)

    W.J. Fokkens (Wytske)

    1991-01-01

    textabstractPresent ideas concerning the pathogenesis of allergic rhinitis are largely deduced from systemic investigations and extrapolated from studies in the skin and the lung. Studies on allergic rhinitis generally comprise clinical aspects and/or biochemical, humoral and cellular features of th

  8. Radioactive Merano SPA Treatment for Allergic Rhinitis Therapy

    Directory of Open Access Journals (Sweden)

    Desiderio Passali

    2016-01-01

    Full Text Available Allergic rhinitis is a common nasal disorder with a high impact on quality of life, high social costs in therapies, and a natural development towards asthma. Pharmacological therapy is based on several genres of medications, of which intranasal corticosteroids are currently the most widespread. Thermal water treatment has traditionally been used as adjunctive treatment for chronic rhinitis and sinusitis. The present study was carried out to assess the clinical efficacy of nasal inhalation of radioactive oligomineral water vapours from the Merano hot spring and to compare it with the clinical efficacy of mometasone furoate nasal spray. A comparative prospective study was performed in 90 allergic patients treated at Merano hot springs: a group of 54 subjects treated with radioactive thermal oligomineral water and a control group of 36 subjects treated with mometasone nasal spray. Patients of both groups were assessed before and after treatment by Sino-Nasal Outcome Test questionnaire, active anterior rhinomanometry with flow and resistance monitoring, measurement of mucociliary transport time, and cytological examination of nasal brushing/scraping. The study showed that inhalation treatment with radioactive hydrofluoric thermal water for two weeks produces an objective clinical and cytological improvement in allergic patients, similar to that obtained with mometasone furoate nasal spray.

  9. Radioactive Merano SPA Treatment for Allergic Rhinitis Therapy

    Science.gov (United States)

    Gabelli, Giacomo; Passali, Giulio Cesare; Magnato, Roberto; Platzgummer, Stefan; Salerni, Lorenzo; Lo Cunsolo, Salvatore; Joos, Alexandra; Bellussi, Luisa Maria

    2016-01-01

    Allergic rhinitis is a common nasal disorder with a high impact on quality of life, high social costs in therapies, and a natural development towards asthma. Pharmacological therapy is based on several genres of medications, of which intranasal corticosteroids are currently the most widespread. Thermal water treatment has traditionally been used as adjunctive treatment for chronic rhinitis and sinusitis. The present study was carried out to assess the clinical efficacy of nasal inhalation of radioactive oligomineral water vapours from the Merano hot spring and to compare it with the clinical efficacy of mometasone furoate nasal spray. A comparative prospective study was performed in 90 allergic patients treated at Merano hot springs: a group of 54 subjects treated with radioactive thermal oligomineral water and a control group of 36 subjects treated with mometasone nasal spray. Patients of both groups were assessed before and after treatment by Sino-Nasal Outcome Test questionnaire, active anterior rhinomanometry with flow and resistance monitoring, measurement of mucociliary transport time, and cytological examination of nasal brushing/scraping. The study showed that inhalation treatment with radioactive hydrofluoric thermal water for two weeks produces an objective clinical and cytological improvement in allergic patients, similar to that obtained with mometasone furoate nasal spray.

  10. Role of leukotriene antagonists and antihistamines in the treatment of allergic rhinitis.

    Science.gov (United States)

    Cobanoğlu, Bengü; Toskala, Elina; Ural, Ahmet; Cingi, Cemal

    2013-04-01

    Allergic rhinitis is the most common atopic disorder seen in ENT clinics. It is diagnosed by history, physical exam and objective testing. Patient education, environmental control measures, pharmacotherapy, and allergen-specific immunotherapy are the cornerstones of allergic rhinitis treatment and can significantly reduce the burden of disease. Current treatment guidelines include antihistamines, intranasal corticosteroids, oral and intranasal decongestants, intranasal anticholinergics, intranasal cromolyn, and leukotriene receptor antagonists. In the mechanism of allergic rhinitis, histamine is responsible for major allergic rhinitis symptoms such as rhinorrhea, nasal itching and sneezing. Its effect on nasal congestion is less evident. In contrast, leukotrienes result in increase in nasal airway resistance and vascular permeability. Antihistamines and leukotriene receptor antagonists are commonly used in the treatment of allergic rhinitis. The published literature about combined antihistamines and leukotriene antagonists in mono- or combination therapy is reviewed and presented.

  11. Physician and patient survey of allergic rhinitis: methodology.

    Science.gov (United States)

    Higgins, V; Kay, S; Small, M

    2007-01-01

    Methodology for Disease Specific Programme (DSP) surveys designed by Adelphi Group Products is used each year to survey patients and physicians on their perceptions of treatment effectiveness, symptoms and impact of diseases. These point-in-time surveys, conducted in the USA and Europe (France, Germany, Italy, Spain and UK), provide useful information on the real-world management and treatment of diseases. This paper describes the methodology for the DSP survey in allergic rhinitis, detailing the preparation of materials, recruitment of physicians, data collection and data management.

  12. Association Between Neonatal Urinary Tract Infection and Risk of Childhood Allergic Rhinitis.

    Science.gov (United States)

    Lin, Chien-Heng; Lin, Wei-Ching; Wang, Yu-Chiao; Lin, I-Ching; Lin, I Ching; Kao, Chia-Hung

    2015-09-01

    The current population-based study investigated the onset of neonatal urinary tract infection (UTI) and the associated risks of allergic rhinitis. From 2000 to 2005, 3285 children with neonatal UTI and 13,128 randomly selected controls were enrolled from the National Health Insurance Research Database in Taiwan and frequency matched by gender, urbanization of residential area, parental occupation, and baseline year. We compared the risk of allergic rhinitis between the non-UTI and UTI cohorts by performing multivariable Cox regression analysis. We observed a significant relationship between UTI and allergic rhinitis. This study examined 16,413 patients, among whom 3285 had UTI and 13,128 did not have UTI. The overall incidence rate ratio of allergic rhinitis was 1.41-fold higher in the UTI cohort than in the non-UTI cohort (100.2 vs 70.93 per 1000 person-y). After potential risk factors were adjusted for, the adjusted hazard ratio of allergic rhinitis was 1.32 (95% confidence interval = 1.23-1.41). Regardless of gender, the UTI cohort had a higher risk of allergic rhinitis than that of the non-UTI cohort. The patients with UTI in different follow-up durations were equally susceptible to developing allergic rhinitis compared with those without UTI, especially in follow-up durations shorter than 5 years. Patients with UTI and particular comorbidities such as infections and neonatal jaundice had a significantly increased risk of allergic rhinitis. UTI in newborns is significantly associated with the development of allergic rhinitis in childhood and might be a risk factor for subsequent childhood allergic rhinitis.

  13. Treating allergic rhinitis by sublingual immunotherapy: a review

    Directory of Open Access Journals (Sweden)

    Cristoforo Incorvaia

    2012-06-01

    Full Text Available OBJECTIVE: Allergic rhinitis (AR is a disease with high and increasing prevalence. The management of AR includes allergen avoidance, anti-allergic drugs, and allergen specific immunotherapy (AIT, but only the latter works on the causes of allergy and, due to its mechanisms of action, modifies the natural history of the disease. Sublingual immunotherapy (SLIT was proposed in the 1990s as an option to traditional, subcutaneous immunotherapy. MATERIAL AND METHODS: We reviewed all the available controlled trials on the efficacy and safety of SLIT. RESULTS AND CONCLUSION: Thus far, more than 60 trials, globally evaluated in 6 meta-analyses, showed that SLIT is an effective and safe treatment for AR. However, it must be noted that to expect clinical efficacy in the current practice SLIT has to be performed following the indications from controlled trials, that is, sufficiently high doses to be regularly administered for at least 3 consecutive years.

  14. Treatment Evaluation with Mometasone Furoate, Alone or in Combination with Desloratadine/ Montelukast in Moderate Severe Allergic Rhinitis

    Directory of Open Access Journals (Sweden)

    Florincescu-Gheorghe Nona-Aura

    2014-06-01

    Full Text Available Introduction: Allergic rhinitis is one of the most common allergic diseases, characterized by the inflammation of the nasal mucosa. Eosinophils play a predominant pro-inflammatory role in allergic inflammation. This study assesses the effect of mometasone furoate alone or in combination with desloratadine/montelukast in patients with moderate-severe allergic rhinitis.

  15. SQ house dust mite sublingually administered immunotherapy tablet (ALK) improves allergic rhinitis in patients with house dust mite allergic asthma and rhinitis symptoms

    DEFF Research Database (Denmark)

    Mosbech, Holger; Canonica, G Walter; Backer, Vibeke;

    2015-01-01

    BACKGROUND: House dust mite (HDM) allergy is associated with persistent allergic rhinitis (AR) and allergic asthma. OBJECTIVE: To investigate the efficacy and safety of a SQ HDM sublingually administered immunotherapy tablet (ALK, Hørsholm, Denmark) in adults and adolescents with HDM respiratory ...

  16. Social class in asthma and allergic rhinitis: a national cohort study over three decades.

    Science.gov (United States)

    Bråbäck, L; Hjern, A; Rasmussen, F

    2005-12-01

    The aim of this study was to assess whether the association with social class differed between allergic rhinitis and asthma and whether these associations have changed over time. The Swedish Military Service Conscription Register was linked to two other national registers for 1,247,038 male conscripts in successive cohorts born between 1952 and 1977. The percentage of asthma cases associated with allergic rhinitis was 15% in the oldest cohort and 44% in the youngest cohort. Low socio-economic status (SES) was associated with an increased risk (assessed as odds ratio) of asthma without allergic rhinitis (1.14, 95% confidence interval (CI) 1.11-1.17) but a slightly reduced risk of asthma with allergic rhinitis (0.96, 95% CI 0.93-1.00). The risk of allergic rhinitis was 0.84, 95% CI 0.82-0.85. A positive interaction between SES and year of birth occurred in all three conditions. Low SES was related to a reduced risk of asthma with allergic rhinitis in the earliest cohort (0.72, 95% CI 0.53-0.82) but a slightly increased risk in the most recent cohort (1.07, 95% CI 1.01-1.14). In conclusion, the role of social class has changed over time. The steepest increase in asthma and allergic rhinitis occurred in conscripts with a low socio-economic status.

  17. Reactions of healthy persons and persons suffering from allergic rhinitis when exposed to office dust

    DEFF Research Database (Denmark)

    Hauschildt, Pernille; Mølhave, Lars; Kjærgaard, Søren K.

    1999-01-01

    Objectives Reactions to airborne office dust among healthy subjects and subjects suffering from allergic rhinitis were investigated. Methods Twelve healthy and 11 subjects suffering from allergic rhinitis were exposed to clean air [17 (SD 2) mg/m3] and office dust [439 (SD 68) mg/m3] for 245...... exposure, and some of the indications were in biologically unexplainable directions. No difference in the reactions to dust was observed between the healthy subjects and the subjects suffering from allergic rhinitis. Conclusion Dust does not seem to have objective or subjective effects on humans, as only...

  18. Association between Allergic Rhinitis and Asthma Control in Peruvian School Children: A Cross-Sectional Study

    Directory of Open Access Journals (Sweden)

    Justo Padilla

    2013-01-01

    Full Text Available Background. Asthma and allergic rhinitis are highly prevalent conditions that cause major illness worldwide. This study aimed to assess the association between allergic rhinitis and asthma control in Peruvian school children. Methods. A cross-sectional study was conducted among 256 children with asthma recruited in 5 schools from Lima and Callao cities. The outcome was asthma control assessed by the asthma control test. A score test for trend of odds was used to evaluate the association between allergic rhinitis severity and the prevalence of inadequate asthma control. A generalized linear regression model was used to estimate the adjusted prevalence ratios of inadequate asthma control. Results. Allergic rhinitis was present in 66.4% of the population with asthma. The trend analysis showed a positive association between allergic rhinitis and the probability of inadequate asthma control (. It was associated with an increased prevalence of inadequate asthma control, with adjusted prevalence ratios of 1.53 (95% confidence interval: 1.19−1.98. Conclusion. This study indicates that allergic rhinitis is associated with an inadequate level of asthma control, giving support to the recommendation of evaluating rhinitis to improve asthma control in children.

  19. Quality of Sexual Life in Males with Allergic Rhinitis

    Directory of Open Access Journals (Sweden)

    Gul Soylu Ozler

    2014-12-01

    Full Text Available Aim: The aim of this study is to evaluate the quality of sexual life of males with allergic rhinitis(AR. Material and Method: 40 patients with AR diagnosed with skin prick test and 40 control subjects with no evidence of allergy completed the study. International Index of Erectile Function questionnaire (IIEF was used to evaluate the quality of sexual life of the subjects. Results: The mean scores of erectile function, orgasmic function, sexual desire, intercourse satisfaction and overall satisfaction for AR group were significantly lower than control group(p=0.0001. Discussion: AR has negative effects on quality of life. The effective treatment of AR by the clinician will also avoid these concomitting social, sexual and sleep disturbances.

  20. Does allergic rhinitis affect communication skills in young adults?

    Science.gov (United States)

    Cingi, Can Cemal; Sakallıoğlu, Öner; Muluk, Nuray Bayar; Cingi, Cemal

    2016-01-01

    Allergic rhinitis (AR) is a chronic disorder with a high prevalence in the general population. The symptoms of AR can impair the cognitive capabilities of the affected people. The study of communication skills and AR interaction has not been adequately discussed. We aimed to analyze Social Communication Skills of university students with AR. Fifty patients suffering from AR and 50 healthy subjects were studied. All participants completed two questionnaires [Social Communication Skills Rating Scale (SCSRS) and Communication Questionnaire] for the assessment of social communication skills. Total scores of both SCSRS and Communication Questionnaire were higher in participants with AR than controls. When the questions of SCSRS were compared between the groups one by one, significant difference was observed between the groups for questions numbered 1-9 and 11, 12 (p Communication Questionnaire (p communication skills of the patients with AR. More research is however needed to validate this hypothesis.

  1. Determinants of allergic rhinitis in young children with asthma.

    Directory of Open Access Journals (Sweden)

    Lise Moussu

    Full Text Available BACKGROUND: In the preschool period, allergic rhinitis (AR is infrequent and thus under-diagnosed. However, recent works have highlighted the occurrence of AR in toddlers although the causes of AR in this young population remain unknown. The objective of this study was to identify determinants of AR in young children with asthma. METHODS: We carried out a case-control study of 227 children with active asthma and enrolled in the Trousseau Asthma Program. AR and other allergic diseases (asthma, food allergy and eczema were diagnosed by medical doctors using standardized questionnaires. Parental history of AR and asthma, biological markers of atopy (total IgE, blood eosinophilia, allergic sensitization towards food and aeroallergens and environmental parameters were also collected. RESULTS: Forty one of the children (18.1% had AR. By univariate logistic regression analysis, AR was mainly associated with peanut sensitization (OR = 6.75; p = 0.002; food allergy (OR = 4.31; p = 0.026; mold exposure (OR = 3.81 p<0.01 and parental history of AR (OR = 1.42; p = 0.046. Due to the strong link between food allergy and peanut sensitization three models of multivariate logistic regression were performed and confirmed that AR is associated with peanut sensitization but also food allergy and mold exposure. A random forest analysis was also performed to explain AR. The results reinforced the logistic analysis that peanut sensitization and mold exposure were the principal determinants of AR. CONCLUSIONS & CLINICAL RELEVANCE: These results stress the importance of investigating AR in young children with asthma to potentially diagnose a particularly severe allergic asthmatic phenotype. Moreover, these data evoke the hypothesis that peanut could be an aeroallergen.

  2. Extranasal symptoms of allergic rhinitis are difficult to treat and affect quality of life

    Directory of Open Access Journals (Sweden)

    Veeravich Jaruvongvanich

    2016-04-01

    Conclusions: Extranasal symptom scores correlated well with physical health and mental health in allergic rhinitis patients. Assessment of extranasal symptoms should be included to evaluate disease severity and assess therapeutic outcomes. Clinical trial NCT02000648, http://www.clinicaltrials.gov.

  3. [Summary of the practice guideline 'allergic and non-allergic rhinitis' (first revision) from the Dutch College of General Practitioners

    NARCIS (Netherlands)

    Balen, J.A. van; Verduijn, M.M.; Sachs, A.P.; Berger, M.Y.; Lucassen, P.L.B.J.; Wiersma, T.J.; Goudswaard, A.N.

    2007-01-01

    The practice guideline 'Allergic and non-allergic rhinitis' of the Dutch College ofGeneral Practitioners has been revised based on developments that have occurred in recent years. The most important modifications are: Impermeable covers for beddings are advised only for patients with serious complai

  4. Probiotics and allergic rhinitis%益生菌与变应性疾病

    Institute of Scientific and Technical Information of China (English)

    黄石; 赵宇

    2013-01-01

    The prevalence of allergic diseases has increased in recent years, and primary prevention of allergic disease is considered to be an elusive goal. This paper summarizes the recent publications on probiotics in allergic rhinitis. It focuses on clinical and laboratory observations of treatment or prevention of allergic rhinitis. Probiotics administration represents different outcome, its effects depend on a variety of factors, such as dosing regimen, delivery method and the types of bacterium. Since the data from different research centers are conflicting, the further studies are required.

  5. Nasal hemophilic pseudotumor in a patient with mild hemophilia A and allergic rhinitis.

    Science.gov (United States)

    Ogata, Yoshiyasu; Monji, Mikio; Kai, Keita; Matsuo, Muneaki

    2017-02-01

    Hemophilic pseudotumor is a rare complication, even in patients with severe hemophilia. Herein we report on a case of hemophilic pseudotumor in a patient with mild hemophilia A and allergic rhinitis, initially suspected to be a nasal tumor. The pseudotumor was cured by supplementation with recombinant factor VIII concentrates, and medication for allergic rhinitis. Pseudotumor should always be considered in hemophiliac patients, even in those with only mild deficiency of coagulation factors.

  6. Google unveils a glimpse of allergic rhinitis in the real world.

    Science.gov (United States)

    Kang, M-G; Song, W-J; Choi, S; Kim, H; Ha, H; Kim, S-H; Cho, S-H; Min, K-U; Yoon, S; Chang, Y-S

    2015-01-01

    Google Trends (GT) is a Web-based surveillance tool used to explore the searching trends of specific queries on Google. Recent studies have suggested the utility of GT in predicting outbreaks of influenza and other diseases. However, this utility has not been thoroughly evaluated for allergic diseases. Therefore, we investigated the utility of GT for predicting the epidemiology of allergic rhinitis. In the USA, GT for allergic rhinitis showed repetitive seasonality that peaked in late April and early May and then rapidly decreased, and a second small peak occurred in September. These trends are highly correlated with the searching trends for other queries such as 'pollen count', antihistamines such as loratadine and cetirizine (all r > 0.88 and all P Google Trends for allergic rhinitis was similar to the monthly changes in rhinitis symptoms according to the US National Health and Nutrition Examination Survey III, sales for Claritin(®) and all over-the-counter antihistamines, and the number of monthly page views of 'claritin.com'. In conclusion, GT closely reflects the real-world epidemiology of allergic rhinitis in the USA and could potentially be used as a monitoring tool for allergic rhinitis.

  7. Allergic rhinitis in northern vietnam: increased risk of urban living according to a large population survey

    Directory of Open Access Journals (Sweden)

    Lâm Hoàng

    2011-08-01

    Full Text Available Abstract Background Little is known about prevalence and risk factors of allergic rhinitis and chronic nasal symptoms among adults in Vietnam. We aimed to estimate the prevalence, risk factor patterns and co-morbidities of allergic rhinitis and chronic nasal symptoms in one urban and one rural area in northern Vietnam. Methods A cross-sectional questionnaire survey was conducted from August 2007 to January 2008 in urban Hoankiem and rural Bavi in Hanoi among adults aged 21-70 years. Of 7008 randomly selected subjects, 91.7% participated in Bavi and 70.3% in Hoankiem. Results Allergic rhinitis ever or chronic nasal symptoms were reported by 50.2%. The prevalence of allergic rhinitis ever was considerably higher in Hoankiem compared to Bavi, 29.6% vs 10.0% (p Conclusions Allergic rhinitis ever was considerably more common in the urban area. Nasal blocking and runny nose was each reported by about one third of the studied sample with no major urban-rural difference. Further, exposure to air pollution at work was significantly associated with allergic rhinitis ever, nasal blocking and runny nose.

  8. The history and progression of treatments for allergic rhinitis.

    Science.gov (United States)

    Ostrom, Nancy K

    2014-01-01

    This article intends to place new treatments in the context of allergic rhinitis (AR) treatment history. The medical literature was searched for significant advances and changes in AR treatment. Historical data on AR treatment options and management were selected. Reviews of AR management published throughout the 20th century were included to provide context for treatment advances. Modern AR treatment began in the early 20th century with immunotherapy and was soon followed by the emergence of antihistamine therapy in the 1930s. Numerous treatments for AR have been used over the ensuing decades, including decongestants, mast cell stabilizers, and leukotriene receptor antagonists. Topical corticosteroid options were developed the 1950s, and, added to baseline antihistamine therapy, became the foundation of AR treatment. Treatment options were significantly impacted after the 1987 Montreal Protocol, which phased out the use of chlorofluorocarbon propellant aerosols because of environmental concerns. From the mid-1990s until recently, this left only aqueous solution options for intranasal corticosteroids (INSs). The approval of the first hydrofluoroalkane propellant aerosol INSs for AR in 2012 restored a "dry" aerosol treatment option. The first combination intranasal antihistamine/INSs was also approved in 2012, providing a novel treatment option for AR. Treatment of AR has progressed with new therapeutic options now available. This should continue to move forward with agents to alter the allergic mechanism itself and impact the disease burden that has a significant impact on patient outcomes.

  9. Indoleamine 2,3-dioxygenase expression in patients with allergic rhinitis: a case-control study

    Directory of Open Access Journals (Sweden)

    Luukkainen Annika

    2011-12-01

    Full Text Available Abstract Background Indoleamine 2,3-dioxygenase (IDO is a tryptophan catalyzing enzyme. It has been suggested that it has a role in lower airway allergic inflammations, but its role in allergic rhinitis has not been investigated. Objective Our aim was to evaluate the expression of IDO in the nasal mucosa of allergic rhinitis patients allergic to birch pollen during peak exposure to birch pollen allergen and compare it to non-atopic patients. Methods IDO expression was immunohistochemically evaluated from nasal specimens obtained in- and off-season from otherwise healthy non-smoking volunteers both allergic to birch pollen (having mild or moderate allergic rhinoconjunctivitis and non-allergic controls. Results: The IDO expression levels were low in healthy controls and remained low also in patients allergic to birch pollen. There were no differences in the expression of IDO in- and off-season in either healthy or allergic subjects. Conclusions There is a controversy in the role of IDO in upper and lower airways during allergic airway disease. It seems that IDO is associated to allergic inflammations of the lower airways, but does not have a local role in the nasal cavity at least in mild or moderate forms of allergic rhinitis.

  10. Influence of degree of specific allergic sensitivity on severity of rhinitis and asthma in Chinese allergic patients

    Directory of Open Access Journals (Sweden)

    Zhao Changqing

    2011-07-01

    Full Text Available Abstract Background The association between sensitizations and severity of allergic diseases is controversial. Objective This study was to investigate the association between severity of asthma and rhinitis and degree of specific allergic sensitization in allergic patients in China. Method A cross-sectional survey was performed in 6304 patients with asthma and/or rhinitis from 4 regions of China. Patients completed a standardized questionnaire documenting their respiratory and allergic symptoms, their impact on sleep, daily activities, school and work. They also underwent skin prick tests with 13 common aeroallergens. Among the recruited subjects, 2268 provided blood samples for serum measurement of specific IgE (sIgE against 16 common aeroallergens. Results Significantly higher percentage of patients with moderate-severe intermittent rhinitis were sensitized to outdoor allergens while percentage of patients sensitized to indoor allergens was increased with increasing severity of asthma. Moderate-severe intermittent rhinitis was associated with the skin wheal size and the level of sIgE to Artemisia vulgaris and Ambrosia artemisifolia (p Dermatophagoides (D. pteronyssinus and D. farinae (p Conclusions Artemisia vulgaris and Ambrosia artemisifolia sensitizations are associated with the severity of intermittent rhinitis and D. pteronyssinus and D. farinae sensitizations are associated with increasing severity of asthma in China. Increase in number of allergens the patients are sensitized to may also increase the severity of rhinitis and asthma.

  11. Citizen science based symptom scores of allergic rhinitis to validate the grass pollen hay fever forecast

    NARCIS (Netherlands)

    Weger, L.A.; Bas Hofstee, H.; Vliet, van A.J.H.; Hiemstra, P.S.; Sont, Jacob K.

    2015-01-01

    Introduction: On average 23% of the European population suffers from allergic rhinitis of which pollen is a major cause. Hay fever symptom forecasts can help these patients to adapt their behaviour and to take their medication in time. We developed the LUMC hay fever forecast for grass pollen allerg

  12. Objective assessments of allergic and nonallergic rhinitis in young children

    DEFF Research Database (Denmark)

    Chawes, B L K; Kreiner-Møller, E; Bisgaard, H

    2009-01-01

    of age from the Copenhagen Prospective Study on Asthma in Childhood birth cohort assessing rhinitis history, specific immunoglobulin E relevant to rhinitis symptoms, nasal eosinophilia and nasal airway patency by acoustic rhinometry before and after decongestion. Associations were studied...

  13. Traffic exposure associated with allergic asthma and allergic rhinitis in adults. A cross-sectional study in southern Sweden

    Directory of Open Access Journals (Sweden)

    Montnémery Peter

    2009-05-01

    Full Text Available Abstract Background There is conflicting evidence that traffic-related air pollution is a risk factor for allergic conditions. Few studies have investigated this in adults. In adults, a high proportion of asthma, rhinitis and eczema is triggered by non-allergic factors. We investigated traffic as a risk factor for allergic versus non-allergic asthma and rhinitis, and eczema, in adults. A questionnaire from 2000 (n = 9319, 18–77 years provided individual data about disease outcome and self-reported traffic exposure. Additional exposure assessments were obtained using Geographical Informations Systems (GIS. Residential addresses were linked to the national Swedish Road Database and to a pollutant database with modelled annual means of NOx (Nitrogen Oxids. Results Living within 100 m from a road with a traffic intensity of >10 cars/min (24 hour mean was associated with prevalence of current asthma reported to be triggered by allergic factors (OR = 1.83, 95% CI = 1.23–2.72 and with allergic rhinitis (OR = 1.30, 95%CI = (1.05–1.61. No relation was seen with asthma or rhinitis triggered by other factors. Living within 100 m of a road with >10 cars/min was also associated with hand-eczema during the last 12 months (OR = 1.63, 95% CI = 1.19–2.23, but not with allergic eczema or diagnosed hand-eczema. Consistent results were seen using self-reported traffic, but the associations with NOx were less consistent. Conclusion Exposure to traffic was associated with a higher prevalence of allergic asthma and allergic rhinitis, but not with asthma or rhinitis triggered by non-allergic factors. This difference was suggested by the overall pattern, but only clear using GIS-measured traffic intensity as a proxy for traffic exposure. An association was also found with hand-eczema during the last 12 months. We suggest that asthma and rhinitis should not be treated as homogenous groups when estimating effects from traffic in adults.

  14. Comparison of Acoustic and Stroboscopic Findings and Voice Handicap Index between Allergic Rhinitis Patients and Controls

    Science.gov (United States)

    Koç, Eltaf Ayça Özbal; Koç, Bülent; Erbek, Selim

    2014-01-01

    Background: In our experience Allergic Rhinitis (AR) patients suffer from voice problems more than health subjects. Aims: To investigate the acoustic analysis of voice, stroscopic findings of larynx and Voice Handicap Index scores in allergic rhinitis patients compared with healthy controls. Study Design: Case-control study. Methods: Thirty adult patients diagnosed with perennial allergic rhinitis were compared with 30 age- and sex-matched healthy controls without allergy. All assessments were performed in the speech physiology laboratory and the testing sequence was as follows: 1. Voice Handicap Index (VHI) questionnaire, 2. Laryngovideostroboscopy, 3. Acoustic analyses. Results: No difference was observed between the allergic rhinitis and control groups regarding mean Maximum Phonation Time (MPT) values, Fo values, and stroboscopic assessment (p>0.05). On the other hand, mean VHI score (p=0.001) and s/z ratio (p=0.011) were significantly higher in the allergic rhinitis group than in controls. Conclusion: Our findings suggest that the presence of allergies could have effects on laryngeal dysfunction and voice-related quality of life. PMID:25667789

  15. Assessment of sensitization to insect aeroallergens among patients with allergic rhinitis in Yazd City, Iran.

    Directory of Open Access Journals (Sweden)

    Mohammad Hassan Bemanian

    2012-09-01

    Full Text Available The  frequency of  allergic diseases such  as allergic rhinitis is considerable in general population. Insect aeroallergens are important allergens which can induce airway inflammation. The aim of this study was to determine the prevalence of sensitization to insect aeroallergens in allergic rhinitis patients in Yazd as a desert city in Iran.A cross-sectional study was undertaken on 95 allergic rhinitis patients who were referred to allergy clinic of Yazd city. Skin prick tests (SPT by standard extracts of three insect aeroallergens including Mosquito,  Corn  moth,  Cockroach  and  two  species of  mites  as common  aeroallergens in allergic rhinitis (Dermatophagoid  Farina, Dermatophagoid Peteronysinus were done.SPT results showed that the most common insect aeroallergens were: mosquito (32.6% followed by corn  moth  (26.3% and cockroach (13.7%.The prevalence of SPT positive response to Dermatophagoid Peteronysinus, Dermatophagoid Farina were 8.4% and 7.4%, respectively. These  results  demonstrated  that  sensitization  to  insect  aeroallergens was significantly more common compared to mites in patients with allergic rhinitis in Yazd city, a city surrounded by deserts.High prevalence of skin reactivity to mosquito and corn moth as insect aeroallergens in Yazd city with hot and dry climate in contrast to humid regions such as north of Iran, where mites are more frequent, indicates differences in the prevalence of aeroallergen reactivity in various areas with different climates. Our  study could highlight the importance of insect aeroallergens for clinicians for better  diagnosis and management of patients with allergic rhinitis.

  16. Toll-like receptor gene polymorphisms are associated with allergic rhinitis: a case control study

    Directory of Open Access Journals (Sweden)

    Nilsson Daniel

    2012-08-01

    Full Text Available Abstract Background The Toll-like receptor proteins are important in host defense and initiation of the innate and adaptive immune responses. A number of studies have identified associations between genetic variation in the Toll-like receptor genes and allergic disorders such as asthma and allergic rhinitis. The present study aim to search for genetic variation associated with allergic rhinitis in the Toll-like receptor genes. Methods A first association analysis genotyped 73 SNPs in 182 cases and 378 controls from a Swedish population. Based on these results an additional 24 SNPs were analyzed in one Swedish population with 352 cases and 709 controls and one Chinese population with 948 cases and 580 controls. Results The first association analysis identified 4 allergic rhinitis-associated SNPs in the TLR7-TLR8 gene region. Subsequent analysis of 24 SNPs from this region identified 7 and 5 significant SNPs from the Swedish and Chinese populations, respectively. The corresponding risk-associated haplotypes are significant after Bonferroni correction and are the most common haplotypes in both populations. The associations are primarily detected in females in the Swedish population, whereas it is seen in males in the Chinese population. Further independent support for the involvement of this region in allergic rhinitis was obtained from quantitative skin prick test data generated in both populations. Conclusions Haplotypes in the TLR7-TLR8 gene region were associated with allergic rhinitis in one Swedish and one Chinese population. Since this region has earlier been associated with asthma and allergic rhinitis in a Danish linkage study this speaks strongly in favour of this region being truly involved in the development of this disease.

  17. Pharmacoeconomic study results of the access to drugs and treatment among patients with allergic rhinitis in Uzbekistan

    Directory of Open Access Journals (Sweden)

    Nizom Suyunov

    2011-03-01

    Full Text Available The paper discusses survey results made among 104 leading physicians of specialized offices with indication of forms and dose for drugs widely used for allergic rhinitis. The aim of the inquiry was carrying out VEN- analysis to define groups of drugs which efficacy should provide their more wide use in treatment of allergic rhinitis in near future.

  18. Association between allergic rhinitis and hospital resource use among asthmatic children in Norway

    DEFF Research Database (Denmark)

    Sazonov Kocevar, V; Thomas, J; Jonsson, L;

    2005-01-01

    of concomitant allergic rhinitis on asthma-related hospital resource utilization among children below 15 years of age with asthma in Norway. METHODS: A population-based retrospective cohort study of children (aged 0-14 years) with asthma was conducted using data from a patient-specific public national database......BACKGROUND: Preliminary evidence suggests that inadequately controlled allergic rhinitis in asthmatic patients can contribute towards increased asthma exacerbations and poorer symptom control, which may increase medical resource use. The objective of this study was therefore to assess the effect...... of hospital admissions during a 2-year period, 1998-1999. Multivariate linear regression, adjusting for risk factors including age, gender, year of admission, urban/rural residence and severity of asthma episode, estimated the association between allergic rhinitis and total hospital days. A multivariate Cox...

  19. Herpes Simplex Type I Infection and Atopy Association in Turkish Children with Asthma and Allergic Rhinitis

    Directory of Open Access Journals (Sweden)

    Mahir Igde

    2009-09-01

    Full Text Available This study investigated the association between HSV-1 infection and atopy by comparing seropositivity to HSV-1 in atopic children with asthma and allergic rhinitis and in non-atopic children.Totally 249 children randomly selected from the university outpatient pediatric clinics were prospectively enrolled in the study between September 1 and November 30, 2007. Serum samples were examined using the virus neutralization test (VNT for HSV-1 Immunoglobulin G(IgG seropositivity. Skin prick tests (SPTs were performed to determine atopic status. The results showed that HSV-1 IgG seropositivity was significantly higher in atopic children (56.8% with asthma and allergic rhinitis than in the age-matched non-atopic children group (30.4% (pThese results support a possible relationship between the atopic status of children with asthma and allergic rhinitis and HSV-1 infection.

  20. Chronobiology and chronotherapy of allergic rhinitis and bronchial asthma.

    Science.gov (United States)

    Smolensky, Michael H; Lemmer, Bjoern; Reinberg, Alain E

    2007-08-31

    Study of the chronobiology of allergic rhinitis (AR) and bronchial asthma (BA) and the chronopharmacology and chronotherapy of the medications used in their treatment began five decades ago. AR is an inflammatory disease of the upper airway tissue with hypersensitivity to specific environmental antigens, resulting in further local inflammation, vasomotor changes, and mucus hypersecretion. Symptoms include sneezing, nasal congestion, and runny and itchy nose. Approximately 25% of children and 40% of adults in USA are affected by AR during one or more seasons of the year. The manifestation and severity of AR symptoms exhibit prominent 24-h variation; in most persons they are worse overnight or early in the morning and often comprise nighttime sleep, resulting in poor daytime quality of life, compromised school and work performance, and irritability and moodiness. BA is also an inflammatory medical condition of the lower airways characterized by hypersensitivity to specific environmental antigens, resulting in greater local inflammation as well as bronchoconstriction, vasomotor change, and mucus hypersecretion. In USA an estimated 6.5 million children and 15.7 million adults have BA. The onset and worsening of BA are signaled by chest wheeze and/or croupy cough and difficult and labored breathing. Like AR, BA is primarily a nighttime medical condition. AR is treated with H1-antagonist, decongestant, and anti-inflammatory (glucocorticoid and leukotriene receptor antagonist and modifier) medications. Only H1-antagonist AR medications have been studied for their chronopharmacology and potential chronotherapy. BA is treated with some of the same medications and also theophylline and beta2-agonists. The chronopharmacology and chronotherapy of many classes of BA medications have been explored. This article reviews the rather extensive knowledge of the chronobiology of AR and BA and the chronopharmacology and chronotherapy of the various medications used in their treatment.

  1. Selecting the optimal oral antihistamine for patients with allergic rhinitis.

    Science.gov (United States)

    Lehman, Jeffrey M; Blaiss, Michael S

    2006-01-01

    Allergic rhinitis (AR) is now recognised as a global health problem that affects 10-30% of adults and up to 40% of children. Each year, millions of patients seek treatment from their healthcare provider. However, the prevalence of AR maybe significantly underestimated because of misdiagnosis, under diagnosis and failure of patients to seek medical attention. In addition to the classical symptoms such as sneezing, nasal pruritus, congestion and rhinorrhoea, it is now recognised that AR has a significant impact on quality of life (QOL). This condition can lead to sleep disturbance as a result of nasal congestion, which leads to significant impairment in daily activities such as work and school. Traditionally, AR has been subdivided into seasonal AR (SAR) or perennial AR (PAR). SAR symptoms usually appear during a specific season in which aeroallergens are present in the outdoor air such as tree and grass pollen in the spring and summer and weed pollens in the autumn (fall); and PAR symptoms are present year-round and are triggered by dust mite, animal dander, indoor molds and cockroaches. Oral histamine H(1)-receptor antagonists (H(1) antihistamines) are one of the most commonly prescribed medications for the treatment of AR. There are several oral H(1) antihistamines available and it is important to know the pharmacology, such as administration interval, onset of action, metabolism and conditions that require administration adjustments. When prescribing oral H(1) antihistamines, the healthcare provider must take into account the clinical efficacy and weigh this against the risk of adverse effects from the agent. In addition to the clinical efficacy, potential for improvement in QOL with a particular treatment should also be considered.

  2. Masticatory Changes in Oral Breath Secondary to Allergic Rhinitis: Integrative Review

    Directory of Open Access Journals (Sweden)

    Bezerra, Luciana Ângelo

    2014-04-01

    Full Text Available Introduction The III Brazilian Consensus on Rhinitis (2012 defines allergic rhinitis as a nasal mucosa inflammation, mediated by immunoglobulin E, after exposure to allergens. The classic signs and symptoms of allergic rhinitis are nasal obstruction, watery rhinorrhea, sneezing, and nasal itching, often reversible either spontaneously or with treatment, and mouth breathing (breathing predominantly through the mouth, regardless of the cause, due to a nasal breathing impairment in some cases. Objective To evaluate the literature on masticatory changes in children with mouth breathing due to allergic rhinitis. Methods We conducted a search of the past 10 years, at Bireme and MEDLINE databases, for articles that covered masticatory changes in children with mouth breathing secondary to allergic rhinitis. Results We found 1,986 articles, including 15 repeated in databases, but only two articles met the inclusion criteria fully. Discussion We found few studies to answer the question raised in this review, and those studies have some methodological limitations. Most articles claimed no have statistically significant differences in masticatory changes in this population. Conclusion A better controlled study (isolating diseases, exposure time, with a larger sample (sample calculation appropriate, would be necessary to examine such changes.

  3. The Link between Allergic Rhinitis and Asthma: A Role for Antileukotrienes?

    Directory of Open Access Journals (Sweden)

    H Kim

    2008-01-01

    Full Text Available Allergic rhinitis and asthma are both chronic heterogeneous disorders, with an overlapping epidemiology of prevalence, health care costs and social costs in quality of life. Both are inflammatory disorders with a similar pathophysiology, and both share some treatment approaches. However, each disorder has an array of treatments used separately in controlling these atopic disorders, from inhaled corticosteroids, beta2-agonists and antihistamines to newer monoclonal antibody-based treatments. The present article reviews the shared components of allergic rhinitis and asthma, and examines recent evidence supporting antileukotrienes as effective agents in reducing the symptoms of both diseases.

  4. Acupuncture for persistent allergic rhinitis: a multi-centre, randomised, controlled trial protocol

    Directory of Open Access Journals (Sweden)

    Kang Kyung-Won

    2009-07-01

    Full Text Available Abstract Background Allergic rhinitis is one of the most common health complaints worldwide. Complementary and alternative medical approaches have been employed to relieve allergic rhinitis symptoms and to avoid the side effects of conventional medication. Acupuncture has been widely used to treat patients with allergic rhinitis, but the available evidence of its effectiveness is insufficient. Our objective is to evaluate the effectiveness of acupuncture in patients in Korea and China with persistent allergic rhinitis compared to sham acupuncture treatment or waitlist control. Methods This study consists of a multi-centre (two centres in Korea and two centres in China, randomised, controlled trial with three parallel arms (active acupuncture, sham acupuncture, and waitlist group. The active acupuncture and sham acupuncture groups will receive real or sham acupuncture treatment, respectively, three times per week for a total of 12 sessions over four weeks. Post-treatment follow-up will be performed a month later to complement these 12 acupuncture sessions. Participants in the waitlist group will not receive real or sham acupuncture treatments during this period but will only be required to keep recording their symptoms in a daily diary. After four weeks, the same treatment given to the active acupuncture group will be provided to the waitlist group. Discussion This trial will provide evidence for the effectiveness of acupuncture as a treatment for persistent allergic rhinitis. The primary outcome between groups is a change in the self-reported total nasal symptom score (i.e., nasal obstruction, rhinorrhea, sneezing, and itching from baseline at the fourth week. Secondary outcome measures include the Rhinitis Quality of Life Questionnaire score and total non-nasal symptom score (i.e., headache, itching, pain, eye-dropping. The quantity of conventional relief medication used during the follow-up period is another secondary outcome measure. Trial

  5. Effect of Local Nasal Immunotherapy on Nasal Blockage in Pollen-Induced Allergic Rhinitis of Guinea Pigs

    OpenAIRE

    Takeshi Nabe; Kayoko Kubota; Nobuaki Mizutani; Masanori Fujii; Tetsuya Terada; Hiroshi Takenaka; Shigekatsu Kohno

    2008-01-01

    Background: As a non-injection route for immunotherapy, local nasal immunotherapy has been examined in allergic rhinitis patients. However, it is unclear how the immunotherapy affects sneezing, biphasic nasal blockage and nasal hyperresponsiveness. Thus, we evaluated the therapeutic effects of nasal immunotherapy on the symptoms of guinea pig allergic rhinitis. Additionally, we also evaluated whether the immunotherapy relieved pollen-induced allergic conjunctivitis. Methods: Sensitized ani...

  6. Treatment of allergic rhinitis and urticaria: a review of the newest antihistamine drug bilastine.

    Science.gov (United States)

    Wang, Xue Yan; Lim-Jurado, Margaret; Prepageran, Narayanan; Tantilipikorn, Pongsakorn; Wang, De Yun

    2016-01-01

    Allergic rhinitis and urticaria are common allergic diseases that may have a major negative impact on patients' quality of life. Bilastine, a novel new-generation antihistamine that is highly selective for the H1 histamine receptor, has a rapid onset and prolonged duration of action. This agent does not interact with the cytochrome P450 system and does not undergo significant metabolism in humans, suggesting that it has very low potential for drug-drug interactions, and does not require dose adjustment in renal impairment. As bilastine is not metabolized and is excreted largely unchanged, hepatic impairment is not expected to increase systemic exposure above the drug's safety margin. Bilastine has demonstrated similar efficacy to cetirizine and desloratadine in patients with seasonal allergic rhinitis and, in a Vienna Chamber study, a potentially longer duration of action than fexofenadine in patients with asymptomatic seasonal allergic rhinitis. It has also shown significant efficacy (similar to that of cetirizine) and safety in the long-term treatment of perennial allergic rhinitis. Bilastine showed similar efficacy to levocetirizine in patients with chronic spontaneous urticaria and can be safely used at doses of up to fourfold higher than standard dosage (80 mg once daily). The fourfold higher than standard dose is specified as an acceptable second-line treatment option for urticaria in international guidelines. Bilastine is generally well tolerated, both at standard and at supratherapeutic doses, appears to have less sedative potential than other second-generation antihistamines, and has no cardiotoxicity. Based on its pharmacokinetic properties, efficacy, and tolerability profile, bilastine will be valuable in the management of allergic rhinitis and urticaria.

  7. Greater risk of incident asthma cases in adults with Allergic Rhinitis and Effect of Allergen Immunotherapy: A Retrospective Cohort Study

    Directory of Open Access Journals (Sweden)

    Piccillo Giovita

    2005-12-01

    Full Text Available Abstract Asthma and rhinitis are often co-morbid conditions. As rhinitis often precedes asthma it is possible that effective treatment of allergic rhinitis may reduce asthma progression. The aim of our study is to investigate history of allergic rhinitis as a risk factor for asthma and the potential effect of allergen immunotherapy in attenuating the incidence of asthma. Hospital-referred non-asthmatic adults, aged 18–40 years between 1990 and 1991, were retrospectively followed up until January and April 2000. At the end of follow up, available subjects were clinically examined for asthma diagnosis and history of allergen specific immunotherapy, second-hand smoking and the presence of pets in the household. A total of 436 non-asthmatic adults (332 subjects with allergic rhinitis and 104 with no allergic rhinitis nor history of atopy were available for final analyses. The highest OR (odds ratio associated with a diagnosis of asthma at the end of follow-up was for the diagnosis of allergic rhinitis at baseline (OR, 7.8; 95%CI, 3.1–20.0 in the model containing the covariates of rhinitis diagnosis, sex, second-hand smoke exposure, presence of pets at home, family history of allergic disorders, sensitization to Parietaria judaica; grass pollen; house dust mites; Olea europea: orchard; perennial rye; and cat allergens. Female sex, sensitization to Parietaria judaica and the presence of pets in the home were also significantly predictive of new onset asthma in the same model. Treatment with allergen immunotherapy was significantly and inversely related to the development of new onset asthma (OR, 0.53; 95%CI, 0.32–0.86. In the present study we found that allergic rhinitis is an important independent risk factor for asthma. Moreover, treatment with allergen immunotherapy lowers the risk of the development of new asthma cases in adults with allergic rhinitis.

  8. Antigen-Specific Immunotherapy against Allergic Rhinitis: The State of the Art

    Directory of Open Access Journals (Sweden)

    Takashi Fujimura

    2010-01-01

    Full Text Available Allergic rhinitis is the most prevalent type I allergy in industrialized countries. Pollen scattering from trees or grasses often induces seasonal allergic rhinitis, which is known as pollinosis or hay fever. The causative pollen differs across different areas and times of the year. Impaired performance due to pollinosis and/or medication used for treating pollinosis is considered to be an important reason for the loss of concentration and productivity in the workplace. Antigen-specific immunotherapy is an only available curative treatment against allergic rhinitis. Subcutaneous injection of allergens with or without adjuvant has been commonly used as an immunotherapy; however, recently, sublingual administration has come to be considered a safer and convenient alternative administration route of allergens. In this review, we focus on the safety and protocol of subcutaneous and sublingual immunotherapy against seasonal allergic rhinitis. We also describe an approach to selecting allergens for the vaccine so as to avoid secondary sensitization and adverse events. The biomarkers and therapeutic mechanisms for immunotherapy are not fully understood. We discuss the therapeutic biomarkers that are correlated with the improvement of clinical symptoms brought about by immunotherapy as well as the involvement of Tr1 and regulatory T cells in the therapeutic mechanisms. Finally, we focus on the current immunotherapeutic approach to treating Japanese cedar pollinosis, the most prevalent pollinosis in Japan, including sublingual immunotherapy with standardized extract, a transgenic rice-based edible vaccine, and an immunoregulatory liposome encapsulating recombinant fusion protein.

  9. New patents of fixed combinations of nasal antihistamines and corticosteroids in allergic rhinitis.

    Science.gov (United States)

    Wolthers, Ole D

    2013-09-01

    During the last few years, fixed combinations of intranasal antihistamines and corticosteroids have been introduced for treatment of allergic rhinitis. The aim of this systematic review was to assess recent patents and clinical evidence for fixed combinations of intranasal antihistamines and intranasal corticosteroids in allergic rhinitis. Data base searches revealed that intranasal combinations of the antihistamine azelastine with the corticosteroids mometasone furoate, ciclesonide and fluticasone propionate, respectively, have been patented. Four randomized, double-blinded, parallel-group, placebo-controlled, multicenter trials sponsored by the manufacturer evaluated the fixed combination of intranasal azelastine 125 µg and fluticasone propionate 50 µg administered as one dose per nostril b.i.d. in patients with moderate-to-severe symptomatic allergic rhinitis ≥ 12 years of age. Three of the studies were published as a meta-analysis which found the fixed combination of azelastine and fluticasone propionate statistically significantly more efficacious in reducing baseline total nasal symptom score by 5.7 as compared to azelastine (4.4; P antihistamines and corticosteroids are needed, especially, in primary care settings and in children before fixed combination treatment can be considered first line therapy in allergic rhinitis. Fixed combination treatment of azelastine and fluticasone propionate may offer additional benefit to selected populations of adolescents and adults with moderate-to-severe symptoms.

  10. Sublingual immunotherapy in children with allergic rhinitis : quality of systematic reviews

    NARCIS (Netherlands)

    de Bot, Cindy M. A.; Moed, Heleen; Berger, Marjolein Y.; Roeder, Esther; van Wijk, Roy G.; van der Wouden, Johannes C.

    2011-01-01

    Systematic reviews have gained popularity as a way to combine the increasing amount of research information. This study assessed the quality of systematic reviews and meta-analyses of sublingual immunotherapy (SLIT) for allergic rhinitis in children, published since 2000. Eligible reviews were ident

  11. Treating allergic rhinitis with depot-steroid injections increase risk of osteoporosis and diabetes

    DEFF Research Database (Denmark)

    Aasbjerg, Kristian; Torp-Pedersen, Christian; Vaag, Allan

    2013-01-01

    In Denmark, 23% of the adult population have allergic rhinitis. We have previously demonstrated that a majority of hay fever patients are treated with depot-steroid injections in violation of the guidelines. It has been hypothesised that 1-2 annual depot-steroid injections are not harmful...

  12. Inconclusive evidence for allergic rhinitis to predict a prolonged or chronic course of acute rhinosinusitis

    NARCIS (Netherlands)

    Frerichs, K.A.; Nigten, G.; Romeijn, K.; Kaper, N.M.; Grolman, W.; van der Heijden, G.J.M.G.

    2014-01-01

    Objective To systematically review the evidence on allergic rhinitis as a predictor for a prolonged or chronic course in adult patients with acute rhinosinusitis. Data Sources Pubmed, EMBASE, and the Cochrane library. Review Methods A systematic literature search was performed on March 15, 2013. Dur

  13. MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis

    NARCIS (Netherlands)

    Bousquet, Jean; Schünemann, Holger J; Hellings, Peter W; Arnavielhe, Sylvie; Bachert, Claus; Bedbrook, Anna; Bergmann, Karl-Christian; Bosnic-Anticevich, Sinthia; Brozek, Jan; Calderon, Moises; Canonica, G Walter; Casale, Thomas B; Chavannes, Niels H; Cox, Linda; Chrystyn, Henry; Cruz, Alvaro A; Dahl, Ronald; De Carlo, Giuseppe; Demoly, Pascal; Devillier, Phillipe; Dray, Gérard; Fletcher, Monica; Fokkens, Wytske J; Fonseca, Joao; Gonzalez-Diaz, Sandra N; Grouse, Lawrence; Keil, Thomas; Kuna, Piotr; Larenas-Linnemann, Désirée; Lodrup Carlsen, Karin C; Meltzer, Eli O; Mullol, Jaoquim; Muraro, Antonella; Naclerio, Robert N; Palkonen, Susanna; Papadopoulos, Nikolaos G; Passalacqua, Giovanni; Price, David; Ryan, Dermot; Samolinski, Boleslaw; Scadding, Glenis K; Sheikh, Aziz; Spertini, François; Valiulis, Arunas; Valovirta, Erkka; Walker, Samantha; Wickman, Magnus; Yorgancioglu, Arzu; Haahtela, Tari; Zuberbier, Torsten; Smit, HA

    2016-01-01

    The selection of pharmacotherapy for patients with allergic rhinitis (AR) depends on several factors, including age, prominent symptoms, symptom severity, control of AR, patient preferences, and cost. Allergen exposure and the resulting symptoms vary, and treatment adjustment is required. Clinical d

  14. Efficacy and safety of the probiotic Lactobacillus paracasei LP-33 in allergic rhinitis

    DEFF Research Database (Denmark)

    Costa, D J; Marteau, P; Amouyal, M;

    2014-01-01

    BACKGROUND/OBJECTIVES: An imbalance between Th1 and Th2 cells is involved in allergic rhinitis (AR) that may be improved by probiotics. To test the efficacy of the probiotic Lactobacillus paracasei subsp. paracasei LP-33, a double-blind, placebo-controlled, randomized trial was carried out...

  15. Hormetic Effect of Chronic Hypergravity in a Mouse Model of Allergic Asthma and Rhinitis

    Science.gov (United States)

    Jang, Tae Young; Jung, Ah-Yeoun; Kim, Young Hyo

    2016-06-01

    We aimed to evaluate the effect of chronic hypergravity in a mouse model of allergic asthma and rhinitis. Forty BALB/c mice were divided as: group A (n = 10, control) sensitized and challenged with saline, group B (n = 10, asthma) challenged by intraperitoneal and intranasal ovalbumin (OVA) to induce allergic asthma and rhinitis, and groups C (n = 10, asthma/rotatory control) and D (n = 10, asthma/hypergravity) exposed to 4 weeks of rotation with normogravity (1G) or hypergravity (5G) during induction of asthma/rhinitis. Group D showed significantly decreased eosinophils, neutrophils, and lymphocytes in their BAL fluid compared with groups B and C (p lung homogenate, the expression of IL-1β was significantly upregulated (p lung parenchyma and turbinate, and the thickness of respiratory epithelium was significantly reduced in group D (p < 0.05). The expression of Bcl-2 and heme oxygenase-1 were significantly downregulated, Bax and extracellular dismutase significantly upregulated in Group D. Therefore, chronic hypergravity could have a hormetic effect for allergic asthma and rhinitis via regulation of genes involved in antioxidative and proapoptotic pathways. It is possible that we could use hypergravity machinery for treating allergic respiratory disorders.

  16. Specific immunotherapy can greatly reduce the need for systemic steroids in allergic rhinitis

    DEFF Research Database (Denmark)

    Aasbjerg, Kristian; Torp-Pedersen, C; Backer, V

    2012-01-01

    Worldwide, more than 400 million individuals have allergic rhinitis, which has a significant impact on the individual's general health. Most patients self-medicate with over-the-counter drugs, but severe cases need treatment with topical corticosteroids and/or immunotherapy (SCIT). Although the A...

  17. Gene therapy for allergic rhinitis with recombinant adenovirus vector containing CTLA4Ig in mice

    Institute of Scientific and Technical Information of China (English)

    朱瑾; 吴军; 陈希炜; 易绍萱; 罗高兴; 贺伟峰

    2003-01-01

    Objective: To examine the role of recombinant adenovirus vector containing CTLA4Ig gene(Ad-CTLA4Ig) in the treatment of induced allergic rhinitis in mice.Methods: Allergic rhinitis was induced by sensitizing and challenging with ovalbumin(OVA).Ad-CTLA4Ig was intraperitoneally injected 30 min before OVA challenge.Adenovirus vector without inserted CTLA4Ig cDNA served as the control.The symptoms and morphological changes of nasal mucosa of each group were observed, and the serum levels of IgE against OVA were detected with ELISA.Results: There were no obvious symptoms and pathological changes in Ad-CTLA4Ig treated group, in which the serum OVA-specific IgE levels were significantly lower than that in control groups(P< 0.05).Conclusion: Ad-CTLA4Ig prevents and treats allergic rhinitis of mice,implying the possibility of the usage of Ad-CTLA4Ig against allergic rhinitis in clinic in future.

  18. ALLERGIC RHINITIS AND ADENOID HYPERTROPHY IN CHILDREN: IS ADENOIDECTOMY ALWAYS REALLY USEFUL?

    Science.gov (United States)

    Colavita, L; Miraglia Del Giudice, M; Stroscio, G; Visalli, C; Alterio, T; Pidone, C; Pizzino, M R; Arrigo, T; Chimenz, R; Salpietro, C; Cuppari, C

    2015-01-01

    Allergic rhinitis (AR) and adenoid hypertrophy (AH) are common in children and are often associated with each other. Recent studies have shown improvement of respiratory symptoms and reduction in the adenoid volume after anti-allergic medical therapy (intranasal corticosteroids, antihistamines). The aim of our retrospective study is to evaluate the effectiveness of adenoidectomy on respiratory symptoms in pediatric patients with AR. We recruited 404 pediatric patients with AR, and we divided them into 4 groups (1. intermittent-mild rhinitis; 2. intermittent-moderate/severe rhinitis; 3. persistent-mild rhinitis; 4. persistent-moderate/severe rhinitis), using ARIA classification. For each patient we evaluated: age at onset of AR; family history of allergy; the presence of other allergic diseases; serum total IgE values; skin prick test (SPT) results; presence of AH evaluated by rhino-laringeal fibroscopy; adenoidectomy and its efficacy on respiratory symptoms. Our data show an association between AR and AH: 90 of 404 (22%) children with AR had AH of a degree greater than 2nd. A significant percentage (80%) of children suffering from AR did not present satisfactory benefits from adenoidectomy. They reported persistence or recurrence of rhinitic symptoms after surgery or only partial benefits, especially of recurrent respiratory tract infections and nasal obstruction. The local allergic persistent inflammation on nasal mucosa and adenoid tissue is probably the cause of the unsatisfactory results of adenoidectomy, therefore surgery cannot be the first therapeutic step for these children. It is important to extinguish the local inflammation by medical anti-allergic therapy to obtain improvements of nasal symptoms and to prevent adenoid regrowth.

  19. Aeroallergens, atopy and allergic rhinitis in the Middle East.

    Science.gov (United States)

    Goronfolah, L

    2016-01-01

    The literature on the nature and prevalence of indoor and/or outdoor aeroallergens, atopy and symptoms of rhinitis and asthma in the Middle East region (defined here as Bahrain, Egypt, Iran, Iraq, Israel, Jordan, Kuwait, Lebanon, Oman, Palestine, Qatar, Kingdom of Saudi Arabia - KSA, Syria, United Arab Emirates and Yemen) was reviewed. Although documentation was poor in all countries other than Iran and the KSA, a wide range of "global" and "local" aeroallergens (grass, weed and tree pollens, fungal spores, insect allergens, dander, and house dust mites) has been observed across the region. The prevalence of current self-reported or parent-reported symptoms of rhinitis ranged from 9% to 38%. Researchers have suggested that the high atopy rates and self-reported rhinitis rates are associated with an on-going shift towards a "western" lifestyle.

  20. Specific immunotherapy (SIT in the treatment of allergic rhinitis

    Directory of Open Access Journals (Sweden)

    Gorenoi, Vitali

    2010-03-01

    Full Text Available Scientific background: Allergic rhinitis (AR exhibits a prevalence of approx. 20% in Germany and causes enormous costs in the health care system. Specific immunotherapy (SIT is considered to be the only potentially causal therapy for AR and mainly administered by two routes, subcutaneous (SCIT and sublinguale (SLIT. SIT promises a reduction of symptoms and the need for medication in patients with AR. Research questions: The question arises, to what extent is SIT effective and cost effective in the treatment of AR and which ethical-social and legal aspects have to be considered regarding its application. Methods: The literature search was accomplished in the electronic data bases MEDLINE, EMBASE etc. in February 2008. The medical evaluation was based on systematic reviews of blinded, randomised controlled studies (RCT. The economic evaluation included health-economic studies on the basis of RCT. Additionally, it was also searched for publications explicitly addressing ethical-social and legal aspects of the use of SIT. Results: Medical evaluationTwo reviews on SCIT and three on SLIT were included in the medical evaluation. For the evaluation of SIT with grass pollen results for short and medium-term effects are considered from several studies, for SIT with other seasonal allergens (e. g. tree pollen and with house dust mite allergens from clearly fewer studies and for SIT with other perennial allergens only from a few. The reviews report a significant reduction of the symptom and medication score in favour of SCIT with seasonal allergens and recognise the effectiveness at least for grass pollen allergens. Also for other seasonal allergens SCIT is appraised as effective. The reviews about SLIT determine a significant reduction of the symptom and the medication score in favour of SLIT vs. placebo in short and medium term follow-up in evaluations across all allergens. The subgroup analyses show a significant reduction of the symptom and medication

  1. Treatment of allergic rhinitis and urticaria: a review of the newest antihistamine drug bilastine

    Directory of Open Access Journals (Sweden)

    Wang XY

    2016-04-01

    Full Text Available Xue Yan Wang,1 Margaret Lim-Jurado,2 Narayanan Prepageran,3 Pongsakorn Tantilipikorn,4 De Yun Wang5 1Department of Allergy, Beijing Shijitan Hospital, Capital Medical University, Beijing, People’s Republic of China; 2St Luke’s Medical Center, Quezon City, Manila, Philippines; 3Department of Otorhinolaryngology, Head & Neck Surgery, University Malaya Faculty of Medicine, Kuala Lumpur, Malaysia; 4Rhinology and Allergy Division, Department of Otorhinolaryngology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand; 5Department of Otolaryngology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore Abstract: Allergic rhinitis and urticaria are common allergic diseases that may have a major negative impact on patients’ quality of life. Bilastine, a novel new-generation antihistamine that is highly selective for the H1 histamine receptor, has a rapid onset and prolonged duration of action. This agent does not interact with the cytochrome P450 system and does not undergo significant metabolism in humans, suggesting that it has very low potential for drug–drug interactions, and does not require dose adjustment in renal impairment. As bilastine is not metabolized and is excreted largely unchanged, hepatic impairment is not expected to increase systemic exposure above the drug’s safety margin. Bilastine has demonstrated similar efficacy to cetirizine and desloratadine in patients with seasonal allergic rhinitis and, in a Vienna Chamber study, a potentially longer duration of action than fexofenadine in patients with asymptomatic seasonal allergic rhinitis. It has also shown significant efficacy (similar to that of cetirizine and safety in the long-term treatment of perennial allergic rhinitis. Bilastine showed similar efficacy to levocetirizine in patients with chronic spontaneous urticaria and can be safely used at doses of up to fourfold higher than standard dosage (80 mg once daily. The

  2. Prevalence and risk factors for allergic rhinitis in two resource-limited settings in Peru with disparate degrees of urbanization

    Science.gov (United States)

    Baumann, L. M.; Romero, K. M.; Robinson, C. L.; Hansel, N. N.; Gilman, R. H.; Hamilton, R. G.; Lima, J. J.; Wise, R. A.; Checkley, W.

    2017-01-01

    Summary Background Allergic rhinitis is a disease with a high global disease burden, but risk factors that contribute to this condition are not well understood. Objective To assess the prevalence and risk factors of allergic rhinitis in two Peruvian populations with disparate degrees of urbanization. Methods We conducted a population-based, cross-sectional study on 1441 children aged 13–15 years at enrollment (mean age 14.9 years, 51% boys) to investigate the prevalence of allergic disease. We used a standardized, Spanish validated questionnaire to determine the prevalence of allergic rhinitis and asked about sociodemographics and family history of allergies. Children also underwent spirometry, exhaled nitric oxide, allergy skin testing to 10 common household allergens and provided a blood sample for measurement of 25OH vitamin D and total serum IgE. Results Overall prevalence of allergic rhinitis was 18% (95% CI 16% to 20%). When stratified by site, the prevalence of allergic rhinitis was 23% Lima vs. 13% in Tumbes (P eczema vs. 17% of those without eczema (P < 0.001). Important risk factors for allergic rhinitis were parental rhinitis (adjusted OR = 3.0, 95% CI 1.9–4.7 for 1 parent and adjusted OR = 4.4, 95% CI 1.5–13.7 for 2 parents); allergic sensitization to common household aeroallergens (1.6, 1.1–2.3); being overweight (1.5, 1.0–2.3); exhaled nitric oxide ≥20 ppb (1.9, 1.3–2.7); and total serum IgE ≥ 95th percentile (2.4, 1.2–4.8). Population attributable risk of important factors for allergic rhinitis were 25% for high exhaled nitric oxide, 22% for allergic sensitization to common household aeroallergens, 22% for paternal rhinitis, 10% for being overweight and 7% for an elevated total serum IgE. Conclusion and Clinical Relevance Allergic rhinitis was prevalent in both settings, and important risk factors include elevated exhaled nitric oxide, allergic sensitization to common household aeroallergens, parental rhinitis, being overweight and

  3. Cytotoxic T lymphocytes mediate chronic inflammation of the nasal mucosa of patients with atypical allergic rhinitis

    Directory of Open Access Journals (Sweden)

    Shuqi Qiu

    2011-01-01

    Full Text Available Background : The prevalence of chronic rhinitis is increasing rapidly; its pathogenesis is to be further understood; immune inflammation is one of the possible causative factors. Antigen specific CD8+ T cells play a critical role in the induction of chronic inflammation. Aims : This study aimed to investigate the role of antigen specific CD8+ T cells in the pathogenesis of chronic atypical allergic rhinitis. Material and Methods : Nasal mucosal epithelial surface scratching samples were obtained from patients with chronic obstruction atypical allergic rhinitis. Exosomes were purified from the scratching samples and examined by immune gold electron microscopy. The effect of exosomes on modulating dendritic cell′s properties, the effect of exosome-pulsed dendritic cells on naïve T cell differentiation and the antigen specific CD8+ T cell activation were observed by cell culture models. Results : Exosomes purified from patients with chronic atypical allergic rhinitis carried microbial products, Staphylococcal enterotoxin B (SEB, and airborne antigen, Derp1. Dendritic cells pulsed by SEB/Derp1-carrying exosomes showed high levels of CD80, CD86 and the major histocompatibility class I (MHCI. Exosome-pulsed dendritic cells could induce the naïve CD3+ T cells to differentiate into CD8+ T cells. Upon the exposure to a specific antigen, the CD8+ T cells released granzyme B and perforin; more than 30% antigen specific CD8+ T cells proliferated. Conclusions : Antigen specific CD8+ T cells play an important role in the pathogenesis of chronic obstruction atypical allergic rhinitis.

  4. How to design and evaluate randomized controlled trials in immunotherapy for allergic rhinitis: an ARIA-GA(2) LEN statement

    DEFF Research Database (Denmark)

    Bousquet, J; Schünemann, H J; Bousquet, P J;

    2011-01-01

    Specific immunotherapy (SIT) is one of the treatments for allergic rhinitis. However, for allergists, nonspecialists, regulators, payers, and patients, there remain gaps in understanding the evaluation of randomized controlled trials (RCTs). Although treating the same diseases, RCTs in SIT...

  5. Evaluation of effectiveness of specific subcutaneous immunotherapy for patients with allergic rhinitis and asthma

    Directory of Open Access Journals (Sweden)

    Mohammad Reza Zandkarimi

    2013-06-01

    Full Text Available Background: Allergen immunotherapy involves the administration of gradually increasing quantities of specific allergens to patients with IgE-mediated conditions until a dose is reached that is effective in reducing disease severity from natural exposure. This study evaluated the clinical efficacy of immunotherapy with extracts of common aeroallergens North-East of Iran in asthma and allergic rhinitis. Material and Methods: In this prospective study 156 cases were chosen randomley. The mean age of patients was 37 years (range 5-65 years. The patients with mild to moderate asthma and allergic rhinitis and history of atopy were selected for immunotherapy when they showed no effective response to medical treatment.Immunotherapy materials were made from common aeroallergens in north-eastern region of Iran by Dome Hollister US company. Immunotherapy schedule for injection of the extract with vial dilution of 1:10000pg was one injection every week for ten weeks and one injection with dilution of 1:1000pg every other week for the other ten weeks and one injection monthly from dilution of 1:100pg for two years. Results: One hundred twenty (77% of cases had allergic rhinitis 29(18.5% cases had allergic asthma and 7(4.5% cases were mixed. Mean age of patients were 37 years old. 48(30.8% cases were male. Analysis of efficacy of treatment showed that immunotherapy significantlyimproved the signs and symptoms of all the groups. In allergic rhinitis group 84(70% cases completely improved, 22(18.4% patients moderately responded and no response to immunotherapy was observed in 14(11.6% patients. In allergic asthma group, 22(75% cases completely improved 4(13.6% cases moderately responded and no response to immunotherapy was detected in 3(11.4% cases. In mixed group, 3(42.8% cases completely improved, 3(42.8% cases moderately responded and no response was observed in 1(14.4% case. Conclusion: Specific allergen immunotherapy for patients with allergic persistent

  6. Mouse Model of Cat Allergic Rhinitis and Intranasal Liposome-Adjuvanted Refined Fel d 1 Vaccine.

    Directory of Open Access Journals (Sweden)

    Natt Tasaniyananda

    Full Text Available Cats (Felis domesticus are rich source of airborne allergens that prevailed in the environment and sensitized a number of people to allergy. In this study, a mouse model of allergic rhinitis caused by the cat allergens was developed for the first time and the model was used for testing therapeutic efficacy of a novel intranasal liposome-entrapped vaccines made of native Fel d 1 (major cat allergen in comparison with the vaccine made of crude cat hair extract (cCE. BALB/c mice were sensitized with cCE mixed with alum intraperitoneally and intranasally. The allergic mice were treated with eight doses of either liposome (L-entrapped native Fel d 1 (L-nFD1, L-cCE, or placebo on every alternate day. Vaccine efficacy evaluation was performed one day after provoking the treated mice with aerosolic cCE. All allergenized mice developed histological features of allergic rhinitis with rises of serum specific-IgE and Th2 cytokine gene expression. Serum IgE and intranasal mucus production of allergic mice reduced significantly after vaccination in comparison with the placebo mice. The vaccines also caused a shift of the Th2 response (reduction of Th2 cytokine expressions towards the non-pathogenic responses: Th1 (down-regulation of the Th1 suppressive cytokine gene, IL-35 and Treg (up-regulation of IL-10 and TGF-β. In conclusions, a mouse model of allergic rhinitis to cat allergens was successfully developed. The intranasal, liposome-adjuvanted vaccines, especially the refined single allergen formulation, assuaged the allergic manifestations in the modeled mice. The prototype vaccine is worthwhile testing further for clinical use in the pet allergic patients.

  7. Mouse Model of Cat Allergic Rhinitis and Intranasal Liposome-Adjuvanted Refined Fel d 1 Vaccine

    Science.gov (United States)

    Tasaniyananda, Natt; Chaisri, Urai; Tungtrongchitr, Anchalee; Chaicumpa, Wanpen; Sookrung, Nitat

    2016-01-01

    Cats (Felis domesticus) are rich source of airborne allergens that prevailed in the environment and sensitized a number of people to allergy. In this study, a mouse model of allergic rhinitis caused by the cat allergens was developed for the first time and the model was used for testing therapeutic efficacy of a novel intranasal liposome-entrapped vaccines made of native Fel d 1 (major cat allergen) in comparison with the vaccine made of crude cat hair extract (cCE). BALB/c mice were sensitized with cCE mixed with alum intraperitoneally and intranasally. The allergic mice were treated with eight doses of either liposome (L)-entrapped native Fel d 1 (L-nFD1), L-cCE), or placebo on every alternate day. Vaccine efficacy evaluation was performed one day after provoking the treated mice with aerosolic cCE. All allergenized mice developed histological features of allergic rhinitis with rises of serum specific-IgE and Th2 cytokine gene expression. Serum IgE and intranasal mucus production of allergic mice reduced significantly after vaccination in comparison with the placebo mice. The vaccines also caused a shift of the Th2 response (reduction of Th2 cytokine expressions) towards the non-pathogenic responses: Th1 (down-regulation of the Th1 suppressive cytokine gene, IL-35) and Treg (up-regulation of IL-10 and TGF-β). In conclusions, a mouse model of allergic rhinitis to cat allergens was successfully developed. The intranasal, liposome-adjuvanted vaccines, especially the refined single allergen formulation, assuaged the allergic manifestations in the modeled mice. The prototype vaccine is worthwhile testing further for clinical use in the pet allergic patients. PMID:26954254

  8. Effects of a Spirulina-based dietary supplement on cytokine production from allergic rhinitis patients.

    Science.gov (United States)

    Mao, T K; Van de Water, J; Gershwin, M E

    2005-01-01

    Spirulina represents a blue-green alga that is widely produced and commercialized as a dietary supplement for modulating immune functions, as well as ameliorating a variety of diseases. We have previously shown that the in vitro culture of Spirulina with human peripheral blood mononuclear cells (PBMCs) modulated the production of cytokines. In the present study, we evaluated the impact of a Spirulina-based dietary supplement (Earthrise Nutritionals, Inc., Irvine, CA) on patients with allergic rhinitis by assessing the production of cytokines [interleukin (IL)-4, interferon (IFN)-gamma, and IL-2] critical in regulating immunoglobulin E-mediated allergy. In a randomized double-blinded crossover study versus placebo, allergic individuals were fed daily with either placebo or Spirulina, at 1,000 mg or 2,000 mg, for 12 weeks. PBMCs isolated before and after the Spirulina feeding were stimulated with phytohemagglutinin (PHA) prior to determining the levels of cytokine from cell culture supernatants. Although Spirulina seemed to be ineffective at modulating the secretion of Th1 cytokines (IFN-gamma and IL-2), we discovered that Spirulina, administered at 2,000 mg/day, significantly reduced IL-4 levels by 32% from PHA-stimulated cells. These results indicate that Spirulina can modulate the Th profile in patients with allergic rhinitis by suppressing the differentiation of Th2 cells mediated, in part, by inhibiting the production of IL-4. To our knowledge, this is the first human feeding study that demonstrates the protective effects of Spirulina towards allergic rhinitis.

  9. Concealing Emotions at Work Is Associated with Allergic Rhinitis in Korea.

    Science.gov (United States)

    Seok, Hongdeok; Yoon, Jin-Ha; Won, Jong-Uk; Lee, Wanhyung; Lee, June-Hee; Jung, Pil Kyun; Roh, Jaehoon

    2016-01-01

    Concealing emotions at work can cause considerable psychological stress. While there is extensive research on the adverse health effects of concealing emotions and the association between allergic diseases and stress, research has not yet investigated whether concealing emotions at work is associated with allergic rhinitis. Allergic rhinitis is a common disease in many industrialized countries, and its prevalence is increasing. Thus, our aim was to determine the strength of this association using data from three years (2007-2009) of the 4th Korean National Health and Nutrition Examination Survey. Participants (aged 20-64) were 8,345 individuals who were economically active and who had completed the questionnaire items on concealing emotions at work. Odds ratio (OR) and 95% confidence intervals (95% CIs) were calculated for allergic rhinitis using logistic regression models. Among all participants, 3,140 subjects (37.6%) reported concealing their emotions at work: 1,661 men and 1,479 women. The OR (95% CIs) for allergic rhinitis among those who concealed emotions at work versus those who did not was 1.318 (1.148-1.512). Stratified by sex, the OR (95% CIs) was 1.307 (1.078-1.585) among men and 1.346 (1.105-1.639) among women. Thus, individuals who concealed their emotions at work were significantly more likely to have a diagnosis of AR in comparison to those who did not. Because concealing emotions at work has adverse health effects, labor policies that aim to reduce this practice are needed.

  10. An overview of the novel H1-antihistamine bilastine in allergic rhinitis and urticaria.

    Science.gov (United States)

    Jáuregui, Ignacio; García-Lirio, Eduardo; Soriano, Ana María; Gamboa, Pedro M; Antépara, Ignacio

    2012-01-01

    Currently available second-generation H1-antihistamines include a wide group of drugs with a better therapeutic index (or risk-benefit ratio) than the classic antihistamines, although their properties and safety profiles may differ. Bilastine is a newly registered H1-antihistamine for the oral treatment of allergic rhinitis and urticaria, with established antihistaminic and antiallergic properties. Clinical studies in allergic rhinitis and chronic urticaria show that once-daily treatment with bilastine 20 mg is effective in managing symptoms and improving patient's quality of life, with at least comparable efficacy to other nonsedative H1-antihistamines. As far as studies in healthy volunteers, clinical assays and clinical experience can establish, bilastine's safety profile is satisfactory, since it lacks anticholinergic effects, does not impair psychomotor performance or actual driving, and appears to be entirely free from cardiovascular effects.

  11. Critical appraisal of Timothy grass pollen extract GRAZAX in the management of allergic rhinitis.

    Science.gov (United States)

    Scaparrotta, Alessandra; Attanasi, Marina; Petrosino, Marianna I; Di Filippo, Paola; Di Pillo, Sabrina; Chiarelli, Francesco

    2015-01-01

    Allergic rhinitis is one of the most common diseases of adult and pediatric age, associated with grass pollen (GP) allergy in >50% cases, with a consistent impact on quality of life of affected patients. A grass allergen tablet, containing standardized extract derived from Timothy grass (Phleum pratense) pollen and ~15 μg major allergen P. pratense (rPhl p 5), may be the future of allergen-specific immunotherapy (IT) for GP allergy. The aim of this review was to critically evaluate the role of Timothy GP extract IT for the management of allergic rhinitis. For this purpose, we have tried to analyze potential mechanisms of action at the basis of Timothy GP extract, we have reviewed efficacy studies to establish potential benefits and clinical response, and we have also evaluated safety and tolerability profiles and patient focus perspective, such as quality of life, satisfaction and acceptability, and compliance to this IT.

  12. Once daily levocetirizine for the treatment of allergic rhinitis and chronic idiopathic urticaria

    Directory of Open Access Journals (Sweden)

    E Nettis

    2008-12-01

    Full Text Available E Nettis1, G F Calogiuri2, E Di Leo1, F Cardinale3, L Macchia1, A Ferrannini1, A Vacca1,41Section of Allergology and Clinical Immunology, Department of Internal Medicine and Infectious Diseases; 24th Pneumology Department, Pneumologic Hospital A Galateo, San Cesario di Lecce, Italy; 3Department of Biomedicina dell’Età Evolutiva, Pediatrics Unit “S Maggiore”; 4Department of Internal Medicine and Clinical Oncology, University of Bari Medical School, Bari, ItalyAbstract: Levocetirizine is the pharmacologically active enantiomer of cetirizine. It is a potent histamine H-1 receptor antagonist with anti-inflammatory and antiallergic properties. The review analyses the levocetirizine’s properties in terms of safety and efficacy both in allergic rhinitis and urticarioid syndromes.Keywords: allergic rhinitis, chronic idiopatic urticaria, levocetirizine

  13. Efficacy comparison of cetirizine and loratadine for allergic rhinitis in children

    Directory of Open Access Journals (Sweden)

    Juliana

    2012-03-01

    Full Text Available Background Allergic rhinitis represents a global health problem affecting 10% to more than 40% of the population worldwide. Several studies in recent years have described the efficacy of second-generation antihistamines in younger children. It is not well established whether cetirizine is more effective than loratadine in reducing symptoms of allergic rhinitis. Objective The objective of this study was to compare the efficacy of loratadine with cetirizine for treatment of allergic rhinitis. Methods We conducted a randomized, double-blind, controlled trial of 100 children, aged 13 to 16 years, from October to November 2009 at two junior high schools in Medan. Group I received 10 mg of cetirizine and group II received 10 mg of loratadine, each once daily in the morning for 14 days. Drug efficacy was assessed by changes from baseline symptom scores and evaluation of therapeutic responses after 3 days, 7 days and 14 days of treatment. Results The efficacy of cetirizine compared to that of loratadine was not statistically significant in diminishing nasal symptoms after 3 days, 7 days and 14 days of treatment (P=0.40, P=0.07, and P=0.057, respectively. Evaluation of side effects, however, revealed significantly fewer headaches in the cetirizine group after 3 days and 7 days of treatment (P=0.01 and P=0.03, respectively than in the loratidine group. In addition, the loratadine group had significantly more instances of palpitations after 7 days of treatment (P=0.04 compared to the cetirizine group. Conclusion There was no significant difference in cetirizine and loratadine treatment effectiveness on allergic rhinitis. However, loratadine was found to cause more headaches and palpitations than cetirizine. [Paediatr Indones. 2012;52:61-6].

  14. COMPARISON OF PARTIAL INFERIOR TURBINECTOMY AND SUBMUCOSAL DIATHERMY FOR HYPERTROPHIED INFERIOR TURBINATE IN ALLERGIC RHINITIS PATIENTS

    Directory of Open Access Journals (Sweden)

    Smitha Chandra

    2015-07-01

    Full Text Available BACKGROUND : The inferior turbinate is the first point of contact of allergen in the nose. In patients with allergic rhinitis the turbinate hypertrophies and its mucosa becomes purplish edematous. This leads to significant obstruction of airway. Hence reduction of this hypertrophied inferior turbinate is essential. AIM: To analyze & evaluate the efficacy of sub mucosal diathermy and partial inferior turbinectomy in the treatment of symptomatic hypertrophied inferior turbinates in allergic rhinitis patients in a rural setup. METHODS AND MATERIAL S: A prospective clinical study of 132 patients between age group of 15 - 55 years of eith er sex were enrolled in the study with bilateral Inferior. Turbinate Hypertrophy who had history of failed medical line of treatment. After informing , the patients were randomized into two groups to eliminate bias byallotting them alternately into the groups. Patients in Group I underwent. Submucosal diathermy and Group II patients underwent Partial Inferior. Turbinectomy. Postoperative follow up was done at regular intervals by objective& subjective assessment. STATISTICAL ANALYSIS USED: Friedman test and Ch i Square test were used for statistical analysis. RESULTS: In group I significant improvement of nasal airflow was seen in 14% patients & 85.9% had moderate improvement. In group II 41.3% of patients had significant improvement & 58.6% had moderate i mprovement. Statistically by analyzing the ranks of subjective nasal obstruction and objective nasal obstruction of Group - I & Group - IIwe conclude that Group - II subjects showed more improvement than Group I. CONCLUSIONS: Various surgical methods have been t ried for enlarged inferior turbinate secondary to allergic rhinitis. Of them the well - known techniques are s ubmucosal Diathermy & Partial Inferior Turbinectomy. In this study Partial Inferior Turbinectomy was found to be more effective in relieving nasal ob structionin allergic rhinitis patients for

  15. Prevalence of allergic rhinitis in Filipino adults based on the National Nutrition and Health Survey 2008

    Science.gov (United States)

    Kwong, Shirley L.; Alava, Hilda Diana A.; Castor, Mary Anne R.; De Leon, Julia C.

    2012-01-01

    Background There has been no documented data on the prevalence of allergic rhinitis among Filipino adults. Objective The objective of this study is to determine the prevalence of allergic rhinitis among adults in the Philippines. Methods Using a multi-staged cluster sampling methodology, this study evaluated 7,202 adults from 3,744 households, 79 provinces and 17 regions. A pre-validated written questionnaire for allergic rhinitis based on the International Study of Asthma and Allergies of Childhood was used as the survey instrument. Results The response rate obtained from the interview was 94.1%. The overall prevalence of nose symptoms in the past 12 months was 20% while prevalence of nose symptoms at any time in the past was 23.8%. The proportion among both sexes was similar. The prevalence was highest among the respondents 40-49 years old. The overall prevalence of nose and eye symptoms for the past twelve months was 14.0%. The prevalence of respondents who reported presence of nose problems for the past twelve months was similar across the 12 months of the year with highest rates noted in the months of June and May. Respondents from the rural area (22.1%) reported a higher prevalence of nose symptoms for the past twelve months compared to respondents from urban area (18%). There was no significant difference in prevalence of nose symptoms among residents living in coastal and/or inland areas. Conclusion The overall prevalence of allergic rhinitis in the Philippines based on the 2008 National Nutrition and Health Survey is 20.0%. PMID:22701863

  16. A possible role for neutrophils in allergic rhinitis revealed after cellular subclassification

    Science.gov (United States)

    Arebro, Julia; Ekstedt, Sandra; Hjalmarsson, Eric; Winqvist, Ola; Kumlien Georén, Susanna; Cardell, Lars-Olaf

    2017-01-01

    A re-examination of former concepts is required to meet today’s medical challenges in allergic rhinitis. Previously, neutrophils have been treated as a relatively homogenous cell population found in the nose both when the patient is suffering at the height of the allergic season as well as when the patient report no symptoms. However, new data indicates that neutrophils can be divided into different subsets with diverse roles in inflammation. We showed increased levels of neutrophils in peripheral blood, nasal biopsies and nasal lavage fluid (NAL) from allergic patients during the pollen season compared to healthy controls. A closer examination revealed that the activated subset of neutrophils, CD16high CD62Ldim, outweighed the normal form CD16high CD62Lhigh in nasal tissue among these patients. This skewed distribution was not seen in controls. The normal subset prevailed in peripheral blood from patients as well as controls, whereas CD16high CD62Ldim and CD16dim CD62Ldim subsets, the latter considered “end state” neutrophils before apoptosis, were elevated in NAL. Functional in vitro experiments revealed that activated neutrophils exhibit a T cell priming capacity and an ability to enhance eosinophil migration. Activated neutrophils may thus contribute to allergic inflammation seen in allergic rhinitis by priming T cells and attracting eosinophils. PMID:28272395

  17. EFFECT OF SHADBINDU GHRITA NASYA AND HARIDRAKHANDA IN PRATISHYAYA: ALLERGIC RHINITIS

    Directory of Open Access Journals (Sweden)

    Sandhya Rani. D

    2013-10-01

    Full Text Available Among Nasagath Rogas, most of the acharyas described pratishyaya with its complications which proves the seriousness of the disease. Acharya susrutha clearly mentioned in Uttar tantra that Pratishyaya is the disease condition in which Vata and Kapha dusti was observed. Allergic Rhinitis is a disease characterized by sudden and frequent attacks of sneezing, profuse watery nasal discharge associated with nasal obstruction which is intermittent, watering of the eyes, heaviness of head, respiratory distress and anosmia. The present study aims to comparatively evaluate the clinical efficacy of shadbindu gritha nasya with haridra khanda internally in pratishayaya. The principle objective of the study is to find a most effective, economical and simple treatment for pratishayaya. Here 45 patients of pratishyaya- Allergic Rhinitis were treated in 3 groups. 15 patient of group A treated with Shadbindu gritha Nasya. 15 patient of group B treated with Haridrakhanda orally. 15 patient of group C treated with both Shadbindu gritha nasya and haridrakhanda as a combined therapy. After the enrollment of the patients in the study, vital signs and symptoms of Pratishyaya-Allergic rhinitis such as Nasa srava, Khavatu, Nasa avarodha, gala talu shuskata, were studied before and after the treatment. The results of the study indicated that the group c bestowed with highly significant relief in almost all the signs and symptoms in comparison to group A and group B.

  18. Allergic rhinitis and asthma: inflammation in a one-airway condition

    Directory of Open Access Journals (Sweden)

    Haahtela Tari

    2006-11-01

    Full Text Available Abstract Background Allergic rhinitis and asthma are conditions of airway inflammation that often coexist. Discussion In susceptible individuals, exposure of the nose and lungs to allergen elicits early phase and late phase responses. Contact with antigen by mast cells results in their degranulation, the release of selected mediators, and the subsequent recruitment of other inflammatory cell phenotypes. Additional proinflammatory mediators are released, including histamine, prostaglandins, cysteinyl leukotrienes, proteases, and a variety of cytokines, chemokines, and growth factors. Nasal biopsies in allergic rhinitis demonstrate accumulations of mast cells, eosinophils, and basophils in the epithelium and accumulations of eosinophils in the deeper subepithelium (that is, lamina propria. Examination of bronchial tissue, even in mild asthma, shows lymphocytic inflammation enriched by eosinophils. In severe asthma, the predominant pattern of inflammation changes, with increases in the numbers of neutrophils and, in many, an extension of the changes to involve smaller airways (that is, bronchioli. Structural alterations (that is, remodeling of bronchi in mild asthma include epithelial fragility and thickening of its reticular basement membrane. With increasing severity of asthma there may be increases in airway smooth muscle mass, vascularity, interstitial collagen, and mucus-secreting glands. Remodeling in the nose is less extensive than that of the lower airways, but the epithelial reticular basement membrane may be slightly but significantly thickened. Conclusion Inflammation is a key feature of both allergic rhinitis and asthma. There are therefore potential benefits for application of anti-inflammatory strategies that target both these anatomic sites.

  19. Critical appraisal of Timothy grass pollen extract GRAZAX® in the management of allergic rhinitis

    Directory of Open Access Journals (Sweden)

    Scaparrotta A

    2015-11-01

    Full Text Available Alessandra Scaparrotta, Marina Attanasi, Marianna I Petrosino, Paola Di Filippo, Sabrina Di Pillo, Francesco Chiarelli Department of Pediatrics, University of Chieti, Chieti, Italy Abstract: Allergic rhinitis is one of the most common diseases of adult and pediatric age, associated with grass pollen (GP allergy in >50% cases, with a consistent impact on quality of life of affected patients. A grass allergen tablet, containing standardized extract derived from Timothy grass (Phleum pratense pollen and ~15 µg major allergen P. pratense (rPhl p 5, may be the future of allergen-specific immunotherapy (IT for GP allergy. The aim of this review was to critically evaluate the role of Timothy GP extract IT for the management of allergic rhinitis. For this purpose, we have tried to analyze potential mechanisms of action at the basis of Timothy GP extract, we have reviewed efficacy studies to establish potential benefits and clinical response, and we have also evaluated safety and tolerability profiles and patient focus perspective, such as quality of life, satisfaction and acceptability, and compliance to this IT. Keywords: Timothy grass pollen extract, allergic rhinitis, Grazax, efficacy, safety, compliance

  20. Effective treatment of house dust mite-induced allergic rhinitis with 2 doses of the SQ HDM SLIT-tablet

    DEFF Research Database (Denmark)

    Demoly, Pascal; Emminger, Waltraud; Rehm, Dorte

    2016-01-01

    BACKGROUND: The SQ HDM SLIT-tablet (ALK) has been developed for treatment of house dust mite (HDM)-induced respiratory allergic disease. OBJECTIVE: This trial investigated the efficacy and safety of the SQ HDM SLIT-tablet in adults with moderate-to-severe HDM-induced allergic rhinitis (AR). METHODS...

  1. Repeated intranasal TLR7 stimulation reduces allergen responsiveness in allergic rhinitis

    Directory of Open Access Journals (Sweden)

    Greiff Lennart

    2012-06-01

    Full Text Available Abstract Background Interactions between Th1 and Th2 immune responses are of importance to the onset and development of allergic disorders. A Toll-like receptor 7 agonist such as AZD8848 may have potential as a treatment for allergic airway disease by skewing the immune system away from a Th2 profile. Objective To evaluate the efficacy and safety of intranasal AZD8848. Methods In a placebo-controlled single ascending dose study, AZD8848 (0.3-600 μg was given intranasally to 48 healthy subjects and 12 patients with allergic rhinitis (NCT00688779. In a placebo-controlled repeat challenge/treatment study, AZD8848 (30 and 60 μg was given once weekly for five weeks to 74 patients with allergic rhinitis out of season: starting 24 hours after the final dose, daily allergen challenges were given for seven days (NCT00770003. Safety, tolerability, pharmacokinetics, and biomarkers were monitored. During the allergen challenge series, nasal symptoms and lavage fluid levels of tryptase and α2-macroglobulin, reflecting mast cell activity and plasma exudation, were monitored. Results AZD8848 produced reversible blood lymphocyte reductions and dose-dependent flu-like symptoms: 30–100 μg produced consistent yet tolerable effects. Plasma interleukin-1 receptor antagonist was elevated after administration of AZD8848, reflecting interferon production secondary to TLR7 stimulation. At repeat challenge/treatment, AZD8848 reduced nasal symptoms recorded ten minutes after allergen challenge up to eight days after the final dose. Tryptase and α2-macroglobulin were also reduced by AZD8848. Conclusions Repeated intranasal stimulation of Toll-like receptor 7 by AZD8848 was safe and produced a sustained reduction in the responsiveness to allergen in allergic rhinitis. Trial registration NCT00688779 and NCT00770003 as indicated above.

  2. Rhinitis symptoms and IgE sensitization as risk factors for development of later allergic rhinitis in adults

    DEFF Research Database (Denmark)

    Bodtger, U; Poulsen, Lars K.; Linneberg, A

    2006-01-01

    Rhinitis symptoms and IgE-sensitization often mismatch. Asymptomatic sensitization is an established risk factor for later rhinitis, whereas it is not clear whether rhinitis is a risk factor for later development of IgE-sensitization.......Rhinitis symptoms and IgE-sensitization often mismatch. Asymptomatic sensitization is an established risk factor for later rhinitis, whereas it is not clear whether rhinitis is a risk factor for later development of IgE-sensitization....

  3. Local cytokines and clinical symptoms in children with allergic rhinitis after different treatments

    Directory of Open Access Journals (Sweden)

    Gesmar RS Segundo

    2009-10-01

    Full Text Available Gesmar RS Segundo1, Fabíola A Gomes2, Karla P Fernandes1, Ronaldo Alves3, Deise AO Silva3, Ernesto A Taketomi31Department of Pediatrics, 2Department of Nursery, 3Laboratory of Allergy and Clinical Immunology, Universidade Federal de Uberlandia, Uberlandia, BrazilBackground: Therapy for allergic rhinitis aims to control symptoms and improve the quality of life. The treatment of allergic rhinitis includes allergen avoidance, environmental controls, pharmacologic treatment, and specific immunotherapy.Objectives: The aim of this study is to evaluate the clinical changes and the levels of interferon-γ (IFN-γ and interleukin-5 (IL-5 in nasal lavage fluid from children with allergic rhinitis after different types of pharmacologic treatment (mometasone, montelukast, or desloratadine.Methods: Twenty-four children aged from six to 12 years with moderate persistent allergic rhinitis were randomized into three groups receiving monotherapy treatment over four weeks: nasal corticosteroid (mometasone, leukotriene modifier (montelukast, or antihistamine (desloratadine. The perception of symptom improvement during the medication use was evaluated at the end of the treatment. Samples of nasal lavage fluid were collected before and after treatment for measuring IFN-γ and IL-5 cytokines by ELISA.Results: All parents perceived an improvement in symptoms. Significant enhancement was seen in the mometasone group compared to those with montelukast (P = 0.01 and desloratadine (P = 0.02. No significant differences were found among the three groups in the levels of IL-5 and IFN-γ in nasal fluid at baseline or after treatment. Only the group treated with mometasone showed a slight but significant reduction in IL-5 levels after the treatment period as compared with levels before the treatment (P = 0.0469.Conclusion: The group treated with mometasone showed better improvement of clinical symptoms and a slight reduction in IL-5 levels in the nasal fluid. This may

  4. IQ Score of Children with Persistent or Perennial Allergic Rhinitis: A Comparison with Healthy Children

    Directory of Open Access Journals (Sweden)

    Javad GHAFFARI

    2014-07-01

    Full Text Available How to Cite This Article: Ghaffari J, Abbaskhanian A, Jalili M, Yazdani Charati Y. IQ Score of Children With Persistent or Perennial Allergic Rhinitis: Comparison with Healthy Children. Iran J Child Neurol. 2014 Summer; 8(3: 44-48. AbstractObjectivePrevalence of allergies is different around the world. Allergic rhinitis is a common chronic disease in children.Intelligence quotient (IQ is an indicator of efficacy and many factors including chronic diseases may affect it. This study compares the IQs of children diagnosed with persistent or perennial allergic rhinitis with healthy children.Material & MethodsThis was a comparative study that was conducted from June 2011–May 2013 in an academic referral clinic. In this study, 90 patients aged 6- to 14-yearsold who were diagnosed with persistent or perennial allergic rhinitis and were compared to 90 age and gender match healthy patients from their respective families. The Wechsler Intelligence Scale for hildren was used to divide and calculate overall IQ, verbal IQ, and practical IQ. The t-test and chi square were used to analyze quantitative variables and qualitative variables, respectively.Results In this study, out of total 180 children, 90 (50% in the case group and 90 children (50%, the control group participated for IQ comparison. One hundred (57% were male and 80 (43% were female. The overall IQ for allergic rhinitis patients and healthy patients was 109.2 and 107.5, respectively. This difference was not considered significant. Furthermore, there was no significant difference between the IQ scores of males and females.ConclusionAlthough allergic rhinitis is a chronic disease and effects quality of life, there were no identifiable negative effects on IQ.  ReferencesGhaffari J, Mohammadzadeh I, Khaliian A, Rafatpanah H, Mohammadjafari H, Davoudi A. Prevalence of asthma, allergic rhinitis and eczema in elementary schools in Sari(Iran. Caspian Journal of Internal Medicine

  5. Allergic Rhinitis and Associated Comorbidities: Prevalence in Oman with Knowledge Gaps in Literature

    Directory of Open Access Journals (Sweden)

    Rashid Al-Abri

    2014-11-01

    Full Text Available Objectives: Allergic rhinitis (AR is a global health problem and its impact on health related quality of life for patients is substantial, and the economic impact often underestimated. The prevalence of allergic rhinitis in Oman is unknown. This study aimed to estimate the prevalence of AR and associated co-morbidities among adults in Oman. Its secondary objective was to identify knowledge gaps in the literature with the aim of directing future research. Methods: A prospective, cross-sectional study of patients who presented to the outpatient otolaryngology clinic at Sultan Qaboos University Hospital with nasal symptoms between June 2010 and June 2011 was conducted. Results: A total of 887 patients were seen with nasal complaints. Among them 127 patients were diagnosed with non-infective rhinitis, the mean age of presentation was 27 years. AR was noted in 48% of patients, and non-allergic rhinitis in 52%. The prevalence of AR was 7%, with females being more affected than males, and age ranging from 18 to 51 years. Prevalence of perennial AR was 84% compared to seasonal AR which was 16%. The most common perennial antigens were house dust mites (80% followed by cockroaches (67%. All patients diagnosed with seasonal AR were found to be sensitive to Russian thistle. The prevalence of chronic rhinosinusitis in patients with AR was 34%. Conclusion: The prevalence of AR in the adult population presenting with nasal symptoms was found to be 7%, with associated chronic rhinosinusitis present in a third of these patients. However, there appears to be substantial knowledge gaps regarding the association of other comorbidities, like otitis media, bronchitis and bronchial asthma, the long-term outcomes of medical management, and indication of surgical intervention in patients with AR. Future research in AR among Omani patients should aim to address these issues.

  6. Current issues on sublingual allergen-specific immunotherapy in children with asthma and allergic rhinitis

    Directory of Open Access Journals (Sweden)

    Živković Zorica

    2016-01-01

    Full Text Available In 1993 the European Academy of Allergy and Clinical Immunology was the first official organization to recognize that sublingual administration could be “promising route” for allergic desensitization. A few years later, the World Health Organization recommended this therapy as “a viable alternative to the injection route in adults.” The first meta-analysis showed sublingual allergen specific immunotherapy (SLIT effectiveness for allergic rhinitis and another study showed SLIT can actually help prevent the development of asthma both in adults and in children. The main goal of this review article is to present insight into the most up-to-date understanding of the clinical efficacy and safety of immunotherapy in the treatment of pediatric patients with allergic rhinitis and asthma. A literature review was performed on PubMed from 1990 to 2015 using the terms “asthma,” “allergic rhinitis,” “children,” “allergen specific immune therapy.” Evaluating data from double-blind placebo-controlled randomized clinical trials (DB-PC-RCTs, the clinical efficacy (assessed as the reduction of symptom score and the need of rescue medicament of SLIT for allergic rhinitis and allergic asthma, has been confirmed in various meta-analysis Outcomes such as rhinoconjunctivitis score and medication scores, combined scores, quality of life, days with severe symptoms, immunological endpoints, and safety parameters were all improved in the SLIT-tablet compared with placebo group. SLIT safety has been already proven in many DB-PC-RCTs and real-life settings. In accordance with all of the above mentioned, the goals for future trials and studies are the development of comprehensive guidelines for clinical practice on immunotherapy, embracing all the different potential participants. The importance of allergen immunotherapy is of special relevance in the pediatric age, when the plasticity and modulability of the immune system are maximal, and when

  7. Inhibitory Effect of Pycnogenol® on Airway Inflammation in Ovalbumin-Induced Allergic Rhinitis

    Science.gov (United States)

    Günel, Ceren; Demirci, Buket; Eryılmaz, Aylin; Yılmaz, Mustafa; Meteoğlu, İbrahim; Ömürlü, İmran Kurt; Başal, Yeşim

    2016-01-01

    Background The supplement Pycnogenol® (PYC) has been used for the treatment of several chronic diseases including allergic rhinitis (AR). However, the in vivo effects on allergic inflammation have not been identified to date. Aims To investigate the treatment results of PYC on allergic inflammation in a rat model of allergic rhinitis. Study Design Animal experimentation. Methods Allergic rhinitis was stimulated in 42 rats by intraperitoneal sensitization and intranasal challenge with Ovalbumin. The animals were divided into six subgroups: healthy controls, AR group, AR group treated with corticosteroid (dexamethasone 1 mg/kg; CS+AR), healthy rats group that were given only PYC of 10 mg/kg (PYC10), AR group treated with PYC of 3mg/kg (PYC3+AR), and AR group treated with PYC of 10 mg/kg (PYC10+AR). Interferon-γ (IFN-γ), interleukin-4 (IL-4), interleukin-10 (IL-10), and OVA-specific immunoglobulin E (Ig-E) levels of serum were measured. Histopathological changes in nasal mucosa and expression of tumor necrosis factor-α (TNF-α) and IL-1β were evaluated. Results The levels of the IL-4 were significantly decreased in the PYC3+AR, PYC10+AR and CS+AR groups compared with the AR group (p=0.002, p<0.001, p=0.006). The production of the IFN-γ was significantly decreased in the PYC3+AR and PYC10+AR groups compared with the AR group (p=0.013, p=0.001). The administration of PYC to allergic rats suppressed the elevated IL-10 production, especially in the PYC3+AR group (p=0.006). Mucosal edema was significantly decreased respectively after treatment at dose 3 mg/kg and 10 mg/kg PYC (both, p<0.001). The mucosal expression of TNF-α has significantly decreased in the PYC3+AR and PYC10+AR groups (p=0.005, p<0.001), while the IL-1β expression significantly decreased in the CS+AR, PYC3+AR, and PYC10+AR groups (p<0.001, p=0.003, p=0.001). Conclusion PYC has multiple suppressive effects on allergic response. Thus, PYC may be used as a supplementary agent in allergic response

  8. The comparison of cetirizine, levocetirizine and placebo for the treatment of childhood perennial allergic rhinitis.

    Science.gov (United States)

    Lee, Chih-Fang; Sun, Hai-Lun; Lu, Ko-Hsiu; Ku, Min-Sho; Lue, Ko-Huang

    2009-08-01

    Cetirizine (Zyrtec) is a potent and long-acting second-generation histamine H1- receptor antagonist for the treatment of allergic disease, such as allergic rhinitis and chronic idiopathic urticaria, in adult and child. It is a racemic mixture of levocetirizine (Xyzal) and dextrocetirizine. The purpose of this present study was to compare the efficacy of cetirizine, levocetirizine and placebo for the treatment of pediatric perennial allergic rhinitis. 74 perennial allergic rhinitis patients, aged 6 to 12 years old, assigned to 1 of 3 treatment groups for 12 weeks randomly. The effects of the three agents were compared with the Pediatric Rhinoconjunctivitis Quality of Life Questionnaire (PRQLQ) and Total Symptom Score (TSS) by diary. Nasal peak expiratory flow rate (nPEFR) and laboratory examinations including serum immunoglobulin E level, eosinophil cationic protein (ECP), blood eosinophil counts and eosinophil percentage in a nasal smear were evaluated among the three groups. The results revealed that both cetirizine and levocetirizine improved TSS in comparison with the placebo group, and ceterizine appeared to be more efficacious than levocetirizine at week 8 and week 12. The PRQLQ score showed significant decreased both in cetirizine and levocetirizine group, but there was no statistic significant difference between both groups. The eosinophil proportion in a nasal smear significantly decreased among the cetirizine in comparison with the placebo group but there was no statistic significant in levocetirizine groups. Both cetirizine and levocetirizine showed significant improvement in nPEFR in comparison with the placebo group, and ceterizine appeared to be more efficacious than levocetirizine. The 12-week treatment program showed that cetirizine was more effectious than levocetirizine.

  9. Evaluation of Prevalence of Allergic Rhinitis Symptoms in Kurdistan, a Western Province in Iran

    Directory of Open Access Journals (Sweden)

    Rasoul Nasiri

    2015-11-01

    Full Text Available Introduction Allergic rhinitis, like other allergic diseases, is one of the most common disorders during childhood; this study was conducted to assess and compare the prevalence and severity of allergic rhinitis in children and adolescents living in Kurdistan province. The study was aimed to provide a ground for the identification of likely causes and risk factors of this disorder. Materials and Methods This study was a cross-sectional study. In order to collect data, 4,000 questionnaires were distributed to elementary schools and junior high schools and 3,890 questionnaires were completed; as a result, the survey response rate was 97%. The study was carried out based on International Study of Asthma and Allergies in Childhood (ISAAC: ISAAC questionnaire. After entering the data into SPSS version 13, they were analyzed using logistic regression and Chi- square test. Results Of a total 3,890 people, 29.7% of the subjects in this study reported a history of sneezing or runny nose in the past 12 months; it was reported more in boys in the age group 13-14 years and the difference between the sexes was significant [Odds ratio(OR=1.35, Confidence interval (CI]: 1.09-1.67, P < 0.01. Based on physician diagnosis, 9.37% of the subjects were overtaken by allergic rhinitis and it was more prevalent in boys at both educational levels and the difference was statistically significant in subjects aged 13-14 years old (OR=1.44 CI: 1.07-1.94, P

  10. Up-regulation of Toll-like receptors 2, 3 and 4 in allergic rhinitis

    Directory of Open Access Journals (Sweden)

    Uddman Rolf

    2005-09-01

    Full Text Available Abstract Background Toll-like receptors enable the host to recognize a large number of pathogen-associated molecular patterns such as bacterial lipopolysaccharide, viral RNA, CpG-containing DNA and flagellin. Toll-like receptors have also been shown to play a pivotal role in both innate and adaptive immune responses. The role of Toll-like receptors as a primary part of our microbe defense system has been shown in several studies, but their possible function as mediators in allergy and asthma remains to be established. The present study was designed to examine the expression of Toll-like receptors 2, 3 and 4 in the nasal mucosa of patients with intermittent allergic rhinitis, focusing on changes induced by exposure to pollen. Methods 27 healthy controls and 42 patients with seasonal allergic rhinitis volunteered for the study. Nasal biopsies were obtained before and during pollen season as well as before and after allergen challenge. The seasonal material was used for mRNA quantification of Toll-like receptors 2, 3 and 4 with real-time polymerase chain reaction, whereas specimens achieved in conjunction with allergen challenge were used for immunohistochemical localization and quantification of corresponding proteins. Results mRNA and protein representing Toll-like receptors 2, 3 and 4 could be demonstrated in all specimens. An increase in protein expression for all three receptors could be seen following allergen challenge, whereas a significant increase of mRNA only could be obtained for Toll-like receptor 3 during pollen season. Conclusion The up-regulation of Toll-like receptors 2, 3 and 4 in the nasal mucosa of patients with symptomatic allergic rhinitis supports the idea of a role for Toll-like receptors in allergic airway inflammation.

  11. Efficacy of chlorophyll c2 for seasonal allergic rhinitis: single-center double-blind randomized control trial.

    Science.gov (United States)

    Fujiwara, Takashi; Nishida, Naoya; Nota, Jumpei; Kitani, Takashi; Aoishi, Kunihide; Takahashi, Hirotaka; Sugahara, Takuya; Hato, Naohito

    2016-12-01

    Chlorophyll c2 extracted from Sargassum horneri improved allergic symptoms in an animal model of allergic rhinitis. In the present study, we explored the efficacy of chlorophyll c2 in patients with seasonal allergic rhinitis. This was a single-center, randomized, double-blind placebo-controlled trial. Sixty-six patients aged 20-43 years, each with a 2-year history of seasonal allergic rhinitis, were randomly assigned to receive either a single daily dose (0.7 mg) of chlorophyll c2 or placebo for 12 weeks. The use of medications including H1-antihistamines and topical nasal steroids was recorded by rescue medication scores (RMSs) noted after 4, 8, and 12 weeks of treatment. Disease-specific quality of life was measured using the Japan Rhinitis Quality of Life Questionnaire (JRQLQ) both before and after 4, 8, and 12 weeks of treatment. The RMS at 8 weeks was significantly better in the chlorophyll c2 than the placebo group (mean RMS difference = -3.09; 95 % confidence interval = -5.96 to -0.22); the mean RMS at 4 weeks was only slightly better in the chlorophyll c2 group. The JRQLQ scores did not differ significantly between the two groups. Chlorophyll c2 would have a potential to be an alternative treatment for allergic rhinitis.

  12. 5-grass pollen tablets achieve disease control in patients with seasonal allergic rhinitis unresponsive to drugs: a real-life study

    Directory of Open Access Journals (Sweden)

    Pastorello EA

    2013-12-01

    Full Text Available Elide Anna Pastorello,1 Laura Losappio,1 Stefania Milani,2 Giuseppina Manzotti,3 Valentina Fanelli,4 Valerio Pravettoni,5 Fabio Agostinis,6 Alberto Flores D’Arcais,7 Ilaria Dell'Albani,8 Paola Puccinelli,9 Cristoforo Incorvaia,10 Franco Frati81Allergy and Immunology Department, Niguarda Hospital, Milan, 2Allergy Department, San Marco General Hospital, Bergamo, 3Allergy Department, Treviglio Hospital, Bergamo, 4Allergy Department, Italian Institute for Auxology, Milan, 5Clinical Allergy and Immunology Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, 6Department of Pediatrics, Riuniti Hospital, Bergamo, 7Department of Pediatrics, Legnano Hospital, Milan, 8Medical and Scientific Department, Stallergenes Italy, Milan, 9Regulatory Department, Stallergenes Italy, Milan, 10Allergy/Pulmonary Rehabilitation, ICP Hospital, Milan, ItalyBackground: An important subpopulation in allergic rhinitis is represented by patients with severe form of disease that is not responsive to drug treatment. It has been reported that grass pollen subcutaneous immunotherapy is effective in drug-resistant patients. In a real-life study, we evaluated the efficacy of 5-grass pollen tablets in patients with grass pollen-induced allergic rhinitis not responsive to drug therapy.Methods: We carried out this multicenter observational study in adults and adolescents with grass-induced allergic rhinitis not responsive to drug therapy who were treated for a year with 5-grass pollen tablets. Clinical data collected before and after sublingual immunotherapy (SLIT included Allergic Rhinitis and its Impact on Asthma (ARIA classification of allergic rhinitis, response to therapy, and patient satisfaction.Results: Forty-seven patients entered the study. By ARIA classification, three patients had moderate to severe intermittent allergic rhinitis, ten had mild persistent allergic rhinitis, and 34 had moderate to severe persistent allergic rhinitis. There were no cases

  13. Evaluation of total IgE, CRP and blood count parameters in children with asthma and allergic rhinitis

    Directory of Open Access Journals (Sweden)

    Feti Tülübaş

    2013-03-01

    Full Text Available Objective: This study aimed to research retrospectivelywhether asthma and allergic rhinitis are related to totalIgE, C-reactive protein (CRP and complete blood countparameters.Materials and methods: Files of 443 children who appliedto pediatric outpatient clinics of our hospital,aged2-18 were retrospectively investigated. Patients weregrouped into three as asthma (n=179, allergic rhinitis (n=171 and control group (n= 93. Patients’ ages, genders,total IgE, CRP and hemogram values were recorded.Results: While eosinophil count, MCHC and total IgElevels were significantly higher in asthma group, MCVlevels were significantly lower. Lymphocyte count, CRPand total IgE levels were significantly higher in allergicrhinitis group compared with control group whereas neutrophilcount were significantly lower and eosinophil countdid not change significantly. Total IgE levels were higherin asthma and allergic rhinitis compared with controls.However, CRP levels were higher only in allergic rhinitisgroup. MCV levels were significantly lower in asthmagroup compared with controls. MCHC levels were significantlyhigher in asthma group compared with allergicrhinitis and control groups. Neutrophil count decreasedwhile lymphocyte count increased significantly. Eosinophilcount significantly increased compared with controlgroup whereas a significant difference was not observedbetween allergic rhinitis and controls.Conclusions: Our findings suggest factors effective inasthma pathogenesis might be effective also in erythrocytemorphology. There are remarkable changes in bloodeosinophil levels in asthma and in neuthrophil and lymphocytelevels in allergic rhinitis. Serum total IgE level increasesin asthma group whereas it decreases in allergicrhinitis group.Key words: Asthma, allergic rhinitis, total IgE, CRP, MCV

  14. Management of allergic and non-allergic rhinitis: a primary care summary of the BSACI guideline.

    Science.gov (United States)

    Angier, Elizabeth; Willington, Jenny; Scadding, Glenis; Holmes, Steve; Walker, Samantha

    2010-09-01

    Rhinitis is a common problem in primary care which is often managed sub-optimally. It causes considerable morbidity and has been shown to have a detrimental impact on people's ability to concentrate at school and at work. Rhinitis and asthma often present together, and symptomatic rhinitis can be associated with poor asthma control and increased risk of exacerbations. There is therefore a clear need to recognise and treat rhinitis according to guideline recommendations. This article is a primary care summary of the British Society for Allergy & Clinical Immunology (BSACI) Standards of Care Committee guideline on the management of rhinitis, written by a multi-disciplinary group of clinicians. It takes into account the time restrictions on assessment and the tests and equipment available in primary care, as well as the need for practical, clear and intuitive strategies for investigation and management. It recommends a stepwise approach to treatment, and highlights the relevance of less frequently prescribed treatments, including nasal douching leukotriene receptor antagonists and anticholinergics. Red flag symptoms are identified, together with indicators for referral. As with many other long term conditions, good communication between primary and secondary care in terms of timely and appropriate referral is a key factor for success.

  15. Apakah terapi pengendalian plak dapat menurunkan keparahan rinitis alergika pada anak? (Does oral plaque control therapy reduce severity of allergic rhinitis in children?

    Directory of Open Access Journals (Sweden)

    Haryono Utomo

    2005-06-01

    Full Text Available Allergic rhinitis is one of the most common ailments in children. In clinical practice approximately 50% of patients with symptoms of rhinitis are diagnosed with non-allergic rhinitis. Positive skin prick test or specific IgE in vitro tests that are relevant to aeroallergens are conclusive diagnostic of allergic rhinitis. However, simple diagnostic method such as "sneezing sign" has already proved to be reliable. Hypersensitive children have humoral immune system (Th2 which release inflammatory factors in the presence of allergen or infection that contribute to allergic response. Immunological reactions occurred and antibodies concentration arise, especially specific IgE instead of IgG because of the isotype switching. A lot of procedures such as allergen avoidance, medication and immunotherapy were done in allergic rhinitis management. However, oral plaque controls were not the point of interest in this case. The aim of this study is to find out the effectiveness of oral plaque control in the reduction of severity of allergic rhinitis symptoms using symptom scores. Fifty children, male and female aged 8–14 years, subjective diagnosed as allergic rhinitis using "sneezing sign" were included in this study. Oral plaque control procedures were done by polishing and flossing followed by 4 days of gargling with 1% povidone iodine. Clinical result showed that after 3 days, oral plaque control 2.925 times more effective than control group. The conclusion was oral plaque control is effective reducing the severity of allergic rhinitis symptoms.

  16. Variation in Uteroglobin-Related Protein 1 (UGRP1 gene is associated with Allergic Rhinitis in Singapore Chinese

    Directory of Open Access Journals (Sweden)

    Wang De Yun

    2011-03-01

    Full Text Available Abstract Background Uteroglobin-Related Protein 1 (UGRP1 is a secretoglobulin protein which has been suggested to play a role in lung inflammation and allergic diseases. UGRP1 has also been shown to be an important pneumoprotein, with diagnostic potential as a biomarker of lung damage. Previous genetic studies evaluating the association between variations on UGRP1 and allergic phenotypes have yielded mixed results. The aim of this present study was to identify genetic polymorphisms in UGRP1 and investigate if they were associated with asthma and allergic rhinitis in the Singapore Chinese population. Methods Resequencing of the UGRP1 gene was conducted on 40 randomly selected individuals from Singapore of ethnic Chinese origin. The polymorphisms identified were then tagged and genotyped in a population of 1893 Singapore Chinese individuals. Genetic associations were evaluated in this population comparing 795 individuals with allergic rhinitis, 718 with asthma (of which 337 had both asthma and allergic rhinitis and 717 healthy controls with no history of allergy or allergic diseases. Results By resequencing the UGRP1 gene within our population, we identified 11 novel and 16 known single nucleotide polymorphisms (SNPs. TagSNPs were then genotyped, revealing a significant association between rs7726552 and allergic rhinitis (Odds Ratio: 0.81, 95% Confidence Interval: 0.66-0.98, P = 0.039. This association remained statistically significant when it was analyzed genotypically or when stratified according to haplotypes. When variations on UGRP1 were evaluated against asthma, no association was observed. Conclusion This study documents the association between polymorphisms in UGRP1 and allergic rhinitis, suggesting a potential role in its pathogenesis.

  17. [Development of an add-on module for the WHOQOL-BREF on patients with allergic rhinitis].

    Science.gov (United States)

    Wang, Chiu-Hua; Maa, Suh-Hwa; Yang, Sien-Hung; Chen, Ying-Lin; Chen, Wei-Chun

    2008-06-01

    The purpose of this study was to develop an add-on module for the Taiwan-version WHOQOL-BREF for assessing the quality of life of people with allergic rhinitis. A cross-sectional survey design was used. In accordance with the seven steps for the development of population-specific modules of the WHOQOL, the instrument added new items on the basis of opinions of expert groups, including patients, families and physicians, to the Taiwan-version WHOQOL-BREF measure. The new questionnaire, comprising 52 items, was tested on 252 patients with allergic rhinitis. For content validity, each item was significantly correlated with the domain to which it belonged (r= .157-.715, pWHOQOL-BREF for patients with allergic rhinitis is reliable, valid and specific.

  18. Acupuncture Treatment of a Patient with Persistent Allergic Rhinitis Complicated by Rhinosinusitis and Asthma

    Directory of Open Access Journals (Sweden)

    Ae-Ran Kim

    2011-01-01

    Full Text Available A pathophysiologic relationship between allergic rhinitis and rhinosinusitis and asthma has long been suggested. However, few clinical studies of acupuncture have been conducted on these comorbid conditions. A 48-year-old male suffering from persistent allergic rhinitis with comorbid chronic rhinosinusitis and asthma since the age of 18 years was studied. He complained of nasal obstruction, sneezing, cough, rhinorrhea and moderate dyspnea. He occasionally visited local ear-nose-throat clinics for his nasal symptoms, but gained only periodic symptom relief. The patient was treated with acupuncture, infrared radiation to the face and electro-acupuncture. Needles were inserted at bilateral LI20, GV23, LI4 and EX-1 sites with De-qi. Electro-acupuncture was performed simultaneously at both LI20 sites and additional traditional Korean acupuncture treatments were performed. Each session lasted for 10 min and the sessions were carried out twice a week for 5 weeks. The patient’s Mini-Rhinoconjunctivitis Quality-of-Life Questionnaire score decreased from 38, at the beginning of treatment, to 23, 3 weeks after the last treatment. The Total Nasal Symptom Score was reduced from six (baseline to five, 3 weeks after the last treatment. There was significant clinical improvement in the forced expiratory volume in 1 s—from 3.01 to 3.50 l—with discontinuation of the inhaled corticosteroid, and no asthma-related complaints were reported. Further clinical studies investigating the effectiveness of acupuncture for the patients suffering from allergic rhinitis and/or rhinosinusitis with comorbid asthma are needed.

  19. Understanding the role of the healthcare professional in patient self-management of allergic rhinitis

    Directory of Open Access Journals (Sweden)

    Bonnie L Kuehl

    2015-08-01

    Full Text Available Objective: Allergic rhinitis is a common, usually long-standing, condition that may be self-diagnosed or have a formal diagnosis. Our aim was to identify how allergic rhinitis sufferers self-manage their condition. Methods: A sample of 276 self-identified adult allergy sufferers pooled from social media completed an online survey comprising 13 questions. The survey was fielded by a professional research organization (Lab42. The main outcome measures included the use of prescription and/or non-prescription allergy medication, and interactions with physician and/or pharmacist with respect to medication use. Results: Of the respondents, 53% (146/276 indicated that they used both prescription and over-the-counter medication to manage their allergy symptoms. Of those who used prescription medication, 53% reported that they discussed their prescription medication in great detail with their physician when it was prescribed, while 42% spoke about it briefly. Following the initial prescription, few discussions about the prescription occur with the physician (45% indicate several discussions, 40% indicate one or two discussions, and 10% indicate no discussions. In most cases (~75% of the time, allergy prescription refills did not require a doctor visit with patients obtaining refills through phone calls to the doctor’s office or through the pharmacy. Two-thirds of patients (69% report that they have discussed their prescription allergy medication with a pharmacist, with greater than half of respondents having discussed the use of the non-prescription medication with their doctor. Conclusion: Patients with diagnosed allergic rhinitis appear to be self-managing their condition with few interactions with their doctor about their allergy prescription. Interactions with a pharmacist about allergy medication (prescription and non-prescription appear to be more common than interactions with a physician.

  20. Association between allergic rhinitis, bottle feeding, non‐nutritive sucking habits, and malocclusion in the primary dentition

    Science.gov (United States)

    Vázquez‐Nava, F; Quezada‐Castillo, J A; Oviedo‐Treviño, S; Saldivar‐González, A H; Sánchez‐Nuncio, H R; Beltrán‐Guzmán, F J; Vázquez‐Rodríguez, E M

    2006-01-01

    Aim To determine the association between allergic rhinitis, bottle feeding, non‐nutritive sucking habits, and malocclusion in the primary dentition. Methods Data were collected on 1160 children aged 4–5 years, who had been longitudinally followed since the age of 4 months, when they were admitted to nurseries in a suburban area of Tampico–Madero, Mexico. Periodically, physical examinations were conducted and a questionnaire was given to their parents or tutors. Results Malocclusion was detected in 640 of the children (51.03% had anterior open bite and 7.5% had posterior cross‐bite). Allergic rhinitis alone (adjusted odds ratio = 2.87; 95% CI 1.57 to 5.25) or together with non‐nutritive sucking habits (adjusted odds ratio = 3.31; 95% CI 1.55 to 7.09) had an effect on anterior open bite. Bottle feeding alone (adjusted odds ratio = 1.95; 95% CI 1.07 to 3.54) or together with allergic rhinitis (adjusted odds ratio = 3.96; 95% CI 1.80 to 8.74) had an effect on posterior cross‐bite. Posterior cross‐bite was more frequent in children with allergic rhinitis and non‐nutritive sucking habits (10.4%). Conclusions Allergic rhinitis alone or together with non‐nutritive sucking habits is related to anterior open bite. Non‐nutritive sucking habits together with allergic rhinitis seem to be the most important factor for development of posterior open bite in children under the age of 5 years. PMID:16769710

  1. PRIMARY NOCTURNAL ENURESIS IN CHILDREN WITH ALLERGIC RHINITIS AND SEVERE ADENOTONSILLAR HYPERTROPHY: A SINGLE CENTER PILOT STUDY.

    Science.gov (United States)

    Chimenz, R; Manti, S; Fede, C; Stroscio, G; Visalli, C; Nicotera, A; Di Rosa, G; Romeo, A C; Salpietro, V; Cuppari, C

    2015-01-01

    Nocturnal enuresis is defined as intermittent urinary incontinence during sleep that occurs at least twice a week for three consecutive months. There is no unifying etiology for nocturnal enuresis in the pediatric population and the disorder is likely to be multifactorial. We aimed to investigate the relationship between primary nocturnal enuresis, allergic rhinitis, and related complications in a paediatric case series from a single Center. We retrospectively reviewed and prospectively followed-up at our Institution (i) 32 children (14 females, 18 males; mean age 6.31±1.21 yrs) affected by allergic rhinitis with adenoidal hypertrophygrade I-II (group A) and (ii) 27 children (11 females, 16 males; mean age 6.52±1.33 yrs) affected by allergic rhinitis with adenoidal hypertrophy grade III-IV (group B). Allergic rhinitis was diagnosed on the basis of (a) typical nasal symptoms due to atopic sensitization (e.g., rhinorrhea , itching, sneezing fits, and nasal congestion and obstruction) and (b) positive skin prick testing and/or increased level of total serum IgE. We identified discrepancies between group A and group B in terms of risk of primary nocturnal enuresis. In fact, only 1 child of group A (3.12%) reported uncomplicated primary nocturnal enuresis; conversely, 6 children of group B (22.22%) showed a history of uncomplicated primary nocturnal enuresis (p=0.040). There was no statistically significant difference between the two groups in terms of atopic sensitization and serum total IgE levels (p=0.43). Allergic rhinitis may potentially influence the onset and the natural history of nocturnal enuresis in some children. Children with allergic rhinitis and more severe respiratory manifestations, seem to be more prone to developing primary nocturnal enuresis, likely due to potential multi-factorial causes (e.g., sleep disorders, chronic phlogosis, immune deregulation).

  2. A clear urban–rural gradient of allergic rhinitis in a population-based study in Northern Europe

    Science.gov (United States)

    Christensen, Stine Holmegaard; Timm, Signe; Janson, Christer; Benediktsdóttir, Bryndis; Forsberg, Bertil; Holm, Mathias; Jogi, Rain; Johannessen, Ane; Omenaas, Ernst; Sigsgaard, Torben; Svanes, Cecilie; Schlünssen, Vivi

    2016-01-01

    Background The protective effect of farm upbringing on allergic rhinitis is well known, but how upbringing in other environments influences the development of allergic rhinitis is scarcely investigated. The aim of this study was to investigate the association between place of upbringing and pet keeping in childhood and allergic rhinitis and nasal symptoms in adulthood. Methods The population-based Respiratory Health in Northern Europe study includes subjects from Denmark, Norway, Sweden, Iceland, and Estonia born in 1945–1973. This paper analyses 13,376 participants of the third study wave. Six categories of place of upbringing were defined: farm with livestock, farm without livestock, village in rural area, small town, city suburb, and inner city. Pets in the home at birth and during childhood were recorded. Data were analysed using adjusted logistic regression models. Results Livestock farm upbringing predicted less adult allergic rhinitis [odds ratio (OR) 0.68, 0.54–0.85] and nasal symptoms (OR 0.82, 0.68–0.99) than city upbringing, and an urban–rural gradient with decreasing risk per level of urbanisation was observed (OR 0.92, 0.88–0.94). Pets in the home at birth (OR 0.78, 0.68–0.88) and during childhood (OR 0.83, 0.74–0.93) were associated with less subsequent allergic rhinitis. Pet keeping did not explain the protective effect of place of upbringing. Conclusion Risk of allergic rhinitis and nasal symptoms in adulthood was inversely associated with the level of urbanisation during upbringing. Pets at birth decreased the risk further, but did not explain the urban–rural gradient. Persistent beneficial effects of microbial diversity in early life might be an explanation for the findings. PMID:27890047

  3. MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis

    DEFF Research Database (Denmark)

    Bousquet, Jean; Schünemann, Holger J; Hellings, Peter W;

    2016-01-01

    decision support systems (CDSSs) might be beneficial for the assessment of disease control. CDSSs should be based on the best evidence and algorithms to aid patients and health care professionals to jointly determine treatment and its step-up or step-down strategy depending on AR control. Contre les......The selection of pharmacotherapy for patients with allergic rhinitis (AR) depends on several factors, including age, prominent symptoms, symptom severity, control of AR, patient preferences, and cost. Allergen exposure and the resulting symptoms vary, and treatment adjustment is required. Clinical...

  4. Potential Involvement of Type I Interferon Signaling in Immunotherapy in Seasonal Allergic Rhinitis

    OpenAIRE

    Lina Mattson; Antonio Lentini; Gawel, Danuta R.; Tejaswi V. S. Badam; Mikael Benson; Torbjorn Ledin; Nestor, Colm E; Mika Gustafsson; Jordi Serra-Musach; Janne Bjorkander; Zou Xiang; Huan Zhang

    2016-01-01

    Specific immunotherapy (SIT) reverses the symptoms of seasonal allergic rhinitis (SAR) in most patients. Recent studies report type I interferons shifting the balance between type I T helper cell (Th1) and type II T helper cells (Th2) towards Th2 dominance by inhibiting the differentiation of naive T cells into Th1 cells. As SIT is thought to cause a shift towards Th1 dominance, we hypothesized that SIT would alter interferon type I signaling. To test this, allergen and diluent challenged CD4...

  5. The Association between Ambient Air Pollution and Allergic Rhinitis: Further Epidemiological Evidence from Changchun, Northeastern China

    Science.gov (United States)

    Teng, Bo; Zhang, Xuelei; Yi, Chunhui; Zhang, Yan; Ye, Shufeng; Wang, Yafang; Tong, Daniel Q.; Lu, Binfeng

    2017-01-01

    With the continuous rapid urbanization process over the last three decades, outdoors air pollution has become a progressively more serious public health hazard in China. To investigate the possible associations, lag effects and seasonal differences of urban air quality on respiratory health (allergic rhinitis) in Changchun, a city in Northeastern China, we carried out a time-series analysis of the incidents of allergic rhinitis (AR) from 2013 to 2015. Environmental monitoring showed that PM2.5 and PM10 were the major air pollutants in Changchun, followed by SO2, NO2 and O3. The results also demonstrated that the daily concentrations of air pollutants had obvious seasonal differences. PM10 had higher daily mean concentrations in spring (May, dust storms), autumn (October, straw burning) and winter (November to April, coal burning). The mean daily number of outpatient AR visits in the warm season was higher than in the cold season. The prevalence of allergic rhinitis was significantly associated with PM2.5, PM10, SO2 and NO2, and the increased mobility was 10.2% (95% CI, 5.5%–15.1%), 4.9% (95% CI, 0.8%–9.2%), 8.5% (95% CI, −1.8%–19.8%) and 11.1% (95% CI, 5.8%–16.5%) for exposure to each 1-Standard Deviation (1-SD) increase of pollutant, respectively. Weakly or no significant associations were observed for CO and O3. As for lag effects, the highest Relative Risks (RRs) of AR from SO2, NO2, PM10 and PM2.5 were on the same day, and the highest RR from CO was on day 4 (L4). The results also indicated that the concentration of air pollutants might contribute to the development of AR. To summarize, this study provides further evidence of the significant association between ambient particulate pollutants (PM2.5 and PM10, which are usually present in high concentrations) and the prevalence of respiratory effects (allergic rhinitis) in the city of Changchun, located in Northeastern China. Environmental control and public health strategies should be enforced to

  6. Use of intranasal corticosteroids in the management of congestion and sleep disturbance in pediatric patients with allergic rhinitis.

    Science.gov (United States)

    Lanier, Bob Q

    2008-06-01

    Allergic rhinitis affects a large number of children and exerts a considerable socioeconomic impact. It is underdiagnosed and inadequately treated, which predisposes children to potentially serious comorbidities. Allergic rhinitis symptoms may create nighttime breathing problems and sleep disturbances and have a negative effect on a child's ability to learn in the classroom. Although antihistamines have shown efficacy in relieving many symptoms, they have little effect on nasal congestion. This article summarizes the advantages of intranasal corticosteroids, including their effectiveness against congestion and excellent safety profile. Intranasal corticosteroids with minimal systemic bioavailability provide topical drug delivery that minimizes the potential for systemic side-effects.

  7. Loratidine buccal films for allergic rhinitis: development and evaluation.

    Science.gov (United States)

    Kumria, Rachna; Nair, Anroop B; Al-Dhubiab, Bandar E

    2014-05-01

    The objective of this study was to develop a novel patient compliant buccoadhesive film capable of providing a prolonged protection against allergic symptoms. Polymeric buccoadhesive films of loratidine were prepared using hydroxypropylmethyl cellulose (HPMC)-E5 and K100 blend and Eudragit® NE 30D as retardant. Films were prepared using solvent-casting method. The developed films were evaluated for physical properties, hydration, mucoadhesion time, drug release, etc. All the prepared films exhibited excellent mechanical strength and uniform drug content. Increase in drug content did not influence the physicomechanical properties of the film. The mucoadhesive strength of films was significantly enhanced with increase in HPMC content. Increase in Eudragit® NE 30 D content in the film decreases the hydration, erosion and drug release, but enhances the mucoadhesion time. Furthermore, the release of loratidine from the prepared films followed Hixson-Crowell kinetics. Studies in healthy human volunteers using placebo films indicate that the prepared films possess prolonged mucoadhesion in-vivo, and this could potentially lead to clinically relevant drug delivery system.

  8. Comprehensive evaluation of genetic variation in S100A7 suggests an association with the occurrence of allergic rhinitis

    Directory of Open Access Journals (Sweden)

    Adner Mikael

    2008-03-01

    Full Text Available Abstract Background S100A7 is a calcium-binding protein with chemotactic and antimicrobial properties. S100A7 protein levels are decreased in nasal lavage fluid from individuals with ongoing allergic rhinitis, suggesting a role for S100A7 in allergic airway inflammation. The aims of this study were to describe genetic variation in S100A7 and search for associations between this variation and allergic rhinitis. Methods Peripheral blood was collected from 184 atopic patients with a history of pollen-induced allergic rhinitis and 378 non-atopic individuals, all of Swedish origin. DNA was extracted and the S100A7 gene was resequenced in a subset of 47 randomly selected atopic individuals. Nine polymorphisms were genotyped in 184 atopic and 378 non-atopic individuals and subsequently investigated for associations with allergic rhinitis as well as skin prick test results. Haplotypes were estimated and compared in the two groups. Results Thirteen polymorphisms were identified in S100A7, of which 7 were previously undescribed. rs3014837 (G/C, which gives rise to an Asp → Glu amino acid shift, had significantly increased minor allele frequency in atopic individuals. The major haplotype, containing the major allele at all sites, was more common in non-atopic individuals, while the haplotype containing the minor allele at rs3014837 was equally more common among the atopic individuals. Additionally, heterozygotes at this site had significantly higher scores in skin prick tests for 9 out of 11 tested allergens, compared to homozygotes. Conclusion This is the first study describing genetic variation, associated with allergy, in S100A7. The results indicate that rs3014837 is linked to allergic rhinitis in our Swedish population and render S100A7 a strong candidate for further investigations regarding its role in allergic inflammation.

  9. AN OPEN LABEL PILOT STUDY TESTING THE ROLE OF CLASSICAL HOMEOPATHY IN CHRONIC ALLERGIC RHINITIS

    Directory of Open Access Journals (Sweden)

    S. Ghosh*, S. Das, M. Mundle Dishari Sengupta, Sk. Intaj Hossain, M. Koley and S. Saha

    2013-04-01

    Full Text Available ABSTRACT: Purpose: The prevalence of allergic rhinitis (AR is increasing at an alarming rate throughout the world. India has an estimated number of 15-20 million patients with allergic bronchial asthma and 30-80% of these suffer from AR. So, AR is considered as a major chronic respiratory disease due to its prevalence, impact on quality of life (QoL, work/school performance and productivity, economic burden and links with asthma. This research aims at testing the role of classical homeopathy in bringing changes in serum immunoglobulin E (IgE level and absolute eosinophil count (primary outcome measures and symptoms score and WHOQOL-BREF score related to AR (secondary outcome measures by comparing the pre-trial and post-trial data.

  10. Atopic Manifestations: Dermatitis, Allergic Rhinitis and Asthma in Patients With Hypogammaglobulinemia

    Directory of Open Access Journals (Sweden)

    Minoo Dadkhah

    2015-10-01

    Full Text Available Background: Most of the hypogammaglobulinemic patients have a clinical history in favor of allergic respiratory disease. Nevertheless, in these patients the importance and prevalence of atopic disorders have not been completely explained. Objectives: This study was aimed to evaluate atopic manifestations (dermatitis, allergic rhinitis and asthma and pulmonary function in patients with hypogammaglobulinemia. Patients and Methods: We used the international study of asthma and allergies in childhood (ISAAC questionnaire in forty-five patients diagnosed with hypogammaglobulinemia and spirometry was done in 41 patients older than 5 years. Results: Spirometry results were normal in 21 (51%, and showed obstructive in 15 (37% and restrictive pattern in 5 (12% of the 41 patients who were evaluated. By the end of the study, asthma was diagnosed in nine (20% patients and other atopies (rhinitis and dermatitis identified in 10 (22%, and four (9%, respectively. Conclusions: Atopic conditions should be investigated in the hypogammaglobulinemic patients and the prevalence in these patients may be higher than in normal population. Also, it is recommended to perform a pulmonary function test as a routine procedure in patients with hypogammaglobulinemia and atopy should be assessed in these patients.

  11. Responses of Six-Weeks Aquatic Exercise on the Autonomic Nervous System, Peak Nasal Inspiratory Flow and Lung Functions in Young Adults with Allergic Rhinitis.

    Science.gov (United States)

    Janyacharoen, Taweesak; Kunbootsri, Narupon; Arayawichanon, Preeda; Chainansamit, Seksun; Sawanyawisuth, Kittisak

    2015-06-01

    Allergic rhinitis is a chronic respiratory disease. Sympathetic hypofunction is identified in all of the allergic rhinitis patients. Moreover, allergic rhinitis is associated with decreased peak nasal inspiratory flow (PNIF) and impaired lung functions. The aim of this study was to investigate effects of six-week of aquatic exercise on the autonomic nervous system function, PNIF and lung functions in allergic rhinitis patients. Twenty-six allergic rhinitis patients, 12 males and 14 females were recruited in this study. Subjects were diagnosed by a physician based on history, physical examination, and positive reaction to a skin prick test. Subjects were randomly assigned to two groups. The control allergic rhinitis group received education and maintained normal life. The aquatic group performed aquatic exercise for 30 minutes a day, three days a week for six weeks. Heart rate variability, PNIF and lung functions were measured at the beginning, after three weeks and six weeks. There were statistically significant increased low frequency normal units (LF n.u.), PNIF and showed decreased high frequency normal units (HF n.u.) at six weeks after aquatic exercise compared with the control group. Six weeks of aquatic exercise could increase sympathetic activity and PNIF in allergic rhinitis patients.

  12. A functional brain-derived neurotrophic factor (BDNF) gene variant increases the risk of moderate-to-severe allergic rhinitis

    NARCIS (Netherlands)

    Jin, Peng; Andiappan, Anand Kumar; Quek, Jia Min; Lee, Bernett; Au, Bijin; Sio, Yang Yie; Irwanto, Astrid; Schurmann, Claudia; Grabe, Hans Joergen; Suri, Bani Kaur; Matta, Sri Anusha; Westra, Harm-Jan; Franke, Lude; Esko, Tonu; Sun, Liangdan; Zhang, Xuejun; Liu, Hong; Zhang, Furen; Larbi, Anis; Xu, Xin; Poidinger, Michael; Liu, Jianjun; Chew, Fook Tim; Rotzschke, Olaf; Shi, Li; Wang, De Yun

    2015-01-01

    Background: Brain-derived neurotrophic factor (BDNF) is a secretory protein that has been implicated in the pathogenesis of allergic rhinitis (AR), atopic asthma, and eczema, but it is currently unknown whether BDNF polymorphisms influence susceptibility to moderate-to-severe AR. Objective: We sough

  13. Comparison of intranasal hypertonic dead sea saline spray and intranasal aqueous triamcinolone spray in seasonal allergic rhinitis.

    Science.gov (United States)

    Cordray, Scott; Harjo, Jim B; Miner, Linda

    2005-07-01

    Intranasal corticosteroids are well known to be efficacious in the treatment of allergic rhinitis. Nasal irrigation with saline, including hypertonic saline, has long been recommended for the treatment of sinonasal disease, and it has been shown to have a positive effect on the physiology of the nasal mucosa. Until now, no study of the clinical efficacy of intranasal hypertonic Dead Sea saline as a monotherapy for seasonal allergic rhinitis has been reported. We conducted a prospective, randomized, single-blind, placebo-controlled comparison of intranasal hypertonic Dead Sea saline spray and intranasal aqueous triamcinolone spray in 15 patients with seasonal allergic rhinitis. Results were based on a 7-day regimen. Based on Rhinoconjunctivitis Quality of Life Questionnaire scores, clinically and statistically significant (p Dead Sea saline solution can be an effective alternative in mild-to-moderate allergic rhinitis, particularly with respect to nasal and eye symptoms. The hypertonicity of the Dead Sea solution may have a positive effect on the physiology of the nasal mucosa by improving mucociliary clearance. In addition, the dominant cation in the Dead Sea solution--magnesium--probably exerts anti-inflammatory effects on the nasal mucosa and on the systemic immune response.

  14. Survey on the Prevalence of Allergic Rhinitis and its Effect on the Quality of High School Students’ Life

    Directory of Open Access Journals (Sweden)

    Maryam Amizadeh

    2013-03-01

    Full Text Available Introduction: Allergic rhinitis (AR is a common airway disease. In order to study  the  prevalence of  AR in high school students  in  Kerman, the Score for Allergic Rhinitis (SFAR was used and the quality of life  in  the  students  affected  by  rhinitis was  evaluated using the SF-36 questionnaire.   Materials and Methods: This was a cross-sectional, analytical, descriptive study, based on the SFAR scale. Quality of life in students with AR was evaluated using the SF-36 questionnaire.   Results: From 1511 students who completed the SFAR questionnaire, 291 (52.6%, girls; 47.4%, boys  had AR. Domestic dust was the most common cause of the disease. The most common symptoms of AR were rhinorrhea (76.6%, epiphora (76.3%, nasal congestion (64.3%, and itching (54.3%. According to the ARYA scale, (Allergic Rhinitis and its Impact on Asthma, 41.9% of students had moderate-to-severe rhinitis and 58.1% had mild rhinitis. A total of 43.1% of patients with moderate-to-severe rhinitis had a persistent condition and 56.9% had an intermediate condition. Results of the SF-36 questionnaire among students with AR showed a significant difference in physical functioning and bodily pain in comparison with healthy students.   Conclusion:  The results of this study show that the prevalence of AR among Kerman high school students is 19.3%. Because of the effect of this disease on the life quality of high school students in terms of both physical functioning and bodily pain, efforts should be made to reduce allergen levels as far as possible.

  15. Impact of self-reported symptoms of allergic rhinitis and asthma on sleep disordered breathing and sleep disturbances in the elderly with polysomnography study

    Science.gov (United States)

    Kim, Sae-Hoon; Won, Ha-Kyeong; Moon, Sung-Do; Kim, Byung-Keun; Chang, Yoon-Seok; Kim, Ki-Woong; Yoon, In-Young

    2017-01-01

    Background Sleep disordered breathing (SDB) and sleep disturbances have been reported to be associated with allergic rhinitis and asthma. However, population-based studies of this issue in the elderly are rare. Objective To investigate the impact of self-reported rhinitis and asthma on sleep apnea and sleep quality using polysomnography in an elderly Korean population. Methods A total of 348 elderly subjects who underwent one-night polysomnography study among a randomly selected sample were enrolled. Study subjects underwent anthropometric and clinical evaluations. Simultaneously, the prevalence and co-morbid status of asthma and allergic rhinitis, and subjective sleep quality were evaluated using a self-reported questionnaire. Results Ever-diagnosis of allergic rhinitis was significantly more prevalent in subjects with SDB compared with those without SDB. Subjects with an ever-diagnosis of allergic rhinitis showed a higher O2 desaturation index and mean apnea duration. Indices regarding sleep efficiency were affected in subjects with a recent treatment of allergic rhinitis or asthma. Waking after sleep onset was longer and sleep efficiency was lower in subjects who had received allergic rhinitis treatment within the past 12 months. Subjects who had received asthma treatment within the past 12 months showed significantly lower sleep efficiency than others. Conclusion Our study indicates that a history of allergic rhinitis is associated with increased risk of SDB in the elderly. Sleep disturbance and impaired sleep efficiency were found in the subjects who had received recent treatment of allergic rhinitis or asthma. Physicians should be aware of the high risk of sleep disorders in older patients with respiratory allergic diseases. PMID:28245272

  16. Local production and detection of (specific) IgE in nasal B-cells and plasma cells of allergic rhinitis patients

    NARCIS (Netherlands)

    J.G. Vinke; L.W. Severijnen; W.J. Fokkens (Wytske); A. Kleinjan (Alex)

    2000-01-01

    textabstractAllergic diseases are characterized by allergic complaints in the shock organ and specific immunoglobulin (Ig)E in serum. Literature data indicate that the nasal mucosa itself could produce at least a large part of the specific IgE in allergic rhinitis patie

  17. Plasminogen activator inhibitor-1 gene 4G/5G polymorphism in Turkish children with asthma and allergic rhinitis.

    Science.gov (United States)

    Ozbek, Ozlem Yilmaz; Ataç, F Belgin; Ogus, Ersin; Ozbek, Namik

    2009-01-01

    Plasminogen activator inhibitor (PAI-1) has an essential role in tissue remodeling after inflammation. Recent literature revealed only one study evaluating PAI-1 4G/5G gene polymorphism in children with asthma and none in children with allergic rhinitis. We aimed to investigate distribution of PAI-1 4G/5G polymorphism in a group of Turkish children with asthma and allergic rhinitis and compare these findings with those obtained in normal peers. Patients with physician-diagnosed asthma (n = 106) and allergic rhinitis (n = 99) and 83 healthy peers were included in this study. We evaluated PAI-1 4G/5G polymorphism genotype as well as the possible association between PAI-1 4G/5G polymorphism and pulmonary function tests, serum total immunoglobulin E (IgE), total eosinophil count, and skin-prick test positivity in our study. The prevalence of the 4G allele significantly exceeded the values found in the controls both in patients with asthma (p = 0.001) and in patients with allergic rhinitis (p = 0.002). Interestingly, comparison of asthmatic patients revealed that mean baseline percent forced expiratory volume in 1 second and forced vital capacity were significantly higher in patients who bear 5G/5G genotype than in those who have 4G/4G or 4G/5G genotypes. No statistically significant relationship were found between PAI-1 polymorphism and total serum IgE levels, total eosinophil count, or selected skin test responses to aeroallergens. Our study suggests that Turkish children with asthma or allergic rhinitis have a higher prevalence of PAI-1 4G allele compared with their healthy peers.

  18. Prostaglandin D2 Modulates Neuronal Excitation of the Trigeminal Ganglion to Augment Allergic Rhinitis in Guinea Pigs.

    Science.gov (United States)

    Nagira, Yoji; Goto, Kumiko; Tanaka, Hiroyuki; Aoki, Miwa; Furue, Shingo; Inagaki, Naoki; Tomita, Yasuhiko; Shichijo, Michitaka

    2016-05-01

    Prostaglandin D2(PGD2) is involved in the pathogenesis of allergic rhinitis. However, the sensory nervous system-mediated contributions of PGD2to the symptoms of allergic rhinitis remain unclear. We investigated the involvement of PGD2in these symptoms and in neuronal excitation by in vivo and ex vivo experiments. In an ovalbumin-induced model of allergic rhinitis in guinea pigs, the number of sneezing, nasal rubbing, and nasal secretion events were assessed after the nasal cavity instillation of PGD2, histamine, or a combination of PGD2and histamine. In situ hybridization for PGD2receptor 1 (DP1) mRNA transcripts and immunohistochemical analysis of histamine H1receptor protein expression in guinea pig trigeminal ganglion (TRG) were performed. The effects of DP1receptor activation on the excitability of TRG neurons to electrical and histamine stimuli were assessed using whole-cell patch-clamp recordings. Histamine induced more sneezing, nasal rubbing, and nasal secretion events than PGD2 PGD2augmented histamine-induced responses, whereas pretreatment with a DP1receptor-selective antagonist completely suppressed PGD2-induced augmentation. DP1receptor mRNA transcripts and H1receptor protein expression could be detected in TRG neurons. Moreover, a DP1receptor agonist caused significant increases in the number of histamine-induced action potentials and depolarization, and reduced the current threshold in small-diameter neurons. Our findings show that PGD2-DP1receptor signaling augments the symptoms of allergic rhinitis via the sensory nervous system by modulating nasal neuronal activation to various stimuli, such as histamine. These findings suggest that DP1receptor antagonist has therapeutic potential for the treatment of allergic rhinitis.

  19. Differences in allergen-induced T cell activation between allergic asthma and rhinitis: Role of CD28, ICOS and CTLA-4

    Directory of Open Access Journals (Sweden)

    Lacoeuille Yannick

    2011-02-01

    Full Text Available Abstract Background Th2 cell activation and T regulatory cell (Treg deficiency are key features of allergy. This applies for asthma and rhinitis. However with a same atopic background, some patients will develop rhinitis and asthma, whereas others will display rhinitis only. Co-receptors are pivotal in determining the type of T cell activation, but their role in allergic asthma and rhinitis has not been explored. Our objective was to assess whether allergen-induced T cell activation differs from allergic rhinitis to allergic rhinitis with asthma, and explore the role of ICOS, CD28 and CTLA-4. Methods T cell co-receptor and cytokine expressions were assessed by flow cytometry in PBMC from 18 house dust mite (HDM allergic rhinitics (R, 18 HDM allergic rhinitics and asthmatics (AR, 13 non allergic asthmatics (A and 20 controls, with or without anti-co-receptors antibodies. Results In asthmatics (A+AR, a constitutive decrease of CTLA-4+ and of CD4+CD25+Foxp3+ cells was found, with an increase of IFN-γ+ cells. In allergic subjects (R + AR, allergen stimulation induced CD28 together with IL-4 and IL-13, and decreased the proportion of CTLA-4+, IL-10+ and CD4+CD25+Foxp3+ cells. Anti-ICOS and anti-CD28 antibodies blocked allergen-induced IL-4 and IL-13. IL-13 production also involved CTLA-4. Conclusions T cell activation differs between allergic rhinitis and asthma. In asthma, a constitutive, co-receptor independent, Th1 activation and Treg deficiency is found. In allergic rhinitis, an allergen-induced Treg cell deficiency is seen, as well as an ICOS-, CD28- and CTLA-4-dependent Th2 activation. Allergic asthmatics display both characteristics.

  20. Antioxidant properties of Aller-7, a novel polyherbal formulation for allergic rhinitis.

    Science.gov (United States)

    D'Souza, P; Amit, A; Saxena, V S; Bagchi, D; Bagchi, M; Stohs, S J

    2004-01-01

    Allergic rhinitis, a frequently occurring immunological disorder affecting men, women and children worldwide, is a state of hypersensitivity that occurs when the body overreacts to a substance such as pollen, mold, mites or dust. Allergic rhinitis exerts inflammatory response and irritation of the nasal mucosal membranes leading to sneezing; stuffy/runny nose; nasal congestion; and itchy, watery and swollen eyes. A novel, safe polyherbal formulation (Aller-7/NR-A2) has been developed for the treatment of allergic rhinitis using a unique combination of extracts from seven medicinal plants including Phyllanthus emblica, Terminalia chebula, Terminalia bellerica, Albizia lebbeck, Piper nigrum, Zingiber officinale and Piper longum. In this study, the antioxidant efficacy of Aller-7 was investigated by various assays including hydroxyl radical scavenging assay, superoxide anion scavenging assay, 1,1-diphenyl-2-picryl hydrazyl (DPPH) and 2,2-azinobis-ethyl-benzothiozoline-sulphonic acid diammonium salt (ABTS) radical scavenging assays. The protective effect of Aller-7 on free radical-induced lysis of red blood cells and inhibition of nitric oxide release by Aller-7 in lipopolysaccharide-stimulated murine macrophages were determined. Aller-7 exhibited concentration-dependent scavenging activities toward biochemically generated hydroxyl radicals (IC50 741.73 microg/ml); superoxide anion (IC50 24.65 microg/ml by phenazine methosulfate-nicotinamide adenine dinucleotide [PMS-NADH] assay and IC50 4.27 microg/ml by riboflavin/nitroblue tetrazolium [NBT] light assay), nitric oxide (IC50 16.34 microg/ml); 1,1-diphenyl-2-picryl hydrazyl (DPPH) radical (IC50 5.62 microg/ml); and 2,2-azinobis-ethyl-benzothiozoline-sulphonic acid diammonium salt (ABTS) radical (IC50 7.35 microg/ml). Aller-7 inhibited free radical-induced hemolysis in the concentration range of 20-80 microg/ml. Aller-7 also significantly inhibited nitric oxide release from lipopolysaccharide-stimulated murine

  1. Role of bilastine in the management of allergic rhinitis and urticaria: an Asia-Pacific consensus statement.

    Science.gov (United States)

    Mösges, Ralph; Lee, Dennis Lip Yen; Abong, Jovilia; Siasoco, Bella; Chow, Steven Kw; Leong, Jern-Lin; Singh, Harvinder; Kuljit, S; Campomanes, Benjamin

    2016-01-01

    The prevalence of allergic diseases is increasing globally, most particularly in middle- to low-income countries. This article examines the burden of allergic rhinitis and chronic urticaria in the Asia-Pacific region, unmet clinical needs, and the potential role of bilastine in the management of these conditions. An International Advisory Group meeting was convened in association with the Asian Pacific Society of Respirology Annual Congress in November 2014, followed by a literature review, and consensus-based outcomes from the meeting and literature review are described. Regional estimates of the prevalence of allergic rhinitis range from 10% to 50%, while little is known regarding the burden of urticaria in the Asia-Pacific region. A survey of allergy patients in the region identified fast, complete, and long-lasting symptom relief as the medication attributes most important to patients. International treatment guidelines for allergic rhinitis and urticaria advocate the first-line use of second-generation, no-sedating H1-antihistamines, such as bilastine, over their first-generation counterparts and a range of these agents are available to Asia-Pacific patients. The newer agents possess many of the properties of an "ideal" antihistamine (once daily administration, rapid and complete symptom relief, limited potential for drug-drug interactions, minimal side effects). The burgeoning prevalence of allergic diseases in the Asia-Pacific region and the uncontrolled symptoms that these patients experience demand a new antihistamine that offers the highest number of positive features according to the international guidelines.

  2. Vitamin D Deficiency and Allergic Rhinitis in Children: A Narrative Review

    Directory of Open Access Journals (Sweden)

    Javad Ghaffari

    2015-07-01

    Full Text Available Context: Allergic diseases such as allergic rhinitis (AR and immune-mediated inflammatory diseases are the most common chronic diseases among children. Although the cause of AR has yet to be clearly identified, genetic and environmental factors are known to play an important role in the development of the disease. Evidence Acquisition: In a more recent classification, AR is categorized as intermittent and permanent. Vitamin D has a known and important role in the absorption of calcium and preservation of bone density. The prevalence of vitamin D deficiency in children is reported to be between 30% and 50% in the world. Vitamin D confers the growth and development of the immune system including the development of regulatory T cells. Results: Two-thirds of the reviewed articles show a correlation between serum levels of vitamin D and allergic diseases, while the reaming ones demonstrate no correlation between vitamin D and AR and some even report a rise in the incidence of AR following the use of vitamin D supplement. Conclusions: It seems that further clinical trials and meta-analytic studies are necessary to confirm this correlation. The present study aimed at reviewing vitamin D deficiency in children with AR.

  3. Expression of Toll-like receptors in nasal epithelium in allergic rhinitis.

    Science.gov (United States)

    Renkonen, Jutta; Toppila-Salmi, Sanna; Joenväärä, Sakari; Mattila, Pirkko; Parviainen, Ville; Hagström, Jaana; Haglund, Caj; Lehtonen, Mikko; Renkonen, Risto

    2015-08-01

    Toll-like receptors (TLRs) are important in barrier homeostasis, but their role in airborne allergies is not fully understood. The aim was to evaluate baseline and allergen-induced expression of TLR proteins in nasal epithelium during allergic rhinitis. Nineteen otherwise healthy non-smoking volunteers both allergic to birch pollen and non-allergic controls were enrolled. We took nasal biopsies before and after off-seasonal intranasal birch pollen or diluent challenge. The expression of epithelial TLR1-7, TLR9-10, and MyD88 proteins was immunohistochemically evaluated from the nasal biopsies. The TLR1-3 and TLR5-10 mRNAs were observed by RNA-microarray. Baseline epithelial expression of TLR proteins was wide and identical in controls and atopics. After off-seasonal intranasal birch pollen challenge, a negative change in the expression score of TLR1 and TLR6 proteins was detected in the atopic group. TLR mRNA expression was not affected by birch pollen challenge. Nasal epithelium seems to express all known TLRs. The mechanisms by which TLR1, and TLR6 proteins could affect pollen allergen transport need further studies.

  4. Allergic rhinitis

    Science.gov (United States)

    ... invader References Baroody FM, Naclerio RM. Allergy and immunology of the upper airway. In: Flint PW, Haughey BH, Lund V, et al, eds. Cummings Otolaryngology: Head & Neck Surgery . 6th ed. Philadelphia, PA: Elsevier Saunders; 2015:chap ...

  5. Allergic Rhinitis

    Science.gov (United States)

    ... dust mites, are in dust. Dust mites are tiny living creatures found in bedding, mattresses, carpeting and upholstered furniture. They live on dead skin cells and other things found in house dust. Diagnosis & TestsHow do I know what I' ...

  6. UK prescribing practices as proxy markers of unmet need in allergic rhinitis: a retrospective observational study

    Science.gov (United States)

    Price, David B; Scadding, Glenis; Bachert, Claus; Saleh, Hesham; Nasser, Shuaib; Carter, Victoria; von Ziegenweidt, Julie; Durieux, Alice M S; Ryan, Dermot

    2016-01-01

    Little data on UK prescribing patterns and treatment effectiveness for allergic rhinitis (AR) are available. We quantified unmet pharmacologic needs in AR by assessing AR treatment effectiveness based on the prescribing behaviour of UK general practitioners (GP) during two consecutive pollen seasons (2009 and 2010). We conducted a retrospective observational study with the data from the Optimum Patient Care Research Database. We assessed diagnoses and prescription data for patients with a recorded diagnosis of rhinitis who took rhinitis medication during the study period. We assessed the data from 25,069 patients in 2009 and 22,381 patients in 2010. Monotherapy was the initial prescription of the season for 67% of patients with seasonal AR (SAR) and 77% of patients with nonseasonal upper airways disease (NSUAD), for both years. Initial oral antihistamine (OAH) or intranasal corticosteroid (INS) monotherapy proved insufficient for >20% of SAR and >37% of NSUAD patients. Multiple therapy was the initial prescription for 33% of SAR and 23% of NSUAD in both years, rising to 45% and >50% by season end, respectively. For NSUAD, dual-therapy prescriptions doubled and triple-therapy prescriptions almost tripled during both seasons. Many patients revisited their GP regardless of initial prescription. Initial OAH or INS monotherapy provides insufficient symptom control for many AR patients. GPs often prescribe multiple therapies at the start of the season, with co-prescription becoming more common as the season progresses. However, patients prescribed multiple therapies frequently revisit their GP, presumably to adjust treatment. These data suggest the need for more effective AR treatment and management strategies. PMID:27334893

  7. GATA3 Gene Polymorphisms Associated with Allergic Rhinitis in an Iranian Population

    Science.gov (United States)

    Shirkani, Afshin; Mansouri, Atena; Abbaszadegan, Mohammad Reza; Faridhosseini, Reza; Jabbari Azad, Farahzad; Gholamin, Mehran

    2017-01-01

    Background: The development of allergic rhinitis (AR) is caused by the interaction between genetic predisposition and environmental factors. In this study, the association between GATA3 single nucleotide polymorphisms and AR in an Iranian population was identified. Methods: This case-control study was performed on 86 patients with AR and 86 healthy subjects. This study aimed to evaluate a potential association between two GATA3 SNPs, rs1269486 and rs2229360, and AR. Blood samples were collected and DNA was extracted for the evaluation of these SNPs by RFLP-PCR. Results: A statistically-significant association was found between rs1269486 and AR (Ppopulation. Because of the significance of this gene in AR, studying the association between GATA3 polymorphisms and AR is recommended for other populations. PMID:28367470

  8. Expression of HSP70 in Peripheral Lymphocytes of the Patients with Allergic Rhinitis

    Institute of Scientific and Technical Information of China (English)

    刘立思; 肖成峰; 张明; 程磊; 王鄂芬; 邬堂春

    2003-01-01

    The expression levels of heat shock protein 70 (HSP70) from peripheral lymphocytes ofthe patients with allergic rhinitis (AR) and the clinical implication were investigated. In the morn-ing, 3 ml of fasting venous blood was taken out. The lymphocytes were isolated by using Ficoll-Hypaque and the expression of HSP70 in the lymphocytes was detected by using Western blot. Inthe AR patients the HSP70 level (41.49± 15.77 integrated optical density, IOD) were significantlyhigher than that in the control group (23.89±10. 13 IOD, P<0.05). Western blot demonstratedthat HSP70 bands in AR patients were more intensive than those in the control group. It was con-cluded that the elevated HSP70 level in peripheral lymphocytes of the AR patients might contributeto the development of AR.

  9. Effect of Inhalation of Aromatherapy Oil on Patients with Perennial Allergic Rhinitis: A Randomized Controlled Trial

    Directory of Open Access Journals (Sweden)

    Seo Yeon Choi

    2016-01-01

    Full Text Available This study aimed to investigate the effects of aromatherapy oil inhalation on symptoms, quality of life, sleep quality, and fatigue level among adults with perennial allergic rhinitis (PAR. Fifty-four men and women aged between 20 and 60 were randomized to inhale aromatherapy oil containing essential oil from sandalwood, geranium, and Ravensara or almond oil (the placebo for 5 minutes twice daily for 7 days. PAR symptoms determined by Total Nasal Symptom Score (TNSS, the Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ, sleep quality by Verran Synder-Halpern (VSH scale, and fatigue level by Chalder Fatigue Scale (CFS were assessed before and after intervention period. Compared with the placebo, the experimental group showed significant improvement in TNSS, especially in nasal obstruction. The aromatherapy group also showed significantly higher improvements in total score of RQLQ and CFS. These findings indicate that inhalation of certain aromatherapy oil helps relieve PAR symptoms, improve rhinitis-specific quality of life, and reduce fatigue in patients with PAR. In conclusion, inhalation of aromatherapy essential oil may have potential as an effective intervention to alleviate PAR.

  10. Effect of Inhalation of Aromatherapy Oil on Patients with Perennial Allergic Rhinitis: A Randomized Controlled Trial.

    Science.gov (United States)

    Choi, Seo Yeon; Park, Kyungsook

    2016-01-01

    This study aimed to investigate the effects of aromatherapy oil inhalation on symptoms, quality of life, sleep quality, and fatigue level among adults with perennial allergic rhinitis (PAR). Fifty-four men and women aged between 20 and 60 were randomized to inhale aromatherapy oil containing essential oil from sandalwood, geranium, and Ravensara or almond oil (the placebo) for 5 minutes twice daily for 7 days. PAR symptoms determined by Total Nasal Symptom Score (TNSS), the Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ), sleep quality by Verran Synder-Halpern (VSH) scale, and fatigue level by Chalder Fatigue Scale (CFS) were assessed before and after intervention period. Compared with the placebo, the experimental group showed significant improvement in TNSS, especially in nasal obstruction. The aromatherapy group also showed significantly higher improvements in total score of RQLQ and CFS. These findings indicate that inhalation of certain aromatherapy oil helps relieve PAR symptoms, improve rhinitis-specific quality of life, and reduce fatigue in patients with PAR. In conclusion, inhalation of aromatherapy essential oil may have potential as an effective intervention to alleviate PAR.

  11. The burden of allergic rhinitis (AR in Canada: perspectives of physicians and patients

    Directory of Open Access Journals (Sweden)

    Keith Paul K

    2012-06-01

    Full Text Available Abstract Background Allergic rhinitis (AR is a common problem and we sought to examine the burden of disease and its management in Canada from the perspectives of patients and physicians. Methods Two parallel, Canadawide structured telephone interviews surveyed 1,001 AR patients and 160 physicians in July 2006. Results 44% of patients had experienced nasal symptoms unrelated to a cold and 20% had a physician diagnosis of AR. At screening 27% reported asthma, 15% chronic or recurrent sinusitis and 5% nasal polyps. With attacks nasal congestion and runny nose were the most bothersome symptoms. Other problems experienced were fatigue (46%, poor concentration (32%, and reduced productivity (23%. Most (77% had not seen a physician in the past year. Physicians estimated they prescribed intranasal cortico steroids (INCS to most AR patients (77% consistent with guidelines but only 19% of patients had used one in the last month. Only 48% of patients were very satisfied with their current INCS. 41% of AR patients reported discontinuing their INCS with the most common reason being a perceived lack of long-lasting symptom relief (44%. 52% of patients felt that their current INCS lost effectiveness over 24 h. The most common INCS side effects included dripping down the throat, bad taste, and dryness. Most AR patients reported lifestyle limitations despite treatment (66%. 61% of patients felt that their symptoms were only somewhat controlled or poorly/not controlled during their worst month in the past year. Conclusions AR symptoms are common and many patients experience inadequate control. Physicians report they commonly prescribe intranasal corticosteroids, but patient’s perceived loss of efficacy and side effects lead to their discontinuation. Persistent relief of allergic rhinitis symptoms remains a major unmet need. Better treatments and education are required.

  12. Study on Cytokines IL-2, IL-6, IL-10 in Patients of Chronic Allergic Rhinitis Treated with Acupuncture

    Institute of Scientific and Technical Information of China (English)

    2002-01-01

    Objectives: To observe the plasmatic concentration of IL-6, IL-10 and IL-2 in the patient of chronic allergic rhinitis before and after acupuncture therapy. Methods: Cytokine levels were determined before and after treatment in 30 healthy volunteers (Group A) and 90 patients of chronic allergic rhinitis (Group B) with an increased plasma IL-10 level. Group B was then divided into 3 subgroups: 30 patients treated with real acupuncture (Group B1); 30 patients treated with sham acupuncture (Group B2); 30 non-treated patients (Group B3). Results: The allergic subjects of group B1, compared with controls, showed a significant reduction of IL-10 after a specific treatment with acupuncture (P<0.05). On the other hand, in those patients treated with sham acupuncture (B2) as well as in non-treated patients (B3), the IL-10 values remained high and unchanged. There was a statistically significant change in IL-2 values at 24 hours (P<0.05) after real acupuncture (Groups A, B1), however the values remained within normal ranges. The IL-6 do not change after therapy. Conclusion: The acupuncture treatment can reduce plasmatic level of IL-10 in chronic allergic rhinitis.

  13. Responses of Six-Weeks Aquatic Exercise on the Autonomic Nervous System, Peak Nasal Inspiratory Flow and Lung Functions in Young Adults with Allergic Rhinitis

    Directory of Open Access Journals (Sweden)

    Taweesak Janyacharoen

    2015-10-01

    Full Text Available Allergic rhinitis is a chronic respiratory disease. Sympathetic hypofunction is identified in all of the allergic rhinitis patients. Moreover, allergic rhinitis is associated with decreased peak nasal inspiratory flow (PNIF and impaired lung functions. The aim of this study was to investigate effects of six-week of aquatic exercise on the autonomic nervous system function, PNIF and lung functions in allergic rhinitis patients.Twenty-six allergic rhinitis patients, 12 males and 14 females were recruited in this study. Subjects were diagnosed by a physician based on history, physical examination, and positive reaction to a skin prick test. Subjects were randomly assigned to two groups. The control allergic rhinitis group received education and maintained normal life. The aquatic group performed aquatic exercise for 30 minutes a day, three days a week for six weeks. Heart rate variability, PNIF and lung functions were measured at the beginning, after three weeks and six weeks.There were statistically significant increased low frequency normal units (LF n.u., PNIF and showed decreased high frequency normal units (HF n.u. at six weeks after aquatic exercise compared with the control group.Six weeks of aquatic exercise could increase sympathetic activity and PNIF in allergicrhinitis patients.

  14. The impact of allergic rhinitis on sexual activity, sleep, and fatigue.

    Science.gov (United States)

    Benninger, Michael S; Benninger, Ryan M

    2009-01-01

    Allergic rhinitis (AR) has been found to impact the daily activities of allergic patients. This includes the effects on sleep and chronic fatigue. The effect of AR on sexual function has not been well studied. The purpose of this study was to assess the impact of AR on sexual function, sleep, and fatigue. The Rhinosinusitis Disability Index (RSDI) is a quality of life (QOL), validated outcomes tool that assesses how AR affects QOL. Specific questions address the adverse consequence on sexual function, sleep, and fatigue. Four subsets of patient with AR who completed the RSDI were evaluated for the specific questions as well as the physical, emotional, functional, and total scores. The scores were compared with a cohort of normal subjects, patients with a diffuse group of rhinologic disorders, and patients scheduled for septal surgery (non-AR patients). Patients with AR had significantly higher (worse) sexual and sleep RSDI scores than the non-AR patients and normal subjects. Although the AR subjects also had significantly higher fatigue RSDI scores than the normal subjects, there was no significant difference between the AR and non-AR patients' fatigue scores. Non-AR patients had significantly higher sexual, sleep, and fatigue RSDI scores than the normal subjects. AR has a significant negative impact on sexual function and can result in sleep disturbances and fatigue as measured by the RSDI.

  15. Effects of Bifidobacterium Breve Feeding Strategy and Delivery Modes on Experimental Allergic Rhinitis Mice.

    Directory of Open Access Journals (Sweden)

    Jian-jun Ren

    Full Text Available Different delivery modes may affect the susceptibility to allergic diseases. It is still unknown whether early intervention with probiotics would counteract this effect.The effect of different delivery modes on immune status and nasal symptoms was investigated on established allergic rhinitis (AR mouse model. In addition, the immunoregulatory effects and mechanisms of different feeding manners with Bifidobacterium breve(B. breve were examined.Live lyophilized B. breve was orally administered to BALB/c mice born via vaginal delivery(VD or cesarean delivery (CD for 8 consecutive weeks, after which they were sensitized by ovalbumin(OVA to establish experimental AR. Nasal symptoms, serum immunoglobulins, cytokines, splenic percentages of CD4(+CD25(+Foxp3(+ regulatory T(Treg cells and nasal eosinophil infiltration were evaluated.Compared with VD mice, mice delivered via CD demonstrated more serious nasal symptoms, higher concentrations of OVA-specific immunoglobulin (Ig E, more nasal eosinophils and lower percentages of splenic CD4(+CD25(+Foxp3(+Treg cells after establishing experimental AR. These parameters were reversed by administering B. breves hortly after birth. However, the effect of B. breve did not differ between different delivery modes.CD aggravates the nasal symptoms of AR mice compared to VD. This is the first report that oral administration of B. breve shortly after birth can significantly alleviate the symptoms of AR mice born via both deliveries, probably via activation of the regulatory capacity of CD4(+CD25(+Foxp3(+Treg cells.

  16. The effect of topical sodium cromoglycate on intranasal histamine challenge in allergic rhinitis.

    Science.gov (United States)

    Birchall, M A; Henderson, J C; Studham, J M; Pride, N B; Fuller, R W

    1994-12-01

    Topical sodium cromoglycate is used to treat allergic diseases of the upper and lower airways. To investigate its mechanisms of action, intranasal histamine challenge was used in nine subjects with perennial allergic rhinitis. After a preliminary day where subjects' reactivity thresholds (D100) for histamine were determined, intranasal sodium cromoglycate was administered in a double-blind, placebo-controlled fashion. Graded (D100/3, D100, D100X3), sequential challenges were performed on days 1 and 21 of each course, and responses measured by changes in nasal airway resistance, sneezes, secretion volume and secretion content: total protein, lysozyme and mucin. After a single dose of sodium cromoglycate, there was no change in resistance, but secretion volumes fell significantly (3.12 ml/5 min c.i. 2.83-3.4; placebo 3.61, c.i. 3.32-3.90: P = 0.026). After a 3-week-course, there was a significant fall in resistance (4.29 cm H2O/l/s, c.i. 3.85-4.72; placebo 5.45, c.i. 5.01-5.88: P sodium cromoglycate has both short- and long-term effects on nasal reactivity to histamine challenge. Acutely, there is a reduction in nasal lavage fluid volume which may be the result of reduced irritant receptor activity. After a 3-week course, there is a reduction in nasal resistance responses, a possible anti-inflammatory effect.

  17. Early indoor aeroallergen exposure is not associated with development of sensitization or allergic rhinitis in high-risk children

    DEFF Research Database (Denmark)

    Schoos, A-M M; Chawes, B L; Jelding-Dannemand, E

    2016-01-01

    aeroallergen exposure and sensitization and rhinitis to such allergens later in childhood. METHODS: Allergic sensitization to cat, dog, and house dust mites was diagnosed longitudinally using skin prick tests and specific IgE measurements at ½, 1½, 4, 6, and 13 years in 399 children from the Copenhagen...... Prospective Study on Asthma in Childhood2000 birth cohort. Rhinitis was diagnosed at 7 and 13 years. Allergen exposure was defined as dog or cat in the home during the 3rd trimester of pregnancy or the first year of life and as allergen levels of dog, cat, and house dust mite in bed dust samples at 1 year....... Associations between exposure and outcomes were analyzed by logistic regression and stratified for eczema status and test method (skin prick test and specific IgE). RESULTS: We found no association between dog or cat exposure in perinatal life and sensitization or rhinitis during childhood. Similarly...

  18. Uso de probióticos na rinite alérgica Probiotics in allergic rhinitis

    Directory of Open Access Journals (Sweden)

    Janaina Cândida Rodrigues Nogueira

    2011-02-01

    Full Text Available Probióticos são microrganismos viáveis, usados como suplemento alimentar, normalmente bactérias ácidas lácticas, que podem modificar a composição e/ou a atividade metabólica da microbiota intestinal, modulando o sistema imune de forma que beneficie a saúde do indivíduo. OBJETIVO: Fazer uma revisão sobre o uso de Probióticos (Lactobacillus e Bifidobacterium na rinite alérgica. MATERIAL E MÉTODO: Foram pesquisados artigos originais no Pubmed. RESULTADOS: Os resultados encontrados indicam que os probióticos, Lactobacillus e Bifidobacterium parecem prevenir as recorrências alérgicas, aliviar a severidade dos sintomas e promover melhora da qualidade de vida dos pacientes com rinite alérgica. Estes efeitos ocorrem devido à modulação do sistema imunológico através da indução da produção de citocinas que promovem uma resposta TH1 dominante em alérgicos, através do efeito da modulação no balanço TH1/TH2. CONCLUSÃO: O uso de bactérias probióticas pode ser uma forma efetiva e segura de prevenção e/ou tratamento de rinite alérgica, mas seu mecanismo exato de ação permanece desconhecido. No entanto, estudos clínicos usando probióticos e intervenção dietética deverão ser o foco de futuras investigações, para permitir um uso mais amplo.Probiotics are live microorganisms used as supplementary food, usually lactic acid bacteria that can change either the composition and/or the metabolic activities of the gut microbiota modulating the immune system in a way that benefits the person's health. AIM: To review the use of Probiotics (Lactobacillus and Bifidobacterium in allergic rhinitis patients. MATERIALS AND METHODS: Pubmed original articles were used as data source. RESULTS: Results indicate that probiotics, Lactobacillus and Bifidobacterium appear to prevent allergy recurrences, alleviate the severity of symptoms and improve the quality of life of patients with allergic rhinitis. This happens because of the immune

  19. Mechanism of traditional Chinese medicine in the treatment of allergic rhinitis

    Institute of Scientific and Technical Information of China (English)

    GUO Hong; LIU Ming-ping

    2013-01-01

    Objective To review the major progress in mechanism of traditional Chinese medicine (TCM) in the treatment of allergic rhinitis (AR).Methods Contents about the treatment mechanism of TCM in the therapy of AR in this article were obtained from 22 original articles and reviews published in Chinese-and English-language journals.All of the references were searched by use of Pubmed (1997-2012).Results AR is one of the most common and most serious public health problems in children and young people.Many AR patients were worried about the possible adverse effects of synthetic drugs they were taking.Thus,they seek complementary and alternative therapy,such as TCM.TCM emphasized on the importance of holistic convalescence,not just the disease itself.The favorable safety profile of TCM makes well-acceptance by the general population.In the recent decade,more and more studies of TCM for AR are developed.These studies indicated that the treatment of allergic disorders with TCM therapy including herbal medicines and acupuncture are of safety and efficacy.The mechanism of TCM in the treatment of AR has been discussed.It has been reported that a number of the herbs in the Chinese herbal formulae used in the treatment possess anti-allergic,anti-inflammatory or immune modulation activity.Such function include the inhibition of the release or the activity of mast cell mediators (such as histamine),inhibition the induction of inflammation reaction by chemical agents,and down regulation of serum (immunoglobulin E) IgE levels or the activity of lymphocyte and/or macrophage.Conclusions TCM are frequently used concurrently to improve the clinical efficacy.This review is focuses on the description of the actions mechanism of Chinese medicine's approach relevant to the treatment of AR.

  20. Modulation of immune tolerance with a Chinese traditional prescription inhibits allergic rhinitis in mice

    Directory of Open Access Journals (Sweden)

    Min-Qiang Xie

    2011-01-01

    Full Text Available Background : Allergic diseases substantially affect human health and social economy. The pathogenesis is to be further understood. The effect of current therapeutic remedies on allergic diseases is not satisfactory. Aims : This study aimed to inhibit allergic rhinitis in a mouse model with a Chinese traditional medical prescription, Bu-Zhong-Yi-Qi-Tang. Material and Methods : A mouse AR model was developed with ovalbumin (OVA plus adjuvant alum. The AR clinical symptoms and immune pathology in the nasal mucosa were assessed with the AR mouse model. Some mice were treated with Bu-Zhong-Yi-Qi-Tang via gavage-fed. The immune tolerance status in the nasal mucosa was evaluated by counting the numbers of tolerogenic dendritic cells (DC and regulatory T cells (Treg. Results : After exposure to the specific antigen, OVA, the sensitized mice had AR-like symptoms including nasal itch and sneeze. The frequency of mast cells, levels of IgE/IL-4 in nasal mucosa was markedly higher in sensitized mice than naïve controls; while the levels of integration alphavbeta6 (avb6, the number of tolerogenic DCs and Tregs in nasal mucosa were significantly lower than naïve control mice. The AR-like symptoms and immune pathology and immune tolerance status in the AR nasal mucosa were substantially improved by administration with Bu-Zhong-Yi-Qi-Tang. Conclusions : The immune tolerance status is impaired in the AR nasal mucosa that can be improved by administering with Bu-Zhong-Yi-Qi-Tang.

  1. Rinite alérgica: indicadores de qualidade de vida Allergic rhinitis: indicators of quality of life

    Directory of Open Access Journals (Sweden)

    Inês Cristina Camelo-Nunes

    2010-02-01

    Full Text Available O objetivo desta revisão foi apresentar evidências da relação entre rinite alérgica e redução da qualidade de vida. As fontes de dados foram artigos originais, revisões e consensos indexados nos bancos de dados Medline e LILACS entre 1997 e 2008. As palavras de busca foram "rinite alérgica", "qualidade de vida" e "distúrbios do sono". Os pacientes com rinite alérgica frequentemente têm redução na qualidade de vida causada pelos sintomas clássicos da doença (espirros, prurido, coriza e obstrução. Além disso, a fisiopatologia da rinite alérgica, com frequência, interrompe o sono, ocasionando fadiga, irritabilidade, déficits de memória, sonolência diurna e depressão. A carga total da doença recai não apenas no funcionamento social e físico prejudicados, mas também no impacto financeiro, que se torna maior quando se consideram as evidências de que a rinite alérgica é um possível fator casual de comorbidades, tais como a asma e a sinusite. A obstrução nasal, o mais proeminente dos sintomas, está associada a eventos respiratórios relacionados aos distúrbios do sono, uma condição que tem profundo efeito sobre a saúde mental, o aprendizado, o comportamento e a atenção. Finalmente, a rinite alérgica - doença crônica que afeta crianças, adolescentes e adultos - frequentemente é subdiagnosticada ou inadequadamente tratada. O impacto deletério dos distúrbios do sono associados à rinite alérgica sobre a habilidade para realizar as atividades de vida diária dos pacientes é um importante componente da morbidade da doença. Com um diagnóstico acurado, existem vários tratamentos disponíveis que podem reduzir a carga associada à rinite alérgica.The objective of this review was to present evidence of the relationship between allergic rhinitis and impairment of quality of life. The data sources were original articles, reviews and consensus statements entered into the Medline and LILACS databases between

  2. [Investigation of the efficacy and tolerability of azelastine nasal spray versus ebastine tablets in patients with seasonal allergic rhinitis].

    Science.gov (United States)

    Antépara, I; Jaúregui, I; Basomba, A; Cadahia, A; Feo, F; García, J J; Gonzalo, M A; Luna, I; Rubio, M; Vázquez, M

    1998-01-01

    The efficacy and safety of the nasally administered histamine H1 receptor blocking drug Azelastine was investigated in an open, multicenter, randomized comparative trial with Ebastine in seasonal allergic rhinitis. 110 patients in two parallel groups were treated for 14 days and efficacy was assessed by the physician using a rating scale measuring 10 nasal and ocular symptoms of seasonal rhinitis (0 = absent, 1 = mild, 2 = moderate, 3 = severe). Tolerability was measured on the basis of reported adverse events. Both treatment groups had dramatic reductions in the physician's total symptom score following treatment (p < 0.0005). There was no significant difference between the two groups. Changes in individual rhinitis symptoms showed no differences between the two groups. During treatment, 19 patients had at least one adverse event, 13 in Azelastine group and 6 in Ebastine group; all were mild. The most frequent adverse events reported were somnolence (4 cases in Ebastine group) and a bitter taste (4 patients in the Azelastine group). In conclusion, the results of the study on 110 patients suggest that both Azelastine and Ebastine are effective treatments of the symptoms of seasonal allergic rhinitis. Both drugs were well tolerated.

  3. Control of Allergic Rhinitis and Asthma Test (CARAT can be used to assess individual patients over time

    Directory of Open Access Journals (Sweden)

    Fonseca Joao A

    2012-08-01

    Full Text Available Abstract Background The Control of Allergic Rhinitis and Asthma Test (CARAT10 has been proposed as the first tool to implement the Allergic Rhinitis and its Impact on Asthma initiative guidelines in clinical practice. To serve this purpose, it must have adequate properties to assess the control of an individual over time. This study aimed to prospectively assess the test-retest reliability, responsiveness and longitudinal validity of CARAT10. Methods Adults with asthma and allergic rhinitis were enrolled at 4 outpatient clinics of Portuguese central hospitals. At each of the two visits, 4 to 6 weeks apart, patients filled out CARAT10 and additional questionnaires, followed by a medical evaluation blinded to the questionnaires’ answers. Results From the 62 patients included, 51 patients completely filled out CARAT10 at both visits. The test-retest reliability, computed as an intra-class correlation coefficient, was 0.82. Regarding responsiveness, a significant change (p = 0.002 of CARAT10 score in clinically unstable patients was observed (95%CI -5.08; -1.31 and the Guyatt’s responsiveness index was 1.54. As for the longitudinal validity assessment, the correlation coefficients of the changes of CARAT10 scores with those of ACQ5 and symptoms VAS ranged from 0.49 to 0.65, while with the physician assessment of control they ranged from 0.31 to 0.41. Conclusion CARAT10 has good test-retest reliability, responsiveness and longitudinal validity. It can be used to assess control of allergic rhinitis and asthma, both to compare groups in clinical studies and to evaluate individual patients in clinical practice.

  4. Allergic rhinitis, feeding and oral habits, toothbrushing and socioeconomic status. Effects on development of dental caries in primary dentition.

    Science.gov (United States)

    Vázquez-Nava, F; Vázquez, R E M; Saldivar, G A H; Beltrán, G F J; Almeida, A V M; Vázquez, R C F

    2008-01-01

    The aim was to determine the effect of feeding and oral habits, toothbrushing, socioeconomic status and allergic rhinitis on the development of dental caries in primary dentition. In a cross-sectional study, data were obtained by means of a structured questionnaire on 1,160 children, 4-5 years old (mean = 4.5 +/- 0.5) and born in 1999, 2000 or 2001. The children also had a physical examination by an allergist and dentists. Dental caries was diagnosed according to WHO criteria. Caries experience was measured as number of deft and defs. Logistic regression analysis assessed the association between dental caries and independent variables. The dental caries prevalence was 17.9%, 28.8% of the children had allergic rhinitis symptoms, digit sucking was reported by 9.8% and pacifier use by 13.6% of the children. The mean number of deft of the sample was 1.02 (SD = 2.37) and that of defs was 1.33 (SD = 3.54). Analysis showed that breast-feeding for >12 months (p < 0.01), toothbrushing frequency (p < 0.01), sugar consumption (p < 0.01) and pacifier use (p < 0.01) each had a significant association with dental caries occurrence in primary dentition. Children with pacifier use and allergic rhinitis had more than double the risk of dental caries development. Allergic rhinitis alone has no effect on dental caries. Healthcare professionals attempting to limit dental caries should consider the effect of prolonged breast-feeding, sugary product consumption between meals and nonnutritive habits on dental caries.

  5. Clinical Profile, Co-Morbidities and Health Related Quality of Life in Pediatric Patients with Allergic Rhinitis and Asthma

    OpenAIRE

    Keya R. Lahiri, Milind S. Tullu* and Rachna Kalra

    2010-01-01

    Background: Co-existence of allergic rhinitis (AR) and bronchial asthma (BA) is well known. We planned to study the clinical profile of patients with AR & BA, the associated co-morbidities and the effect of AR &/ or BA on health related quality of life (HRQOL) in Pediatric patients. Methods: Patients attending the Pediatric out-patients department and Pediatric Chest Clinic of tertiary care center were enrolled. The sample size included 100 subjects with BA & AR (Group 1) with control groups ...

  6. The anti-inflammatory effects of acupuncture and their relevance to allergic rhinitis: a narrative review and proposed model.

    Science.gov (United States)

    McDonald, John L; Cripps, Allan W; Smith, Peter K; Smith, Caroline A; Xue, Charlie C; Golianu, Brenda

    2013-01-01

    Classical literature indicates that acupuncture has been used for millennia to treat numerous inflammatory conditions, including allergic rhinitis. Recent research has examined some of the mechanisms underpinning acupuncture's anti-inflammatory effects which include mediation by sympathetic and parasympathetic pathways. The hypothalamus-pituitary-adrenal (HPA) axis has been reported to mediate the antioedema effects of acupuncture, but not antihyperalgesic actions during inflammation. Other reported anti-inflammatory effects of acupuncture include an antihistamine action and downregulation of proinflammatory cytokines (such as TNF- α , IL-1 β , IL-6, and IL-10), proinflammatory neuropeptides (such as SP, CGRP, and VIP), and neurotrophins (such as NGF and BDNF) which can enhance and prolong inflammatory response. Acupuncture has been reported to suppress the expression of COX-1, COX-2, and iNOS during experimentally induced inflammation. Downregulation of the expression and sensitivity of the transient receptor potential vallinoid 1 (TRPV1) after acupuncture has been reported. In summary, acupuncture may exert anti-inflammatory effects through a complex neuro-endocrino-immunological network of actions. Many of these generic anti-inflammatory effects of acupuncture are of direct relevance to allergic rhinitis; however, more research is needed to elucidate specifically how immune mechanisms might be modulated by acupuncture in allergic rhinitis, and to this end a proposed model is offered to guide further research.

  7. The Anti-Inflammatory Effects of Acupuncture and Their Relevance to Allergic Rhinitis: A Narrative Review and Proposed Model

    Directory of Open Access Journals (Sweden)

    John L. McDonald

    2013-01-01

    Full Text Available Classical literature indicates that acupuncture has been used for millennia to treat numerous inflammatory conditions, including allergic rhinitis. Recent research has examined some of the mechanisms underpinning acupuncture's anti-inflammatory effects which include mediation by sympathetic and parasympathetic pathways. The hypothalamus-pituitary-adrenal (HPA axis has been reported to mediate the antioedema effects of acupuncture, but not antihyperalgesic actions during inflammation. Other reported anti-inflammatory effects of acupuncture include an antihistamine action and downregulation of proinflammatory cytokines (such as TNF-α, IL-1β, IL-6, and IL-10, proinflammatory neuropeptides (such as SP, CGRP, and VIP, and neurotrophins (such as NGF and BDNF which can enhance and prolong inflammatory response. Acupuncture has been reported to suppress the expression of COX-1, COX-2, and iNOS during experimentally induced inflammation. Downregulation of the expression and sensitivity of the transient receptor potential vallinoid 1 (TRPV1 after acupuncture has been reported. In summary, acupuncture may exert anti-inflammatory effects through a complex neuro-endocrino-immunological network of actions. Many of these generic anti-inflammatory effects of acupuncture are of direct relevance to allergic rhinitis; however, more research is needed to elucidate specifically how immune mechanisms might be modulated by acupuncture in allergic rhinitis, and to this end a proposed model is offered to guide further research.

  8. Paediatric rhinitis

    DEFF Research Database (Denmark)

    Roberts, G; Xatzipsalti, M; Borrego, L M

    2013-01-01

    Rhinitis is a common problem in childhood and adolescence and impacts negatively on physical, social and psychological well-being. This position paper, prepared by the European Academy of Allergy and Clinical Immunology Taskforce on Rhinitis in Children, aims to provide evidence-based recommendat......Rhinitis is a common problem in childhood and adolescence and impacts negatively on physical, social and psychological well-being. This position paper, prepared by the European Academy of Allergy and Clinical Immunology Taskforce on Rhinitis in Children, aims to provide evidence...... conditions such as adenoidal hypertrophy, septal deviation and nasal polyps. Examination by anterior rhinoscopy and allergy tests may help to substantiate a diagnosis of allergic rhinitis. Avoidance of relevant allergens may be helpful for allergic rhinitis (AR). Oral and intranasal antihistamines and nasal...

  9. Active or passive exposure to tobacco smoking and allergic rhinitis, allergic dermatitis, and food allergy in adults and children: a systematic review and meta-analysis.

    Directory of Open Access Journals (Sweden)

    Jurgita Saulyte

    2014-03-01

    Full Text Available Allergic rhinitis, allergic dermatitis, and food allergy are extremely common diseases, especially among children, and are frequently associated to each other and to asthma. Smoking is a potential risk factor for these conditions, but so far, results from individual studies have been conflicting. The objective of this study was to examine the evidence for an association between active smoking (AS or passive exposure to secondhand smoke and allergic conditions.We retrieved studies published in any language up to June 30th, 2013 by systematically searching Medline, Embase, the five regional bibliographic databases of the World Health Organization, and ISI-Proceedings databases, by manually examining the references of the original articles and reviews retrieved, and by establishing personal contact with clinical researchers. We included cohort, case-control, and cross-sectional studies reporting odds ratio (OR or relative risk (RR estimates and confidence intervals of smoking and allergic conditions, first among the general population and then among children. We retrieved 97 studies on allergic rhinitis, 91 on allergic dermatitis, and eight on food allergy published in 139 different articles. When all studies were analyzed together (showing random effects model results and pooled ORs expressed as RR, allergic rhinitis was not associated with active smoking (pooled RR, 1.02 [95% CI 0.92-1.15], but was associated with passive smoking (pooled RR 1.10 [95% CI 1.06-1.15]. Allergic dermatitis was associated with both active (pooled RR, 1.21 [95% CI 1.14-1.29] and passive smoking (pooled RR, 1.07 [95% CI 1.03-1.12]. In children and adolescent, allergic rhinitis was associated with active (pooled RR, 1.40 (95% CI 1.24-1.59 and passive smoking (pooled RR, 1.09 [95% CI 1.04-1.14]. Allergic dermatitis was associated with active (pooled RR, 1.36 [95% CI 1.17-1.46] and passive smoking (pooled RR, 1.06 [95% CI 1.01-1.11]. Food allergy was associated with SHS (1

  10. Geo-climatic heterogeneity in self-reported asthma, allergic rhinitis and chronic bronchitis in Italy

    Energy Technology Data Exchange (ETDEWEB)

    Pesce, G., E-mail: giancarlo.pesce@univr.it [Unit of Epidemiology and Medical Statistics, Department of Diagnostics and Public Health, University of Verona, Verona (Italy); Bugiani, M. [Unit of Respiratory Medicine and Allergology, CPA-ASL TO-2, Turin (Italy); Marcon, A.; Marchetti, P. [Unit of Epidemiology and Medical Statistics, Department of Diagnostics and Public Health, University of Verona, Verona (Italy); Carosso, A. [Unit of Respiratory Medicine and Allergology, CPA-ASL TO-2, Turin (Italy); Accordini, S. [Unit of Epidemiology and Medical Statistics, Department of Diagnostics and Public Health, University of Verona, Verona (Italy); Antonicelli, L. [Dept of Internal Medicine, Immuno-Allergic and Respiratory Diseases, Ospedali Riuniti di Ancona, Ancona (Italy); Cogliani, E. [Casaccia Research Centre, Italian National Agency for New Technologies, Energy, and Substainable Economic Development (ENEA), Rome (Italy); Pirina, P. [Institute of Respiratory Diseases, University of Sassari, Sassari (Italy); Pocetta, G. [Dept of Experimental Medicine, University of Perugia, Perugia (Italy); Spinelli, F. [Casaccia Research Centre, Italian National Agency for New Technologies, Energy, and Substainable Economic Development (ENEA), Rome (Italy); Villani, S. [Dept of Public Health, Experimental and Forensic Medicine, University of Pavia, Pavia (Italy); Marco, R. de [Unit of Epidemiology and Medical Statistics, Department of Diagnostics and Public Health, University of Verona, Verona (Italy)

    2016-02-15

    Background: Several studies highlighted a great variability, both between and within countries, in the prevalence of asthma and chronic airways diseases. Aim: To evaluate if geo-climatic variations can explain the heterogeneity in the prevalence of asthma and respiratory diseases in Italy. Methods: Between 2006 and 2010, a postal screening questionnaire on respiratory health was administered to 18,357 randomly selected subjects, aged 20–44, living in 7 centers in northern, central, and southern Italy. A random-effects meta-analysis was fitted to evaluate the between-centers heterogeneity in the prevalence of asthma, asthma-like symptoms, allergic rhinitis, and chronic bronchitis (CB). A principal component analysis (PCA) was performed to synthetize the geo-climatic information (annual mean temperature, range of temperature, annual rainfalls, global solar radiations, altitude, distance from the sea) of all the 110 Italian province capital towns. The associations between these geo-climatic components obtained with PCA and the prevalence of respiratory diseases were analyzed through meta-regression models. Results: 10,464 (57%) subjects responded to the questionnaire. There was a significant between-centers heterogeneity in the prevalence of asthma (I{sup 2} = 59.5%, p = 0.022) and CB (I{sup 2} = 60.5%, p = 0.019), but not in that of asthma-like symptoms or allergic rhinitis. Two independent geo-climatic components explaining together about 80% of the overall geo-climatic variability were identified: the first principally summarized the climatic variables; the second the topographic ones. Variations in the prevalence of asthma across centers were significantly associated with differences in the climatic component (p = 0.017), but not with differences in the topographic one. Conclusions: Our findings suggest that climate play a role in determining the between-center heterogeneity in the prevalence of asthma in Italy, with higher prevalence in dry-hot Mediterranean

  11. Consumption of artificially-sweetened soft drinks in pregnancy and risk of child asthma and allergic rhinitis.

    Directory of Open Access Journals (Sweden)

    Ekaterina Maslova

    Full Text Available BACKGROUND: Past evidence has suggested a role of artificial sweeteners in allergic disease; yet, the evidence has been inconsistent and unclear. OBJECTIVE: To examine relation of intake of artificially-sweetened beverages during pregnancy with child asthma and allergic rhinitis at 18 months and 7 years. METHODS: We analyzed data from 60,466 women enrolled during pregnancy in the prospective longitudinal Danish National Birth Cohort between 1996 and 2003. At the 25th week of gestation we administered a validated Food Frequency Questionnaire which asked in detail about intake of artificially-sweetened soft drinks. At 18 months, we evaluated child asthma using interview data. We also assessed asthma and allergic rhinitis through a questionnaire at age 7 and by using national registries. Current asthma was defined as self-reported asthma diagnosis and wheeze in the past 12 months. We examined the relation between intake of artificially-sweetened soft drinks and child allergic disease outcomes and present here odds ratios with 95% CI comparing daily vs. no intake. RESULTS: At 18 months, we found that mothers who consumed more artificially-sweetened non-carbonated soft drinks were 1.23 (95% CI: 1.13, 1.33 times more likely to report a child asthma diagnosis compared to non-consumers. Similar results were found for child wheeze. Consumers of artificially-sweetened carbonated drinks were more likely to have a child asthma diagnosis in the patient (1.30, 95% CI: 1.01, 1.66 and medication (1.13, 95% CI: 0.98, 1.29 registry, as well as self-reported allergic rhinitis (1.31, 95% CI: 0.98, 1.74 during the first 7 years of follow-up. We found no associations for sugar-sweetened soft drinks. CONCLUSION: Carbonated artificially-sweetened soft drinks were associated with registry-based asthma and self-reported allergic rhinitis, while early childhood outcomes were related to non-carbonated soft drinks. These results suggest that consumption of artificially

  12. 变应性鼻炎治未病探讨%The discuss about preventive treatment of allergic rhinitis

    Institute of Scientific and Technical Information of China (English)

    严道南; 陈旭青; 吴继勇

    2016-01-01

    Allergic rhinitis disease is widespread and there is an upward trend in incidence year by year,so early treatment of allergic rhinitis is of great significance.With the support from the state administration of traditional Chinese medicine,our team has carried out the work of traditional Chinese medicine practice guidelines about preventive treatment of allergic rhinitis.The aim is to form advanced, standard, practical evidence-based otolaryngology of traditional Chinese medicine"preventive treatment"standard.At present, the group has finished ancient literature research, modern literature research, the Delphi expert questionnaire survey, expert discussion meeting and has formed first draft.Our team will strive to do a good job in the next step research work.Eventually formed practice guidelines not only guide the preventive treatment of allergic rhinitis and lay the basis of research work about the allergic rhinitis preventive treatment in the future, but also will enrich and perfect the system of traditional Chinese medicine preventive treatment,servicing in the cause of human health.%变应性鼻炎发病广泛且发病率呈逐年上升的趋势,故其治未病研究意义重大。本课题组在国家中医药管理局支持下开展了《治未病中医实践指南·鼻鼽》制订工作,旨在形成先进、规范、实用的循证中医耳鼻喉科“治未病”标准。目前课题组已完成古代文献研究、现代文献研究、德尔菲法专家问卷调查、召开专家论证会的研究工作,形成《中医治未病实践指南·鼻鼽(制订)》初稿,课题组必将努力做好下一步研究工作,最终形成的指南不仅为指导各地鼻鼽“治未病”工作,奠定今后鼻鼽中医治未病研究工作的基础,也将丰富和完善中医学治未病体系,为人类健康事业服务。

  13. Allergic rhinitis and its associated co-morbidities at Bugando Medical Centre in Northwestern Tanzania; A prospective review of 190 cases

    Directory of Open Access Journals (Sweden)

    Said Said A

    2012-11-01

    Full Text Available Abstract Background Allergic rhinitis is one of the commonest atopic diseases which contribute to significant morbidity world wide while its epidemiology in Tanzania remains sparse. There was paucity of information regarding allergic rhinitis in our setting; therefore it was important to conduct this study to describe our experience on allergic rhinitis, associated co-morbidities and treatment outcome in patients attending Bugando Medical Centre. Methods This was descriptive cross-sectional study involving all patients with a clinical diagnosis of allergic rhinitis at Bugando Medical Centre over a three-month period between June 2011 and August 2011. Data was collected using a pre-tested coded questionnaire and analyzed using SPSS statistical computer software version 17.0. Results A total of 190 patients were studied giving the prevalence of allergic rhinitis 14.7%. The median age of the patients was 8.5 years. The male to female ratio was 1:1. Adenoid hypertrophy, tonsillitis, hypertrophy of inferior turbinate, nasal polyps, otitis media and sinusitis were the most common co-morbidities affecting 92.6% of cases and were the major reason for attending hospital services. Sleep disturbance was common in children with adenoids hypertrophy (χ2 = 28.691, P = 0.000. Allergic conjunctivitis was found in 51.9%. The most common identified triggers were dust, strong perfume odors and cold weather (P χ2 = 4.583, P = 0.032. In this study family history of allergic rhinitis was not a significant risk factor (P =0.423. The majority of patients (68.8% were treated surgically for allergic rhinitis co morbidities. Post operative complication and mortality rates were 2.9% and 1.6% respectively. The overall median duration of hospital stay of in-patients was 3 days (2 – 28 days. Most patients (98.4% had satisfactory results at discharge. Conclusion The study shows that allergic rhinitis is common in our settings representing 14.7% of all

  14. Sensitization Rates for Various Allergens in Children with Allergic Rhinitis in Qingdao, China.

    Science.gov (United States)

    Lin, Hang; Lin, Rongjun; Li, Na

    2015-09-07

    The aim of this study was to determine the prevalence of sensitization to common allergens in children with allergic rhinitis (AR) living in Qingdao, China. We conducted a retrospective analysis for AR cases, who underwent skin prick tests (SPT) in Qingdao. A total of 2841 children with AR qualified for the inclusion criteria (Age 3-5 years: 1500 children; Age 6-12 years: 1341 children). The most common inhaled allergens to which the AR children were sensitive were Dermatophagoides pteronyssinus (69.3%), Dermatophagoides farinae (66.2%) and mould 1 (Penicillium notatum 38.9%); while the corresponding ingested allergens were mussel (39.2%), shrimp (36.3%) and carp (36.5%). The prevalence of sensitization to inhaled allergens and food allergens was higher in children >6 years of age as compared to that in children 3-5 years of age (all p 6 years old were more sensitive to dust mite as compared to children 3-5 years old (p allergens causing AR in children in Qingdao, China. Older children with AR, particularly males, were found to be more sensitive to dust mite.

  15. MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis.

    Science.gov (United States)

    Bousquet, Jean; Schünemann, Holger J; Hellings, Peter W; Arnavielhe, Sylvie; Bachert, Claus; Bedbrook, Anna; Bergmann, Karl-Christian; Bosnic-Anticevich, Sinthia; Brozek, Jan; Calderon, Moises; Canonica, G Walter; Casale, Thomas B; Chavannes, Niels H; Cox, Linda; Chrystyn, Henry; Cruz, Alvaro A; Dahl, Ronald; De Carlo, Giuseppe; Demoly, Pascal; Devillier, Phillipe; Dray, Gérard; Fletcher, Monica; Fokkens, Wytske J; Fonseca, Joao; Gonzalez-Diaz, Sandra N; Grouse, Lawrence; Keil, Thomas; Kuna, Piotr; Larenas-Linnemann, Désirée; Lodrup Carlsen, Karin C; Meltzer, Eli O; Mullol, Jaoquim; Muraro, Antonella; Naclerio, Robert N; Palkonen, Susanna; Papadopoulos, Nikolaos G; Passalacqua, Giovanni; Price, David; Ryan, Dermot; Samolinski, Boleslaw; Scadding, Glenis K; Sheikh, Aziz; Spertini, François; Valiulis, Arunas; Valovirta, Erkka; Walker, Samantha; Wickman, Magnus; Yorgancioglu, Arzu; Haahtela, Tari; Zuberbier, Torsten

    2016-08-01

    The selection of pharmacotherapy for patients with allergic rhinitis (AR) depends on several factors, including age, prominent symptoms, symptom severity, control of AR, patient preferences, and cost. Allergen exposure and the resulting symptoms vary, and treatment adjustment is required. Clinical decision support systems (CDSSs) might be beneficial for the assessment of disease control. CDSSs should be based on the best evidence and algorithms to aid patients and health care professionals to jointly determine treatment and its step-up or step-down strategy depending on AR control. Contre les MAladies Chroniques pour un VIeillissement Actif en Languedoc-Roussillon (MACVIA-LR [fighting chronic diseases for active and healthy ageing]), one of the reference sites of the European Innovation Partnership on Active and Healthy Ageing, has initiated an allergy sentinel network (the MACVIA-ARIA Sentinel Network). A CDSS is currently being developed to optimize AR control. An algorithm developed by consensus is presented in this article. This algorithm should be confirmed by appropriate trials.

  16. Anti-Inflammatory Effect of IL-37b in Children with Allergic Rhinitis

    Directory of Open Access Journals (Sweden)

    Wenlong Liu

    2014-01-01

    Full Text Available Background. Interleukin-37 (IL-37, a newly described member of IL-1family, functioned as a fundamental inhibitor of innate inflammatory and immune responses, especially its isoform IL-37b. Objective. This study was undertaken to evaluate the expression and regulation of IL-37b in children with allergic rhinitis (AR. Methods. Forty children with AR and twenty-five normal controls were included. The relationship between IL-37b and Th1/2 cytokines production in serum and nasal lavage was examined by enzyme-linked immunosorbent assay (ELISA. Peripheral blood mononuclear cells (PBMCs were purified for in vitro regulation experiment of IL-37b. Intranasal mometasone furoate was given in AR children and IL-37b change after one-month treatment was detected using ELISA. Results. We observed significantly decreased IL-37b expression levels in both serum and nasal lavage compared to controls. IL-37b was negatively correlated with Th2 cytokines. Our results also showed that IL-37b downregulated Th2 cytokine expressed by PBMCs and this modulation was through mitogen-activated protein kinase (MAPK and phosphatidylinositol 3-kinase (PI3K pathway. We also found that intranasal mometasone furoate therapy can promote nasal IL-37b expression. Conclusion. IL-37b may be involved in Th2 cytokine regulation in AR and its expression was related to the efficacy of intranasal steroid therapy.

  17. Sensitization to Airborne Ascospores, Basidiospores, and Fungal Fragments in Allergic Rhinitis and Asthmatic Subjects in San Juan, Puerto Rico

    Science.gov (United States)

    Rivera-Mariani, Félix E.; Nazario-Jiménez, Sylvette; López-Malpica, Fernando; Bolaños-Rosero, Benjamín

    2011-01-01

    Background Fungal spores are the predominant biological particulate in the atmosphere of Puerto Rico, yet their potential as allergens has not been studied in subjects with respiratory allergies. The purpose of this study was to determine the level of sensitization of subjects with respiratory allergies to these particles. Methods Serum samples were drawn from 33 subjects with asthma, allergic rhinitis, or nonallergic rhinitis and 2 controls with different skin prick test reactivity. An MK-3 sampler was used to collect air samples and the reactivity of the sera to fungal particles was detected with a halogen immunoassay. Results All subjects reacted to at least 1 fungal particle. Thirty-one subjects reacted to ascospores, 29 to basidiospores, 19 to hyphae/fungal fragments, and 12 to mitospores. The median percentage of haloes in allergic rhinitis subjects was 4.82% while asthma or nonallergic rhinitis subjects had values of 1.09 and 0.39%, respectively. Subjects with skin prick tests positive to 3, 2, 1, or no extract had 5.24, 1.09, 1.61, and, 0.57% of haloed particles, respectively. If skin prick tests were positive to basidiomycetes, pollen, animals, or deuteromycetes, the percentages of haloes were 4.72, 4.15, 3.63, and 3.31%, respectively. Of all haloed particles, 46% were unidentified, 25% ascospores, 20% basidiospores, 7% hyphae/fungal fragments, and 2% mitospores. IgE levels and the number of positive skin prick test extracts correlated with the percentage of haloes. Conclusion In tropical environments, sensitization to airborne basidiomycetes, ascomycetes, and fungal fragments seems to be more prevalent than sensitization to mitospores in subjects with active allergies, suggesting a possible role in exacerbations of respiratory allergies. PMID:21346362

  18. Antileucotrienos no tratamento da asma e rinite alérgica Antileukotrienes in the treatment of asthma and allergic rhinitis

    Directory of Open Access Journals (Sweden)

    Jose Dirceu Ribeiro

    2006-11-01

    Full Text Available OBJETIVO: Comparar os antagonistas de leucotrienos (ARLT aos outros grupos de medicamentos utilizados para tratar a asma e a rinite alérgica. FONTES DOS DADOS: MEDLINE, LILACS e Biblioteca Cochrane. Palavras chaves: leucotrienos, antileucotrienos, tratamento da asma, tratamento da rinite alérgica, asma e rinite alérgica. Procurou-se agrupar os principais trabalhos e revisões sobre o assunto. SÍNTESE DOS DADOS: Os ARLT são mais eficazes do que placebo e potencializam os efeitos dos corticosteróides inalados. A associação de corticosteróides inalados com agentes beta2 agonistas de longa duração (LABA é mais eficaz do que a associação de cortiscoteróides inalados + ARLT. Embora pareça racional o uso de ARLT na crise aguda de asma e rinite alérgica, mais estudos são necessários para comprovar esse benefício. Os ARLT promovem redução no tempo de hospitalização e no número de crises de sibilância em lactentes com bronquiolite viral aguda pelo vírus respiratório sincicial e na sibilância recorrente após bronquiolite viral aguda. Os ARLT são menos eficazes que os corticosteróides intranasais no manejo da rinite alérgica. Os ARLT são eficazes na asma induzida por exercício (AIE, embora não constituam a primeira linha de tratamento. CONCLUSÃO: Estudos controlados e randomizados mostram que os corticosteróides inalados são as drogas de escolha para o tratamento da asma persistente e rinite alérgica. :Não existem evidências suficientes para recomendar o uso de ARLT como medicamento de primeira linha (monoterapia em crianças com asma (nível I. Nas crianças que não podem usar corticosteróides inalados, os ARLT podem ser uma alternativa (nível II.OBJECTIVE: To compare leukotriene antagonists (LTA to other groups of drugs used in asthma and allergic rhinitis treatment. SOURCES: MEDLINE, LILACS and Cochrane Library. Keywords: leukotrienes, antileukotrienes, asthma treatment, allergic rhinitis treatment, asthma and

  19. Suppression of Immunotherapy on Group 2 Innate Lymphoid Cells in Allergic Rhinitis

    Institute of Scientific and Technical Information of China (English)

    Da-Chuan Fan; Xiang-Dong Wang; Cheng-Shuo Wang; Yang Wang; Fei-Fei Cao; Luo Zhang

    2016-01-01

    Background:Group 2 innate lymphoid cells (ILC2s) are regarded as a novel population of lineage-negative cells that induce innate Type 2 responses by producing the critical Th2-type cytokines interleukin (IL)-5 and IL-13.ILC2s as key players in the development of allergic rhinitis (AR) have been proved,however,the effect of subcutaneous immunotherapy (SCIT) with dermatophagoides pteronyssinus extract (Der p-SCIT) on ILC2s in AR patients is not clear.This study aimed to investigate the response of ILC2s of peripheral blood in house dust mites (HDM)-sensitized Chinese patients with AR who received SCIT with Der P extract.Methods:Seven healthy controls without symptoms of AR who had negative reactions to any of the allergens from skin-prick testing,nine patients diagnosed with persistent AR according to the Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines,and 24 AR patients who received Der p-SCIT for 1.0-3.5 years were recruited for the study.ILC2s in the peripheral blood were evaluated using flow cytometry.The severity of their symptoms of all participants was rated based on the Total 5 symptom score.Results:Among 40 participants,9 AR patients were assigned to the untreated group,24 AR patients receiving Der p-SCIT were assigned to the immunotherapy group,and 7 healthy controls without symptoms of AR were assigned to healthy control group.The mean Total 5 symptom score of immunotherapy group was significantly lower than that of untreated group (4.3 ± 1.4 vs.10.1 ± 2.5,P < 0.001).Similarly,the levels of ILC2s in the peripheral blood of immunotherapy group were significantly reduced compared with that in untreated group (P < 0.001),but were not significantly different from healthy controls (P =0.775).Further subgroup analysis based on the duration of SCIT therapy (1.0-2.0 years [SCIT1-2],2.0-3.0 years [SCIT2-3],and 3.0-3.5 years [SCIT3-3.5]) showed that the percentage of ILC2s was not significantly different between SCIT1-2,SCIT2-3,and SCIT3

  20. Effects of intranasal TNFα on granulocyte recruitment and activity in healthy subjects and patients with allergic rhinitis

    Directory of Open Access Journals (Sweden)

    Andersson Morgan

    2008-01-01

    Full Text Available Abstract Background TNFα may contribute to the pathophysiology of airway inflammation. For example, we have recently shown that nasal administration of TNFα produces late phase co-appearance of granulocyte and plasma exudation markers on the mucosal surface. The objective of the present study was to examine indices of granulocyte presence and activity in response to intranasal TNFα challenge. Methods Healthy subjects and patients with allergic rhinitis (examined out of season were subjected to nasal challenge with TNFα (10 μg in a sham-controlled and crossover design. Nasal lavages were carried out prior to and 24 hours post challenge. Nasal biopsies were obtained post challenge. Nasal lavage fluid levels of myeloperoxidase (MPO and eosinophil cationic protein (ECP were analyzed as indices of neutrophil and eosinophil activity. Moreover, IL-8 and α2-macroglobulin were analyzed as markers of pro-inflammatory cytokine production and plasma exudation. Nasal biopsy numbers of neutrophils and eosinophils were monitored. Results Nasal lavage fluid levels of MPO recorded 24 hours post TNFα challenge were increased in healthy subjects (p = 0.0081 and in patients with allergic rhinitis (p = 0.0081 (c.f. sham challenge. Similarly, α2-macroglobulin was increased in healthy subjects (p = 0.014 and in patients with allergic rhinitis (p = 0.0034. Lavage fluid levels of ECP and IL-8 were not affected by TNFα challenge. TNFα increased the numbers of subepithelial neutrophils (p = 0.0021, but not the numbers of eosinophils. Conclusion TNFα produces a nasal inflammatory response in humans that is characterised by late phase (i.e., 24 hours post challenge neutrophil activity and plasma exudation.

  1. New product development with the innovative biomolecular sublingual immunotherapy formulations for the management of allergic rhinitis

    Directory of Open Access Journals (Sweden)

    Frati F

    2014-09-01

    Full Text Available Franco Frati,1 Lorenzo Cecchi,2,3 Enrico Scala,4 Erminia Ridolo,5 Ilaria Dell'Albani,1 Eleni Makrì,6 Giovanni Pajno,7 Cristoforo Incorvaia6 1Medical and Scientific Department, Stallergenes, Milan, Italy; 2Interdepartmental Centre of Bioclimatology, University of Florence, Florence, Italy; 3Allergy and Clinical Immunology Section, Azienda Sanitaria di Prato, Prato, Italy; 4Experimental Allergy Unit, IDI-IRCCS, Rome, Italy; 5Department of Clinical and Experimental Medicine, University of Parma, Parma, Italy; 6Allergy/Pulmonary Rehabilitation, ICP Hospital, Milan, Italy; 7Department of Pediatrics, Allergy Unit, University of Messina, Messina, Italy Abstract: The molecular allergy technique, currently defined as component-resolved diagnosis, significantly improved the diagnosis of allergy, allowing for differentiation between molecules actually responsible for clinical symptoms (genuine sensitizers and those simply cross-reacting or shared by several sources (panallergens, thus influencing the appropriate management of a patient's allergy. This also concerns allergen immunotherapy (AIT, which may be prescribed more precisely based on the component-resolved diagnosis results. However, the advance in diagnosis needs to be mirrored in AIT. According to consensus documents and to expectations of specialists, therapy should be based on standardized extracts containing measured amounts of the clinically relevant molecules, ie, the major allergens. The new generation of extracts for sublingual immunotherapy fulfills these requirements and are thus defined as biomolecular (BM. BM refers to natural extracts with a defined content of major allergens in micrograms. All Staloral BM products are indicated for the treatment of allergic rhinitis with or without asthma. The effectiveness of AIT is related to its ability to modify the immunological response of allergic subjects. The 5-grass and house dust mite extracts were evaluated addressing the T helper 1, T

  2. H1 antihistamines in allergic rhinitis: The molecular pathways of interleukin and toll - like receptor systems

    Directory of Open Access Journals (Sweden)

    Jonny Karunia Fajar

    2016-03-01

    Full Text Available The complex interaction between inflammatory mediators in allergic rhinitis (AR is determined by the role of genetic polymorphisms, including interleukin (IL and toll-like receptor (TLR genes. This study aimed to discuss the effects of H1-antihistamines on IL and TLR systems. Several ILs involved in AR pathogenesis are: IL-4 (rs2243250, rs1800925, rs1801275, rs2227284, rs2070874, IL-6 (rs1800795, rs1800797, IL-10 (rs1800871, rs1800872, IL-12R (rs438421, IL-13 (rs1800925, rs20541, IL-17 (rs3819024, IL-18 (rs360721, rs360718, rs360717, rs187238, IL-23R (rs7517847, and IL-27 (rs153109, rs17855750. In the IL system, histamines stimulate the IL production in Type 2 helper T (Th2 cells through protein kinase A (PKA, janus kinase-signal transducer and activator of transcription (JAK-STAT pathway, and the activation of H1-histamine receptor and histidine decarboxylase (HDC genes. On contrary, antihistamines down-regulate the H1-histamine receptor gene expression through the transcription suppression of HDC and IL genes and suppress histamine basal signaling through the inverse agonistic activity. TLRs involved in AR pathogenesis are TLR2 (rs4696480, rs3804099, rs5743708, TLR4 (rs4986790, TLR6 (rs2381289, TLR7 (rs179008, rs5935438, TRL8 (rs2407992, rs5741883, rs17256081, rs4830805, rs3788935, rs178998, and TLR10 (rs11466651. In the TLR system, histamines trigger the TLR expression by stimulating interferon-γ (IFN-γ to up-regulate mast cells and by stimulating receptor-interacting protein (RIP to activate IκB kinase-β. Contrastingly, antihistamines suppress TIR-domain-containing adaptor protein inducing IFN-β (TRIF and RIP protein and thus inhibit the expression of TLR. In addition, several studies indicated that H1-antihistamines inhibit the IL and TLR systems indirectly.

  3. A survey of the burden of allergic rhinitis in Hungary from a specialist’s perspective

    Directory of Open Access Journals (Sweden)

    Szilasi Mária

    2012-11-01

    Full Text Available Abstract Background The casual and severity distribution of allergic rhinitis (AR in Hungary is unknown. The aim of this survey was to evaluate symptom perception, disease severity, concomitant asthma frequency and the impact of AR on everyday life activities in a cross-sectional, multicenter study in Hungary under the supervision of Hungarian Respiratory Society. Methods Data were recorded by 933 AR patients (65.93% women and their treating specialists. The perceptions of patients regarding the symptoms (nasal, ocular and others of AR and its severity, together with its impact on everyday life were assessed. Physicians recorded data regarding the diagnosis and severity of AR, and comorbidities. Results 52.5% of patients suffered from seasonal AR, 35.1% from perennial AR. A large proportion of patients had moderate to severe disease (MS-AR (57.34%, persistent disease (98.0% and concomitant asthma (53.32% in the mild, 57.52% in the MS-AR group. MS-AR was more frequent among women. Despite the treatment used, in MS-AR the proportions of patients reporting moderate to severe rhinorrhoea, nasal obstruction, ocular itching/redness, watering, itchy throat and sneezing were as high as 52.0%, 54.0%, 33.8%, 26.5%, 44.0% and 31.2%, respectively. Overall, there was a poor agreement between disease severity reported by patients and specialists. The adherence to oral antihistamines and intranasal corticosteroids was found to be between 50 and 65%; mostly depending on the dosage form. Conclusions AR remains a significant health problem in Hungary because of the burden of symptoms, high rate of concomitant asthma and the significant proportion of MS-AR affecting general well being.

  4. Prevalence and socioeconomic associations of asthma and allergic rhinitis in northern [corrected] Africa.

    Science.gov (United States)

    Georgy, V; Fahim, H I; El-Gaafary, M; Walters, S

    2006-10-01

    The aims of the current study were to ascertain the prevalence of asthma and allergic rhinoconjunctivitis symptoms in Cairo, Egypt (northern Africa), and to elucidate the socioeconomic factors associated with symptom prevalence and severity. A translated and adapted version of the International Study of Asthma and Allergies in Childhood (ISAAC) questionnaire was distributed to a sample of 2,645 11-15-yr-olds in state and fee-paying schools in Cairo. The overall prevalences of wheeze ever, wheeze during the last year and physician-diagnosed asthma were 26.5% (697 out of 2,631), 14.7% (379 out of 2,570) and 9.4% (246 out of 2,609), respectively. The prevalence of rhinoconjunctivitis was 15.3% (399 out of 2,616). Asthma symptoms were independently associated with attendance at a state school, parental asthma, age, history of rhinitis and owning a pet cat. Rhinoconjunctivitis was independently associated with attendance at a state school, father's education, parental history of asthma, asthma symptoms and owning a pet cat. In spite of a higher prevalence of severe asthma symptoms in state schools prevalence of physician diagnosis of asthma was the same in both school types, suggesting inequalities in access to healthcare. In conclusion, the prevalence of physician-diagnosed asthma in Cairo was 9.4%, while the prevalence of rhinoconjunctivitis was 15.3%. There is a higher prevalence and increased severity of asthma symptoms in children of lower socioeconomic groups, as defined by state school attendance in Cairo.

  5. Seasonal variations of nasal resistance in allergic rhinitis and environmental pollen counts. II: Efficacy of preseasonal therapy.

    Science.gov (United States)

    Naito, K; Ishihara, M; Senoh, Y; Takeda, N; Yokoyama, N; Iwata, S

    1993-01-01

    We gave Mao-bushi-saishin-to, a Chinese blended medicine, and azelastine to an adult patient with hay fever due to Japanese cedar pollen and measured nasal resistance and ambient floating pollen counts throughout the time of Japanese cedar pollination in separated years. In the patient Mao-bushi-saishin-to was effective against preseasonal increases in nasal airway resistance but could not control severe episodes of allergic rhinitis caused by high dose exposure to Japanese cedar pollen and also perhaps caused by a priming effect. Azelastine inhibited both pre- and post-seasonal increases in nasal airway resistance but not only on high pollen counts days.

  6. Clinical Research into Ke Min Yin for Treatment of Persistent Allergic Rhinitis in Patients with Qi Deficiency and Blood Stasis

    Institute of Scientific and Technical Information of China (English)

    刘巧平; 刘建华; 刘大新

    2003-01-01

    @@ Persistent allergic rhinitis (PAR) is one of the common diseases at ear-nose-throat department. From August 1998 to May 2001, we randomly selected 60 cases of PAR with qi deficiency and blood stasis for a clinical observation. 30 patients in the treatment group were treated with Ke Min Yin (克敏饮), a herbal medicine, to supplement qi, expel wind, nourish blood and promote blood circulation; and the other 30 cases in the control group were treated with cetrine. Through systematic observation and statistical processing, the clinical research is summarized and reported in the following.

  7. Correlations of nasal responses to leukotriene D4 and histamine nasal provocation with quality of life in allergic rhinitis

    OpenAIRE

    Zhu, Zheng; Xie, Yanqing; Guan, Weijie; Gao, Yi; Xia, Shu; Shi, Xu; Zheng, Jinping

    2016-01-01

    Background The symptoms of allergic rhinitis (AR) greatly affect the quality of life (QoL) in the patients with AR. The correlations of nasal response to leukotriene D4 (LTD4) and histamine nasal provocation with health related QoL in AR are not clear. Objective To evaluate the correlations of nasal response to LTD4 and histamine nasal challenge with QoL in AR. Methods Patients randomly underwent LTD4 and histamine nasal challenge tests, completed the rhinoconjunctivitis quality of life quest...

  8. Science Letters: A synthetic Toll-like receptor 2 ligand decreases allergic immune responses in a mouse rhinitis model sensitized to mite allergen

    Institute of Scientific and Technical Information of China (English)

    Cheng ZHOU; Xiao-dong KANG; Zhi CHEN

    2008-01-01

    It has been proposed that activation of Toll-like receptors (TLRs) plays crucial roles in the polarization of adaptive immune responses. A synthetic Toll-like receptor 2 (TLR2) ligand, Pam3CSK4, has been reported to modulate the balance of Thl/Tn2 responses. We evaluated the modulation effect of Pam3CSK4 on allergic immune response in a mouse rhinitis model sensitized to house dust mite allergen (HDM). Mice were sensitized and challenged with Dermatophagoides farinae allergen (Der f), and then the allergic mice were treated by Pam3CSK4. Nasal allergic symptoms and eosinophils were scored. Der f-specific cytokine responses were examined in the splenocytes and bronchoalveolar lavage fluid (BALF). Serum level of total IgE was also detected. After establishing a mouse allergic rhinitis model with HDM, we have showed that Pam3CSK4 treatment not only ameliorated the nasal allergic symptoms remarkably but also decreased the eosinophils and total inflammation cells in BALF significantly. Analysis of cytokine profile found that' IFN-γ released from either BALF or stimulated splenocytes increased markedly in Pam3CSK4-treated mice, while IL-13 decreased significantly. Moreover, serum level of total IgE was significantly lower in Pam3CSK4-treated mice than in the untreated. Thus, in an allergic rhinitis mouse model developed with HDM, Pam3CSK4 was shown to exhibit an antiallergic effect, indicating its potential application in allergic diseases.

  9. 变应性鼻炎相关危险因素的Logistic回归分析%Logistic regression analysis of related risk factors in allergic rhinitis

    Institute of Scientific and Technical Information of China (English)

    冯婷; 黄世铮; 鲁航

    2015-01-01

    目的:探讨变应性鼻炎致病的相关因素。方法通过系统抽样方法选取200例变应性鼻炎患者与200例健康体检者,详细记录每例试验者的体育锻炼、饮食习惯、有变应性鼻炎家族史、吸烟史、工作环境粉尘情况、营养状态、晾晒被褥、花粉过敏、每日睡眠、尘螨过敏、养宠物史、食物过敏、开窗通风等情况,采用Logistic回归分析变应性鼻炎致病的相关因素。结果体育锻炼、营养状况、每日睡眠、饮食习惯与变应性鼻炎无相关性,晾晒被褥、开窗通风及空调开放为变应性鼻炎的保护因素,有变应性鼻炎家族史、吸烟史、花粉过敏、尘螨过敏、养宠物史、食物过敏为变应性鼻炎的危险因素。结论有变应性鼻炎家族史、吸烟史、花粉过敏、尘螨过敏、养宠物史、食物过敏是变应性鼻炎的危险因素。%Objective To investigate the factors related to allergic rhinitis disease. Method Chose 200 cases of allergic rhinitis and 200 cases of healthy people through systematic sampling method, detail recorded each case with the physical exercise, diet habit, family history, smoking history, work environment of dust, status, airing quilts, pollen allergy, daily sleep, dust mite allergy history, pet history, food allergies, ventilation windows, used Logistic regression analysis of factors related to allergic rhinitis. Result Physical exercise, nutrition, sleep, diet were not associated with allergic rhinitis, airing quilts, window ventilation and air conditioning open indicated that were protective factors, the rest of family history, smoking history of allergic rhinitis, allergic to pollen, dust mites allergic, pet history and food allergies were risk factors for allergic rhinitis. Conclusion Family history, smoking history, pollen allergy, dust mite allergy, pet history, food allergies are the risk factors of allergic rhinitis.

  10. CLINICAL INVESTIGATIONS ON THE AYURVEDIC MANAGEMENT OF ALLERGIC RHINITIS (VATAJA PRATISHYAYA BY PRATIMARSHA NASYAAS NASAL DRUG DELIVERY SYSTEM.

    Directory of Open Access Journals (Sweden)

    Shiva Kumar

    2014-12-01

    Full Text Available Allergic Rhinitis (AR is an immunoglobulin (Ig E mediated inflammatory disease caused by the inflammation of airway mucosa with hypersensitivity resulting from seasonal or perennial responses to specific allergens. Prevalence of AR is increasing and has risen considerably in the past few decades with self reported prevalence up to 41%. According to Ayurvedic texts indication of Anutaila (classical Ayurvedic oil preparation used in the form of Pratimarsha Nasya a traditional nasal drug delivery system has been used for a long period has shown beneficial effects on diseases of head and neck. A pretest and post test design of single group consisting of 37 patientsdiagnosed as allergic rhinitis were administered Pratimarsha Nasya (PNwith Anutaila daily for a period of 60 days. Effect ofPratimarsha Nasya with Anutaila on the chief complaints and totals nasal symptom score showed ameliorative improvement with statistical significance. Laboratory immunological parameters which included Total Leucocyte Count, Absolute Eosinophil Count, Neutrophils and Lymphocytes showed improvement with high statistical significance (< 0.001. At the end after 60 days of medication the patients showed marked relief in symptoms which can open a new direction in Ayurveda inspired novel targeted drug delivery systems.

  11. Efficacy of sublingual swallow immunotherapy in children with rye grass pollen allergic rhinitis: a double-blind placebo-controlled study.

    Science.gov (United States)

    Ahmadiafshar, Akefeh; Maarefvand, Mina; Taymourzade, Babak; Mazloomzadeh, Saeedeh; Torabi, Zohreh

    2012-06-01

    Specific local immunotherapy has been recently introduced as an alternative to classic subcutaneous immunotherapy in treatment of allergic rhinitis. In this study, the effects of sublingual immunotherapy (SLIT) on symptoms and medication score and skin prick test evaluation of patients with allergic rhinitis were investigated.In this placebo controlled trial, twenty four patients aged 5-18 years old with grass pollen induced rhinitis and sensitive to rye grass by positive skin prick test received randomly sublingual extract of rye grass or placebo for 6 months. Symptom and medication scores and adverse effects of SLIT were assessed during treatment. Skin prick test induced wheal at the beginning and the end of therapy were also measured. Data were analyzed with SPSS software.We found significant reduction of symptoms in intervention group from 21st week of immunotherapy (pgrass and rye grass was significantly reduced in SLI group after immunotherapy.This study indicates that SLIT in grass-pollen rhinitis is well tolerated, improves overall clinical symptoms, and reduces drug consumes. We recommend this therapy as a safe therapy in patients with allergic rhinitis.

  12. Hypertonic saline is more effective than normal saline in seasonal allergic rhinitis in children.

    Science.gov (United States)

    Marchisio, P; Varricchio, A; Baggi, E; Bianchini, S; Capasso, M E; Torretta, S; Capaccio, P; Gasparini, C; Patria, F; Esposito, S; Principi, N

    2012-01-01

    Allergic rhinitis (AR) is a very common childhood disease that is associated with a significant reduction in the patients' quality of life. Its treatment combines educating the patients and their parents, immunotherapy and drug administration. However, even the best approach does not relieve the symptoms of a number of patients. Alternative therapies are particularly needed for children because the fear of adverse events frequently reduces parental compliance to the prescribed drugs, and immunotherapy is less easy to administer than in adults. In this prospective investigator-blinded study we evaluated whether children, with a documented history of seasonal grass pollen-related AR, benefit from nasal irrigation by assessing the effects on nasal signs and symptoms, on middle ear effusion and on adenoidal hypertrophy. We randomized children aged 5 to 9 years (median age 82 months) to normal saline or hypertonic saline (a 2.7% sodium chloride solution), administered twice-daily using a disposable 20 ml syringe, or no treatment. Nasal symptoms (rhinorrhea, itching, sneezing, nasal obstruction), swelling of turbinates, adenoid hypertrophy or middle ear effusion were assessed at baseline and after 4 weeks of treatment. Two hundred and twenty children (normal saline: 80; hypertonic saline: 80; no treatment: 60) completed the study. After four weeks, all the considered items were significantly reduced in the group receiving hypertonic saline (P < 0.0001), whereas in the group receiving normal saline only rhinorrhea (P = 0.0002) and sneezing (P = 0.002) were significantly reduced. There was no significant change in any of the items in the control group. The duration of oral antihistamines was significantly lower in the children receiving hypertonic saline than in those treated with normal saline or in controls. No adverse events were reported and parental satisfaction and compliance with the procedure were globally very good, regardless of the solution used. Using our

  13. Role of sphingosine 1-phosphate receptor expression in eosinophils of patients with allergic rhinitis, and effect of topical nasal steroid treatment on this receptor expression.

    LENUS (Irish Health Repository)

    Mackle, T

    2008-12-01

    Recent research has indicated that sphingosine 1-phosphate plays a role in allergy. This study examined the effect of allergen challenge on the expression of sphingosine 1-phosphate receptors on the eosinophils of allergic rhinitis patients, and the effect of steroid treatment on this expression.

  14. Comparison of cetirizine with astemizole in the treatment of perennial allergic rhinitis and study of the concomitant effect on histamine and allergen-induced wheal responses.

    Science.gov (United States)

    Lobaton, P; Moreno, F; Coulie, P

    1990-11-01

    Thirty patients suffering from perennial allergic rhinitis took astemizole and cetirizine, 10 mg/d, under double-blind, crossover randomized conditions for 4 weeks. Four weeks washout separated the two periods. Nasal condition was improved, histamine and allergen-induced wheal responses were inhibited by both treatments with a slight advantage for cetirizine. Both treatments were well tolerated.

  15. Prevention of allergic rhinitis by ginger and the molecular basis of immunosuppression by 6-gingerol through T cell inactivation.

    Science.gov (United States)

    Kawamoto, Yoshiyuki; Ueno, Yuki; Nakahashi, Emiko; Obayashi, Momoko; Sugihara, Kento; Qiao, Shanlou; Iida, Machiko; Kumasaka, Mayuko Y; Yajima, Ichiro; Goto, Yuji; Ohgami, Nobutaka; Kato, Masashi; Takeda, Kozue

    2016-01-01

    The incidence of allergies has recently been increasing worldwide. Immunoglobulin E (IgE)-mediated hypersensitivity is central to the pathogenesis of asthma, hay fever and other allergic diseases. Ginger (Zingiber officinale Roscoe) and its extracts have been valued for their medical properties including antinausea, antiinflammation, antipyresis and analgesia properties. In this study, we investigated the antiallergic effects of ginger and 6-gingerol, a major compound of ginger, using a mouse allergy model and primary/cell line culture system. In mice with ovalbumin (OVA)-induced allergic rhinitis, oral administration of 2% ginger diet reduced the severity of sneezing and nasal rubbing by nasal sensitization of OVA and suppressed infiltration of mast cells in nasal mucosa and secretion of OVA-specific IgE in serum. 6-Gingerol inhibited the expression of not only Th2 cytokines but also Th1 cytokines in OVA-sensitized spleen cells. Accordingly, 6-gingerol suppressed in vitro differentiation of both Th1 cells and Th2 cells from naïve T cells. In addition, 6-gingerol suppressed both superantigen staphylococcal enterotoxin B (SEB)- and anti-CD3-induced T cell proliferation. 6-Gingerol also abrogated PMA plus ionomycin- and SEB-induced IL-2 production in T cells, suggesting that 6-gingerol affected T cell receptor-mediated signal transduction rather than the antigen-presentation process. Indeed, 6-gingerol inhibited the phosphorylation of MAP kinases, calcium release and nuclear localization of c-fos and NF-κB by PMA and ionomycin stimulation. Thus, our results demonstrate that 6-gingerol suppresses cytokine production for T cell activation and proliferation, thereby not causing B cell and mast cell activation and resulting in prevention or alleviation of allergic rhinitis symptoms.

  16. Factors confusing the diagnosis of laryngopharyngeal reflux: the role of allergic rhinitis and inter-rater variability of laryngeal findings.

    Science.gov (United States)

    Eren, Erdem; Arslanoğlu, Seçil; Aktaş, Ayşe; Kopar, Aylin; Ciğer, Ejder; Önal, Kazım; Katılmiş, Hüseyin

    2014-04-01

    The objective of the study was to determine the inter-rater variability in assessment of laryngeal findings and whether diagnosing laryngopharyngeal reflux based on the laryngeal findings and history alone without considering allergic rhinitis leads to the overdiagnosis and overtreatment of laryngopharyngeal reflux. Patients with positive and negative skin prick tests were recruited from an allergy clinic in a tertiary teaching university hospital. All subjects completed the Reflux Symptom Index (RSI) and underwent laryngeal examinations by three physicians blinded to the skin prick test results and the Reflux Finding Score (RFS) was determined. RFS >7 or RSI >13 was considered reflux positive. Fleiss' kappa (κ) was used to measure inter-rater agreement. The inter-rater agreement was low for pseudosulcus vocalis (κ = 0.078), ventricular obliteration (κ = 0.206), diffuse laryngeal edema (κ = 0.204), and posterior laryngeal hypertrophy (κ = 0.27), intermediate for laryngeal erythema/hyperemia (κ = 0.42) and vocal fold edema (κ = 0.42), and high for thick endolaryngeal mucus (κ = 0.61). Although the frequency of allergy was high, there was no significant difference between allergy-positive and laryngopharyngeal reflux-positive patients. On logistic regression analysis, thick endolaryngeal mucus was a significant predictor of allergy (p = 0.012, odds ratio 0.264, 95 % confidence interval 0.093-0.74). The laryngeal examination for reflux is subject to marked inter-rater variability and allergic laryngitis was not misdiagnosed as laryngopharyngeal reflux. The presence of thick endolaryngeal mucus should alert physicians to the possibility of allergic rhinitis/laryngitis.

  17. Effects of antiallergic herbal agents on cystic fibrosis transmembrane conductance regulator in nasal mucosal epithelia of allergic rhinitis rabbits

    Institute of Scientific and Technical Information of China (English)

    LI Qiang; LI Xiao-li; YANG Xue; BAO Jian-min; SHEN Xiao-hong

    2009-01-01

    Background It has been found that the expression of cystic fibrosis transmembrane conductance regulator (CFTR) is closely related to allergic rhinitis (AR). In the previous study, we have demonstrated that antiallergic herbal agents (AHA) can obviously inhibit the allergic reaction of AR. The aim of this study was to explore the expression of CFTR and the effects of AHA on CFTR to improve the allergic reaction of AR.Methods An animal model of an AR rabbit was established using ovalbumin (OVA). The rhinitis rabbits were randomly assigned to three groups: AHA treating group (AHATG), modeling group (MG) and healthy controlling group (HCG). The expressions of CFTR protein were examined by immunohistochemical method. The mucosal epithelial cells of all the rabbits were primarily cultured with tissue culture method in vitro and treated with or without glibenclamide for 24 hours. The levels of monocyte chemotactic factor-1 (MCP-1) and RANTES protein in supernatants of culture were measured by ELISA, and the expressions of CFTR mRNA were detected by real-time PCR.Results The expressions of CFTR mRNA and protein greatly increased in mucosal epithelial cells of MG. The protein concentrations of MCP-1, RANTES in culture supernatants of MG were significantly higher than those in the other two groups (P0.05).Conclusions AHA can inhibit the secretions of CFTR, RANTES and MCP-1 in mucosal epithelia and improve inflammatory reaction of AR. CFTR may play an important role in the secretion of RANTES and mucosal inflammatory response in AR. Glibenclamide can inhibit the CFTR secretion in mucosal epithelial cells, in particular during AR process. These effects of glibenclamide on secretion of RANTES can be effectively strengthened by AHA.

  18. Anti-Interleukin-1 Beta/Tumor Necrosis Factor-Alpha IgY Antibodies Reduce Pathological Allergic Responses in Guinea Pigs with Allergic Rhinitis.

    Science.gov (United States)

    Wei-Xu, Hu; Wen-Yun, Zhou; Xi-Ling, Zhu; Zhu, Wen; Li-Hua, Wu; Xiao-Mu, Wu; Hui-Ping, Wei; Wen-Ding, Wang; Dan, He; Qin, Xiang; Guo-Zhu, Hu

    2016-01-01

    This study aims to determine whether the combined blockade of IL-1β and TNF-α can alleviate the pathological allergic inflammatory reaction in the nasal mucosa and lung tissues in allergic rhinitis (AR) guinea pigs. Healthy guinea pigs treated with saline were used as the healthy controls. The AR guinea pigs were randomly divided into (1) the AR model group treated with intranasal saline; (2) the 0.1% nonspecific IgY treatment group; (3) the 0.1% anti-TNF-α IgY treatment group; (4) the 0.1% anti-IL-1β IgY treatment group; (5) the 0.1% combined anti-IL-1β and TNF-α IgY treatment group; and (6) the fluticasone propionate treatment group. The inflammatory cells were evaluated using Wright's staining. Histopathology was examined using hematoxylin-eosin staining. The results showed that the number of eosinophils was significantly decreased in the peripheral blood, nasal lavage fluid, and bronchoalveolar lavage fluid (P guinea pigs. The data suggest that topical blockade of IL-1β and TNF-α could reduce pathological allergic inflammation in the nasal mucosa and lung tissues in AR guinea pigs.

  19. Effect of pre-seasonal seasonal treatment with budesonide topical nasal powder in patients with seasonal allergic rhinitis

    Directory of Open Access Journals (Sweden)

    Maria C Morelli

    1996-01-01

    Full Text Available The efficacy and safety of budesonide nasal powder (Rhinocort Turbuhaler® in seasonal allergic rhinitis when given only at the onset of symptoms during the pollen season or when also given before the pollen season, were compared. The study was carried out in 364 patients from 14 centres in Italy as a randomized, double-blind, parallel-group, placebo- controlled comparison of five alternative treatment regimens given for 4 weeks during the pre-pollen and early pollen season (PPS and for 6 weeks during the pollen season (PS. It was concluded that either 200μg or 400μg of budesonide given once daily PPS provides significant control of symptoms experienced during PPS. The 400μg dose, however, also provides additional prophylactic protection against symptoms during early PS. When the pollen season is established, the dose of budesonide may be reduced to 200μg.

  20. A clear urban-rural gradient of allergic rhinitis in a population-based study in Northern Europe

    DEFF Research Database (Denmark)

    Christensen, Stine Holmegaard; Timm, Signe; Janson, Christer;

    2016-01-01

    categories of place of upbringing were defined: farm with livestock, farm without livestock, village in rural area, small town, city suburb, and inner city. Pets in the home at birth and during childhood were recorded. Data were analysed using adjusted logistic regression models. RESULTS: Livestock farm...... upbringing predicted less adult allergic rhinitis [odds ratio (OR) 0.68, 0.54-0.85] and nasal symptoms (OR 0.82, 0.68-0.99) than city upbringing, and an urban-rural gradient with decreasing risk per level of urbanisation was observed (OR 0.92, 0.88-0.94). Pets in the home at birth (OR 0.78, 0...... upbringing. Pets at birth decreased the risk further, but did not explain the urban-rural gradient. Persistent beneficial effects of microbial diversity in early life might be an explanation for the findings....

  1. Rationally designed nanocarriers for intranasal therapy of allergic rhinitis: influence of carrier type on in vivo nasal deposition

    Directory of Open Access Journals (Sweden)

    Sallam MA

    2016-05-01

    Full Text Available Marwa Ahmed Sallam, Hala Mahmoud Helal, Sana Mohamed Mortada Department of Industrial Pharmacy, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt Abstract: The aim of this study is to develop a locally acting nasal delivery system of triamcinolone acetonide (TA for the maintenance therapy of allergic rhinitis. The effect of encapsulating TA in different nanocarriers on its mucosal permeation and retention as well as in vivo nasal deposition has been studied. A comparative study was established between polymeric oil core nanocapsules (NCs, lipid nanocarriers such as nanoemulsion (NE, and nanostructured lipid carriers (NLCs. The elaborated nanocarriers were compared with TA suspension and the commercially available suspension “Nasacort®”. The study revealed that NC provided the highest mucosal retention, as 46.14%±0.048% of the TA initial dose was retained after 24 hours, while showing the least permeation through the nasal mucosa. On the other hand, for TA suspension and Nasacort®, the mucosal retention did not exceed 23.5%±0.047% of the initial dose after 24 hours. For NE and NLC, values of mucosal retention were 19.4%±0.041% and 10.97%±0.13%, respectively. NC also showed lower mucosal irritation and superior stability compared with NE. The in vivo nasal deposition study demonstrated that NC maintained drug in its site of action (nasal cavity mucosa for the longest period of time. The elaborated polymeric oil core NCs are efficient carriers for the administration of nasally acting TA as it produced the least permeation results, thus decreasing systemic absorption of TA. Although NCs have been administered via various routes, this is the first study to implement the polymeric oil core NC as an efficient carrier for localized nasal drug delivery. Keywords: allergic rhinitis, nanocapsules, triamcinolone acetonide, nasal mucosa, nasal deposition

  2. Association study on ADAM33 polymorphisms in mite-sensitized persistent allergic rhinitis in a Chinese population.

    Directory of Open Access Journals (Sweden)

    Ruo-Xi Chen

    Full Text Available BACKGROUND: The ADAM33 gene has been identified as a potentially important asthma candidate gene and polymorphisms in this gene have been shown to be associated with asthma and seasonal allergic rhinitis. OBJECTIVE: To assess whether the ADAM33 polymorphisms are associated with persistent allergic rhinitis (PER due to house dust mites in a Chinese population. METHODS: In a hospital-based case-control study of 515 patients with mite-sensitized PER and 495 healthy controls, we genotyped seven single nucleotide polymorphisms (SNPs in ADAM33. Serum levels of eosinophil cationic protein, total IgE and allergen-specific IgE against Dermatophagoides pteronyssinus and Dermatophagoides farinae were measured by the ImmunoCAP assays. RESULTS: In the single-locus analysis, three polymorphisms, rs3918392 (F1, rs528557 (S2 and rs2787093, were significantly associated with mite-sensitized PER. SNP S2 was associated with significantly increased risk both of asthmatic and nonasthmatic mite-sensitized PER. In the combined genotypes analysis, individuals with 2-4 risk alleles had a significantly higher risk of mite-sensitized PER (adjusted OR = 1.99, 95% CI = 1.50-2.62 than those with 0-1 risk alleles. Haplotype-based association analysis revealed that the ACAGCCT haplotype might have potential to protect against mite-sensitized PER (adjusted OR = 0.67; 95% CI = 0.49-0.90. CONCLUSIONS: Polymorphisms in the ADAM33 gene may contribute to susceptibility of mite-sensitized PER in this Chinese population.

  3. Fish intake during pregnancy and the risk of child asthma and allergic rhinitis - longitudinal evidence from the Danish National Birth Cohort.

    Science.gov (United States)

    Maslova, Ekaterina; Strøm, Marin; Oken, Emily; Campos, Hannia; Lange, Christoph; Gold, Diane; Olsen, Sjurdur F

    2013-10-01

    Maternal fish intake during pregnancy may influence the risk of child asthma and allergic rhinitis, yet evidence is conflicting on its association with these outcomes. We examined the associations of maternal fish intake during pregnancy with child asthma and allergic rhinitis. Mothers in the Danish National Birth Cohort (n 28 936) reported their fish intake at 12 and 30 weeks of gestation. Using multivariate logistic regression, we examined the associations of fish intake with child wheeze, asthma and rhinitis assessed at several time points: ever wheeze, recurrent wheeze (>3 episodes), ever asthma and allergic rhinitis, and current asthma, assessed at 18 months (n approximately 22,000) and 7 years (n approximately 17,000) using self-report and registry data on hospitalisations and prescribed medications. Compared with consistently high fish intake during pregnancy (fish as a sandwich or hot meal > or equal to 2-3 times/week), never eating fish was associated with a higher risk of child asthma diagnosis at 18 months (OR 1·30, 95% CI 1·05, 1·63, P=0·02), and ever asthma by hospitalisation (OR 1·46, 95% CI 0·99, 2·13, P=0·05) and medication prescription (OR 1·37, 95% CI 1·10, 1·71, P=0·01). A dose-response was present for asthma at 18 months only (P for trend=0·001). We found no associations with wheeze or recurrent wheeze at 18 months or with allergic rhinitis. The results suggest that high (v. no) maternal fish intake during pregnancy is protective against both early and ever asthma in 7-year-old children.

  4. Comparison of nasal responsiveness to histamine, methacholine and phentolamine in allergic rhinitis patients and controls

    NARCIS (Netherlands)

    R. Gerth van Wijk (Roy); P.H. Dieges

    1987-01-01

    textabstractIn a selected group of rhinitis patients with an IgE‐mediated allergy to house dust mites the nasal response to insufflation of histamine chloride, methacholine and phentolamine was demonstrated to be higher than in a control group. With the methods used histamine chloride was better at

  5. Rinite alérgica: aspectos epidemiológicos, diagnósticos e terapêuticos Allergic Rhinitis: epidemiological aspects, diagnosis and treatment

    Directory of Open Access Journals (Sweden)

    Cássio da Cunha Ibiapina

    2008-04-01

    Full Text Available Este estudo tem como objetivo revisar a literatura a respeito da rinite alérgica quanto aos aspectos epidemiológicos, clínicos, diagnósticos e terapêuticos. A revisão da bibliografia foi realizada utilizando-se as bases de dados Medline, Literatura Latino-Americana e do Caribe em Ciências da Saúde e HighWire, nos últimos trinta anos, utilizando-se os descritores allergic rhinitis, epidemiology, diagnosis, e treatment. Foram selecionados 60 artigos. Este estudo destaca o aumento na prevalência da rinite alérgica, sua associação com a asma, os critérios diagnósticos e seu tratamento. A classificação da rinite alérgica é apresentada, bem como as estratégias de tratamento. As modalidades terapêuticas apresentadas e discutidas são anti-histamínicos, corticóides, imunoterapia, antileucotrienos, cromoglicato dissódico e anticorpos anti-IgE, bem como a redução da exposição aos alérgenos. Finalmente, ressalta-se a importância da abordagem da rinite alérgica em saúde pública.This study was a review of the literature on the epidemiological, clinical, diagnostic and therapeutic aspects of allergic rhinitis. Bibliographic searches were based on the information contained within the Medline, Latin American and Caribbean Health Sciences Literature and HighWire databases, covering the last thirty years and using the following search terms: 'allergic rhinitis', 'epidemiology', 'diagnosis' and 'treatment'. Sixty articles were selected. This study describes the increase in the prevalence of allergic rhinitis, its relationship with asthma, the diagnostic criteria and the treatment. The classification of allergic rhinitis and strategies for its treatment are presented. Therapeutic modalities presented and discussed include the administration of antihistamines, corticosteroids, immunotherapy, anti-leukotrienes, sodium cromoglycate and anti-IgE antibodies, as well as minimizing exposure to inhaled allergens. Finally, the importance of

  6. Effect of RNA interference therapy on the mice eosinophils CCR3 gene and granule protein in the murine model of allergic rhinitis

    Institute of Scientific and Technical Information of China (English)

    Xin-Hua Zhu; Bing Liao; Ke Liu; Yue-Hui Liu

    2014-01-01

    Objective:To observe the clinical manifestations of allergic rhinitis mice and the expression changes of the eosinophilsCCR3 and the granule protein mRNA in the bone marrow, peripheral blood and nasal lavage fluid.Methods:Twenty-fourBALB/c mice were randomly divided into the control group,PBS therapy group, siRNA therapy group and theCCR3 siRNA therapy group (n=6).Allergic rhinitis model were sensitized and stimulated by ovalbunfin, andCCR3 siRNA therapy group were administered withCCR3 transnasally before stimulated.The levels of the eosinophilsCCR3,MBP,ECP andEPO in bone marrow, peripheral blood and nasal lavage fluid were detected byRT-PCR.Results:Compared to the control group andCCR3 siRNA therapy group, the nasal mucosa of thePBS therapy group and siRNA therapy group developed epithalaxy, goblet cells hyperplasia, squamous epithelium metaplasia, epithelium necrosis, lamina propria and submucosa gland hyperplasia, vasodilatation, tissue edema, and the characterized eosinophil infiltration.RT-PCR indicated that theCCR3 mRNA,MBP ,ECP andEPO expression in bone marrow, peripheral blood and nasal lavage fluid of theCCR3 siRNA therapy group was lower than thePBS therapy group andsiRNA therapy group(P<0.05).Conclusions:TheRNA interference therapy toCCR3 by local administration pernasal can suppress the process of the development, migration and invasion of the allergic rhinitis eosinophil, thus can reduce the effect of eosinophils and then reduce the inflammation effect of the allergic rhinitis.It may be a new treatment for respiratory tract allergic inflammation.

  7. Obesity is a risk factor for allergic rhinitis in children of Wuhan (China)

    OpenAIRE

    Lei, Yang; Yang, Huang; Zhen, Long

    2016-01-01

    Background The relationship between obesity and allergic diseases in children of China is unclear. Objective To analysis the relationship between obesity and overweight and the prevalence of allergic diseases and the impact of gender. Methods Questionnaire based on those used in National Study of Asthma and Allergies in Childhood in China. The study included 3,327 participants (23.7% aged 2–6 years, 65.8% aged 7–12 years, 10.5% aged 13–14 years) in Wuhan City. Allergic diseases were determine...

  8. Resolution of Allergic Rhinitis and Reactive Bronchospasm With Supplements and Food-specific Immunoglobulin G Elimination: A Case Report.

    Science.gov (United States)

    Kwiatkowski, Laura; Mitchell, Jessica; Langland, Jeffrey

    2016-10-01

    Context • Allergies are a common affliction, whether they are respiratory, food related, or dermatological. People often resort to continuous use of over-the-counter medications, such as antihistamines, to manage their symptoms. Controversy still remains over testing serum immunoglobulin (Ig) G to diagnose food allergies. Objective • This study intended to examine the benefits of treatment of a pediatric patient with natural supplements and an elimination diet for IgG food allergies. Design • The research team reported a case study. Setting • The study was conducted at Southwest Naturopathic Medical Center (Tempe, AZ, USA). Participant • The participant was a 10-y-old Caucasian female who had diagnoses of allergic rhinitis and reactive bronchospasm, the second of which was exacerbated by allergens such as wheat, perfumes, and seasonal flora. Intervention • Following testing for IgE- and IgG-reactive foods, the patient was treated with natural supplements to reduce her allergic responses and was instructed to make dietary changes to eliminate the IgG-reactive foods. Outcome Measures • The patient's symptom severity was tracked starting 1 mo after her initial visit to Southwest Naturopathic Medical Center. The severity was based on the patient's subjective reports about her congestion to her mother and on her mother's observations of the effect of symptoms on her attention and school performance. The bronchospasm severity was based on the frequency of a sensation of wheezing and chest tightness, the frequency of inhaler use, and the occurrence of any exacerbation of symptoms with acute respiratory illness Results • After 1 mo, in which the patient used the natural supplements, she experienced a 90% improvement in coughing; a 70% improvement in nasal congestion; less chest tightness; and no need for use of loratadine, diphenhydramine, or albuterol. At the 8-mo follow-up visit, her nasal congestion was reported to be entirely gone. Conclusions • The

  9. Effect of antiallergic herbal agents on chloride channel-3 and immune microenvironment in nasal mucosal epithelia of allergic rhinitis rabbits

    Institute of Scientific and Technical Information of China (English)

    WANG Li-feng; XU Li-juan; GUO Feng-hua; WANG Li-na; SHEN Xiao-hong

    2010-01-01

    Background Allergic rhinitis (AR) is a Th2 dominant cytokine response. Chloride channel-3 (CIC-3) plays an important role in nasal mucosal edema and inflammatory pathologic changes in AR. Antiallergic herbal agents (AHA) are antiallergic herbal products. In the previous study, we have demonstrated that AHA clearly inhibited allergic medium and relieved allergic reaction of AR. The aim of this study was to evaluate the function of CIC-3 and discuss the possible therapeutic effects of AHA on immune microenvironment in AR.Methods AHA were produced and used to treat AR. An animal model of an AR rabbit was established by ovalbumin (OVA). The rhinitis rabbits were randomly divided into three groups: AHA treated group (AHATG), model group (MG) and healthy control group (HCG). The expressions of CIC-3 protein were examined by immunohistochemical method. The mucosal epithelial cells of all the rabbit groups were primarily cultured with tissue culture method in vitro with or without rhlL-4 or rhlL-2. Furthermore, the expressions of CIC-3 mRNA were detected by real-time PCR. The levels of monocyte chemotactic factor-1 (MCP-1) and vascular cell adhesion molecule-1 (VCAM-1) protein in culture supernatants were measured by ELISA.Results The expressions of CIC-3 mRNA increased more in mucosal epithelial cells of MG than those in AHATG and HCG (P0.05).Conclusions AHA can inhibit the secretions of CIC-3, MCP-1 and VCAM-1 in mucosal epithelia and improve inflammatory reaction of AR. CIC-3 plays an important role in the secretion of cytokines and mucosal inflammatory response in AR. RhlL-4 can enhance the secretion of CIC-3, MCP-1 and VCAM-1 in mucosal epithelial cells, especially during the AR process. These enhanced effects of rhlL-4 were significantly suppressed by AHA. The secretions of CIC-3, MCP-1 and VCAM-1 can not be induced obviously by rhlL-2 in mucosal epithelial cells in AR.

  10. New therapeutic strategies in allergic rhinitis%变应性鼻炎治疗新策略

    Institute of Scientific and Technical Information of China (English)

    沙骥超; 孟粹达; 修倩; 朱冬冬

    2016-01-01

    Allergic rhinitis (AR) is a nasal inflammatory,IgE-mediated disease that occurs when some individuals inhales something he or she is allergic to,such as pollen or animal dander.It is also a refractory disease with high prevalence in the field of rhinology.The treatment of AR is really a difficult and challenging task because of the high prevalence,economic burden and the interference to the quality of life.At present,nasal corticosteroid and antihistamines were the mainly therapies,however,there is up to 40% patients not satisfactory to these therapies.So exploring new therapy or target is necessary.This article will review the results of previous studies focused on the new therapies of AR.%变应性鼻炎(allergic rhinitis,AR)是机体吸入变应原后主要由IgE介导的鼻黏膜非感染性炎性疾病,是鼻科领域高患病率的难治性疾病.随着患病率的逐年增高,AR引起了一系列社会问题,包括对患者生活质量的影响、对工作、学习的干扰以及经济负担的逐渐加重.目前,AR的治疗任务及难度都面临着巨大的挑战,临床常用鼻用糖皮质激素和抗组胺药物控制鼻部症状,然而有研究显示,对疗效不满意的患者约高达40%.因而AR的治疗仍迫切需要开拓思路,探索新的有效治疗方法.本文对治疗AR新方法的临床研究进行综述.

  11. Patients with asthma and comorbid allergic rhinitis: is optimal quality of life achievable in real life?

    Directory of Open Access Journals (Sweden)

    Fulvio Braido

    Full Text Available OBJECTIVES: Asthma trials suggest that patients reaching total disease control have an optimal Health Related Quality of Life (HRQoL. Moreover, rhinitis is present in almost 80% of asthmatics and impacts asthma control and patient HRQoL. We explored whether optimal HRQoL was reachable in a real-life setting, and evaluated the disease and patient related patterns associated to optimal HRQoL achievement. METHODS AND FINDINGS: Asthma and rhinitis HRQoL, illness perception, mood profiles, rhinitis symptoms and asthma control were assessed by means of validated tools in patients classified according to GINA and ARIA guidelines. Optimal HRQoL, identified by a Rhinasthma Global Summary (GS score ≤20 (score ranging from 0 to 100, where 100 represents the worst possible HRQoL, was reached by 78/209 (37.32%. With the exception of age, no associations were found between clinical and demographic characteristics and optimal HRQoL achievement. Patients reaching an optimal HRQoL differed in disease perception and mood compared to those not reaching an optimal HRQoL. Asthma control was significantly associated with optimal HRQoL (χ(2 = 49.599; p<0.001 and well-controlled and totally controlled patients significantly differed in achieving optimal HRQoL (χ(2 = 7.617; p<0.006. CONCLUSION: Approximately one third of the patients in our survey were found to have an optimal HRQoL. While unsatisfactory disease control was the primary reason why the remainder failed to attain optimal HRQoL, it is clear that illness perception and mood also played parts. Therefore, therapeutic plans should be directed not only toward achieving the best possible clinical control of asthma and comorbid rhinitis, but also to incorporating individualized elements according to patient-related characteristics.

  12. Non-invasive sampling methods of inflammatory biomarkers in asthma and allergic rhinitis

    NARCIS (Netherlands)

    Boot, Johan Diderik

    2009-01-01

    In this thesis, a series of clinical studies have been described, in which we applied, evaluated or modified novel and existing non- or semi-invasive sampling methods and detection techniques for the assessment of biomarkers in allergic airway inflammation.

  13. Efficacy of Sublingual Swallow Immunotherapy in Children with Rye Grass Pollen Allergic Rhinitis: A Double-blind Placebo-Controlled Study

    Directory of Open Access Journals (Sweden)

    Akefeh Ahmadiafshar

    2012-06-01

    Full Text Available Specific local immunotherapy has been recently introduced as an alternative to classic subcutaneous immunotherapy in treatment of allergic rhinitis. In this study, the effects of sublingual immunotherapy (SLIT on symptoms and medication score and skin prick test evaluation of patients with allergic rhinitis were investigated.In this placebo controlled trial, twenty four patients aged 5-18 years old with grass pollen induced rhinitis and sensitive to  rye grass by positive skin prick test received randomly sublingual extract of rye grass or placebo for 6 months. Symptom and medication scores and adverse effects of SLIT were assessed during treatment. Skin prick test induced wheal at the beginning and  the  end  of  therapy were also measured. Data  were analyzed with SPSS software.We found significant reduction of symptoms in intervention group from 21st  week of immunotherapy (p<0.05. Medication scores were also reduced after 16th  week (p<0.05, adverse effects were low and insignificant in both groups. Erythema induced diameter with skin  prick  test  for  grass  and  rye  grass  was  significantly reduced  in  SLI  group  after immunotherapy.This study indicates that SLIT in grass-pollen rhinitis is well tolerated, improves overall clinical symptoms,  and  reduces drug consumes.  We recommend  this  therapy as a safe therapy in patients with allergic rhinitis.

  14. 非变应性鼻炎与变应性鼻炎患者患病相关因素比较%Comparison of risk factors between patients with non-allergic rhinitis and allergic rhinitis

    Institute of Scientific and Technical Information of China (English)

    朱鲁平; 王菲; 孙小青; 陈若希; 陆美萍; 殷敏; 程雷

    2010-01-01

    Objective To investigate and describe the differences in age, sex, seasonality distribution, and related environmental factors between patients with non-allergic rhinitis (NAR) and allergic rhinitis (AR). Methods One hundred and eleven patients with NAR and 112 patients with AR were enrolled in this study. All patients were first diagnosed in outpatient department between January and August 2010. Questionnaires were distributed to all participants to record the general information, medical history, and the factors relevant to symptom onset. Statistical analysis was performed using a SPSS13.0 software. Results The proportion of patients with NAR increased with age, compared to patients with AR.The peak age was 21 -30 years old in patients with NAR, whereas 11 -20 years old in patients with AR. In adults more than 18 years old, the average age (years, -x±s) of patients with NAR (38.6 ± 14. 5) was significantly higher than those with AR (32. 8 ± 13.0; t =2. 58, P =0. 024). NAR was more likely to be males before 30 years old, while after 30 years old, it likely to be female predominance. The same case occurred in AR subjects but in their 20 years old. NAR was symptomatically worse in winter (χ2 = 27. 57,P = 0. 000), whereas AR worse in spring (χ2 = 13. 75, P = 0. 003). The cases of NAR were significantly more than those of AR during the winter season (x2 = 12. 34, P = 0. 000). Among the disease-related environmental factors, living or working place near the traffic artery had 1.94-fold increased risk for development of NAR compared with AR; however, living or working in ground floor or sunshine time less than 2 h per day had 1.77- or 1.91-fold increased risk for development of NAR compared with NAR.Subjects with personal or family history of allergic disease had 2. 14 to 4. 06-fold increased risk for development of AR compared with NAR. The self-reported predisposing factors in NAR patients were mainly including temperature shift (56. 3%), common cold (52. 8

  15. Efficacy and safety of bilastine in Japanese patients with perennial allergic rhinitis: A multicenter, randomized, double-blind, placebo-controlled, parallel-group phase III study

    OpenAIRE

    Kimihiro Okubo; Minoru Gotoh; Mikiya Asako; Yasuyuki Nomura; Michinori Togawa; Akihiro Saito; Takayuki Honda; Yoshihiro Ohashi

    2017-01-01

    Background: Bilastine, a novel non-sedating second-generation H1 antihistamine, has been approved in most European countries since 2010. This study aimed to evaluate the superiority of bilastine over placebo in Japanese patients with perennial allergic rhinitis (PAR). Methods: This randomized, double-blind, placebo-controlled, parallel-group, phase III study (trial registration number JapicCTI-142600) evaluated the effect of a 2-week treatment period with bilastine (20 mg once daily), fexo...

  16. Elevated levels of manna-binding lectin (MBL) and eosinophilia in patients of bronchial asthma with allergic rhinitis and allergic bronchopulmonary aspergillosis associated with a novel intronic polymorphism in MBL

    DEFF Research Database (Denmark)

    Kaur, S.; Gupta, G.K.; Shah, A.;

    2006-01-01

    Mannan-binding lectin (MBL), an important component of innate immunity, binds to a range of foreign antigens and initiates the lectin complement pathway. Earlier studies have reported high plasma MBL levels in allergic patients in comparison to healthy controls. In view of varied plasma MBL levels...... being determined by genetic polymorphisms in its collagen region, we investigated the association of single nucleotide polymorphisms (SNPs) in the collagen region of human MBL with respiratory allergic diseases. The study groups comprised patients of bronchial asthma with allergic rhinitis (n = 49......) and allergic bronchopulmonary aspergillosis (APBA) (n = 11) and unrelated age-matched healthy controls of Indian origin (n = 84). A novel intronic SNP, G1011A of MBL, showed a significant association with both the patient groups in comparison to the controls (P

  17. Clinical Profile, Co-Morbidities and Health Related Quality of Life in Pediatric Patients with Allergic Rhinitis and Asthma

    Directory of Open Access Journals (Sweden)

    Keya R. Lahiri, Milind S. Tullu* and Rachna Kalra

    2010-10-01

    Full Text Available Background: Co-existence of allergic rhinitis (AR and bronchial asthma (BA is well known. We planned to study the clinical profile of patients with AR & BA, the associated co-morbidities and the effect of AR &/ or BA on health related quality of life (HRQOL in Pediatric patients. Methods: Patients attending the Pediatric out-patients department and Pediatric Chest Clinic of tertiary care center were enrolled. The sample size included 100 subjects with BA & AR (Group 1 with control groups of 60 asthmatic children (Group 2 & 40 children suffering from AR (Group 3. The patients were subjected to a questionnaire & a through physical examination and the details were recorded in a pre-designed proforma. General medical, environmental, occupational, personal & family history was procured along with examination of respiratory system. The standard heath related quality of life (HRQOL parameters were studied. Findings: The study was conducted over a period of 13 months (February 2004 to March 2005. 200 patients between ages of 3 to 15 years (mean 7.95 years were enrolled (100 patients with BA and AR- group 1, 60 patients with asthma alone- group 2 and 40 patients with AR alone- group 3. Dust, smoke, outdoor dust, holi festival, winter season, exercise, and smoking by father were important exacerbating factors in all the three groups. Additionally, diwali festival and family history of asthma were important in Group 2 (BA; while pollen, weeds, diwali festival and family history of allergic rhinitis were important causes of exacerbation in group 3 (AR. Cough was commonly seen in all three groups. Wheezing, sneezing, itching throat, rhinorrhea, watering, altered taste, and nasal block was common in patients in group 1 while wheezing was important symptom in patients in group 2 (BA. Sneezing, itching throat, rhinorrhea, watering, altered taste, and nasal block were common symptoms in patients in group 3 (AR. Conjunctivitis, pharyngitis, and post-nasal drip

  18. Association pattern of interleukin-1 receptor-associated kinase-4 gene polymorphisms with allergic rhinitis in a Han Chinese population.

    Directory of Open Access Journals (Sweden)

    Yuan Zhang

    Full Text Available OBJECTIVE: Interleukin-1 receptor-associated kinase-4 (IRAK-4 encodes a kinase that is essential for NF-kB activation in Toll-like receptor and T-cell receptor signaling pathways, indicating a possible crosstalk between innate and acquired immunities. We attempted to determine whether the polymorphisms in the Interleukin-1 receptor-associated kinase-4 (IRAK-4 gene are associated with allergic rhinitis (AR in the Han Chinese population. METHODS: A population of 379 patients with AR and 333 healthy controls was studied. Blood was drawn for DNA extraction and total serum immunoglobulin E (IgE. A total of 11 single nucleotide polymorphisms (SNPs in IRAK-4 were selected and individually genotyped. RESULTS: Significant allelic differences between cases and controls were obtained for the SNP of rs3794262 in the IRAK-4 gene. In the stratified analysis for gender, two SNPs (rs4251431 and rs6582484 in males appeared as significant associations. Subgroup analysis for the presence of different allergen sensitivities displayed associations only in the house dust mite-allergic cohorts (rs3794262, rs4251481. None of the selected SNPs in IRAK-4 was associated with total IgE level. The haplotype analysis indicated GCCTGCGA was significantly associated with AR. The SNP-SNP interaction information analysis indicated that the selected sets of polymorphisms had no synergistic effect. CONCLUSIONS: Our findings did not support the potential contribution of the IRAK-4 gene to serum IgE levels. However, the results demonstrated a gender- and allergen-dependant association pattern between polymorphisms in IRAK-4 and AR in Chinese population.

  19. Sublingual Immunotherapy Induces Regulatory Function of IL-10-Expressing CD4+CD25+Foxp3+ T Cells of Cervical Lymph Nodes in Murine Allergic Rhinitis Model

    Directory of Open Access Journals (Sweden)

    Takaya Yamada

    2012-01-01

    Full Text Available Sublingual immunotherapy (SLIT has been considered to be a painless and efficacious therapeutic treatment of allergic rhinitis which is known as type I allergy of nasal mucosa. Nevertheless, its mechanisms need to be further investigated. In this study, we constructed an effective murine model of sublingual immunotherapy in allergic rhinitis, in which mice were sublingually administered with ovalbumin (OVA followed by intraperitoneal sensitization and nasal challenge of OVA. Sublingually treated mice showed significantly decreased specific IgE responses as well as suppressed Th2 immune responses. Sublingual administration of OVA did not alter the frequency of CD4+CD25+ regulatory T cells (Tregs, but led to upregulation of Foxp3- and IL-10-specific mRNAs in the Tregs of cervical lymph nodes (CLN, which strongly suppressed Th2 cytokine production from CD4+CD25− effector T cells in vitro. Furthermore, sublingual administration of plasmids encoding the lymphoid chemokines CCL19 and CCL21-Ser DNA together with OVA suppressed allergic responses. These results suggest that IL-10-expressing CD4+CD25+Foxp3+ Tregs in CLN are involved in the suppression of allergic responses and that CCL19/CCL21 may contribute to it in mice that received SLIT.

  20. Occupational allergic rhinitis and contact urticaria caused by bishop's weed (Ammi majus).

    Science.gov (United States)

    Kiistala, R; Mäkinen-Kiljunen, S; Heikkinen, K; Rinne, J; Haahtela, T

    1999-06-01

    Bishop's weed (Ammi majus) has been known to induce toxic phytophotodermatitis. We now describe IgE-mediated rhinitis and contact urticaria caused by exposure to bishop's weed in a 31-year-old atopic female florist. A skin prick-prick test with bishop's weed flowers gave an 8-mm wheal, and the bishop's weed-specific IgE level in the patient's serum was 9.7 PRU/ml (RAST class 3). In an immunoblotting experiment with the patient's serum, nine IgE-binding protein bands with the molecular weights 19, 34, 39-41 (doublet), 52-61 (doublet), and >67 (triplet) kDa were detected in bishop's weed extract. The patient became symptomless after she had ceased to work as a florist.

  1. Adverse Events During Immunotherapy Against Grass Pollen-Induced Allergic Rhinitis - Differences Between Subcutaneous and Sublingual Treatment.

    Science.gov (United States)

    Aasbjerg, Kristian; Dalhoff, Kim Peder; Backer, Vibeke

    2015-08-01

    Allergic rhinitis (AR) triggered by grass pollen is a common disease, affecting millions of people worldwide. Treatment consists of symptom-alleviating drugs, such as topical corticosteroids or antihistamines. Another option is potentially curative immunotherapy, currently available as sublingual and subcutaneous treatment. We investigated the potential differences in the prevalence and severity of adverse events related to subcutaneous and sublingual immunotherapy (SLIT) against grass pollen-induced AR. A thorough literature search was performed with PubMed and EMBASE. The findings were compared with the available summaries of product characteristics (SPC) and with commercial pharmacology databases (Micromedex). The majority of available safety data originate from registered products of standardized allergens. A surprisingly large percentage of drugs, especially those used in the United States, have no systematically collected safety data. No sufficiently powered randomized trials comparing sublingual and subcutaneous immunotherapy (SCIT) were available, but general safety assessments indicate that sublingual tablet treatment is safer than subcutaneous treatment. Not all commonly used immunotherapy drugs are officially registered, and not all have systematically collected safety data. This is especially true for older drugs used in the United States. In contrast, newer drugs that have undergone extensive clinical testing have better documentation, but unified collection of safety data is still lacking. Considering the evidence available, most drugs elicit similar side effects from the same organ systems, and symptoms from the sublingual drug classes are probably less severe. However, a head-to-head comparison of safety and efficacy is lacking.

  2. Justification of advisability of using physical factors in the treatment of patients with allergic rhinitis and associated bronchial asthma

    Directory of Open Access Journals (Sweden)

    T. N. Zaripova

    2012-01-01

    Full Text Available The efficiency of treatment of patients with allergic rhinitis and associated bronchial asthma by physical factors and advisability of two-stage treatment are justified. Sixty six patients were observed. The conclusion on the efficiency of treatment was based on the data about the dynamics clinical state of the primary and associated diseases, intensity of inflammation activity in respiratory tract (rhinocytograms, biochemical indices of nasal lavages, level of nitrogen oxide in expired air were studied, patency of airways (manometry, spirography. We compared two versions of treatment: two- and one-stage. Patients of the first group (30 patients received elimination therapy for 3 to 5 days with the following peaty mud application, current of supersonic frequency, massage, inhalations, physical therapy. Patients of the second group (36 patients did not receive elimination therapy. We have found a decrease in intensity of clinical implications of the primary and associated diseases, decrease in inflammation activity, better nasal and bronchial носовой patency, improvement of the mucociliary function in patients of the first group. In the second group, the recovery of the surface epithelium and nasal patency was not observed against the background of improvement of the clinical state.

  3. Aeroallergen spectrum of patients with child allergic rhinitis in Changsha area of China%长沙地区562例变应性鼻炎患儿变应原谱分析

    Institute of Scientific and Technical Information of China (English)

    钟竹青; 王芳; 王天生; 李亮明; 谭国林

    2011-01-01

    目的:调查长沙地区变应性鼻炎患儿的变应原分布情况及其阳性率,并分析其相关因素.方法:应用13种标准化吸入变应原对562例变应性鼻炎患儿进行变应原皮肤点刺试验,并详细采集病史资料.结果:457例呈阳性反应(81.3%),其主要变应原均为粉尘螨和屋尘螨,其次为热带螨、美洲大蠊、德国小蠊及狗毛等.花粉变应原在该组十分少见,城市儿童变应性鼻炎的患病率显著高于农村(P<0.01).结论:长沙地区变应性鼻炎患儿的主要变应原为尘螨,与居住环境有关,多数患儿可应用螨变应原进行特异性免疫治疗.变应原皮肤点刺试验应用于儿童变应性鼻炎的诊断是一种安全的方法.%Objective:To investigate aeroallergen spectrum and allergy positive rates of patients with child allergic rhinitis and analyze its related factors. Method:Skin prick test was carried out in 562 cases with child allergic rhinitis using 13 inhaled allergens, and detailed history was collected in all cases. Result: Four hundred and fifty-seven (81. 3%) of 562 cases showed positive reaction to at least one allergen out of 13 allergens. The most common allergens found in patients was dermatophagoides farinae and dermatophagoides pteronyssinus,and positive reaction was 93. 1% in child allergic rhinitis, followed by tropical mite, periplaneta americana, blattella germanica and dog hair. The pollen allergen, most common in American and European, was pretty rare in this study. The prevalence of child allergic rhinitis was significantly higher in urban than in rural(P<0. 01). There was no adverse effect appeared in children with allergic rhinitis underwent skin prick test. Conclusion: The major allergen of allergic rhinitis is mite for child allergic rhinitis, and relates to housing enviroment. Most of patients with child allergic rhinitis can be treated by the mite specific immunotherapy. The skin prick test is a safe technique for diagnosis of

  4. Treatment of Allergic Rhinitis with Ectoine Containing Nasal Spray and Eye Drops in Comparison with Azelastine Containing Nasal Spray and Eye Drops or with Cromoglycic Acid Containing Nasal Spray

    Directory of Open Access Journals (Sweden)

    Nina Werkhäuser

    2014-01-01

    Full Text Available Objectives. Allergic rhinitis is a common disease with increasing prevalence and high impact on economic burden and comorbidities. As treatment with pharmacological drugs is not always satisfactory due to side effects and incomplete efficacy, alternative treatment strategies are needed. Ectoine is an osmolyte with membrane stabilizing and inflammation reducing capacities. Nasal spray and eye drops containing ectoine are promising new treatment regimens for allergic rhinitis sufferers. Design and Methods. The current two noninterventional trials evaluated the efficacy and safety of ectoine containing nasal spray and eye drops for treating allergic rhinitis in comparison with either azelastine or cromoglycic acid containing products. Nasal and ocular symptom developments as well as judgment of tolerability and efficacy were assessed both by investigators and patients over a time period of one to two weeks. Results. Both trials confirmed that ectoine containing products reduced nasal and ocular symptoms in allergic rhinitis patients. Results clearly demonstrated good safety profiles of the ectoine products comparable to those of azelastine and even better to those of cromoglycate products. Conclusion. Ectoine containing nasal spray and eye drops are interesting new treatment strategies for sufferers of allergic rhinitis, combining both good efficacy and absence of side effects.

  5. Treatment of allergic rhinitis with ectoine containing nasal spray and eye drops in comparison with azelastine containing nasal spray and eye drops or with cromoglycic Acid containing nasal spray.

    Science.gov (United States)

    Werkhäuser, Nina; Bilstein, Andreas; Sonnemann, Uwe

    2014-01-01

    Objectives. Allergic rhinitis is a common disease with increasing prevalence and high impact on economic burden and comorbidities. As treatment with pharmacological drugs is not always satisfactory due to side effects and incomplete efficacy, alternative treatment strategies are needed. Ectoine is an osmolyte with membrane stabilizing and inflammation reducing capacities. Nasal spray and eye drops containing ectoine are promising new treatment regimens for allergic rhinitis sufferers. Design and Methods. The current two noninterventional trials evaluated the efficacy and safety of ectoine containing nasal spray and eye drops for treating allergic rhinitis in comparison with either azelastine or cromoglycic acid containing products. Nasal and ocular symptom developments as well as judgment of tolerability and efficacy were assessed both by investigators and patients over a time period of one to two weeks. Results. Both trials confirmed that ectoine containing products reduced nasal and ocular symptoms in allergic rhinitis patients. Results clearly demonstrated good safety profiles of the ectoine products comparable to those of azelastine and even better to those of cromoglycate products. Conclusion. Ectoine containing nasal spray and eye drops are interesting new treatment strategies for sufferers of allergic rhinitis, combining both good efficacy and absence of side effects.

  6. Analysis of allergens with allergic rhinitis in Rizhao%山东省日照地区变应性鼻炎患者过敏原分析

    Institute of Scientific and Technical Information of China (English)

    黄咏梅; 乔秀军; 尹华; 牟军伟

    2011-01-01

    Objective To find out common allergens in Rizhao by investigating the allergens in patients with allergic rhinitis.Method The allergens in 686 patients with allergic rhinitis in Rizhao were detected by skin prick test.Results 509 of 686(74.20%)cases presented positive reaction,in which,the positive rate was 70.99%in inhalation group and 30.61%in food group,the most common inhalation allergen was pteronyssinus,then was dermatophagoides farinae,cockroaches;The most common food allergen was the jellyfish,then was peaches,peanuts.Conclusion The inhaled allergens were the main risk factors for allergic rhinitis,in which,mites was the most common allergens.%目的 通过对山东省日照地区变应性鼻炎患者进行过敏原检测及分析,筛查该地区常见过敏原.方法 采用皮肤点刺法对686例变应性鼻炎患者进行过敏原检测.结果 686例患者中过敏原阳性509例(74.20%),其中吸入组阳性率70.99%,较高的为户尘螨、粉尘螨、蟑螂;食物组阳性率30.61%,较高的为海蜇、桃子、花生.结论 吸入性变应原为日照地区过敏性鼻炎主要的致病因素,螨类为最常见的变应原.

  7. Evaluation of serum specific IgE for the diagnosis of allergic rhinitis with multi-allergens

    Institute of Scientific and Technical Information of China (English)

    LIU Cheng-yao; ZHANG Yuan; HAN De-min; ZHANG Luo

    2010-01-01

    Background Objective evaluation of allergic rhinitis (AR) requires in vivo and in vitro tests. In vitro tests are important to assist or ensure the main allergens in multi-allergen-sensitive patients. The aim of this study was to evaluate the utility of serum specific IgE (slgE) in the diagnosis of AR patients with multi-allergens in the Chinese population.Methods Combining a positive skin prick test (SPT) and clinical history as the diagnostic reference criteria of AR, we estimated concentrations of slgE produced in response to the 7 most frequent allergens among 85 AR patients, using the UniCAP assay system.Results Among 85 individuals with positive SPT results and allergen-specific nasal symptoms, slgE concentration correlated well with SPT classes among all the tested allergens. Based on a clinical diagnosis and SPT results using a positive cut-off value of a class 1 score, the CAP test performed well and the sensitivity for different allergens ranged from 0.5 (giant ragweed) to 0.91 (Dermatophagoides pteronyssinus (Der p) and Dermatophagoides farinae (Der f), while specificity ranged from 0.93 (Der f) to 1.0 (animal hair, Derp and mugwort). When the cut-off score was adjusted to class 2, the sensitivity showed an increase overall while the remaining assessed items, including specificity, positive predictive value, negative predictive value and efficiency, showed an unacceptable decline.Conclusions Well-established serum slgE tests correlated well with SPTs. Setting a class 1 cut-off for positivity of SPT results was better than a class 2 setting for assessing the AR diagnostic value.

  8. Correlations of nasal responses to leukotriene D4 and histamine nasal provocation with quality of life in allergic rhinitis

    Science.gov (United States)

    Zhu, Zheng; Xie, Yanqing; Guan, Weijie; Gao, Yi; Xia, Shu; Shi, Xu

    2016-01-01

    Background The symptoms of allergic rhinitis (AR) greatly affect the quality of life (QoL) in the patients with AR. The correlations of nasal response to leukotriene D4 (LTD4) and histamine nasal provocation with health related QoL in AR are not clear. Objective To evaluate the correlations of nasal response to LTD4 and histamine nasal challenge with QoL in AR. Methods Patients randomly underwent LTD4 and histamine nasal challenge tests, completed the rhinoconjunctivitis quality of life questionnaire (RQoLQ), and rating the symptom severity score (total symptom score 4, TSS4) in the previous week. The correlations between nasal challenge tests induced nasal responses and QoL in RQoLQ were analyzed. Results A total of 25 eligible AR patients enrolled and finished both LTD4 and histamine nasal challenge and completed the questionnaire of RQoLQ. Histamine nasal challenge induced sneezing, increased nasal resistant were correlated with most of the dimensions (general, practical, nasal, eye problems, and quality of sleep, p < 0.05), while LTD4 nasal challenge induced sneeze, increased nasal resistant only correlated with nasal and ocular problems. On the contrary, the severity of the sneeze assessed by TSS4, was not correlated with QoL, while the severity of rhinorrhea, congestion, and nasal pruritus were correlated with nasal and practical problems, and nasal congestion was also correlated with ocular problems (r = 0.60, p = 0.01). Conclusion LTD4 and histamine nasal challenge induced nasal responses were correlated with different clinical symptoms severity and QoL, which can be used as a good diagnosis and evaluation methods for the management of AR.

  9. 变应性鼻炎患者焦虑状态分析%The impact of allergic rhinitis on state-trait anxiety

    Institute of Scientific and Technical Information of China (English)

    锡琳; 曹飞飞; 熊巍; 贺飞; 张罗

    2014-01-01

    Objective To investigate the relationship between the different types of allergic rhinitis and anxiety.Methods State-trait anxiety (State-Trait Anxiety Inventory,STAI) was adopted to 98 cases,moderate to severe persistent allergic rhinitis (PAR,male 43 cases,female 55 cases) and 165 cases of moderate to severe intermittent allergic rhinitis (IAR,male 89 cases,female 76 cases) and compared with the Chinese standard norm.SPSS 15.0 software was used to analyze the data.Results There was no significant difference in state anxiety (S-AI) and trait anxiety (T-AI) score (PPAR:0.411,0.724 ; PIAR:0.400,0.061) between male patients with allergic rhinitis (PAR and IAR) and the 1998 Chinese male norm.There was no significant difference (PPAR:0.503,P1AR:0.789) between female AR patients and normal in T-AI.The S-AI score was significantly higher in female AR patients than that in Chinese women norm scores (PPAR =0.007,PIAR =0.004).PAR and IAR showed no significant difference on T-AI and S-AI.(P value was 0.748 and 0.967).Conclusions Female patients with allergic rhinitis can cause anxiety and continued,but there is no obvious anxiety potential in T-AI.The male patients do not show significantly different from normal people in terms of state and trait anxiety.And then,different types of allergic rhinitis have no significant correlation with anxiety.%目的 探讨不同性别及不同类型变应性鼻炎患者与焦虑状态的关系.方法 采用状态-特质焦虑问卷(State-Trait Anxiety Inventory,STAI)对98例中-重度持续性变应性鼻炎(persistent allergic rhinitis,PAR)患者(其中男43例,女55例)和165例中-重度间歇性变应性鼻炎(intermittent allergic rhinitis,IAR)患者(其中男89例,女76例)进行焦虑状态分析,并与国人标准常模进行比较.采用SPSS 15.0软件进行统计学分析.结果 男性变应性鼻炎(allergic rhinitis,AR)患者(PAR和IAR)与1998年国人男性常模在状态焦虑和特质焦虑得分上差异无

  10. Phenotyping asthma, rhinitis and eczema in MeDALL population-based birth cohorts : an allergic comorbidity cluster

    NARCIS (Netherlands)

    Garcia-Aymerich, J.; Benet, M.; Saeys, Y.; Pinart, M.; Basagana, X.; Smit, H. A.; Siroux, V.; Just, J.; Momas, I.; Ranciere, F.; Keil, T.; Hohmann, C.; Lau, S.; Wahn, U.; Heinrich, J.; Tischer, C. G.; Fantini, M. P.; Lenzi, J.; Porta, D.; Koppelman, G. H.; Postma, D. S.; Berdel, D.; Koletzko, S.; Kerkhof, M.; Gehring, U.; Wickman, M.; Melen, E.; Hallberg, J.; Bindslev-Jensen, C.; Eller, E.; Kull, I.; Carlsen, K. C. Lodrup; Carlsen, K. -H.; Lambrecht, B. N.; Kogevinas, M.; Sunyer, J.; Kauffmann, F.; Bousquet, J.; Anto, J. M.

    2015-01-01

    BackgroundAsthma, rhinitis and eczema often co-occur in children, but their interrelationships at the population level have been poorly addressed. We assessed co-occurrence of childhood asthma, rhinitis and eczema using unsupervised statistical techniques. MethodsWe included 17209 children at 4years

  11. Multiple grass mixes as opposed to single grasses for allergen immunotherapy in allergic rhinitis.

    Science.gov (United States)

    Gangl, K; Niederberger, V; Valenta, R

    2013-11-01

    Grass pollen allergy affects approximately 40% of allergic patients. Subcutaneous allergen immunotherapy (SCIT) is the only allergen-specific and disease-modifying treatment available. Currently available therapeutic vaccines for the treatment of grass pollen allergy are based on natural grass pollen extracts which are either made from pollen of one cross-reactive grass species or from several related grass species. Clinical studies have shown that SCIT performed with timothy grass pollen extract is effective for the treatment of grass pollen allergy. Moreover, it has been demonstrated that recombinant timothy grass pollen allergens contain the majority of relevant epitopes and can be used for SCIT in clinical trials. However, recent in vitro studies have suggested that mixes consisting of allergen extracts from several related grass species may have advantages for SCIT over single allergen extracts. Here, we review current knowledge regarding the disease-relevant allergens in grass pollen allergy, available clinical studies comparing SCIT with allergen extracts from timothy grass or from mixes of several related grass species of the Pooideae subfamily, in vitro cross-reactivity studies performed with natural allergen extracts and recombinant allergens and SCIT studies performed with recombinant timothy grass pollen allergens. In vitro and clinical studies performed with natural allergen extracts reveal no relevant advantages of using multiple grass mixes as opposed to single grass pollen extracts. Several studies analysing the molecular composition of natural allergen extracts and the molecular profile of patients' immune responses after SCIT with allergen extracts indicate that the major limitation for the production of a high quality grass pollen vaccine resides in intrinsic features of natural allergen extracts which can only be overcome with recombinant allergen-based technologies.

  12. Measuring outcomes in allergic rhinitis: psychometric characteristics of a Spanish version of the congestion quantifier seven-item test (CQ7

    Directory of Open Access Journals (Sweden)

    Mullol Joaquim

    2011-03-01

    Full Text Available Abstract Background No control tools for nasal congestion (NC are currently available in Spanish. This study aimed to adapt and validate the Congestion Quantifier Seven Item Test (CQ7 for Spain. Methods CQ7 was adapted from English following international guidelines. The instrument was validated in an observational, prospective study in allergic rhinitis patients with NC (N = 166 and a control group without NC (N = 35. Participants completed the CQ7, MOS sleep questionnaire, and a measure of psychological well-being (PGWBI. Clinical data included NC severity rating, acoustic rhinometry, and total symptom score (TSS. Internal consistency was assessed using Cronbach's alpha and test-retest reliability using the intraclass correlation coefficient (ICC. Construct validity was tested by examining correlations with other outcome measures and ability to discriminate between groups classified by NC severity. Sensitivity and specificity were assessed using Area under the Receiver Operating Curve (AUC and responsiveness over time using effect sizes (ES. Results Cronbach's alpha for the CQ7 was 0.92, and the ICC was 0.81, indicating good reliability. CQ7 correlated most strongly with the TSS (r = 0.60, p Conclusions The Spanish version of the CQ7 is appropriate for detecting, measuring, and monitoring NC in allergic rhinitis patients.

  13. A randomized, double-blind, placebo-controlled exploratory study to evaluate the potential of pycnogenol for improving allergic rhinitis symptoms.

    Science.gov (United States)

    Wilson, Dale; Evans, Malkanthi; Guthrie, Najla; Sharma, Prachi; Baisley, Joshua; Schonlau, Frank; Burki, Carolina

    2010-08-01

    The potential of Pycnogenol for relieving allergic rhinitis (birch pollen) symptoms was explored in a double-blind, placebo-controlled trial. In 2008 19 subjects started treatment 3 weeks prior to the onset of birch pollen season in Ontario, Canada. While there was an improvement of eye and nasal symptoms with Pycnogenol, there was no significance versus placebo. It was postulated that Pycnogenol may require a lag-time between the start of therapy and the onset of action. Therefore 39 subjects were treated 5-8 weeks prior to the 2009 birch allergy season. The evaluation of subjects in 2009 showed much lower scores for eye (-35%) and nasal (-20.5%) symptoms with Pycnogenol compared with placebo. In succession of the allergy season birch specific IgE increased by 31.9% in the placebo group compared with only 19.4% in the Pycnogenol group. Detailed analysis suggested that symptom-relief was better the longer subjects were on Pycnogenol prior to the allergen exposure. The best results were found with subjects who took Pycnogenol 7-8 weeks ahead of the allergy season. With the limited number of 39 patients statistical predications were unattainable. In conclusion, Pycnogenol improved allergic rhinitis symptoms when supplementation was started at least 5 weeks before the onset of the allergy season.

  14. Noninterventional open-label trial investigating the efficacy and safety of ectoine containing nasal spray in comparison with beclomethasone nasal spray in patients with allergic rhinitis.

    Science.gov (United States)

    Sonnemann, Uwe; Möller, Marcus; Bilstein, Andreas

    2014-01-01

    Objectives. The current study aimed to compare the efficacy and safety of a classical anti-inflammatory beclomethasone nasal spray in comparison to a physic-chemical stabilizing ectoine containing nasal spray in the treatment of allergic rhinitis. Design and Methods. This was a noninterventional, open-label, observational trial investigating the effects of beclomethasone or ectoine nasal spray on nasal symptoms and quality of life. Over a period of 14 days, patients were asked to daily document their symptoms. Efficacy and tolerability were assessed by both physicians and patients. Results. Both treatments resulted in a significant decrease of TNSS values. An equivalence test could not confirm the noninferiority of ectoine treatment in comparison with beclomethasone treatment. Although clear symptom reduction was achieved with the ectoine products, the efficacy judgment showed possible advantages for the beclomethasone group. Importantly, tolerability results were comparably good in both groups, and a very low number of adverse events supported this observation. Both treatments resulted in a clear improvement in the quality of life as assessed by a questionnaire answered at the beginning and at the end of the trial. Conclusion. Taken together, it was shown that allergic rhinitis can be safely and successfully treated with beclomethasone and also efficacy and safety were shown for ectoine nasal spray.

  15. Valuing the Economic Costs of Allergic Rhinitis, Acute Bronchitis, and Asthma from Exposure to Indoor Dampness and Mold in the US

    Directory of Open Access Journals (Sweden)

    David H. Mudarri

    2016-01-01

    Full Text Available Two foundational methods for estimating the total economic burden of disease are cost of illness (COI and willingness to pay (WTP. WTP measures the full cost to society, but WTP estimates are difficult to compute and rarely available. COI methods are more often used but less likely to reflect full costs. This paper attempts to estimate the full economic cost (2014$ of illnesses resulting from exposure to dampness and mold using COI methods and WTP where the data is available. A limited sensitivity analysis of alternative methods and assumptions demonstrates a wide potential range of estimates. In the final estimates, the total annual cost to society attributable to dampness and mold is estimated to be $3.7 (2.3–4.7 billion for allergic rhinitis, $1.9 (1.1–2.3 billion for acute bronchitis, $15.1 (9.4–20.6 billion for asthma morbidity, and $1.7 (0.4–4.5 billion for asthma mortality. The corresponding costs from all causes, not limited to dampness and mold, using the same approach would be $24.8 billion for allergic rhinitis, $13.5 billion for acute bronchitis, $94.5 billion for asthma morbidity, and $10.8 billion for asthma mortality.

  16. 三联疗法治疗过敏性鼻炎疗效观察%Clinical observation on treating allergic rhinitis with the Sanlian therapy

    Institute of Scientific and Technical Information of China (English)

    张茂亮

    2013-01-01

    Allergic rhinitis is a common disease, sneezing, nasal itching, runny nose and nasal congestion are the four most common symptoms, usually caused by exposure to pollen, dust and cold air, often causing dizziness, headache, suffocation and other symptoms. Seriously affected daily life and work; and the disease easily relapse. The author used the Sanlian therapy to treat allergic rhinitis and achieved a more satisfactory outcome, reported as follows.%过敏性鼻炎是临床常见病之一,喷嚏、鼻痒、流涕和鼻塞是最常见的四大症状。多因接触花粉、尘土及冷空气等诱发,常引起头昏,头痛;憋气窒息等症状,严重影响日常生活和工作;且此病较易复发。笔者采用三联疗法治疗过敏性鼻炎,取得较满意疗效,报道如下。

  17. Noninterventional Open-Label Trial Investigating the Efficacy and Safety of Ectoine Containing Nasal Spray in Comparison with Beclomethasone Nasal Spray in Patients with Allergic Rhinitis

    Directory of Open Access Journals (Sweden)

    Uwe Sonnemann

    2014-01-01

    Full Text Available Objectives. The current study aimed to compare the efficacy and safety of a classical anti-inflammatory beclomethasone nasal spray in comparison to a physic-chemical stabilizing ectoine containing nasal spray in the treatment of allergic rhinitis. Design and Methods. This was a noninterventional, open-label, observational trial investigating the effects of beclomethasone or ectoine nasal spray on nasal symptoms and quality of life. Over a period of 14 days, patients were asked to daily document their symptoms. Efficacy and tolerability were assessed by both physicians and patients. Results. Both treatments resulted in a significant decrease of TNSS values. An equivalence test could not confirm the noninferiority of ectoine treatment in comparison with beclomethasone treatment. Although clear symptom reduction was achieved with the ectoine products, the efficacy judgment showed possible advantages for the beclomethasone group. Importantly, tolerability results were comparably good in both groups, and a very low number of adverse events supported this observation. Both treatments resulted in a clear improvement in the quality of life as assessed by a questionnaire answered at the beginning and at the end of the trial. Conclusion. Taken together, it was shown that allergic rhinitis can be safely and successfully treated with beclomethasone and also efficacy and safety were shown for ectoine nasal spray.

  18. Study of nasal exhaled nitric oxide levels in diagnosis of allergic rhinitis in subjects with and without asthma

    Science.gov (United States)

    Duong-Quy, Sy; Vu-Minh, Thuc; Hua-Huy, Thong; Tang-Thi-Thao, Tram; Le-Quang, Khiet; Tran-Thanh, Dinh; Doan-Thi-Quynh, Nhu; Le-Dong, Nhat-Nam; Craig, Timothy J; Dinh-Xuan, Anh-Tuan

    2017-01-01

    Background The measure of fractional exhaled nitric oxide (FENO) in the airways is a useful tool to guide the diagnosis and titration of inhaled corticosteroids in patients with asthma. However, its role in diagnosis of allergic rhinitis (AR), especially in subjects with asthma, is not well established. Objective To study the cutoff of nasal FENO in the diagnosis of subjects with AR and AR-asthma compared to age-matched subjects without AR or asthma and its correlations with the clinical and functional characteristics. Methods The study was cross sectional and descriptive. Subjects were grouped into control subjects, AR, and AR-asthma, based on the inclusion criteria. Exhaled NO (nasal FENO, bronchial FENO, and alveolar concentration of NO) was measured by multiple flow electro-luminescence device. Results Six hundred twenty-eight subjects were included: 217 control subjects (children: n=98, 10±4 years; adults: n=119, 50±16 years), 168 subjects with AR (children: n=54, 10±3 years; adults: n=114, 49±15 years), and 243 subjects with AR-asthma (children: n=115, 10±3 years; adults: n=128, 51±14 years). Nasal peak inspiratory flow and peak expiratory flow were lower in subjects with AR and AR-asthma than in control subjects (P<0.01 and P<0.01; and P<0.05 and P<0.01, respectively). Nasal FENO levels were significantly higher in subjects with AR and AR-asthma than in control subjects (1614±629 and 1686±614 ppb vs 582±161 ppb; P<0.001 and P<0.001, respectively). In subjects with AR non-asthma, the cutoffs of nasal FENO for those diagnosed with AR were 775 ppb in children, 799 ppb in adults, and 799 in the general population (sensitivity: 92.68%, 92.63%, and 92.65%, respectively; specificity: 91.67%, 95.00%, and 96.87%, respectively). In subjects with AR-asthma, the cutoffs of nasal FENO were higher, especially in asthma children (1458 ppb; sensitivity: 72.97% and specificity: 95.83%). Conclusion Nasal FENO measurement is a useful technique for the diagnosis of AR

  19. 'Help for Hay Fever', a goal-focused intervention for people with intermittent allergic rhinitis, delivered in Scottish community pharmacies: study protocol for a pilot cluster randomized controlled trial

    NARCIS (Netherlands)

    Porteous, T.; Wyke, S.; Smith, S.; Bond, C.; Francis, J.; Lee, A.J.; Lowrie, R.; Scotland, G.; Sheikh, A.; Thomas, M.; Smith, Lorraine

    2013-01-01

    BACKGROUND: Despite the availability of evidence-based guidelines for managing allergic rhinitis in primary care, management of the condition in the United Kingdom (UK) remains sub-optimal. Its high prevalence and negative effects on quality of life, school performance, productivity and co-morbid re

  20. Allergen-specific regulation of allergic rhinitis in mice by intranasal exposure to IgG1 monoclonal antibody Fab fragments against pathogenic allergen.

    Science.gov (United States)

    Matsuoka, Daiko; Mizutani, Nobuaki; Sae-Wong, Chutha; Yoshino, Shin

    2014-09-01

    Fab fragments (Fabs) have the ability to bind to specific antigens but lack the Fc portion for binding to receptors on immune and inflammatory cells that play a critical role in allergic diseases. In the present study, we investigated whether Fabs of an allergen-specific IgG1 monoclonal antibody (mAb) inhibited allergic rhinitis in mice. BALB/c mice sensitized by intraperitoneal injections of ovalbumin (OVA) plus alum on days 0 and 14 were intranasally challenged with OVA on days 28-30, and 35. Fabs prepared by the digestion of an anti-OVA IgG1 mAb (O1-10) with papain were also intranasally administered 15min before each OVA challenge. The results showed that treatment with O1-10 Fabs significantly suppressed the sneezing frequency, associated with decrease of OVA-specific IgE in the serum and infiltration by mast cells in the nasal mucosa seen following the fourth antigenic challenge; additionally, the level of mouse mast cell protease-1, a marker of mast cell activation, in serum was decreased. Furthermore, infiltration of eosinophils and goblet cell hyperplasia in the nasal mucosa at the fourth challenge were inhibited by treatment with O1-10 Fabs. In conclusion, these results suggest that intranasal exposure to Fabs of a pathogenic antigen-specific IgG1 mAb may be effective in regulating allergic rhinitis through allergen capture by Fabs in the nasal mucosa before the interaction of the intact antibody and allergen.

  1. The influence of lifestyle intervention on patients with allergic rhinitis%生活方式干预对过敏性鼻炎患者的影响

    Institute of Scientific and Technical Information of China (English)

    吴美芝; 揭桂莲; 吴凤玲

    2014-01-01

    目的:探讨生活方式干预对过敏性鼻炎患者的影响。方法将116例过敏性鼻炎患者随机分为实验组和对照组,每组各58例,对照组给予常规对症护理,实验组在对照组的基础上给予生活方式干预,采用生活方式情况评价表、治疗效果评价表对两组患者干预前、干预1年后的生活方式情况、治疗效果进行比较。结果与干预前比较,干预1年后实验组的生活方式情况、治疗效果明显优于对照组,差异有统计学意义( P<0.05)。结论生活方式干预有利于过敏性鼻炎患者建立健康的生活方式,提高治疗效果,从而进一步提高患者的生活质量。%Objective To investigate the influence of lifestyle intervention on patients with allergic rhinitis. Methods 116 cases with allergic rhinitis were randomly divided into the experimental group and the control group, each group had 58 cases, the control group was given general symptomatic care, the experimental group was given lifestyle intervention based on the control group, compared the lifestyle and clinical efficacy of the two groups before intervention and 1 year after intervention by lifestyle evaluation form and treatment evaluation form. Results Compared with before the intervention,the lifestyle and clinical efficacy of the experimental group were significantly better than the control group 1 year after intervention.The difference had statistically significant(P < 0.05). Conclusion It is conducive to lead a healthy lifestyle for patients with allergic rhinitis by lifestyle intervention, improve the therapeutic effect, thereby further improving the patients' life quality.

  2. Allergic Rhinitis Quiz

    Science.gov (United States)

    ... Education Center Fellows-in-Training Grants & Awards Program Directors Practice Resources ASTHMA IQ Consultation and Referral Guidelines Practice Financial Survey Practice Tools Running a Practice Statements and Practice Parameters About AAAAI Advocacy Allergist / Immunologists: ...

  3. [Rhinitis in adults].

    Science.gov (United States)

    Kalogjera, Livije

    2011-01-01

    Rhinitis is a very common disorder caused by inflammation or irritation of nasal mucosa. Dominant symptoms are nasal obstruction; however, in some patients, runny nose, excessive sneezing or nasal itch may be the most bothersome symptoms. The most common causes of nasal inflammation are viral infections and allergic response to airborne allergens. Response to irritants may cause similar symptoms, although signs of inflammation may not always be present. Viral rhinitis is lasting up to 10 days and it is part of the common cold syndrome. In short-lived rhinitis, lasting for 7 to 10 days, sometimes it is not easy to differentiate between the potential causes of the disorder, if general symptoms of infection like fever and malaise are not present. In long-living rhinitis, it is important to differentiate between infectious, allergic, non-allergic non-infectious rhinitis, and chronic rhinosinusitis. Itch and ocular symptoms are more common in allergic rhinitis, while other symptoms like nasal obstruction, rhinorrhea and sneezing may affect patients with allergic and non-allergic rhinitis. Patients with allergic rhinitis often have symptoms after exposure to irritants, temperature and humidity changes, like patients with non-allergic rhinitis, and such exposure may sometimes cause more severe symptoms than exposure to allergens. Sensitivity to a non-specific trigger is usually called non-specific nasal hyperreactivity. Allergic rhinitis occurs due to immunoglobulin E (IgE) interaction with allergen in contact with nasal mucosa in a sensitized patient. Sensitization to certain airborne allergen, like pollens, dust, molds, animal dander, etc. usually occurs in families with allergy background, which is helpful in making diagnosis in patients who have rhinitis in a certain period of the year, or aggravation of nasal symptoms occurs in the environment typical of certain allergen. The diagnosis is clinically confirmed by proving sensitivity to certain allergen on skin prick

  4. Alcohol consumption and the risk of self-reported perennial and seasonal allergic rhinitis in young adult women in a population-based cohort study

    DEFF Research Database (Denmark)

    Bendtsen, P; Grønbæk, M; Kjær, S. K.;

    2008-01-01

    Background Alcohol consumption has been suggested to be associated with the development of allergic rhinitis (AR), but there is limited data on the topic. Objectives The objective of this study was to investigate the association between alcohol consumption and the risk of developing AR among young...... associated with the risk of developing seasonal (OR, 2.01; 95% CI, 1.65-2.45) and perennial AR (OR, 2.28; 95% CI, 1.70-2.74). Smoking was not associated with an increased risk of developing AR. Conclusion In this population of young adult women, alcohol consumption was associated with an increased risk...... women. Methods Five thousand eight hundred and seventy Danish women aged 20-29 years participated in a prospective cohort study, and were free of seasonal and perennial AR at baseline (1991-1993). Alcohol consumption was assessed by a food frequency questionnaire. The main outcome measures were self...

  5. 活化嗜碱粒细胞在变应性鼻炎患者外周血中的表达%Expression of activated basophile in peripheral blood in patients with allergic rhinitis

    Institute of Scientific and Technical Information of China (English)

    张淳; 石嘉俪; 徐雅男; 王利民; 王家东

    2011-01-01

    目的 探讨嗜碱粒细胞在变应性鼻炎患者外周血中数量及活化率的变化及其临床意义.方法 以化学诱导趋向性受体单抗作为特异性的荧光标记,采用三色免疫荧光标记流式细胞术对20例急性发作期变应性鼻炎患者(急性组)、20例反复发作变应性鼻炎患者(慢性组)及30例健康者(对照组)的外周血嗜碱粒细胞及其活化率进行定量检测.结果 慢性组外周血化学诱导趋向性受体及嗜碱粒细胞高于急性组(P<0.01)和对照组(P<0.05),对照组高于急性组(P<0.01).慢性组与急性组嗜碱粒细胞活化率均高于对照组(P<0.01).结论 嗜碱粒细胞活化是导致变应性鼻炎症状出现的主要因素之一.慢性期患者嗜碱粒细胞的持续增高和活化可能与变应性鼻炎反复发作有关.%Objective To evaluate the number and the activation rate of basophile in peripheral blood in patients with allergic rhinitis and their clinical significance. Methods The chemoattractant receptor-homologus molecule expressed on T helper cells was used as a specific fluorescent marker. Twenty patients with acute allergic rhinitis, 20 patients with chronic allergic rhinitis and 30 healthy controls were evaluated the number and the activation rate of basophile in peripheral blood with three-color fluorescent flow cytometry analysis. Results The numbers of chemoattractant receptor-homologus molecule expressed on T helper cells and basophile were significantly larger in chronic allergic rhinitis group than those in acute allergic rhinitis group (P<0. 01) and normal group (P< 0. 05). The activation rate of basophile was significantly higher in acute allergic rhinitis and chronic allergic rhinitis group than that in control group(P<0. 01). Conclusion The activation of basophile is one of the main factors inducing the symptoms of allergic rhinitis. The continuous increase of the number and the activation rate of basophile may be involved in

  6. The effect of generalist and specialist care on quality of life in asthma patients with and without allergic rhinitis

    DEFF Research Database (Denmark)

    Harmsen, Lotte; Nolte, Hendrik; Backer, Vibeke

    2010-01-01

    Treatment of asthma and rhinitis patients is often provided by both generalists (GPs) and specialists (SPs). Studies have shown differences in clinical outcomes of treatment between these settings. The aim of this study was to evaluate the effect of GP and SP care on health-related quality of life...... (HRQoL)....

  7. The effect of generalist and specialist care on quality of life in asthma patients with and without allergic rhinitis

    DEFF Research Database (Denmark)

    Harmsen, Lotte; Nolte, Hendrik; Backer, Vibeke

    2010-01-01

    Treatment of asthma and rhinitis patients is often provided by both generalists (GPs) and specialists (SPs). Studies have shown differences in clinical outcomes of treatment between these settings. The aim of this study was to evaluate the effect of GP and SP care on health-related quality of life...

  8. Safety of sublingual immunotherapy Timothy grass tablet in subjects with allergic rhinitis with or without conjunctivitis and history of asthma

    DEFF Research Database (Denmark)

    Maloney, J; Durham, S; Skoner, D

    2015-01-01

    ). CONCLUSIONS: In the AR/C subjects with reported well-controlled mild asthma included in these studies, grass SLIT-tablet did not increase TEAE frequency, severe local allergic swelling, or systemic allergic reactions versus subjects without asthma. There was no indication that treatment led to acute asthma...

  9. 过敏性鼻炎患儿过敏原特异性IgE检测与临床意义%Detection of Specific IgE in Serum of Children with Allergic Rhinitis and Its Clinical Significance

    Institute of Scientific and Technical Information of China (English)

    王红; 楼金吐

    2012-01-01

    目的 了解过敏性鼻炎儿童主要过敏原分布情况及特点,以指导临床防治.方法 采用免疫印迹法体外定量检测患儿血清中特异性IgE抗体及20种常见过敏原.结果 938例过敏性鼻炎患儿中,100%至少对一种以上的过敏原呈阳性反应,其中487例患儿总IgE>400IU/Ml,230例患儿总IgE在200IU/ml~400IU/ml之间.在检测20种过敏原中以户尘螨和屋尘的阳性率最高(90.0%,80.8%).结论 过敏性鼻炎患儿至少有一种特异性IgE抗体显著增加,户尘螨、屋尘、动物皮屑、羊肉和牛奶是引起儿童过敏性鼻炎的主要过敏原.儿童在春秋温暖季节易发过敏性鼻炎.%Objective To investigate the main allergen distribution and characteristic in the children with allergic rhinitis, as to guide the clinical prevention and treatment. Methods 938 cases with allergic rhinitis used immune print detecting the special IgE antibody and twenty kinds of common allergen in serum. Results In 938 cases with allergic rhinitis there were a positive result for special allergen at least. Among them the total IgE of 487 cases were more than 400IU/ml, the total IgE of 230 cases were between 200 and 400 IU/ml. In 20 common allergen, the leading allergen was house dust and mite, the positive results were 90.0% and 80. 8%. Conclusion The children with allergic rhinitis were more than one kind positive of specific allergen. The main allergens for the children with allergic rhinitis were house dust, dust mite, pet skin scraps, mutton and milk etc. The Bpring and autumn season caused easily allergic rhinitis in children.

  10. Diagnosis and clinical characteristics of patients with non-allergic rhinitis%非变应性鼻炎的诊断及临床特征分析

    Institute of Scientific and Technical Information of China (English)

    王洪田; 张静; 尤少华; 奥彦云; 白银; 石怀银; 籍灵超; 贾婧杰; 张悦

    2014-01-01

    Objective To explore a step-by-step exclusive diagnosis and analyze the clinical characters of non-allergic rhinitis (NAR).Methods Patients with symptoms (nasal itching,sneezing,rhinorrhea,nasal congestion) were selected to take four-step exclusive diagnosis for NAR.The false NAR was eliminated and the true NAR was retained.First step was to exclude the patients who were not suitable for skin prick test (SPT,such as during pregnancy,breastfeeding,asthma,oral antihistamine medication in 7 day,severe skin diseases).The second step was to exclude the patients with positive SPT and the third step was to exclude the patients with 1 level or above of specific seroimmunoglobulin E (sIgE).The fourth step was to exclude the patients with infection rhinitis,clear abnormal nasal structure,drug-induced rhinitis,nasal neoplasm.The remained patients were finally diagnosed as NAR and who were further differential diagnosed as vasomotor rhinitis (VMR) or non-allergic rhinitis with eosinophilia syndrome (NARES) according to the eosinophilia counts in nasal secretion and venous blood.The common characters of patients with NAR were analyzed and their symptoms and quality of life were evaluated by visual analogue scale (VAS) and rhino-conjunctivitis quality of life questionnaire (RQLQ) separately.Results One thousand four hundred and thirty-seven patients were included after first step exclusion and 735 cases with negative SPT were remained after second step exclusion.Of 735 patients,302 were tested in vitro for sIgE and 93 cases with 0 level of sIgE and total IgE were remained after third step exclusion.Sixty-two patients were finally diagnosed as NAR after fourth step exclusion.The NAR diagnosis rate was 51.15% (735/1 437) with negative SPT alone and the NAR diagnosis rate was 29.06% (93/302) with combination of negative SPT and sIgE.Of 62 patients with NAR,47 patients (75.81%) were diagnosed as VMR and 15 cases (24.19%) as NARES.There were 23 males and 39 females in the 62

  11. A new era of targeting the ancient gatekeepers of the immune system: toll-like agonists in the treatment of allergic rhinitis and asthma.

    Science.gov (United States)

    Aryan, Zahra; Holgate, Stephen T; Radzioch, Danuta; Rezaei, Nima

    2014-01-01

    Toll-like receptors (TLR) belong to a large family of pattern recognition receptors known as the ancient 'gatekeepers' of the immune system. TLRs are located at the first line of defense against invading pathogens as well as aeroallergens, making them interesting targets to modulate the natural history of respiratory allergy. Agonists of TLRs have been widely employed in therapeutic or prophylactic preparations useful for asthma/allergic rhinitis (AR) patients. MPL® (a TLR4 agonist) and the CpG oligodeoxynucleotide of 1018 ISS, a TLR9 agonist, show strong immunogenicity effects that make them appropriate adjuvants for allergy vaccines. Targeting the TLRs can enhance the efficacy of specific allergen immunotherapy, currently the only available 'curative' treatment for respiratory allergies. In addition, intranasal administration of AZD8848 (a TLR7 agonist) and VTX-1463 (a TLR8 agonist) as stand-alone therapeutics have revealed efficacy in the relief of the symptoms of AR patients. No anaphylaxis has been so far reported with such compounds targeting TLRs, with the most common adverse effects being transient and local irritation (e.g. redness, swelling and pruritus). Many other compounds that target TLRs have been found to suppress airway inflammation, eosinophilia and airway hyper-responsiveness in various animal models of allergic inflammation. Indeed, in the future a wide variability of TLR agonists and even antagonists that exhibit anti-asthma/AR effects are likely to emerge.

  12. A review of clinical efficacy, safety, new developments and adherence to allergen-specific immunotherapy in patients with allergic rhinitis caused by allergy to ragweed pollen (Ambrosia artemisiifolia)

    Science.gov (United States)

    Turkalj, Mirjana; Banic, Ivana; Anzic, Srdjan Ante

    2017-01-01

    Allergic rhinitis is a common health problem in both children and adults. The number of patients allergic to ragweed (Ambrosia artemisiifolia) is on the rise throughout Europe, having a significant negative impact on the patients’ and their family’s quality of life. Allergen-specific immunotherapy (AIT) has disease-modifying effects and can induce immune tolerance to allergens. Both subcutaneous immunotherapy and sublingual immunotherapy with ragweed extracts/preparations have clear positive clinical efficacy, especially over pharmacological treatment, even years after the treatment has ended. AIT also has very good safety profiles with extremely rare side effects, and the extracts/preparations used in AIT are commonly well tolerated by patients. However, patient adherence to treatment with AIT seems to be quite low, mostly due to the fact that treatment with AIT is relatively time-demanding and, moreover, due to patients not receiving adequate information and education about the treatment before it starts. AIT is undergoing innovations and improvements in clinical efficacy, safety and patient adherence, especially with new approaches using new adjuvants, recombinant or modified allergens, synthetic peptides, novel routes of administration (epidermal or intralymphatic), and new protocols, which might make AIT more acceptable for a wider range of patients and novel indications. Patient education and support (eg, recall systems) is one of the most important goals for AIT in the future, to further enhance treatment success.

  13. 海南省蜉蝣过敏原临床致敏性%Allergenicity of Ephemeroptera Allergen in Allergic Rhinitis Patients of Hainan Province

    Institute of Scientific and Technical Information of China (English)

    孟光; 刘硕; 李春林; 谢伟伟; 张淑芳; 蔡琼香; 邓晓聪

    2011-01-01

    目的 了解海南省临床蜉蝣过敏情况,为过敏性鼻炎的流行病学研究及临床诊断、治疗和预防提供依据.方法 对500例过敏性鼻炎患者用蜉蝣过敏原进行前臂皮肤点刺试验,然后随机选择20例蜉蝣点刺阳性患者进行蜉蝣过敏原鼻黏膜激发试验.结果 500例皮肤点刺试验中,蜉蝣阳性者占58.6%(293/500),20例阴性对照者皮肤点刺均为阴性100%(20/20);20例蜉蝣皮肤点刺阳性患者中过敏原鼻黏膜激发试验阳性者为20例(100%),20例阴性对照未见阳性反应.结论 皮肤点刺和过敏原鼻黏膜激发试验结果相符合,蜉蝣为海南省重要过敏原.%Objective To investigate the allergenicity of Ephemeroptera allergen in allergic rhinitis (AR) patients of Hainan province, as a basis for epidemiological survey, clinical diagnosis, treatment and prevention. Methods 500 patients with allergic rhinitis were detected with Ephemeroptera allergen extract by skin prick test (SPT), and 20 cases of the SPT positive patients were chosen randomly to be prescribed the nasal provocation test. Allergen extract was produced by Beijing MacroUnion Pharmaceutical Co. ,Ltd. Results 293 cases in AR group showed positive SPT results; the positive rate was 58.6% (293/500). All the SPT results were negative in 20 cases in control group; the negative rate was 100% (20/20). All the nasal provocation test results were positive in 20 cases positive SPT patients, while all negative in 20 cases of control group. Conclusion The SPT results were shown to accord with the results of nasal provocation test. Ephemeropterais one kind of important inhalant allergens in Hainan province, which provide evidence as a basis for clinical diagnosis, treatment, prevention and specific immunotherapy in allergic disease patients in Hainan province.

  14. The Effectiveness of Levocetirizine in Comparison with Loratadine in Treatment of Allergic Rhinitis —A Meta-Analysis

    Directory of Open Access Journals (Sweden)

    Ralph Mösges

    2011-01-01

    Conclusions: The results of this meta-analysis illustrate greater effectiveness for treatment with the active substance levocetirizine as monotherapy in reducing allergic symptoms when compared to treatment with loratadine.

  15. Minnesota multiphasic personality inventory of patients with allergic rhinitis%变应性鼻炎患者心理人格特征研究

    Institute of Scientific and Technical Information of China (English)

    锡琳; 张伟; 赵岩; 张罗

    2011-01-01

    Objective To explore the relationship between allergic rhinitis(AR) and personality traits in nonpsychiatric population of allergic status. Methods Subjects were assigned to the allergic (84 cases) or nonallergic health group (37 cases) on the basis of skin prick test (SPT) and allergic symptoms. The psychological aspects of subjects were assessed by using the minnesota muliphasic personality inventory (MMPI). Results The allergic group scored higher than the nonallergic group on five clinical scales, hypochondriasis ( Hs ), depression ( D), hysteria ( Hy ), hypomania ( Ma ), social introversion ( Si ), and one research scale manifest aniety scale (Mas). The differences were significant ( t value was respectively 2. 169, 2.711, 2.010, 2.577, 2.390 and 2. 196, all P <0.05). In addition, the grade of resultant skin wheal was positively correlated with T scores on the Hs, Hy, psychopathic deviance (Pd) and psychasthenia ( Pt ). The r value was 0. 366, 0. 449, 0. 345 and 0. 355 respectively ( all P < 0. 05 ).Conclusion Subjects with AR show poorer psychological functioning, indicating the close relationship between AR and psychological status.%目的 探讨变应性鼻炎(allergic rhinitis,AR)患者的基本心理人格特征.方法 应用明尼苏达多相个性调查表(minnesota muliphasic personality inventory,MMPI)分析84例AR患者和37例健康对照者的心理人格特征.结果 AR患者在疑病量表(hypochondriasis,Hs)、抑郁量表(depression,D)、癔病量表(hysteria,Hy)、轻躁狂量表(hypomania,Ma)、社会内向量表(social introversion,Si)5个临床量表T分和外显焦虑量表(manifest aniety scale,Mas)T分明显高于健康对照(t值分别为2.169、2.711、2.010、2.577、2.390、2.196,P值均<0.05).皮肤点刺风团等级与Hs、Hy、精神病态量表(psychopathic deviance,Pd)、精神衰弱量表(psychasthenia,Pt)的T分呈正相关(r值分别为0.366、0.449、0.345、0.355,P值均<0.05),风团直径越大患者Hs、Hy、Pd

  16. ANALYSIS OF CONDITION CONTROL IN ASTHMA PATIENTS WITH ALLERGIC RHINITIS%合并变应性鼻炎的支气管哮喘病情控制分析

    Institute of Scientific and Technical Information of China (English)

    陈海珍; 郭百凌; 张建霞; 张金春; 焦方刚

    2012-01-01

    [目的]分析合并变应性鼻炎的支气管哮喘患者病情控制情况和肺通气功能.[方法]对入选的无其他心肺疾病、糖尿病和职业病的住院支气管哮喘患者,分单纯支气管哮喘组(单纯哮喘组)和合并变应性鼻炎组(鼻炎组)两组,进行病例对照研究,以问卷形式调查哮喘控制情况,以肺功能仪测定肺活量(VC)、一秒呼气/用力肺活量(FEV1%)和最大分钟通气量(MVV),建立个人数据库,对数据进行统计分析.[结果]275例支气管哮喘患者中鼻炎组126例,占45.8%,其发作频率、近1年住院次数和每次住院天数均高于单纯哮喘组,且差异有统计学意义(P<0 05);哮喘控制测试分值差于单纯哮喘组,且差异有统计学意义(P<0 05);鼻炎组VC、FEV1%和MVV均低于单纯哮喘组,差异有统计学意义(P<0.05).[结论]变应性鼻炎的控制情况影响支气管哮喘的发作和肺通气功能,临床工作中要高度重视支气管哮喘患者有无合并变应性鼻炎并规范化治疗.%[ObjeCtive] To analyze condition control and lung function in asthma patients with allergic rhinitis. [Meth-ods] A total of 275 aslhma patients admitted to hospital without cardiopulmonaiy disease, diabetes and occupational disease. Cases of asthma were classified as asthma and asthma with allergic rhinitis and their characteristics were compared. The ques-tionnaire survey was carried out, values of vital capacity (VC), forced expiratory volume in 1 second (FEV1%) and maximal ventilatory volume/minute (MVV) were obtained by measurements of lung function, and demographic and clinical data were collected and analyzed. [Results] Allergic rhinitis occurred in 126 (45.8%) of asthma patients. Aslhma patients with allergic rhinitis presented higher frequency of asthma, experienced more hospitalizalions in a year and longer hospital days than asthma patients without allergic rhinitis, with poorer scores in asthma control (P < 0.05). The lung

  17. Increase in the prevalence of rhinitis among Danish children from 1986 to 2001

    DEFF Research Database (Denmark)

    Håkansson, K; Thomsen, SF; Ulrik, Charlotte Suppli;

    2007-01-01

    .001). The increase was most pronounced among subjects who suffered from non-allergic rhinitis (p history of asthma and parental atopic disease were...... strong predictors of non-allergic rhinitis, whereas a history of asthma, parental atopic disease, bronchial hyperresponsiveness, eczema, and age at examination were statistically significant predictors of allergic rhinitis. The prevalence of non-allergic rhinitis among Danish children has increased...

  18. 变应性鼻炎与IRF5的单核苷酸多态性关系%Study on IRF5 polyMorphism in Patients with Allergic Rhinitis

    Institute of Scientific and Technical Information of China (English)

    冯会杰; 李文秀; 白素娟; 王德云

    2013-01-01

    Objective:To investigate the relationship oflRF5 polymorphism and allergic rhinitis.Methods:Three independent single nucleotide polymorphisms (SNP) were analyzed.The genotype and allele frequencies were detected in 110 allergic rhinitis patients and 101 health controls by polymerase chain reaction (PCR) and restriction fragment length polymorphism (RFLP).Results:No statistically significant difference was detected between allergic rhinitis and controls (all P-value > 0.05).Conclusion:No association was observed between 1RF5 and allergic rhinitis in Singapore Chinese population.%目的:探讨变应性鼻炎与干扰素调节因子5(IRFS)的单核苷酸多态性(SNP)的相关性.方法:采用聚合酶链(PCR)和限制性片段长度多态性(RFL P)方法在新加坡华人中检测110例变应性鼻炎患者及101健康对照组IRF5位点上的3个单核苷酸多态性(rs4728142,rs11770589,rs2280714)计算基因型和等位基因频率.结果:IRF5基因的3个位点的基因型和等位基因频率在变应性鼻组和对照组间差异无统计学意义.结论:新加坡华人IRF5 rs4728142,rsl1770589,rs2280714多态性与变应性鼻炎无明显相关性.

  19. 捏脊配合针刺在瑞士治疗过敏性鼻炎58例%Fifty-eight cases of allergic rhinitis treated with chiropractic and acupuncture in Switzerland

    Institute of Scientific and Technical Information of China (English)

    高军; 韩景献; ZHANG Yi

    2010-01-01

    @@ Allergic rhinitis (AR) pertains to anaphylaxis in biomedicine while to the domain of "Bigiu"(鼻鼽)in Chinese medicine with the main symptoms of rhinocnesmus, sneezing, thin nasal discharge and nasal obstruction.The disease is often persistent with high ratio of recurrent attacks.Specific medicine or methods for the radical treatment are still not available.However, great progress on treatment of AR with acupuncture has been made in recent 10 years.

  20. Effect of a thromboxane A2 receptor antagonist ramatroban (BAY u 3405, on inflammatory cells, chemical mediators and non-specific nasal hyperreactivity after allergen challenge in patients with perennial allergic rhinitis

    Directory of Open Access Journals (Sweden)

    Nobuhisa Terada

    1998-01-01

    Full Text Available In some clinical studies performed in patients with perennial allergic rhinitis, ramatroban, a new thromboxane A2 receptor antagonist, significantly improved nasal symptoms. As yet the mechanism of action of this drug has not been fully elucidated. In the present study we investigated the effects of ramatroban on changes in nasal reactivity and levels of inflammatory cells and mediators in nasal lavage fluid after allergen challenge. Ramatroban was administered orally at a daily dose of 150 mg (b.i.d. for 4 weeks to 11 patients with perennial allergic rhinitis exhibiting positive responses to nasal allergen challenge with house dust mite. Analysis of variance revealed that there was a significant decrease in eosinophil counts and eosinophil cationic protein levels in nasal lavage fluid when compared with values immediately before allergen challenge before and after ramatroban treatment. Histamine, tryptase and albumin levels were significantly decreased in analysis of variance before and after ramatroban treatment. The degree of nasal reactivity to histamine was also significantly decreased after the ramatroban treatment. These findings indicate that ramatroban decreases important pathogenic factors in allergic rhinitis, resulting in an improvement in nasal symptoms.

  1. La estria supranuclear de las células ciliadas en la rinitis alérgica Supranuclear stria of ciliated cells in allergic rhinitis

    Directory of Open Access Journals (Sweden)

    Ana Zerdiew

    2007-08-01

    Full Text Available Se estudiaron 80 pacientes adultos alérgicos, que cursaron con los siguientes cuadros clínicos: 16 casos de rinitis intermitente y 64 de rinitis persistente. Se realizó el recuento porcentual de la estría supranuclear de las células ciliadas, respecto de los leucocitos presentes en los extendidos obtenidos por toma endonasal. Con los datos obtenidos se clasificaron los extendidos en 4 grupos; Grupo A (N=23: predominio leucocitario eosinófilo con eosinofilia nasal >10%, Grupo B (N=15: abundantes leucocitos neutrófilos y eosinofilia nasal >10%, Grupo C (N=29: con escasos leucocitos, Grupo D (N=13: con abundantes leucocitos de predominio neutrófilo sin eosinofilia. Se observó que el incremento porcentual de estría supranuclear se correlacionó con eosinofilia nasal >10% y con las muestras que presentaron escasos leucocitos. Sin embargo se evidenció una marcada disminución del porcentaje de estría supranuclear en la leucocitosis neutrófila de etiología bacteriana.Nasal secretions were studied in 80 allergic adults patients: 16 with intermittent rhinitis and 64 with persistent rhinitis. The percentage of supranuclear stria of ciliated cells with regard to leucocytes was studied by nasal scraping. Four groups of patients were classified according to nasal leucocytic predominance: patients with eosinophilic predominance with eosinophils > 10% in Group A (N=23, patients with abundant neutrophils and eosinophils >10% in Group B (N=15, patients with scant leucocytes in Group C (N=29, patients with neutrophilic predominance without eosinophils in Group D (N=13. An increase of supranuclear stria percentage was correlated to eosinophils > 10% and also correlated to scant leucocytes. Nevertheless, a significant decrease of supranuclear stria percentage was observed in neutrophilic leukocytosis of bacterial etiology.

  2. 预防性治疗季节性变应性鼻炎临床研究%Clinical study of prophylactic treatment of seasonal allergic rhinitis

    Institute of Scientific and Technical Information of China (English)

    罗超; 刘巧平; 刘建华; 闫占峰; 周蕾; 矫璐璐; 巩政; 耿燕

    2016-01-01

    目的:观察预防性治疗季节性变应性鼻炎(AR)的疗效。方法选择变应原为蒿属花粉的中-重度持续性 AR 患者60例,随机分为预防性治疗组(以下简称治疗组)及对照组各30例,治疗组在花粉季开始前2周口服中药进行预防性治疗,对照组不予干预。花粉季开始后,2组患者均口服中药治疗6周。随访观察并记录2组患者流涕、鼻痒、喷嚏、鼻塞、眼痒症状评分及鼻部体征,并定期采用鼻结膜炎相关生活质量问卷评价 AR 对生活质量的影响。结果在花粉季高峰时治疗组流涕、鼻痒、鼻塞症状评分及 RQLQ 评分均轻于对照组,差异具有统计学意义(P <0.01)。整个花粉季期间,治疗组眼痒症状轻于对照组,差异具有统计学意义(P <0.01);治疗组鼻部体征总体程度轻于对照组,差异具有统计学意义(P <0.05)。结论花粉季前2周预防性治疗秋季蒿属花粉过敏的 AR 患者,可有效缓解患者临床症状,提高生活质量。%Objective To investigate the effect of prophylactic treatment on seasonal allergic rhinitis (AR).Methods 60 patients with moderate-severe persistent allergic rhinitis based on mugwort allergen were randomly divided into two groups,with 30 cases each in prophylactic group and control group re-spectively.Patients in prophylactic group were treated with traditional Chinese medicine 2 weeks before pollen season,and control group was given no treatment.At the beginning of pollen season,two groups accepted traditional Chinese medicine for 6 weeks.The symptom score of nose and eye was recorded by using a visual analogue scale.The quality of life was evaluated by rhinoconjunctivitis quality of life ques-tionnaire (RQLQ)periodically.Results In the peak pollen season,the symptom scores of nasal con-gestion,nasal itching,eye itching and nasal signs were significantly lower in the prophylactic group than those in the

  3. Allergic rhinitis is a local disease: the role of local IgE production, basophils and mast cells

    NARCIS (Netherlands)

    A. Kleinjan (Alex)

    2002-01-01

    textabstractThe introduction to this thesis summarizes the literature which indicates that there is a discrepancy between sensitisation and allergic disease. Two aspects which might play a role in this discrepancy are the differences between production and funtion of local versus systemic lgE and th

  4. Effect of Local Nasal Immunotherapy on Nasal Blockage in Pollen-Induced Allergic Rhinitis of Guinea Pigs

    Directory of Open Access Journals (Sweden)

    Takeshi Nabe

    2008-01-01

    Conclusions: Local nasal immunotherapy may be clinically useful for allergic nasal blockage associated with nasal hyperresponsiveness. The mechanisms responsible for this effectiveness might not be related to IgE production. Additionally, the effectiveness for nasal tissue was dissociated from that seen for the ocular tissue.

  5. Analyzing of the inhaled allergens profiles of 890 allergic rhinitis patients%上海地区890例变应性鼻炎患者吸入变应原谱分析

    Institute of Scientific and Technical Information of China (English)

    丁俊杰; 张建华; 许芳; 徐颖; 朱华斌

    2012-01-01

    目的:了解上海地区变应性鼻炎患者吸入变应原分布情况,为该地区变应性鼻炎的流行病学研究和防治方案提供依据.方法:回顾分析890例门诊变应性鼻炎患者对13种吸入变应原进行皮肤点刺试验的临床资料,并比较不同年龄段及不同性别对吸入变应原阳性率的差异.结果:在上海地区变应性鼻炎患者中,最主要的吸入性变应原是屋尘螨(91.24%)、粉尘螨(86.58%)、热带螨(51.98%);其次是狗毛(15.96%),并且阳性率随年龄的增长有明显下降趋势,男女性别组间阳性率无明显差别.结论:屋尘螨、粉尘螨是上海地区变应性鼻炎最常见的变应原,变应原点刺试验有助于发现变应原,从而为脱敏治疗提供重要依据.%Objective:To investigate the inhaled allergens spectrum of 890 allergic rhinitis patients in Shanghai, and to provide basic epidemiologic information for the prevention and treatment of allergic rhinitis. Method: Thirteen allergens skin prick test results of 890 allergic rhinitis patients recruited were retrospectively analyzed. Result: The main common inhaled allergens in allergic rhinitis patients in Shanghai were house dust mite (91. 24%),dermatophagoides farinae(86. 58%) , tropical mite(51. 98%),dog hair(15. 96%). Moreover, the positive frequency was decreased with age increasing, and gender group had no obvious difference. Conclusioni House dust mite and dermatophagoides farinae were the main allergens of allergic rhinitis patients in Shanghai. Skin prick test is helpful for the discovery of the allergens so as to provide important basis of immunotherapy.

  6. Analyzing of the inhaled allergens profiles of 583 allergic rhinitis patients in district of QingPu%青浦地区变应性鼻炎患者吸入变应原检测分析

    Institute of Scientific and Technical Information of China (English)

    陈国辉; 白广平; 王丽英

    2012-01-01

    Objective To investigate the profiles of inhaled allergic rhinitis patients in district of Qingpu,and to provide basic epidetniologic information for the prevention and treatment of allergic rhinitis in this area.Methods Retrospectively analyze 14 allergens Skin prick test results of 583 allergic rhinitis patients recruited. Results the main common inhaled allergens in allergic rhinitis patients in QingPu were house dust mite(72.6%),dermatophagoides farinae(68.8%),tropical mite(41.3%),dog hair(12.7%),Moreover,the positive frequency was decreased with age increasing. Conclusion House dust mite and dermatophagoides farinae were the most common allergens in allergic rhinitis patients in QingPu area SPT is help&l for the discovery of the allergens so as to provide important basis of immunotherapy.%目的 了解青浦地区变应性鼻炎患者吸入变应原分布情况,为青浦地区变应性鼻炎的流行病学研究和防治提供重要依据.方法 回顾分析583例变应性鼻炎患者对14种吸入变应原进行皮肤点刺试验的临床资料,并比较两组年龄段及吸入变应原阳性率在分布上的差异.结果 在青浦地区变应性鼻炎患者中,最主要的吸入变应原是屋尘螨(72.6%)、粉尘螨(68.8%)、热带螨(41.3%),其次是狗毛(12.7%),并且阳性率随年龄的增长有明显下降趋势.结论屋尘螨、粉尘螨是青浦地区变应性鼻炎最常见的变应原.皮肤点刺试验(Skin Prick Test,SPT)有助于发现变应原,为免疫治疗提供重要依据.

  7. Development and validation of a 5-day-ahead hay fever forecast for patients with grass-pollen-induced allergic rhinitis.

    Science.gov (United States)

    de Weger, Letty A; Beerthuizen, Thijs; Hiemstra, Pieter S; Sont, Jacob K

    2014-08-01

    One-third of the Dutch population suffers from allergic rhinitis, including hay fever. In this study, a 5-day-ahead hay fever forecast was developed and validated for grass pollen allergic patients in the Netherlands. Using multiple regression analysis, a two-step pollen and hay fever symptom prediction model was developed using actual and forecasted weather parameters, grass pollen data and patient symptom diaries. Therefore, 80 patients with a grass pollen allergy rated the severity of their hay fever symptoms during the grass pollen season in 2007 and 2008. First, a grass pollen forecast model was developed using the following predictors: (1) daily means of grass pollen counts of the previous 10 years; (2) grass pollen counts of the previous 2-week period of the current year; and (3) maximum, minimum and mean temperature (R (2)=0.76). The second modeling step concerned the forecasting of hay fever symptom severity and included the following predictors: (1) forecasted grass pollen counts; (2) day number of the year; (3) moving average of the grass pollen counts of the previous 2 week-periods; and (4) maximum and mean temperatures (R (2)=0.81). Since the daily hay fever forecast is reported in three categories (low-, medium- and high symptom risk), we assessed the agreement between the observed and the 1- to 5-day-ahead predicted risk categories by kappa, which ranged from 65 % to 77 %. These results indicate that a model based on forecasted temperature and grass pollen counts performs well in predicting symptoms of hay fever up to 5 days ahead.

  8. Prevalence of sensitivity to cockroach allergens and IgE crossreactivity between cockroach and house dust mite allergens in Chinese patients with allergic rhinitis and asthma

    Institute of Scientific and Technical Information of China (English)

    SUN Bao-qing; LAI Xu-xin; Birgitte Gjesing; Michael Dho Spangfort; ZHONG Nan-shan

    2010-01-01

    Background Cockroaches are an important indoor allergen source causing allergic rhinitis and asthma. The aim of this study was to investigate the cockroach prevalence in mainland of China and the cross-reactivity of IgE between cockroach and house dust mite allergen in Chinese patients.Methods The cockroach sensitization pattern was based on a skin prick test (SPT) obtained from a national multicenter prevalence study, in which 6304 patients from 25 allergy centers across China participated. Factors, including different regions of China, age, gender and the correlations between the American and German cockroaches and house dust mite Der p were investigated. Eighteen out of 1236 clinical sera from south China were selected to perform the cross-inhibition assay between house dust mites and cockroaches.Results Totally 25.7% of patients were SPT positive to the American cockroach (Periplaneta Americana, Per a) and 18.7% SPT positive to the German cockroach (Blattella germanica, Bla g). The prevalence of positive cockroach SPT was higher in southern than in northern China, higher in adults than in children, and higher in males than in females.Patients had relatively low levels of cockroach SPT reactions, mainly class 1 or 2. Of the SPT positive cockroach patients,88% were also SPT positive to house dust mite (Dermatophagoides pteronyssinus, Der p). An IgE cross-inhibition study confirmed that Der P sensitization could cause false positive SPT reactions against cockroach.Conclusions A relatively high prevalence of cockroach sensitivity was found in mainland of China. However, a cross-inhibition study showed that only a small number of patients appear to have Bla g and/or Per a as primary sensitizing source. The importance of cockroaches as a risk factor for sensitization and triggers of allergic symptoms in mainland of China needs to be further investigated.

  9. Allergic rhinitis and difficult asthma%治疗支气管哮喘必须同时兼顾过敏性鼻炎

    Institute of Scientific and Technical Information of China (English)

    何权瀛

    2004-01-01

    @@ 2001年由世界各国专家制定了过敏性鼻炎及其对哮喘的影响(allergic rhinitis and its impact onasthma,ARIA)指南[1],并成为世界卫生组织(WHO)创议的一部分,其中建议临床医生(包括呼吸科、耳鼻咽喉及变态反应科医生)对于支气管哮喘和过敏性鼻炎进行联合治疗和管理.目前对于上述两种疾病之间的关系已取得共识,即所谓"一个气道,一种疾病".Van Cauwenberge教授等[2]认为,变态反应性疾病其实是一种全身性疾病,如过敏性鼻炎与渗出性中耳炎、鼻息肉、上呼吸道感染、哮喘彼此相互关联(图1),他们估计80%的哮喘患者有过敏性鼻炎症状,而大约30%的过敏性鼻炎患者合并哮喘.

  10. Nasal sodium cromoglycate (Lomusol) modulates the early phase reaction of mild to moderate persistent allergic rhinitis in patients mono-sensitized to house dust mite: a preliminary study.

    Science.gov (United States)

    Lejeune, Margaux; Lefebvre, Philipe P; Delvenne, Philippe; El-Shazly, Amr E

    2015-05-01

    We evaluated the clinical improvement of patients with mild to moderate persistent allergic rhinitis (AR) due to mono-sensitization to house dust mite (HDM) allergen, by sodium cromoglycate nasal spray (Lomusol 4%). Lomusol was used as a single agent treatment, and its anti-inflammatory effects, in the early phase reaction were evaluated. Herein we showed that Lomusol significantly improved the subjective nasal symptom scores especially nasal obstruction. This was associated with significant and specific reduction in neutrophils influx in nasal cytology but had no effect on other cell types. This selective anti-inflammatory effect on nasal cytology was associated with significant reduction in the levels of platelet activating factor (PAF) and histamine in nasal secretions but had no effect on PGD2, LTC4 or CysLt levels. Lomusol was also able to induce significant reduction in eosinophil cationic protein (ECP) levels in nasal secretions without altering the percentage of eosinophil influx in nasal cytology. Taken collectively, we showed the first evidence that nasal sodium cromoglycate possesses a selective inhibition on neutrophil recruitment into nasal cytology in the early phase reaction of AR patients mono-sensitized to HDM. This may be attributed to the ability of Lomusol to significantly reduce the amount of PAF recovered in nasal secretion. These results were associated with significant improvement in subjective symptom scores especially nasal obstruction that may in addition, be due to the ability of Lomusol to down-regulate eosinophil degranulation activity as well.

  11. Angiotensin-converting enzyme insertion/deletion polymorphism and susceptibility to allergic rhinitis in Chinese populations: a systematic review and meta-analysis.

    Science.gov (United States)

    Huang, Ruo-Fei; Dong, Pin; Zhang, Tian-Zhen; Ying, Xin-Jiang; Hu, Hua

    2016-02-01

    In view of the controversies surrounding the angiotensin-converting enzyme (ACE)-allergic rhinitis (AR) association, a systematic review and meta-analysis of the ACE genetic association studies of AR was performed in Chinese populations. PubMed, Springer Link, OvidSP, Chinese biomedical database, Chinese national knowledge infrastructure, Chinese VIP and Wanfang databases were searched for related studies. A total of 4 studies including 415 AR patients and 309 controls were involved in this meta-analysis. Overall, significant association was found between ACE I/D polymorphism and AR risk when all studies in Chinese populations pooled into the meta-analysis (allele, OR 1.50, 95 % CI 1.19-1.90; homozygous, OR 2.59, 95 % CI 1.52-4.41, recessive, OR 2.05, 95 % CI 1.27-3.32). In the subgroup analysis by ethnicity, ACE I/D polymorphism was associated with significant elevated risks of AR in Chinese Han under homozygous and recessive models (homozygous, OR 4.36, 95 % CI 1.76-10.82, recessive, OR 2.51, 95 % CI 1.18-5.34). In conclusion, this meta-analysis provides the evidence that ACE I/D polymorphism may contribute to the AR development in Chinese populations and studies with large sample size and wider spectrum of population are warranted to verify this finding.

  12. miR-143 inhibits interleukin-13-induced inflammatory cytokine and mucus production in nasal epithelial cells from allergic rhinitis patients by targeting IL13Rα1.

    Science.gov (United States)

    Teng, Yaoshu; Zhang, Ruxin; Liu, Chunhui; Zhou, Lingling; Wang, Hong; Zhuang, Wenjie; Huang, Yu; Hong, Zhicong

    2015-01-30

    Allergic rhinitis (AR) is a common chronic inflammatory condition of the nasal mucosal tissue. The interleukin-13 (IL-13) signaling pathway is of great importance in the pathogenesis of AR. However, how the signaling molecules in this pathway are regulated, particularly through microRNAs (miRNAs), remains unclear. In the present study, we investigated the regulatory role and mechanism of miRNA-143 (miR-143) in IL-13-induced inflammatory cytokine and mucus production in nasal epithelial cells (NECs) from AR patients. Our results showed that forced expression of miR-143 significantly decreased the mRNA and protein expression levels of granulocyte-macrophage colony-stimulating factor (GM-CSF), eotaxin and mucin 5AC (MUC5AC) in IL-13-stimulated NECs. Moreover, we confirmed that miR-143 directly targeted and significantly suppressed IL-13 receptor α1 chain (IL13Rα1) gene expression. This study thus suggests that miR-143 regulation of IL-13-induced inflammatory cytokine and mucus production in NECs from AR patients probably partly depends on inhibition of IL13Rα1. Therefore, the IL13Rα1 signaling pathway may be a potential target for the prevention and treatment of AR by miR-143.

  13. Progress in diagnosis and treatment of children combined allergic rhinitis and asthma syndrome%儿童过敏性鼻炎-哮喘综合征诊治进展

    Institute of Scientific and Technical Information of China (English)

    郭茹茹

    2014-01-01

    过敏性鼻炎和支气管哮喘是儿童常见的呼吸道过敏性疾病,发病率逐年上升.既往认为两者是完全独立的疾病,而近年的研究表明两者从病因学、发病机制、病理学变化以及治疗方面高度相似,故提出“过敏性鼻炎-哮喘综合征”这一新的概念,是指同时发生临床或亚临床的过敏性鼻炎和支气管哮喘症状,二者需整体看待,进行联合诊断和治疗,从而极大程度减少了误诊,并减少药物的重复使用,提高临床疗效.该文就儿童过敏性鼻炎-哮喘综合征诊治进展作一综述.%Allergic rhinitis and bronchial asthma are two common respiratory allergic diseases in children and the incidence of the two diseases is increasing.They are regarded as mutually separate diseases,but recent studies suggest that there is a strong link between the two diseases,which is represented at the etiology,mechanisms,pathologic and therapeutic levels.So combined allergic rhinitis and asthma syndrome (CARAS),a new terminology has formally introduced to illustrate concurrent symptoms of allergic rhinitis and bronchial asthma.The diagnosis and treatment of CARAS need to be considered collectively.Therefore the incidence of misdiagnosis and repeated use of drugs can be significantly reduced,then improving the clinical efficacy.This article reviews progress of the diagnosis and treatment of CARAS in children.

  14. Análise de citocinas pela RT-PCR em pacientes com rinite alérgica RT-PCR cytokine study in patients with allergic rhinitis

    Directory of Open Access Journals (Sweden)

    Tarcimara Moreira da Silva

    2009-02-01

    Full Text Available Rinite alérgica é uma doença que decorre de um processo inflamatório da mucosa nasal conseqüente à reação de hipersensibilidade a alérgenos inalatórios e, eventualmente, alimentares. É mediada por IgE, envolvendo diferentes células, mediadores e citocinas. OBJETIVO: Avaliar as transcrições para as seguintes citocinas: IL-4, IL-5, IL-8 e IFN-gama, particularmente importantes no processo alérgico nasal, principalmente IL-4 e IL-5. Neste estudo, optou-se por avaliar os pacientes atópicos fora das crises alérgicas, com a finalidade de se conhecer as expressões das citocinas neste período. MATERIAL E MÉTODO: Realizou-se um estudo transversal e prospectivo, selecionando-se 30 pacientes, sendo 13 pacientes portadores de rinite alérgica paucissintomáticos e 17 pacientes não-atópicos. Os grupos foram selecionados através da história, do exame clínico otorrinolaringológico e do teste alérgico cutâneo - Prick Test. O perfil das citocinas foi pesquisado nos fragmentos de mucosa nasal, através da RT-PCR semiquantitativa, escolhida por apresentar boa reprodutibilidade e especificidade, utilizando-se como referência o gene da Beta-actina. RESULTADOS: Os valores de IL-5, IL-8, IFN-gama mantiveram-se homogêneos em relação ao grupo controle. A IL-4 apresentou diferença com significância estatística. CONCLUSÃO: Os pacientes alérgicos paucissintomáticos apresentaram normalização da expressão das citocinas na mucosa nasal à exceção de IL-4.Allergic rhinitis is an inflammatory reaction of the nasal mucosa, in consequence of an IgE mediated hypersensitive reaction to inhaling allergens, involving different mediators and cytokine cells. AIM: The purpose of this study was to evaluate the transcriptions for IL-4, IL-5, IL-8 and IFN-gama, particularly important in the nasal allergy process, especially IL-4 and IL-5. For this study we decided to evaluate atopic patients who were free from allergic crises, with the purpose of

  15. 云南保山地区变应性鼻炎花粉变应原调查分析%Investigation on Pollen Allergen in Patients with Allergic Rhinitis in Baoshan, Yunnan

    Institute of Scientific and Technical Information of China (English)

    杨国宁; 李明华; 马亚

    2016-01-01

    Objective:To investigate the distribution of pollen allergens in patients with allergic rhinitis(AR)in Baoshan, Yunnan, and to offer basis for the diagnosis, prevention and treatment. Methods:980 allergic rhinitis were examined by skin prick test(SPT) with 15 kinds of pollen antigen extract of allergic rhinitis. Results: Among 980 cases, 269 cases(27.4%)were detected with one antigen, 460 cases(46.9%)were detected with two or more antigens. The main common pollen allergens in patients with allergic rhinitis in Baoshan were 348 cases of Gramineae (35.5%), 310 cases of aestivo-autumnal (31.6%), 251 cases of Chinese ash (25.6%), 2 cases of sakura(0.2%)which is the least one. Positive rate of pollen allergens were different between youngsters group and middle-aged group. Conclusion:Gramineae, stivo-autumnal and Chinese ash were the main pollen allergens of allergic rhinitis in Baoshan. Most patients with allergic rhinitis were allergic to two or more kinds of pollen allergens. Skin prick test(SPT)is helpful for the discovery of the allergens so as to provide important basis of desensitization therapy.%目的:了解保山地区变应性鼻炎患者花粉变应原分布情况,为变应性鼻炎的诊断、预防和治疗提供依据。方法:采用15种花粉变应原提取液对980例变应性鼻炎的患者进行皮肤皮内试验。结果:980例患者中,检出1种变应原阳性者269例(27.4%),检出2种及2种以上变应原阳性者460例(46.9%),主要的花粉变应原是禾本科348例(35.5%)、夏秋310(31.6%)、白蜡树251(25.6%),最少的是樱花,2例(0.2%)。年龄不同,变应原阳性率也不同。结论:禾本科、夏秋、白蜡树是保山地区变应性鼻炎最常见的花粉变应原。大部分患者对2种及2种以上花粉过敏。变应原点刺试验有助于发现变应原,并为脱敏治疗提供依据。

  16. 南阳市慢性过敏性鼻炎患者过敏原检测结果分析%Analysis of Allergen Detection Results in Patients With Chronic Allergic Rhinitis in Nanyang City

    Institute of Scientific and Technical Information of China (English)

    宋彬

    2015-01-01

    Objective To understand the types and distribution of allergens in patients with chronic allergic rhinitis in nanyang, and to provide reliable evidence for the prevention and treatment of this disease.Methods ELISA method was used for the determination of serum total IgE and specific IgE in patients with chronic allergic rhinitis, and the comparative analysis was carried out.Results Patients with chronic allergic rhinitis in total IgE positive rate of 100%, the 2 cases of specific allergen test negative, specific allergen detection results for dermatophagoides pteronyssinus 113 cases of the positive (37.7%), house dust was positive in 90 cases (30.0%), trees (oak, elm, sycamore, willow, cottonwood yang) was positive in 54 cases (18.0%). Conclusion Nanyang city cause chronic allergic rhinitis allergic principle mainly in household dust mites, house dust, trees (oak, elm, sycamore, willow, cottonwood yang).%目的 了解南阳市慢性过敏性鼻炎患者过敏原的种类及分布,为本病预防和治疗提供可靠依据.方法 采用ELISA法对慢性过敏性鼻炎患者的血清总IgE和特异性IgE进行半定量测定,并进行对比分析.结果 慢性过敏性鼻炎患者中总IgE阳性率100%,其中2例特异性过敏原检测阴性,特异性过敏原检测结果 为:户尘螨阳性113例(37.7%),屋尘阳性90例(30.0%),树木(栎树、榆树、梧桐、柳树、三角叶杨)阳性54例(18.0%).结论 南阳市引起慢性过敏性鼻炎的过敏原主要是户尘螨,屋尘,树木(栎树、榆树、梧桐、柳树、三角叶杨).

  17. 咪唑斯汀治疗荨麻疹并发过敏性鼻炎的疗效和安全性观察%Therapeutic effect and safety of mizolastine in the treatment of urticaria and allergic rhinitis

    Institute of Scientific and Technical Information of China (English)

    朱宇

    2012-01-01

    目的:观察咪唑斯汀(皿治林)治疗急慢性荨麻疹并发过敏性鼻炎的临床疗效及安全性.方法:选取我院2007年3月-2010年4月收治的120例急、慢性荨麻疹并发过敏性鼻炎患者,随机分为试验组(咪唑斯汀组)和对照组(西替利嗪组)各60例,比较两组患者的治疗效果及不良反应情况.结果:①试验组在用药1h内起效效果明显优于对照组.②试验组总有效率为88.3%,对照组总有效率为76.7%,两组患者总有效率比较差异有统计学意义.急性荨麻疹并发过敏性鼻炎患者中,试验组与对照组差异无统计学意义;慢性荨麻疹并发过敏性鼻炎患者中,试验组与对照组差异有统计学意义.③试验组患者出现轻微口干2例,对照组出现头痛1例,嗜睡3例,口干2例.两组患者不良反应比较差异有统计学意义(P<0.05).④试验组患者的满意度明显高于对照组.结论:咪唑斯汀(皿治林)治疗急慢性荨麻疹并发过敏性鼻炎的效果理想,且不良反应轻微,不嗜睡,临床用药安全性较高.%Objective: To observe the therapeutic effect and safety of mizolastine in the treatment of acute /chronic urticaria with allergic rhinitis. Method: One hundred and twenty cases of acute /chronic urticaria with allergic rhinitis were recruited in our hospital from March 2007 to April 2010, and randomly divided them into observation group (mizolastine treatment group) and control group (cetirizine group), each group consisted of 60 cases. The therapeutic effect and adverse reactions of these two groups were compared. Results: ①The therapeutic effect of the observation group within one hour of treatment was evi dently better than that of the control group. ②The total effective rate of the observation group was 88.3%, and the control group 76.7%. There was a significant difference between the total effective rates of the two groups. There was no a significant difference between the total effective rates of

  18. The efficacy of Rhinos® SR on nasal resistance and nasal symptoms in patients with perennial allergic rhinitis : a randomized, double-blind, placebo-controlled study

    Directory of Open Access Journals (Sweden)

    Arini Setiawati

    2008-06-01

    Full Text Available Rhinos® SR is a fixed combination of 5 mg loratadine and 60 mg pseudoephedrine immediate release and 60 mg pseudoephedrine sustained release. The present study was aimed to assess the efficacy of Rhinos® SR on nasal airway resistance (NAR objectively using rhinomanometer and on nasal symptoms in patients with perennial allergic rhinitis (PAR in a tropical country. This was a randomized, double-blind, parallel group study in 59 PAR patients who visited the ENT clinic at Dr. Soetomo General Hospital, Surabaya. Outpatients of both gender, having moderate to severe PAR for a minimal of 2 years, aged 12 years or older, with a total nasal symptom score (TNSS > 6 and a nasal congestion score > 2, received Rhinos® SR or placebo twice daily for 7 days. The primary efficacy parameter was the decrease in the NAR values (measured by rhinomanometer on Day 1 of Rhinos® SR from those of placebo. The NAR values were calculated as the area under the curve (AUC of NAR versus time. The secondary efficacy parameters were the percentage reduction of the clinical symptoms (nasal and nonnasal evaluated by both the patient and the physician after 1 week use of Rhinos® SR or placebo. From 59 eligible patients, all completed this 1-week trial. For NAR values, after the baseline were considered as 100%, the AUC0-10 h were not significantly different between Rhinos® SR and placebo. However, as the pseudoephedrine reached its peak concentration, i.e. 2 hrs for the immediate release and 6 hrs for the sustained release, then AUC0-2 h and AUC0-6 h of Rhinos® SR were significantly lower compared to those of placebo. Total nasal symptom score (TNSS evaluated by the patient (sum of the last 3 mornings for Rhinos® SR decreased 33.0% from baseline (p < 0.001, for placebo decreased 21.9% from baseline (p = 0.002, but the decrease by Rhinos® SR was not significantly different from the decrease by placebo. TNSS evaluated by the physician, nasal congestion score (NCS and total

  19. 三伏天穴位敷贴治疗过敏性鼻炎疗效观察%Observation on Therapeutic Effect of Acupoint Application for Treating Allergic Rhinitis on Dog Days

    Institute of Scientific and Technical Information of China (English)

    臧江红; 王丽华; 郭裕

    2012-01-01

    Objective:To observe the clinical efficacy of acupoint application for allergic rhinitis on Dog Days. Methods: Acupoint application was adopted on dog days. 65 cases with allergic rhinitis were treated by acupoint application at the selected point of Chu Fu, Zhongfu and Mofu with three times as a course of treatment,and then a follow-up was conducted in six months after the treatment. The therapeutic effect was analyzed and compared before and after the treatment. Results;The total effective rate was 81. 54% ;the main clinical symptoms and signs were improved significantly after the treatment and there was significant difference before and after the treatment(P <0.05). Conclusion;Acupoint Application on Dog Days has good therapeutic effect for the treatment of allergic rhinitis.%目的:观察三伏天穴位敷贴治疗过敏性鼻炎的临床疗效.方法:在三伏天采用选定腧穴敷贴的方法,治疗过敏性鼻炎患者65例,于初伏、中伏、末伏各敷贴1次,3次为1疗程,治疗结束0.5a后随访,分析比较治疗前后的疗效.结果:有效率为81.54%;治疗后主要临床症状、体征改善明显,治疗前后比较有显著性差异(P<0.05).结论:三伏天穴位敷贴治疗过敏性鼻炎具有较好的疗效.

  20. Common aeroallergens in patients with asthma and allergic rhinitis living in southwestern part of iran: based on skin prick test reactivity.

    Directory of Open Access Journals (Sweden)

    Shokrollah Farrokhi

    2015-04-01

    Full Text Available Aeroallergens continue to have a key role in the pathogenesis of asthma and allergic diseases and have recently received increased attention in medical research throughout the world. The prevalence of aeroallergens vary in different regions, depending on the type of climate. The aim of the present study was to determine prevalence of the sensitivity to aeroallergens among patients with asthma and allergic rhinitis (AR, based on skin prick test (SPT reactivity in the province of Bushehr, Iran. In this cross-sectional study, 743 patients were enrolled. The participants had asthma and AR and reacted to at least one allergen with SPT. Skin prick test with standard extracts including house dust mites (HDMs, animal dander, molds and pollens were performed on patients according to the herbal geography of the area. The male to female ratio and mean age of the patients were 1.03 and 27.6± 15.4 year, respectively. Out of 567 patients with AR, the common aeroallergens were HDMs (88.5%, molds (82.9%, animal dander (79.5%, weeds (77.6%, trees (75.5% and grass pollen (71.5%. Moreover, among 176 patients with asthma, the prevalence of aeroallergens were HDMs (90.5 %, molds (80.7%, animal dander (77.5%, weeds (73.3%, trees (73.3% and grass pollen (67.9%. The sensitivity to animal dander, Chenopodium album and Russian thistle pollens were significantly associated with the severity of AR. Moreover, sensitivity to animal dander such as cat and feather of birds, cockroach, Bermuda grass and Chenopodium album pollens were significantly associated with the severity of asthma. The results of this study revealed that HDM was the most common sensitizing aeroallergen in patients with asthma and AR. Molds and animal dander as indoor allergens were also common aeroallergens. We suggest that the hot weather and ambient humidity in the region may be the main cause of the change in the pattern of SPT reactivity.

  1. Effect of Treatment with Intranasal Corticosteroid and Oral Antihistamine on Cytokine Profiles of Peripheral Blood Mononuclear Cells of Patients with Allergic Rhinitis Sensitive to Chenopodium album

    Directory of Open Access Journals (Sweden)

    Shokrollah Farrokhi

    2010-12-01

    Full Text Available Patients with allergic rhinitis (AR show increased production of the Th2-related cytokines. Almost always, intranasal corticosteroid (INC and antihistamine are used as routine therapy of AR. This study was performed to determine the in vitro secretion of cytokines profiles of PBMCs in patients with AR sensitive to Chenopodium album (Ch.a pollens before and after treatment with INC (Fluticasone propionate and oral antihistamine (Loratadine. PBMCs of 20 patients with AR, were tested in vitro for cytokine production. These cells were stimulated with natural or recombinant Ch.a. The levels of IL-4, IL-13 and IFN-, were measured in supernatants of cultured cell 96h after stimulation using ELISA. The PBMCs of 20 normal individuals were also similarly treared for comparison of results. The production of IL-4 by the patients' cells stimulated with either Ch.a or rCh.a was significantly higher than normal levels before therapy (p=0.04 and p=0.02, respectively. After therapy, a significant decrease in production of IL-4 and a significant increase in production of IL-10 were found in PBMCs stimulated with natural Ch.a, in comparison to the results before stimulation (p=0.03 for IL-4; p=0.04 for IL-10. Similarly, these results were seen in the production of IL-4 and IL-10 stimulated with rCh.a allergen after therapy in comparison to the results before stimulation (p=0.01 for IL-4; p=0.03 for IL-10. This study suggests INC (Fluticasone propionate and oral antihistamine (Loratadine have the capacity to inhibit the production of IL-4 and shift Th2/Th1 responses, probably due to increase the level of immunoregulatory IL-10. Therefore, it could be concluded that therapy with INC and antihistamine has pharmacologic and immunologic therapeutic effects on AR patients.

  2. An aryl hydrocarbon receptor ligand acts on dendritic cells and T cells to suppress the Th17 response in allergic rhinitis patients.

    Science.gov (United States)

    Wei, Ping; Hu, Guo-Hua; Kang, Hou-Yong; Yao, Hong-Bing; Kou, Wei; Liu, Hong; Zhang, Cheng; Hong, Su-Ling

    2014-05-01

    A predominant Th17 population is a marker of allergic rhinitis (AR). The aryl hydrocarbon receptor (AhR) exhibits strong immunomodulation potential via regulation of the differentiation of T lymphocytes and dendritic cells (DCs) after activation by its ligand, such as 2-(1'H-indole-3'-carbonyl)-thiazole-4-carboxylic acid methyl ester (ITE). The aim of this study was to analyze the effect of AhR on Th17 differentiation by investigating the action of ITE on DCs and CD4(+) T cells from patients with AR. In all, 26 AR patients and 12 healthy controls were included in this study. The expression of interleukin (IL)-1β, IL-6, IL-10, and IL-17 in the culture supernatant and the presence of Th17 cells in CD4(+) T cells and DC-CD4(+) T-cell co-culture system were measured before and after treatment with ITE. We show that ITE significantly induced cell secretion of IL-10 and inhibited IL-1β and IL-6 production in DCs, and promoted IL-10 production and suppressed IL-17 expression in CD4(+) T cells in vitro. It also suppressed the expansion of Th17 cells in vitro. Our work demonstrates that ITE acts on DCs and CD4(+) T cells to inhibit the Th17 response that suppresses AR; the AhR-DC-Th17 axis may be an important pathway in the treatment of AR. ITE, a nontoxic AhR ligand, attenuated the Th17 response; thus, it appears to be a promising therapeutic candidate for suppressing the inflammatory responses associated with AR.

  3. In vivo and in vitro studies of Th17 response to specific immunotherapy in house dust mite-induced allergic rhinitis patients.

    Directory of Open Access Journals (Sweden)

    Chun Wei Li

    Full Text Available T helper (Th17 cells have been implicated in the development of allergic rhinitis (AR, but their response to specific immunotherapy (SIT remains unclear. We investigated the impact of SIT on Th17 response and Th1/Th2 changes in AR patients. Blood samples from AR patients (n = 20 who were monosensitized to house dust mite (HDM were collected before the initiation of SIT (SIT-untreated and after the end of 2-year SIT (SIT-treated treatment. Twenty healthy volunteers were recruited as controls. In vitro HDM stimulation in peripheral blood mononuclear cells (PBMCs was also performed. Expression levels of Th17 associated genes were determined in both PBMCs and plasma by PCR and ELISA, while Th17/Th1/Th2/IL10 producing cell proportions were evaluated in PBMCs by flow cytometry. The SIT effect was evaluated by assessing clinical symptoms. mRNA levels of Th17 specific genes (IL17 and RORC were increased in SIT-untreated AR versus controls, and decreased following SIT treatment. SIT can change the production of Th17 associated genes (reduction of IL17, IL6, and IL23, but increase of IL27 in plasma from AR patients. Th2/Th1 ratio and proportions of Th17 cells were suppressed while IL10 producing CD4+ T cells were elevated after SIT. In vitro HDM challenge presents concordant patterns with in vivo findings: 1 increase of Th2 and Th17 response in AR patients; 2 suppression of IL10 producing CD4+ T cells in SIT-untreated AR but elevation in SIT-treated AR patients. Most importantly, a positive correlation between IL17 mRNA/protein levels and clinical symptom scores was observed. SIT significantly inhibits Th17 mediated inflammation in AR and IL17 may be a useful biomarker for both AR severity and SIT therapeutic effect.Australian New Zealand Clinical Trials Registry (ANZCTR ACTRN12613000445774.

  4. Effect of Air Pollutants on Allergic Rhinitis in Beijing%北京市空气污染物对过敏性鼻炎的影响研究

    Institute of Scientific and Technical Information of China (English)

    张凤英; 王五一; 徐进; 梁莺; 黄魏宁

    2011-01-01

    To investigate the effect of the global environment change on urbanization and health, daily numbers of persons consulting general practitioners for allergic rhinitis ( AR) between March 19th 2009 and March 18th 2010 were obtained from Department of Otolaryngology-Head and Neck Surgery, Beijing Hospital, Ministry of Public Health.Data of atmospheric concentrations of PM10, NO2 and sulfur dioxide SO2 were collected.The relationship between concentration of air pollutants and the number of outpatients and emergency for allergic rhinitis in Beijing was studied.The results showed that the number of both male patients and female patient has the same increasing trends with the age.About 74.34% of the patients were 21 to 50 years.Spring and autumn had a higher morbidity of AR than summer and winter.The number of medical consultations for allergic rhinitis was correlated with the three air pollutants during March 19th 2009 to September 18th 2009, showed that the air pollutants had short-term effects on allergic rhinitis, exacerbating symptoms and increasing hospital admissions.%以2009年3月19日至2010年3月18日间北京医院耳鼻喉-头颈外科的过敏性鼻炎(AR)门诊就诊病人观测为基础,结合北京市空气质量,探讨空气质量与AR的关系.结果表明,AR患者的人数均随年龄的增长呈现先增加后减少的趋势,以中青年龄段(21~50岁)人数最多.春、秋季是过敏性鼻炎的易发时期,夏、冬季发病率相对较低.AR日就诊人数的时间变化趋势与空气中PM10,SO2,NO2的浓度变化具有一定的时间对应性,在观测的上半期内尤为明显,表明在短期内空气中PM10,SO2,NO2浓度的增加会直接影响AR的发生与症状加重,并导致就诊人数增加.

  5. Observation of clinical efficacy of low-intensity laser irradiation in treatment of allergic rhinitis%低强度激光照射治疗变应性鼻炎的临床疗效观察

    Institute of Scientific and Technical Information of China (English)

    倪伟鹏

    2013-01-01

    Objective To analyze and evaluate the efficacy and safety of low-intensity laser irradiation in the treatment of allergic rhinitis. Methods 128 patients with allergic rhinitis (AR) admitted to our hospital were randomly divided into the treatment group and the control group and received the low-intensity laser irradiation treatment and the intranasal corticosteroid nasal spray treatment respectively.The efficacy of the two groups was compared. Results The differences between the treatment group and the control group were not statistically significant (P >0.05). Conclusion For patients with allergic rhinitis, the low-intensity laser nasal irradiation treatment is a safe and effective method of treatment;The intranasal application of corticosteroid is a recommended therapy for allergic rhinitis and the low-intensity laser nasal irradiation can be used as an adjuvant therapy.%  目的分析并评价低强度激光照射治疗变应性鼻炎的疗效及安全性。方法将我院收治的128例变应性鼻炎(AR)患者随机均分成治疗组和对照组,分别采用低强度激光照射治疗和鼻内应用糖皮质激素喷鼻治疗,比较两组疗效。结果治疗组与对照组对比差异无统计学意义(P>0.05)。结论对变应性鼻炎患者进行低强度激光鼻腔照射治疗是一种安全、有效的治疗方法;鼻内应用糖皮质激素是变应性鼻炎的推荐疗法,低强度激光鼻腔照射治疗可作为辅助治疗。

  6. 上海地区变应性鼻炎患儿主要变应原的临床研究%Variability analysis of allergic rhinitis related allergens in children

    Institute of Scientific and Technical Information of China (English)

    朱华明; 张玉君; 张维天; 苏开明; 时海波

    2011-01-01

    目的 了解近年来上海地区变应性鼻炎患儿的变应原特征,为儿童变应性鼻炎的防治提供临床依据.方法 2005年6月~2010年5月间,对上海地区拟诊变应性鼻炎的儿童行皮肤点刺试验(SPT),分析检测结果,并探讨了阳性病例在性别、年龄、检测的年份及季节等方面的差异性.结果 646例患儿中SPT阳性率81.73%,变应原分布以屋尘螨、粉尘螨为主;阳性病例在性别及检测年、月份分布上的差异无统计学意义(P>0.05);年龄较小组(3~5岁组)的SPT阳性率较低(P<0.05).结论 尘螨为上海地区变应性鼻炎患儿的的主要变应原,致敏阳性率常年维持较高水平,提示了加强尘螨的长期管理在防治儿童变应性鼻炎方面的重要意义.%Objective To determine the features of allergens in children with allergic rhinitis during the recent 5 years of Shanghai, and provide clinical reference for local management strategies. Methods Children with primary diagnosis of allergic rhinitis in shanghai area were given skin prick test (SPT) from June, 2005 to May, 2010. The positive rates were calculated and further analysed in regarding to age, gender, testing months. Results Among 646 children, the total positive rate of SPT was 81.73%. Dermatophagoides farinae (Der. F) and Dermatophagoides pteronyssinus (Der. P) were identified as the mostly responsible allergens. Among the positive subjects, the younger group showed a lower SPT positive rate than the elder (P0.05), but no significant difference was found between the gender, years, or testing months (all, P>0.05). Conclusion Dust mite was the most common allergen in children with allergic rhinitis in Shanghai area, and its sensitization rate sustained constantly a high level around the year, suggesting the importance of long-term mite control during the management of children with allergic rhinitis in Shanghai area.

  7. 青岛市儿童支气管哮喘合并变应性鼻炎问卷调查分析%CHILDREN WITH BRONCHIAL ASTHMA COMPLICATED WITH ALLERGIC RHINITIS IN QINGDAO: A QUESTIONNAIRE INVESTIGATION AND ANALYSIS

    Institute of Scientific and Technical Information of China (English)

    许美; 林荣军; 刘莹莹; 路玲

    2012-01-01

    目的 了解青岛市儿童支气管哮喘合并变应性鼻炎的情况及二者关系.方法 随机抽取2010年5月-2011年10月在我院儿科门诊确诊的年龄≤14岁哮喘病儿372例,其中单纯哮喘232例(Ⅰ组),哮喘合并变应性鼻炎140例(Ⅱ组),选取非呼吸道疾病儿童372例作为对照组(Ⅲ组).通过家长笔答问卷,调查病儿一般情况、伴发疾病、家族史、个人过敏史、治疗情况等.结果 Ⅰ、Ⅱ组有家族及个人药物过敏史者明显多于Ⅲ组(x2=47.11~149.73,P<0.05),Ⅱ组有皮肤过敏史者明显多于Ⅰ组(x2=8.50,P<0.05).哮喘合并变应性鼻炎病儿中有63例(45.0%)先发生变应性鼻炎,55例(39.3%)先发生支气管哮喘.72.1%的哮喘合并变应性鼻炎病儿接受了鼻炎治疗,以单用或联合使用抗组胺药物和使用鼻用糖皮质激素为主要治疗措施.结论 支气管哮喘和变应性鼻炎是同一种疾病在不同部位的表现,两者有一定关联性,积极联合防治,可以提高治疗效果.%Objective To investigate the condition of children suffering from bronchial asthma complicated with allergic rhinitis in Qingdao and the relationship between the two conditions. Methods A random sampling of 372 asthma patients, aged ≤14 years old, confirmed in out-patient department of our hospital, from May 2010 to October 2011 , were divided into simple asthma group (Group 1,232 cases) , bronchial asthma complicated with allergic rhinitis group (Group 2,140 cases) , and 372 children with non-respiratory tract diseases (Group 3) served as controls. A questionnaire was used to survey their parents on genera! condition, concomitant diseases history of allergy, and treatment. Results The history of allergy of individuals and family members were more recorded in groups 1 and 2 than in group 3 (x2=47. 11 — 149. 73,P<0. 05). In group 2, the history of skin allergy was more than that in group 1 (x2 — 8. 50 , P<0. 05). Of the patients with combined

  8. Research on prevalence and related factors in allergic rhinitis%变应性鼻炎患病率及相关因素调查

    Institute of Scientific and Technical Information of China (English)

    王泽海; 林文森; 李书彦; 赵绍成; 王丽; 杨仲刚; 陈杰; 张振富; 于金珍

    2011-01-01

    Objective To obtain the prevalence and related factors in allergic rhinitis (AR) and other allergic diseases in rural area in China through epidemiological investigation with large sample and multi-faceted survey data. Methods Face to face survey was conducted in different regions( rural areas of Cangzhou, Hebei, coastal fishing village of Bohai Bay, area of Wuling Mountain, Chengde, urban areas of Tianjin) from April 2007 to May 2009. In the same time, serum specific IgE(sIgE) was detected in the digits of every 0, 1or 5 in them. SPSS 13.0 software was used to analyze the data. Results Five thousand and ten cases were investigated. There were 823 cases with the symptoms or signs of AR ( 16. 4% ). Four hundred and two cases were found to have positive serum sIgE antibody in 1576 detected cases(25.5% ).One hundred and fourty-six cases with nasal allergic symptoms or signs were diagnosed as AR. The incidence of AR was 9. 3% ( 146/1576 ). The occurrence of allergic symptoms or signs had a significant statistical difference with factors such as age, occupation, atopic constitution ( x2 value were 7. 96, 9. 73, 16. 53,8.95 respectively, all P < 0. 05 ), and it was closely related to lower respiratory tract allergies ( β = 2. 544,P <0. 01 ). The most common allergens were dog and cat epithelium in rural areas and dust mites in city.Conclusions The incidence of AR is higher whether in urban or rural areas, it should be taken seriously as the impact on human health. The occurrence is closely related to physical characteristics and environmental factors.%目的 通过对变应性鼻炎(alkrgic rhinitis,AR)流行病学之大样本的调查,获得以农村为主的AR的患病率及相关患病因素.方法 2007年4月至2009年5月在河北省沧州市农村、渤海湾黄骅市沿海渔村、承德市雾灵山区、天津市区分别以行政乡、村和街道、居民小区等为单位,按行政乡、村和街道、居民小区名册通过随机多级抽样和整群

  9. 心身并治变应性鼻炎_哮喘综合征临床研究%Clinical Research on Psychosomatic Treatment of Combined Allergic Rhinitis and Asthma Syndrome

    Institute of Scientific and Technical Information of China (English)

    席斌; 席冬青; 蒋西玲; 程延安

    2015-01-01

    Objective:To observe the clinical curative effect of psychosomatic treatment of combined allergic rhinitis and asthma syn_drome( CARAS ). Methods:Patients were selected through the Hamilton anxiety scale( HAMA ) and Hamilton depression scale ( HAMD),a total of 62 cases. They were randomly divided into the study group and the control group. The control group was given by o_ral Chinese medicine decoction,and budesonide aerosol nasal spray,and the study group was given psychological treatment on the basis of control group. 4 weeks as a course of treatment. Asthma control test( ACT)score,rhinitis symptoms score,HAMA score and HAMD score of the two groups before and after treatment were compared. Results:After treatment,ACT score,rhinitis symptoms score,HAMA score,HAMD score of the two groups were improved(P0. 05),the other three showed difference (P0.05),其他三项均有显著差异( P<0.05)。结论:心身并治CARAS临床疗效显著。

  10. Allergic disease as an association of steroid sulphatase deficiency.

    Science.gov (United States)

    Sakura, N; Nishimura, S; Matsumoto, T; Ohsaki, M; Ogata, T

    1997-11-01

    Ten of 31 patients with steroid sulphatase (STS) deficiency were found to have an allergic disease (bronchial asthma, allergic rhinitis, or atopic dermatitis). STS deficiency may predispose patients to allergic disease.

  11. 宁夏地区变应性鼻炎与慢性鼻-鼻窦炎鼻息肉相关性研究%The correlation study of allergic rhinitis and chronic rhinosinusitis with nasal polyps in Ningxia region

    Institute of Scientific and Technical Information of China (English)

    马瑞霞; 底玲玲; 侯丽; 赵迪; 闫小会

    2012-01-01

    To investigate the correlation of allergic rhinitis and chronic rhinosinusitis with nasal polyps in the Ningxia region. Method;One hundred and sixteen patients diagnosed with allergic rhinitis, chronic rhinosinusitis with nasal polyps, allergic rhinitis combined with chronic rhinosinusilis with nasal polyps in the department of Otorhinolaryngology Head and Neck Surgery,Ningxia Medical University Hospital from 2009 January to December was analysed in this study, followed by grouping the experimental group 1 : allergic rhinitis(AR) group(46 cases), the experimental group Ⅱ : chronic rhinosinusitis with nasal polyps group(46 cases) , the experimental group Ⅲ : allergic rhinitis combined with chronic rhinosinusitis with nasal polyps group(24 cases), and the normal control group (31 cases). The skin prick test was used and the serum specific IgE concentration of selected objects was measured by enzyme linked immunosorbent assay. Result:①The positive rate of specific IgE in the experimental group I was 83, 3% ,the concentrated for specific IgE mainly graded in 0 to 3 level, The total positive rate of specific IgE in the experimental group U and Dl were 75. 0% and 87. 5%, ②The specific IgE concentration in the experimental group I , Ⅱ , Ⅲ and control group were 10.33 ± 2. 12(kU/L),8. 43±2. 23(kU/L)>5. 28±2. 16(kU/L), 1, 03 ± 3, 96 (kU/L) , respectively. The data analyzed using ANOVA showed that the specific IgE concentration in the experimental group I ,Ⅱ ,Ⅲ compared with the control group was significantly different;Conclusion :①The specific IgE concentration in the Ningxia region of allergic rhinitis, chronic rhinosinusitis with nasal polyps were graded in 0 to 3 level, mainly graded in 1 level and lower than other regions The positive rates of the skin prick test about Wormwood, German cockroach, house dust mites and pollen Ⅳ allergen were relatively higher in Ningxia region, ② The specific IgE concentration was relatively higher in the

  12. 中西医学方法对变应性鼻炎疗效比较%The Comparison of Curative Effection on Allergic Rhinitis between Traditional Chinese Medicine and Western Medicine

    Institute of Scientific and Technical Information of China (English)

    汪晓凯; 李彩霞; 李竹梅; 张秋红

    2011-01-01

    This text compares the curative effection on Allergic Rhinitis between Traditional Chinese Medicine (TCM) and Western Medicine. The disadvantages of Western Medicine include : axiomatize the pathomechanism and therapeutic schedule,without paying attention to premorbid phase,without holism concept. The features of TCM include: holism concept,harmonization between soma and spirit, the dialectic conception. There are advantages and disadvantages both in TCM and Western Medicine. Combination of TCM and Western Medicine is the developmental direction of Allergic Rhinitis in the future.%本文分别从中医学和西医学体系对变应性鼻炎疗效进行分析比较.西医学主要不足:病理机制和治疗方案的公理化,缺乏关注病前状态,缺乏整体观.中医学主要特点:整体观念、形神合一、辩证理念.中西医学均存在优势和不足.中西医学结合是今后诊治变应性鼻炎的发展方向.

  13. 孔嗣伯老中医清热化湿通窍法治疗变应性鼻炎经验%Experience of Notable TCM Doctor Kong Sibo in Treating Allergic Rhinitis by Removing Heat Dampness and Relieving Stuffy Nose

    Institute of Scientific and Technical Information of China (English)

    段颖; 支楠

    2014-01-01

    孔嗣伯老中医治疗变应性鼻炎经验丰富,疗效显著。孔老认为变应性鼻炎属中医鼻鼽范畴,湿热内蕴是鼻鼽发生的重要病因病机,称之湿热鼻鼽。清热化湿通窍是治疗湿热鼻鼽的总则,临床治疗应注意整体观念,多因素考虑,辨别湿热所在脏腑经络而遣方用药。%Dr.Kong Si bo,is a veteran practitioner of traditional Chinese medicine,who has rich experience in treating curative effect of allergic rhinitis.Dr.Kong believes that allergic rhinitis belongs to Bi Qiu category of traditional Chinese medicine,and the interior reten-tion of damp heat is the main important pathogenesis of allergic rhinitis.Clearing heat and dampness and relieving stuffy nose is the gen-eral principles of treating damp heat of allergic rhinitis.As for clinical treatment,attention shall be paid to the integrated conception,mul-tiple factors to identify the damp heat position of meridians and collaterals including the viscera system.

  14. Aeroallergen spectrum of patients with allergic rhinitis in Enshi area%恩施州地区变应性鼻炎患者的吸入变应原谱分析

    Institute of Scientific and Technical Information of China (English)

    刘军; 周意; 万静; 刘忠

    2011-01-01

    目的:调查恩施州地区变应性鼻炎患者变应原的分布,并分析其相关因素.方法:应用13种标准化吸入变应原对463例疑似变应性鼻炎患者进行皮肤点刺实验,并详细采集病史资料.结果:387例(83.6%)患者变应原呈阳性反应,阳性率相对较高的变应原依次为粉尘螨、屋尘螨、热带螨、美洲大蠊、德国小蠊及狗毛.对单类变应原呈阳性反应的占51.9%,其中大多数是螨类,占49.6%.变应原阳性强弱与家族史、是否伴哮喘、年龄及居住环境显著相关.结论:恩施州地区变应性鼻炎的主要变应原为尘螨,其阳性强弱与遗传、哮喘、年龄及居住环境有关.%Objective: To investigate aeroallergen spectrum of patients with allergic rhinitis in Enshi area and analyze its related factors. Method:Skin prick test was carried out in 463 patients with allergic rhinitis with 13 inhaled allergens. Detailed history was collected in all cases. Result: Three hundred and eigty-seven cases(83. 6 %)showed positive reaction to at least one allergen of 13 allergens. The most common allergens found in patients were dermatophagoides farinae and dermatophagoides pteronyssinus, followed by tropical mite、periplaneta americana,blattella germanica and dog hair. The positive reaction rate of single specie allergen were 51.9%, and most of them was positive to mites(49. 6 %). The positive reaction degree was significantly related to family history, asthma ,age and housing enviroment. Conclusion:The major allergen of allergic rhinitis was mite. The positive reaction degree related to genetics, asthma, age and housing enviroment.

  15. Role of mucosal immunity in pathogenesis of asthma and allergic rhinitis%黏膜免疫在支气管哮喘及变应性鼻炎发病中的作用

    Institute of Scientific and Technical Information of China (English)

    李风森; 徐丹; 杜丽娟

    2011-01-01

    目的 探讨黏膜免疫在哮喘、变应性鼻炎发病过程中的作用,寻找两种病发病时共同的联系物质,以揭示哮喘与变应性鼻炎发病之间的关联性.方法 收集急性发作期哮喘患者82例(其中单纯哮喘44例,哮喘合并鼻炎38例),单纯变应性鼻炎患者30例,正常对照组30例.分别采集受检者唾液、痰液、鼻腔分泌物各2 ml,用ELISA法测定分泌型免疫球蛋白A(sIgA)的变化.采肘静脉血各2 ml,用流式细胞仪检测CD4+、CD8+淋巴细胞,荧光酶联免疫法检测血清嗜酸性阳离子蛋白(eosinophil cationic protein,ECP)、总免疫球蛋白E(total immunoglobulin E,T-IgE).结果 痰液中sIgA含量在单纯哮喘组、哮喘合并鼻炎组、单纯变应性鼻炎组均较正常组降低(P<0.01);唾液sIgA含量在哮喘组、合并组较正常组有降低趋势但差异无统计学意义.鼻腔分泌物中sIgA各组比较,哮喘组与合并组均高于正常组(P<0.05)及鼻炎组(P<0.01),而鼻炎组与正常组之间差异无统计学意义.血液中CD4+细胞在哮喘组、合并组均高于正常组(P<0.05);血液中CD8+细胞在各组间差异无统计学意义;CD4+/CD8+在哮喘组较正常组和鼻炎组增高(P<0.05).血清T-IgE在合并组及鼻炎组均较正常组增高(P<0.01).正常组血清ECP检出率极低;哮喘组血清ECP高于鼻炎组(P<0.05),而哮喘组与合并组、鼻炎组与合并组差异无统计学意义.哮喘组ECP与T-IgE正相关(r=0.467,P<0.05),合并组与鼻炎组ECP与T-IgE无相关性.结论 哮喘和变应性鼻炎都与黏膜免疫有密切关系,黏膜免疫可能是其发病过程中相同的病理特征在不同部位的体现.而sIgA、CD4+、CD8+、ECP、T-IgE等免疫介质可能是黏膜免疫的物质基础之一.%Objective To explore the role of mucosal immunity in the pathogenesis of asthma and allergic rhinitis and to search for common materials for the two conditions, so as to reveal the relationship of asthma and allergic

  16. ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle

    NARCIS (Netherlands)

    J. Bousquet (Jean); P.W. Hellings (P.); I. Agache; A. Bedbrook (A.); C. Bachert (Claus); K.-C. Bergmann (Karl-Christian); Bewick, M.; C. Bindslev-Jensen; Bosnic-Anticevitch, S.; Bucca, C.; Caimmi, D.P.; P. Camargos; G. Canonica (Gwalter); T.B. Casale (Thomas); N.H. Chavannes (Nicolas); A.A. Cruz; De Carlo, G.; R. Dahl; P. Demoly; Devillier, P.; J. Fonseca; W.J. Fokkens (Wytske); Guldemond, N.A.; T. Haahtela; Illario, M.; P.M. Just; M. Keil (Mark); L. Klimek (Ludger); P. Kuna; D. Larenas-Linnemann (Désirée); M. Morais-Almeida; Mullol, J.; Murray, R.; R. Naclerio; R.E. O'hehir; N. Papadopoulos; R. Pawankar (Ruby); Potter, P.; D. Ryan (Dermot); Samolinski, B.; H.J. Schünemann (Holger); A. Sheikh (Aziz); F.E.R. Simons; Stellato, C.; A. Todo Bom; Tomazic, P.V.; A. Valiulis (Arunas); E. Valovirta (Erkka); Ventura, M.T.; M. Wickman (Magnus); Young, I.; A. Yorgancioglu; T. Zuberbier (Torsten); W. Aberer (W.); C.A. Akdis; C.A. Akdis; I. Annesi-Maesano; Ankri, J.; I.J. Ansotegui (I.); J.M. Antó (Josep M.); Arnavielhe, S.; Asarnoj, A.; Arshad, H.; Avolio, F.; I. Baiardini (Ilaria); Barbara, C.; Barbagallo, M.; E.D. Bateman (Eric); B. Beghe; E.H. Bel; K.S. Bennoor (K.); Benson, M.; Białoszewski, A.Z.; T. Bieber (Thomas); L. Bjermer (Leif); Blain, H.; F. Blasi (Francesco); A.L. Boner; M. Bonini (Matteo); S. Bonini (Sergio); Bosse, I.; J. Bouchard (Jacques); L.P. Boulet; Bourret, R.; J. Bousquet (Jean); F. Braido (Fulvio); A. Briggs (Andrew); C.E. Brightling (C.); J. Brozek; Buhl, R.; Bunu, C.; Burte, E.; A. Bush (Andrew); Caballero-Fonseca, F.; M. Calderon (Moises); Camuzat, T.; D. Cardona (Doris); Carreiro-Martins, P.; Carriazo, A.M.; K.H. Carlsen (Karin); W.W. Carr (Warner); Cepeda Sarabia, A.M.; Cesari, M.; L. Chatzi (Leda); Chiron, R.; Chivato, T.; Chkhartishvili, E.; A.G. Chuchalin; Chung, K.F.; G. Ciprandi (G.); De Sousa, J.C. (J. Correia); L. Cox (Linda); Crooks, G.; A. Custovic; S.E. Dahlen; U. Darsow (U.); Dedeu, T.; D. Deleanu (D.); J. Denburg; De Vries, G.; Didier, A.; Dinh-Xuan, A.T.; D. Dokic (D.); H. Douagui; Dray, G.; R. Dubakiene (R.); S.R. Durham (Stephen); G. Du Toit (George); Dykewicz, M.S.; Eklund, P.; Y. El-Gamal (Y.); Ellers, E.; R. Emuzyte; Farrell, J.; A. Fink-Wagner (A.); A. Fiocchi (Alessandro); M. Fletcher (M.); Forastiere, F.; M. Gaga (Mina); A. Gamkrelidze (Amiran); Gemicioǧlu, B.; J.E. Gereda (J.); Van Wick, R.G. (R. Gerth); S. González Diaz (S.); Grisle, I.; L. Grouse; Gutter, Z.; M.A. Guzmán (M.); B. Hellquist-Dahl (B.); J. Heinrich (Joachim); Horak, F.; J.O.B. Hourihane; Humbert, M.; Hyland, M.; Iaccarino, G.; Jares, E.J.; Jeandel, C.; S.L. Johnston; G.F. Joos (Guy); Jonquet, O.; Jung, K.S.; M. Jutel (M.); Kaidashev, I.; Khaitov, M.; O. Kalayci; A.F. Kalyoncu (A.); Kardas, P.; P.K. Keith; M. Kerkhof (Marjan); H.A.M. Kerstjens (Huib); N. Khaltaev; M. Kogevinas (Manolis); Kolek, V.; G.H. Koppelman (Gerard); M.L. Kowalski; Kuitunen, M.; C.A. Kull (Christian); V. Kvedariene (V.); B.N.M. Lambrecht (Bart); S. Lau (Susanne); Laune, D.; L.T. Le; A.P. Lieberman (Andrew); B. Lipworth; J. Li (J.); K.C. Lødrup Carlsen (K. C.); R. Louis (Renaud); Lupinek, C.; W. MacNee; Magar, Y.; Magnan, A.; B. Mahboub; Maier, D.; Majer, I.; Malva, J.; Manning, P.; De Manuel Keenoy, E.; G.D. Marshall; M.R. Masjedi (M.); Mathieu-Dupas, E.; Maurer, M.; S. Mavale-Manuel; E. Melén (Erik); Melo-Gomes, E.; E.O. Meltzer; Mercier, J.; J. Merk (Jeroen); Miculinic, N.; F. Mihaltan (F.); B. Milenkovic (Branislava); Millot-Keurinck, J.; Y. Mohammad; I. Momas (I.); R. Mösges; Muraro, A.; L. Namazova-Baranova (L.); R. Nadif (Rachel); Neffen, H.; Nekam, K.; A. Nieto (Antonio); B. Niggemann; Nogueira-Silva, L.; Nogues, M.; T.D. Nyembue (T.); K. Ohta; Y. Okamoto; Okubo, K.; Olive-Elias, M.; S. Ouedraogo; P. Paggiaro (Pierluigi); I. Pali-Schöll (I.); S. Palkonen; P. Panzner (P.); Papi, A.; Park, H.S.; G. Passalacqua (Giovanni); S.E. Pedersen (Soren E.); Pereira, A.M.; O. Pfaar (Oliver); Picard, R.; B. Pigearias (B.); I. Pin (Isabelle); Plavec, D.; Pohl, W.; T.A. Popov; Portejoie, F.; D.S. Postma (Dirkje); L.K. Poulsen; D. Price (David); K.F. Rabe (Klaus F.); Raciborski, F.; G. Roberts; Robalo-Cordeiro, C.; Rodenas, F.; L. Rodríguez-Mañas (Leocadio); Rolland, C.; M. Roman Rodriguez (M.); A. Romano; J. Rosado-Pinto; K. Rosario (Karyna); Rottem, M.; M. Sanchez-Borges; Sastre-Dominguez, J.; G.K. Scadding; Scichilone, N.; P. Schmid-Grendelmeier (Peter); Serrano, E.; M.D. Shields; V. Siroux (V.); J.C. Sisul (J.); Skrindo, I.; H.A. Smit (Henriëtte); D. Solé (D.); Sooronbaev, T.; O. Spranger; Stelmach, R.; P.J. Sterk (Peter); Strandberg, T.; J. Sunyer (Jordi); C. Thijs (Carel); M. Triggiani (M.); R. Valenta; A.L. Valero (A.); Van Eerd, M.; Van Ganse, E.; Van Hague, M.; O. Vandenplas (Olivier); Varona, L.L.; Vellas, B.; Vezzani, G.; Vazankari, T.; G. Viegi; Vontetsianos, T.; Wagenmann, M.; Walker, S.; D.Y. Wang (De Yun); U. Wahn (Ulrich); Werfel, T.; Whalley, B.; D. Williams; Williams, S.; Wilson, N.; J. Wright (Juliet); B.P. Yawn (Barbara); P.K. Yiallouros (P.); O.M. Yusuf (Osman); Zaidi, A.; H.J. Zar; M. Zernotti; Zhang, L.; Zhong, N.; M. Zidarn (M.)

    2016-01-01

    textabstractThe Allergic Rhinitis and its Impact on Asthma (ARIA) initiative commenced during a World Health Organization workshop in 1999. The initial goals were (1) to propose a new allergic rhinitis classification, (2) to promote the concept of multi-morbidity in asthma and rhinitis and (3) to de

  17. ARIA 2016 : Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle

    NARCIS (Netherlands)

    Bousquet, J; Hellings, P W; Agache, I; Bedbrook, A; Bachert, C; Bergmann, K C; Bewick, M; Bindslev-Jensen, C; Bosnic-Anticevitch, S; Bucca, C; Caimmi, D P; Camargos, P A M; Canonica, G W; Casale, T; Chavannes, N H; Cruz, A A; De Carlo, G; Dahl, R; Demoly, P; Devillier, P; Fonseca, J; Fokkens, W J; Guldemond, N A; Haahtela, T; Illario, M; Just, J; Keil, T; Klimek, L; Kuna, P; Larenas-Linnemann, D; Morais-Almeida, M; Mullol, J; Murray, R; Naclerio, R; O'Hehir, R E; Papadopoulos, N G; Pawankar, R; Potter, P; Samolinski, B; Schunemann, H J; Sheikh, A; Simons, F E R; Stellato, C; Todo-Bom, A; Tomazic, P V; Valiulis, A; Valovirta, E; Ventura, M T; Wickman, M; Young, I; Yorgancioglu, A; Zuberbier, T; Aberer, W; Akdis, C A; Akdis, M; Annesi-Maesano, I; Ankri, J; Ansotegui, I J; Anto, J M; Arnavielhe, S; Asarnoj, A; Arshad, H; Avolio, F; Baiardini, I; Barbara, C; Barbagallo, M; Bateman, E D; Beghé, B; Bel, E H; Bennoor, K S; Benson, M; Białoszewski, A Z; Bieber, T; Bjermer, L; Blain, H; Blasi, F; Boner, A L; Bonini, M; Bonini, S; Bosse, I; Bouchard, J; Boulet, L P; Bourret, R; Bousquet, P J; Braido, F; Briggs, A H; Brightling, C E; Brozek, J; Buhl, R; Bunu, C; Burte, E; Bush, A; Caballero-Fonseca, F; Calderon, M A; Camuzat, T; Cardona, V; Carreiro-Martins, P; Carriazo, A M; Carlsen, K H; Carr, W; Cepeda Sarabia, A M; Cesari, M; Chatzi, L; Chiron, R; Chivato, T; Chkhartishvili, E; Chuchalin, A G; Chung, K F; Ciprandi, G; de Sousa, J Correia; Crooks, G; Custovic, A; Dahlen, S E; Darsow, U; Dedeu, T; Deleanu, D; Denburg, J A; Didier, A; Dinh-Xuan, A T; Dokic, D; Douagui, H; Dray, G; Dubakiene, R; Durham, S R; Du Toit, G; Dykewicz, M S; El-Gamal, Y; Ellers, E; Emuzyte, R; Farrell, J; Fink Wagner, A; Fiocchi, A; Fletcher, M; Forastiere, F; Gaga, M; Gamkrelidze, A; Gemicioğlu, B; Gereda, J E; van Wick, R Gerth; González Diaz, S; Grisle, I; Grouse, L; Gutter, Z; Guzmán, M A; Hellquist-Dahl, B; Horak, F; Hourihane, J O' B; Humbert, M; Hyland, M; Iaccarino, G; Jares, E J; Jeandel, C; Johnston, S L; Joos, G; Jonquet, O; Jung, K S; Jutel, M; Kaidashev, I; Khaitov, M; Kalayci, O; Kalyoncu, A F; Kardas, P; Keith, P K; Kerkhof, M; Kerstjens, H A M; Khaltaev, N; Kogevinas, M; Kolek, V; Koppelman, G H; Kowalski, M L; Kuitunen, M; Kull, I; Kvedariene, V; Lambrecht, B; Lau, S; Laune, D; Le, L T T; Lieberman, P; Lipworth, B; Lodrup Carlsen, K C; Louis, R; Lupinek, C; MacNee, W; Magar, Y; Magnan, A; Mahboub, B; Maier, D; Majer, I; Malva, J; Manning, P; De Manuel Keenoy, E; Marshall, G D; Masjedi, M R; Mathieu-Dupas, E; Mavale-Manuel, S; Melén, E; Melo-Gomes, E; Meltzer, E O; Mercier, J; Miculinic, N; Mihaltan, F; Milenkovic, B; Millot-Keurinck, J; Mohammad, Y; Momas, I; Mösges, R; Muraro, A; Namazova-Baranova, L; Nadif, R; Neffen, H; Nekam, K; Nieto, A; Niggemann, B; Nogueira-Silva, L; Nogues, M; Nyembue, T D; Ohta, K; Okamoto, Y; Okubo, K; Olive-Elias, M; Ouedraogo, S; Paggiaro, P; Pali-Schöll, I; Palkonen, S; Panzner, P; Papi, A; Park, H S; Passalacqua, G; Pedersen, S; Pereira, A M; Pfaar, O; Picard, R; Pigearias, B; Pin, I; Plavec, D; Pohl, W; Popov, T A; Portejoie, F; Poulsen, L K; Price, D; Rabe, K F; Raciborski, F; Robalo-Cordeiro, C; Rodenas, F; Rodriguez-Mañas, L; Rolland, C; Romano, A; Rosado-Pinto, J; Rosario, N; Rottem, M; Sanchez-Borges, M; Sastre-Dominguez, J; Scadding, G K; Scichilone, N; Schmid-Grendelmeier, P; Serrano, E; Shields, M; Siroux, V; Sisul, J C; Skrindo, I; Solé, D; Sooronbaev, T; Spranger, O; Stelmach, R; Sterk, P J; Strandberg, T; Sunyer, J; Triggiani, M; Valenta, R; Valero, A; van Eerd, M; van Ganse, E; van Hague, M; Vandenplas, O; Varona, L L; Vellas, B; Vezzani, G; Vazankari, T; Viegi, G; Vontetsianos, T; Wagenmann, M; Walker, S; Wahn, U; Werfel, T; Whalley, B; Wilson, N; Wright, J; Yawn, B P; Yiallouros, P K; Yusuf, O M; Zar, H J; Zernotti, M E; Zhong, N; Zidarn, M

    2016-01-01

    The Allergic Rhinitis and its Impact on Asthma (ARIA) initiative commenced during a World Health Organization workshop in 1999. The initial goals were (1) to propose a new allergic rhinitis classification, (2) to promote the concept of multi-morbidity in asthma and rhinitis and (3) to develop guidel

  18. Allergic rhinitis - self-care

    Science.gov (United States)

    ... Installing furnace filters or other air filters Removing furniture and carpets from your floors Using a dehumidifier ... Assistant Studies, Department of Family Medicine, UW Medicine, School of Medicine, University of Washington, Seattle, WA. Also ...

  19. [Allergic rhinitis in asthmatic patients].

    Science.gov (United States)

    Reyes, Paola; Larreal, Yraima; Arias, Julia; Rincón, Enrique; Valero, Nereida

    2014-01-01

    Antecedentes: la rinitis alérgica y el asma bronquial son procesos inflamatorios crónicos de las vías respiratorias, con una correlación que varía entre 28 y 78%. Objetivos: determinar la prevalencia de rinitis alérgica en pacientes asmáticos y clasificarla según las guías Rinitis Alérgica y su Impacto en Asma (ARIA), así como detectar las concentraciones séricas de IgE total y la existencia de eosinofilia nasal y en sangre periférica. Material y método: estudio en el que pacientes asmáticos entre 7 y 14 años de edad, consultantes del servicio de Pediatría del Hospital General del Sur Dr. Pedro Iturbe, Maracaibo, Estado Zulia, Venezuela, fueron encuestados acerca de signos y síntomas sugerentes de rinitis alérgica y su efecto en la calidad de vida. Se tomaron muestras sanguíneas e hisopado nasal para hacer las determinaciones objeto de estudio. Resultados: se evaluaron 60 pacientes asmáticos, 73.3% del sexo masculino y 70% escolares. La prevalencia de rinitis alérgica se estableció en 93.3%, el tipo más frecuente según ARIA fue el intermitente leve, con 42.8%. El signo clínico más frecuente fueron las ojeras alérgicas (86.6%) y el síntoma predominante fue el goteo nasal acuoso (83.3%), la afectación en cuanto a calidad de vida estuvo representada por trastornos del sueño (39.2%). El 85.7% de los encuestados tuvo porcentajes de eosinófilos mayores a 3% y 75% tuvo valores mayores de 100 UI de IgE total sérica. El 61.9% de las muestras de moco nasal de pacientes con rinitis mostró porcentajes de eosinófilos mayores a 10%. Conclusión: existe alta prevalencia de rinitis alérgica en asmáticos confirmada mediante pruebas de laboratorio que evidencian una respuesta inflamatoria mediada por IgE.

  20. Curative effect analysis of sublingual immunotherapy in 62 cases of children with allergic rhinitis%舌下免疫治疗儿童变应性鼻炎62例疗效观察

    Institute of Scientific and Technical Information of China (English)

    沈荣

    2011-01-01

    目的 评价标准化粉尘螨变应原疫苗滴剂舌下含服治疗儿童变应性鼻炎的疗效并初步探索其免疫学机制.方法 选择粉尘螨阳性的儿童变应性鼻炎患者62例,随机分为2组:免疫治疗组31例,给予舌下含服标准化粉尘螨变应原疫苗滴剂脱敏治疗;药物治疗组31例,根据患者情况,给予适量抗组胺药口服,或鼻用类固醇激素局部喷鼻.治疗疗程为2年,治疗后观察患者症状、体征变化,采用视觉模拟量表(VAS)评定疗效,并比较治疗前后血清中总IgE、尘螨特异性IgE的水平.结果 免疫治疗组有效率为80.6%,药物治疗组有效率为64.5%,2组有效率比较差异有统计学意义(P0.05).免疫治疗组治疗前后血清总IgE、尘螨特异性IgE水平比较差异无统计学意义(P>0.05).结论 应用标准化粉尘螨变应原疫苗滴剂舌下含服对变应性鼻炎患者进行免疫治疗能够有效改善变应性鼻炎患儿的症状.%Objective To evaluate the curative effect of sublingual immunotherapy in children allergic rhinitis by standardized dermatophagoides farinae allergen vaccine drops and explore the immunological mechanisms. Methods 62 cases of children with allergic rhinitis whose test result was positive for dermatophagoides farinae were divided into two groups randomly:The sublingual immunotherapy group( 31 cases )which accepted standardized dermatophagoides farinae allergen vaccine drops sublingual immunotherapy and the control group( 31 cases ) which accepted antihistamine drug therapy or local nasal steroid spray. The course of treatment was two years. Evaluating the curative effect by the changes of symptoms and physical signs which were measured by VAS ( visual analogue scale ) and detecting the serum levels of total IgE, specific IgE levels of dermatophagoides farinae. Results The effective rate was 80.6% in the sublingual immunotherapy group, and 64.5% in the control group. Although the symptom score was statistically

  1. Therapeutic potential of combined anti-IL-1β IgY and anti-TNF-α IgY in guinea pigs with allergic rhinitis induced by ovalbumin.

    Science.gov (United States)

    Guo-Zhu, Hu; Xi-Ling, Zhu; Zhu, Wen; Li-Hua, Wu; Dan, He; Xiao-Mu, Wu; Wen-Yun, Zhou; Wei-Xu, Hu

    2015-03-01

    We have previously demonstrated that anti-IL-1β immunoglobulin yolk(IgY) inhibits pathological responses in allergic asthma guinea pigs induced by ovalbumin(OVA). This study aims to determine whether the combined blockade of IL-1β and TNF-α can more effectively inhibit allergic inflammation in allergic rhinitis(AR) guinea pigs induced by OVA. Healthy guinea pigs treated with saline were used as the healthy control. The AR guinea pigs induced by OVA were randomly divided into (1) the AR model group containing negative control animals treated with intranasal saline; (2) the 0.1% non-specific IgY treatment group treated with non-specific IgY; (3) the 0.1% anti-TNF-α IgY treatment group treated with 0.1% anti-TNF-α IgY; (4) the 0.1% anti-IL-1β IgY treatment group treated with 0.1% anti-IL-1β IgY; (5) the 0.1% combined anti-IL-1β IgY and anti-TNF-α IgY treatment group treated with 0.1% combined anti-IL-1β IgY and anti-TNF-α IgY; and (6) the fluticasone propionate treatment group treated with fluticasone propionate. Cytokines were measured using an enzyme-linked immunosorbent assay. The results showed that IL-1β, IL-5, IL-9, IL-13, IL-18, IL-22, IL-33, TNF-α, TGF-β1 and OVA-specific IgE levels in the peripheral blood (PB) and nasal lavage fluid (NLF) significantly decreased at 2h, 4h or 8h in the 0.1% combined anti-IL-1β IgY and anti-TNF-α IgY treatment group compared to the AR model group and the 0.1% non-specific IgY treatment group (P<0.05). The data suggest that blockade of IL-1β and TNF-α by intranasal instillation of combined anti-IL-1β IgY and anti-TNF-α IgY could be a potential alternative strategy for preventing and treating allergic rhinitis.

  2. 热敏灸疗法对发作期变应性鼻炎患者症状的影响%The treatment of heat sensitive moxibution impact on the symptom of allergic rhinitis in the stage of attack

    Institute of Scientific and Technical Information of China (English)

    徐璐; 夏纪严; 王露; 朱栋

    2016-01-01

    Objective To evaluate the effect of heat sensitive moxibution on cases of Allergic rhinitis in the stage of attack .Methods Scored the symptom grades before and after the treatments by symptoms signs scale and visual analogue scale ,and then analyzed statistically .Results ① scoring according symptoms and signs :The symptoms grades after the treatments were lower than before (P< 0 .05) .② visual analogue scale :The symptoms grades before and after the treatments were have significant difference .Conclusion The treatment of heat sensitive moxibution can instantly relieves the symptom of Allergic rhinitis in the stage of attack .%目的:评价热敏灸疗法对发作期变应性鼻炎患者症状的影响。方法对30例发作期变应性鼻炎患者采用热敏灸治疗,治疗前后用症状体征评分量表和视觉模拟评分量表(VAS)进行评分,比较患者治疗前后的症状情况。结果①症状体征评分,治疗前后各项症状比较,均具有统计学意义(P<0.05);②VAS 症状评分,治疗前后各项症状比较,均具有统计学意义(P<0.05)。结论热敏灸可以迅速缓解发作期变应性鼻炎患者的症状。

  3. Pathological conditions associated with rhinitis medicamentosa

    Directory of Open Access Journals (Sweden)

    Milošević Dušanka

    2004-01-01

    Full Text Available Rhinitis medicamentosa (nose-drop-nose" is a term used for pathological condition of the nasal mucous membrane that results from long-term abuse with intranasal vasoconstrictors. The aim of this work was to examine what lead the patients with nosedropnose rhinitis to the initial usage of intranasal vasoactive drugs, in this prospective study, 92 patients with rhinitis medicamentosa were included. The evaluation of all study subjects comprised the history, ORL, microbiological and radiological examination, skin prick tests with a battery of routine respiratory and nutritive allergens and nasal cytology. The results of this study showed that the pathological conditions for initial use of intranasal vasoactive drugs were: acute upper respiratory infections in 293%, vasomotor rhinitis in 21.7%, allergic rhinitis in 16.3%, deviated nasal septum in 13.0%, nasal polyposis in 12%, rhinitis induced by mechanical trauma in 4.4%, and hormonal rhinitis in 3.3% of patients with rhinitis medicamentosa. In conclusion, the most common pathological conditions for developing rhinitis medicamentosa were chronic inflammatory and structural diseases manifested by permanent nasal obstruction as well as acute upper respiratory infections are.

  4. Prevalence of atopic dermatitis, asthma, allergic rhinitis, and hand and contact dermatitis in adolescents. The Odense Adolescence Cohort Study on Atopic Diseases and Dermatitis

    DEFF Research Database (Denmark)

    Mørtz, Charlotte G; Lauritsen, J M; Bindslev-Jensen, C

    2001-01-01

    BACKGROUND: Atopic diseases are common in children and adolescents. However, epidemiological knowledge is sparse for hand eczema and allergic contact dermatitis in this age group. Furthermore, no population-based studies have evaluated the prevalence of atopic diseases and hand and contact...... or past allergic contact dermatitis was found in 7.2% (girls 11.3% vs. boys 2.5%). Contact allergy was most common to nickel (8.6%) and fragrance mix (1.8%). CONCLUSIONS: High prevalence figures were found for atopic diseases, hand eczema and allergic contact dermatitis, and the diseases were closely...

  5. 儿童分泌性中耳炎与变应性鼻炎相关研究进展%Advances in Clinical Research on Otitis Media with Effusion and Allergic Rhinitis in Children

    Institute of Scientific and Technical Information of China (English)

    李颖; 赵守琴

    2016-01-01

    分泌性中耳炎是儿童的常见病与多发病,是引起儿童听力下降的常见原因之一。为深入了解儿童分泌性中耳炎与变应性鼻炎之间的内在联系,本文收集了相关研究文献。研究表明分泌性中耳炎与变应性鼻炎之间存在流行病学、病理生理学方面的联系,抗过敏治疗对分泌性中耳炎具有短期疗效并可有效防止分泌性中耳炎复发。采用鼻内类固醇激素治疗后,其治愈率明显增加。这些发现为人们深入研究变态反应性疾病与分泌性中耳炎形成机制间的联系、抗过敏治疗对复发性分泌性中耳炎的有效性以及针对该病更广泛的药物治疗研究提供了重要参考。%Otitis media with effusion is a common and frequently occurring disease in children, and one of the most common causes of hearing loss in the pediatric population. To further understand the relationship between otitis media with effusion and allergic rhinitis in children, relevant research literature was reviewed. Research shows that, from epidemiology and pathophysiology evidence, otitis media with effusion and allergic rhinitis are related, and treatments against allergy are beneficial for otitis media with effusion in short-term and can effectively prevent its recurrence. The rate of recovery from otitis media with effusion is significantly increased after treatment with steroids. These findings provide an important refer-ence for further studies of the relationship between allergic diseases and the mechanisms of pathogenesis of otitis media with effusion, the effectiveness of anti-allergy treatments for recurrent otitis media with effusion, and development of addi-tional medical treatments for the disease.

  6. 广东惠州地区成人支气管哮喘合并过敏性鼻炎的流行病学调查分析%Epidemiology analysis of patients with bronchial asthma combined with allergic rhinitis in Huizhou

    Institute of Scientific and Technical Information of China (English)

    吴峰; 林伟明; 陈宫玉; 陈钊成; 陈必达; 周五铁; 吴思仿; 吴海桂

    2012-01-01

    Objective To study the status of bronchial asthma (asthma) in patients with allergic rhinitis in Huizhou,and to analyze the correlation of clinical characteristic between allergic rhinitis and bronchial asthma,to investigate the patients' cognitions and treatment situation about the allergic rhinitis.Methods The questionnaire survey of 280 cases of asthma in Huizhou,their medical history,severity,asthma control test (ACT) were investigated in details.The rhinitis survey included prevalence,cognition,family history and treatment situation.The patients,data were collected and analyzed.Results In 280 cases of bronchial asthma,203 cases(72.5%) combined with allergic rhinitis.There was no statistical significance ( P >0.05) between the group of asthma combined with allergic rhinitis and the group of simple asthma on the age,sex,and the disease course.Compared with the group of simple asthma on case,the group of asthma combined with allergic rhinitis were more cases at the grade 2(mild persistence),grade 3(moderate persistence),and grade 4 (severe persistence),and few cases in complete control,good control through ACT ( P <0.05),while more cases in the uncontrol through ACT ( P <0.05).Allergic rhinitis:in the the group of asthma combined with allergic rhinitis,there were 59.61% of the patients got allergic rhinitis earlier than asthma,about 17.24% got those two disease at the same time.The inducements of allergic rhinitis were cold air (82.10%),irritant gas (61.58%),about 25.62% patients had been allergen tested,56.65 % patients had used drug treatment.27.10 % patients had family history of asthma or allergic rhinitis.Conclusions The morbidity of asthma combining with allergic rhinitis is high in Huizhou city,the cognition is low,and treatment status are not optimistic,which can be the basis of prevention and treatment in future.%目的 了解惠州地区支气管哮喘(简称哮喘)患者合并过敏性鼻炎的情况,分析两者在临床表现

  7. Analysis of inhaled allergen spectrum of children with allergic rhinitis in Guangzhou%广州地区儿童变应性鼻炎患者吸入变应原谱分析

    Institute of Scientific and Technical Information of China (English)

    王洁; 周丽枫; 陈彦球; 罗仁忠; 陶佳; 刘碧霞

    2012-01-01

    目的:了解广州地区儿童变应性鼻炎(AR)患者吸入变应原分布,分析其相关因素,为预防和治疗儿童AR提供科学依据.方法:采用10种标准化常见吸入变应原,选取2009-01—2011-12期间在我科门诊拟诊为AR的广州地区626例患儿,进行皮肤点刺试验(SPT),计算各种变应原阳性率,并结合性别、年龄、居住环境、哮喘史、湿疹史、家族史等临床资料进行分析.结果:变应原SPT阳性率为84.82%(531/626),以粉尘螨、屋尘螨阳性率最高,分别是76.36%和72.84%,其次依次为狗毛11.98%、猫毛7.03%、德国小蠊4.31%等.变应原阳性率高低与家族史、湿疹史、是否伴哮喘显著相关,与性别、居住环境无关.而阳性率强弱与性别无显著关系,与其他因素显著相关.不同年龄段的SPT阳性率不同,>10~14岁最高(SPT为93.8%),>7~10岁、4~7岁分别为86%、78.6%,3组年龄段间两两比较差异有统计学意义(x2=16.972,P<0.05).在螨类过敏阳性率、猫毛与狗毛阳性率,>10~14岁组的点刺阳性率最高,4~7岁组最低,差异有统计学意义(x2=30.017、48.254,P<0.05),而3组在蟑螂类、真菌类及树草类阳性率的差异无统计学意义(P>0.05).结论:广州地区儿童AR主要变应原是尘螨,其次是狗毛、猫毛、蟑螂等.儿童期AR的发病与发展和多种因素相关,研究不同年龄、居住环境、家族史、湿疹史、是否伴哮喘的AR患儿的变应原特征,有助于疾病的早期诊断和早期干预.%To explore the inhaled allergen distribution of children with allergic rhinitis in Guangzhou area and to analyze the relevant factors. Method:Six hundred and twenty-six cases children in Guangzhou region diagnosed with allergic rhinitis from January 2009 to December 2011 in our outpatient department were tested with skin prick test (SPT), Ten of standardized common inhaled allergens were analysed. The variety of allergens positive rate was

  8. Clinical Analysis of Perennial Allergic Rhinitis Specific Immunotherapy%常年性变应性鼻炎特异性免疫治疗的临床分析

    Institute of Scientific and Technical Information of China (English)

    陈紫晖

    2015-01-01

    Objective To study the clinical efficacy of perennial allergic rhinitis specific immune therapy, hoping to provide reference for the clinical treatment of.Methods For 205 cases of 2011-01~2011-12 in our hospital with specific immune therapy for perennial allergic rhinitis patients were retrospectively analyzed, as the observation group, after three years of treatment, pay a return visit to the 205 patients in 2014;205 cases of perennial allergic rhinitis patients and then take the same period with traditional antihistamines drugs com-bined hormone therapy as the control group, the difference in the overall effect of the two groups, Immunology Examination of the two groups of patients before and after treatment, improvement of immunological function of observation period.Results The total efficiency of two groups of patients were more than 85%, shows obvious curative effect of therapy has two groups of patients, but the difference is not obvi-ous, is not statistically significant (P>0.05);second, immunological function tests showed.The observation group venous blood IL-2, IL4 and IL5 levels were significantly improved in the control group before and after treatment, but the detection of several functional level was greatly improved, with significant difference (P<0.05).Conclusion The specific immune therapy has a good clinical curative effect of perennial allergic rhinitis, and significant improvement for immune function, can be effective in the prevention and treatment of allergic rhinitis, so it is worth popularizing in clinic.%目的:对常年性变应性鼻炎特异性免疫治疗的临床疗效进行研究,希望可以为临床治疗提供借鉴。方法对2011-01~2011-12间在我院用特异性免疫治疗方法治疗常年性变应性鼻炎的205例患者进行回顾分析,并将其作为观察组,经过三年治疗后,在2014年对这205例患者进行回访;然后选取同时期用传统抗组胺类药物联合激素治疗的205例常年

  9. 腧穴激光照射加神阙穴闪罐治疗过敏性鼻炎36例%Laser Irradiation Acupuncture Point Combined with Quick Cupping on Shenque Point in Treating 36 Cases of Allergic Rhinitis

    Institute of Scientific and Technical Information of China (English)

    乔志娟

    2012-01-01

    Objective: Seeking better therapy for treatment of allergic rhinitis. Method: Using near-infrared beam of semiconductor laser irradiated on the YingXiang up-YingXiang Lieque Feishu and Fengmen point and combined with quick cupping on the Shenque point .This method treated 36 cases of the allergic rhinitis. Results, 22 persons recovered, effected in 8 cases, improved in 4and invalid 2. Conclusion: laser irradiation combined with quick cupping on shenque point therapy for treatment of allergic rhinitis has a significant effect, total effective rate 94.5%.%目的:探寻治疗过敏性鼻炎的较佳疗法.方法:利用半导体激光的近红外线光束照射迎香、上迎香、列缺、肺俞和风门穴并配合神阙穴闪罐方法治疗过敏性鼻炎患者36例.结果:治愈22例,显效8例,有效4例,无效2例.结论:腧穴激光照射加神阙穴闪罐疗法治疗过敏性鼻炎有显著疗效,总有效率94.5%.

  10. Curative Effect Observation of Montelukast Sodium Joint Budesonide Nasal Spray in the Treatment of Allergic Rhinitis%孟鲁司特钠联合布地奈德鼻喷剂治疗变应性鼻炎的疗效观察

    Institute of Scientific and Technical Information of China (English)

    郑艳

    2015-01-01

    Objective To analysis the clinical curative effect of budesonide nasal spray joint meng LuSi sodium of treatment with allergic rhinitis. Methods Choose 80 patients with allergic rhinitis,(35) were randomly divided into control group and observation group (45), compared two groups of clinical curative effect. Results Observation group effective rate was 97.78%,the control group was 45.71%,the observation group is significantly higher than control group (P<0.05). Conclusion For allergic rhinitis take budesonide nasal spray joint meng LuSi sodium treatment,curative effect is obvious.%目的:分析布地奈德鼻喷剂联合孟鲁司特钠治疗变应性鼻炎临床疗效。方法选取80例变应性鼻炎患者,随机分为对照组(35)与观察组(45),对比两组临床疗效。结果观察组有效率为97.78%,对照组为45.71%,观察组明显高于对照组(P<0.05)。结论对变应性鼻炎采取布地奈德鼻喷剂联合孟鲁司特钠治疗,疗效明显。

  11. The significance of allergen detection for eczema, allergic rhinitis and asthma patients%过敏原检测对湿疹、过敏性鼻炎和哮喘患者的意义

    Institute of Scientific and Technical Information of China (English)

    尧荣凤; 姜培红; 许国祥; 徐龙; 李智; 薛龙; 赵迪

    2015-01-01

    Objective To understand allergen IgE antibody distribution for different allergic diseases, in order to provide the reference for clinical prevention and treatment.Methods A total of 236 patients with allergic rhinitis, 250 patients with asthma and 275 patients with eczema were enrolled.Western blot was performed to detect the serological specific allergen IgE antibody.The allergens for allergic rhinitis, asthma and eczema were analyzed comparatively. Results The inhaled allergen detection rate was 41.66% in the 761 patients, and the ingested allergen detection rate was 8.28%.Dust mite(43.10%) was the most common allergen, and dog hair (12.22%),milk(11.43%) and house dust(10.78%) were the other 3 common allergens.The prevalence rates of dust mite(62.35%), dog hair(21.11%), house dust(18.89%) and milk (26.47%) in 11-30 years old group were higher than those in the other age groups (P 0.05).Conclusions Serum allergen detection might be conducive to identify the allergic status of patients, and provides a reliable reference to assist in the diagnosis of allergic diseases, prevent from environmental factors and make treatment plan.%目的:了解过敏原 IgE 抗体在不同过敏性疾病中的分布情况,为临床防治提供依据。方法采用免疫印迹法检测过敏性鼻炎(236例)、哮喘(250例)和湿疹(275例)患者血清过敏原特异性 IgE 抗体,同时对过敏性鼻炎、哮喘和湿疹患者的过敏原进行比较分析。结果761例患者吸入性过敏原检出率为41.66%,食入性过敏原检出率为8.28%;最常见的过敏原为户尘螨(43.10%)、狗毛皮屑(12.22%)、牛奶(11.43%)和屋尘(10.78%)。11~30岁组的户尘螨(62.35%)、狗毛皮屑(21.11%)、屋尘(18.89%)和牛奶(26.47%)阳性率明显高于其他年龄组(P <0.05)。湿疹患者蟑螂、牛奶和点青霉/分枝孢霉/烟曲霉/黑曲霉/交链孢霉的阳

  12. [Secretory eosinophilia and obstructive rhinitis].

    Science.gov (United States)

    Rouvier, P; Mondain, M; Elkhoury, J

    1992-01-01

    Detecting eosinophilia in the nasal secretions of patients complaining of nasal obstruction makes it possible to identify a group of high risk patients. Hosty use of surgery in these patients carries a high risk of iatrogenic complications and little potential for improvement. The 2 most frequently used methods of obtaining cytologic specimens (swabbing versus washing) were compared in 37 patients with obstructive rhinitis (early stage polyposis and nonallergic rhinitis with eosinophilia syndrome, NARES). Swabbing gave reliable results. Eosinophilia was negligible in a group of 25 control subjects. The mean eosinophil count was 2.5% and only 1 patient had a positive cystogram. The 220 patients which nasal obstruction were classed in 5 groups according to the severity of clinical signs and symptoms. The mean eosinophil count and the percentage of patients with positive cystogram increased with increased severity of the clinical syndrome. 28 patients had uncomplicated obstructive rhinitis, 10 had NARES, 43 had allergic rhinitis, 52 had chronic obstructive rhinitis, and 87 had nasosinal polyposis. The respective mean eosinophil counts were 6.42%, 10.3%, 13.8% 16.8% and 31.4%. The percentage of patients with positive cytograms was respectively, 10.8%, 20%, 23.3%, 28.8% and 54%.

  13. Influence of corticosteroids on system of cortisol-growth hormone in children withAllergic rhinitis%糖皮质激素鼻喷雾剂对儿童肾上腺皮质功能的影响

    Institute of Scientific and Technical Information of China (English)

    张文; 韩想莉; 刘晖; 李世东; 高小娥; 丁瑜

    2012-01-01

    目的:探讨应用糖皮质激素对变应性鼻炎儿童皮质醇、生长激素(GH)及身高的影响.方法:变应性鼻炎患儿25例(观察组)给予布地奈德鼻喷雾剂治疗,每鼻孔1掀,2次/d,疗程4周.同时口服氯雷他定糖浆,用药剂量为0.11~0.24mg/kg,1次/d,用药4周.治疗前和治疗后6个月采静脉血5ml,采用放射免疫分析法(RIA)测定其血清皮质醇、生长激素(GH)水平,应用标准法测量并记录观察组及对照组身高.结果:观察组儿童用药前及用药6个月后其血清皮质醇和GH水平均无显著性差异.观察组身高治疗前、治疗后6个月时与对照组儿童身高比较无显著性差异.结论:糖皮质激素对变应性鼻炎儿童血清皮质醇和GH及身高的生长发育无明显影响.%Objective: To explore the changes of cortisol-growth hormone before and after corticosteroids in children with allergic rhinitis and to observe the variation of height between sick children and healthy children. Methods: Twenty-five children with allergic rhinitis were collected as observation group, and the patients were re-ceived budesonide one spray per nostril, two times per day for 4 weeks. Meanwhile these children took orally lorata dine syrup for 4 weeks. The serum blood were collected before treatment and after treatment 6 months; the contents of cortisol and growtn normone (GH) were measured by radio immunoassay(RIA). Tne heignt was measured and recorded by standard method. Results: The levels of serum cortisol and GH in children with allergic rhinitis had no significant differences before and after 6 months therapy. The height of children in observation group and control group which were healthy and had the same age and gender had no significant differences before therapy and after 6 months therapy. Conclusions:The serum consentbations of cortisol and GH in children suffered from allergis rhini tis have no obvious change before and after 6 months budesonide spray. The height changes

  14. Treatment of combined allergic rhinitis and asthma syndrome by nasal inhalation of budesonide%经鼻吸入布地奈德治疗过敏性鼻炎-哮喘综合征

    Institute of Scientific and Technical Information of China (English)

    刘颖慧; 付蔷; 张迎俊; 李明华

    2008-01-01

    Objective In recent years WAO advocated combined allergic rhinitis and asthma syndrome (CARAS),a new diagnostic term. Meanwhile, both upper and lower respiratory tract need united diagnosis and treatment. So CARAS patients were treated through inhalation of glucocorticoid using spacer for nose and mouth, thus to evaluate the value of inhaled glucocorticoid through nose in treatment of CARAS.Methods Eighty-six CARAS patients treated by inhaling budesonide through nose-mouth spacer were randomly assigned to mouth-inhaled group and nose-inhaled group. The score for nosal symptoms, chest symptoms,lung function and airway responsiveness were observed before and after treatment. Results Both nose-inhaled group and mouth-inhaled group improved the chest symptoms and pulmonary ventilation function and reduce airway hyperreactivity, showing significant difference after treatment( P<0.01). There was no significant difference between two groups after treatment ( P>0.05). But the nose-inhaled group was superior to the mouth-inhaled group in nosal symptoms improvement( P<0.01). Conclusions Compared with the oral inhalation, nasal inhalation of budesonide could not only control allergic rhinitis, but also prevent asthma,which should be recommended to apply in the prevention and treatment of CARAS patients.%目的 最近世界变态反应组织(WAO)提出了过敏性鼻炎-哮喘综合征(combined allergic rhinitis and asthma syndrome,CARAS)这一新的诊断术语.同时指出上、下呼吸道疾病需要进行联合诊断和联合治疗.采用了鼻-口两用雾化器(spacer),分别经口或经鼻吸入糖皮质激素治疗CARAS患者,以评价经鼻吸入糖皮质激素在防治CARAS的价值.方法 采用鼻-口两用雾化器(商品名:吸保)吸入布地奈德气雾剂治疗86例CARAS患者,随机将患者分为经口吸入组和经鼻吸入组,同时观察了两组治疗前后的鼻部症状记分、胸部症状记分、肺功能和气道反应性.结果 鼻吸组

  15. 玉屏风颗粒治疗过敏性鼻炎的临床疗效观察%Clinical effects of Yu Pingfeng granule in the treatment of allergic rhinitis

    Institute of Scientific and Technical Information of China (English)

    罗懿明; 易伟民

    2015-01-01

    目的:观察玉屏风颗粒联合西药治疗过敏性鼻炎的临床疗效。方法:将64例过敏性鼻炎患者随机分为对照组和观察组,每组各32例,两组患者均以西药进行抗过敏治疗,观察组在此治疗基础上加用中药复方制剂玉屏风散颗粒进行治疗,并比较两组患者喷嚏、流涕、鼻塞、鼻痒等临床症状改善时间及治疗2个月后的复发率。结果:观察组患者喷嚏、流涕、鼻塞、鼻痒等临床症状改善时间显著短于对照组,且治疗2个月后的复发率显著低于对照组,差异显著,均具有统计学意义( P﹤0.05)。结论:玉屏风颗粒联合西药治疗过敏性鼻炎的临床疗效显著,值得临床上推广应用。%Objective To observe the clinical effect of Yu Pingfeng granule combined with western medicine in the treatment of allergic rhinitis. Method 64 cases of patients with allergic rhinitis were randomly divided into control group and observation group,32 cases in each group,the patients of two groups were treated with western medicine of anti allergy treatment,on the basis of this,the patients of the observa-tion group were treated with Yu Pingfeng granule,and the improvement time of the clinical symptoms such of sneezing,runny nose,nasal con-gestion,nasal itching of patients in the two groups were compared,the recurrence rate were compared after 2 months of treatment. Results In the observation group,sneezing,runny nose,nasal congestion,nasal itching and other symptoms improved time was significantly shorter than that in control group after 2 months of treatment,and the recurrence rate was significantly lower than the control group,the difference was sig-nificant,the differences were statistically significant(P﹤0. 05). Conclusion The curative effect of Yu Pingfeng granule combined with west-ern medicine in the treatment of allergic rhinitis is significant,which was of clinical application.

  16. Clinical efficacy of improved incision septoplasty for patients with allergic rhinitis%改良切口鼻中隔成形术治疗变应性鼻炎

    Institute of Scientific and Technical Information of China (English)

    王爱平; 孙海波

    2016-01-01

    Objective To analyze the clinical efficacy of improved incision septoplasty in treatment of allergic rhinitis and its effect on the life quality of patients.Methods A total of 42 patients with persistent allergic rhinitis and merge nasal septum in our hospital from July 2013 to April 2015 were divided into observation group and control group.The observation group were treated by improved incision septoplas-ty,and the control group received traditional KillIan incision treatment.The clinical efficacy,survival quality and visual analog scale between two groups were compared.Results After treatment,The total efficiency rate of observation group(94.24%)was significantly higher than that of control group(85.71%)(χ2 =7.15,P <0.05).The nasal congestion,nasal itching,sneezing and other symptoms score of observa-tion group were significantly lower than those of control group(P <0.05).The score of nasal problems,eye problems,eye problems and non-nasal sleep disorders in observation group were also significantly lower than those in control group(P <0.05).Intraoperative situation of ob-servation group was significantly better than that of control group(P <0.05).Conclusion Improved incision septoplasty has a good clinical efficacy for patients with persistent allergic rhinitis and merge nasal septum,which can significantly improve the clinical symptoms and life quality of patients.%目的:分析改良切口鼻中隔成形术治疗变应性鼻炎的临床疗效及对患者生存质量的影响。方法选取2013年7月至2015年4月在我院耳鼻喉科手术治疗的42例持续性中重度合并鼻中隔偏曲的变应性鼻炎患者,按手术方式不同分为观察组和对照组,观察组给予改良切口鼻中隔成形术治疗,对照组给予传统 KillIan 切口单纯鼻中隔黏膜切除术治疗,对2组患者的临床疗效,生存质量及视觉模拟评分进行比较。结果治疗后观察组总有效率94.24%,显著高于对照组的85.71

  17. Effect of steroid nasal spray on pediatric allergic rhinitis in children with adenoidal hypertrophy%鼻用类固醇治疗儿童变应性鼻炎伴腺样体肥大疗效分析

    Institute of Scientific and Technical Information of China (English)

    韦一; 王德乐; 王韶鉴; 曾莉

    2015-01-01

    Objective To evaluate the curative effect of steroid nasal spray on pediatric allergic rhinitis with adenoidal hypertrophy.Methods A total of 261 children with adenoids served as the control group,of them,190 children (72.7%)were with adenoid hypertrophy.A total of 162 children with allergic rhinitis and adenoids served as the ex-perimental group,of them,110 children(67.2%)were with adenoid hypertrophy.The two groups were both treated by Fluticasone propionate nasal spray (50 μg per nostril a day)for 3 months.Results Adenoidal hypertrophy incidence was 72.7% in the control group and 67.2% in the experimental group (χ2 =1.16,P >0.05).112 (58.9%)patients in the control group and 89 (80.9%)patients in the experimental group had the adenoidal volume decreased (χ2 =19.04,P <0.01).Conclusion After steroid nasal spray treatment,the adenoidal volume is much more decreased in the experimental group than in the experimental group.Steroid nasal spray is the first choice for children with allergic rhinitis and adenoidal hypertrophy.%目的:探讨儿童变应性鼻炎(AR)与腺样体肥大的关系,评价鼻用类固醇治疗儿童变应性鼻炎伴腺样体肥大的疗效。方法对照组为单纯腺样体生长儿童261例,其中腺样体肥大190例(72.7%)。观察组为变应性鼻炎伴腺样体生长儿童162例,其中腺样体肥大110例(67.2%)。两组均给予鼻用类固醇(丙酸氟替卡松喷剂)持续喷鼻3个月后于鼻内镜下复查。结果对照组并发腺样体肥大构成比为72.7%,观察组并发腺样体肥大构成比为67.2%,差异无统计学意义(χ2=1.16,P >0.05)。对照组采用鼻用类固醇治疗后有效腺样体体积减少112例(58.9%),观察组有效腺样体体积减小89例(80.9%)(χ2=19.04,P <0.01)。结论经鼻用类固醇治疗,变应性鼻炎伴腺样体肥大患儿腺样体体积减小程度较单纯腺样体肥大患儿明显。对

  18. Behavior research of allergic rhinitis with adenoid hypertrophy in children%变应性鼻炎伴腺样体肥大儿童行为调查研究

    Institute of Scientific and Technical Information of China (English)

    敬云龙; 胡彬雅; 黄晶; 赵斯君; 陶礼华; 彭湘粤

    2012-01-01

    目的:探讨变应性鼻炎伴腺样体肥大患儿手术治疗对其行为方面的影响.方法:117例变应性鼻炎伴腺样体肥大患儿随机分成研究组和对照组,其中对照组42例,局部使用类固醇喷鼻剂,连续使用2~3个月,同时给予口服抗组胺药治疗;研究组75例,给予内镜下腺样体切除术,同时使用药物治疗,治疗方法同对照组.3个月后对所有患儿进行行为调查比较,内容包括睡眠、性格、记忆等方面.结果:治疗前两组患儿在腺样体肥大、鼻部症状以及临床问卷分值方面无显著差异,具有可比性.研究组经治疗后在“响鼾”、“不安宁的睡眠或频繁醒觉”、“鼻阻塞而张口呼吸”以及“频繁的上呼吸道感染”4个症状较对照组的改善差异有统计学意义(P<0.05).结论:变应性鼻炎伴腺样体肥大患儿宜采用手术治疗,腺样体切除利于行为症状的改善.%Objective;To investigate the behavior difference of allergic rhinitis with adenoid hypertrophy between study group and control group. Method: One hundred and seventeen children diagnosed as allergic rhinitis with adenoid hypertrophy were enrolled in our study were divided into study group and control group. Forty-two children treated with local steroid nasal spray for two to three months and antihistamine were control group. Seventy-five children treated with endoscopic adenoidectomy and drug treatment were study group; All children' parents were inquired for their clinical presentation. Result; No distinctive differences were found between the two groups(P>0. 05 Jin adenoid hypertrophy, accompanying nasal problems and clinical questionnaire scoring. Significant sratistical distinction were found(P<0. 05)in snoring, sleep disturbance and frequent arousal, nasal obstructive moth-breathing, and recurrent respiratory tract infection between the two groups after three-month follow up. Conclusion: Endoscopic adenoidectomy should be taken into

  19. 儿童变应性鼻炎合并支气管哮喘协同治疗及管理研究进展%Research on collaborative treatment and management of allergic rhinitis and asthma in children

    Institute of Scientific and Technical Information of China (English)

    刘晓颖(综述); 向莉(审校)

    2016-01-01

    Allergic rhinitis (AR)and bronchial asthma often coexist in the same individual,in which they influence development and severity of each other.Both domestic and foreign research has showed that Syn-ergistic treatment to children with AR and asthma could be achieved by inhaled corticosteroids(ICS),oral leu-kotriene receptor antagonist and subcutaneous /sublingual allergen specific immunotherapy;collaborative manage-ment will be realized by doctors'Comprehensive clinical assessment,children and caregivers'self-assessment and chronic disease management tools.Collaborative treatment and management is significant to children with both allergic rhinitis and asthma.In addition,it has an edge in improving compliance of children and their parents during the treatment,the quality of childrens'life,and reducing burden of the diseases.%儿童变应性鼻炎和支气管哮喘常在同一个体共存,两者交互影响疾病进程及疾病严重程度。国内外研究显示给予变应性鼻炎合并哮喘患儿糖皮质激素、口服白三烯受体拮抗剂和皮下/舌下过敏原特异性免疫治疗,可协同治疗两种疾病。由于变应性鼻炎和哮喘均为慢性呼吸道疾病,需要长期随访并阶梯性调整用药,因而患儿及照护者的自主评估有助于疾病的协同管理,慢性疾病管理工具对疾病的协同管理亦是不可或缺的。重视儿童变应性鼻炎和哮喘协同治疗和管理,对提高治疗依从性,改善生活质量,减轻疾病负担有重要意义。

  20. 变应性鼻炎儿童的智力结构与个性特征分析%Analysis of intelligence structure and personality characteristics of children with allergic rhinitis

    Institute of Scientific and Technical Information of China (English)

    刘萍; 郭杰峰; 吴郁丽; 伍慧卿

    2016-01-01

    Objective To study the intelligence structure and personality characteristics of children with allergic rhinitis.Methods 126 children who were diagnosed as allergic rhinitis were divided into mild group and moderate to severe group according to the severity of the disease. And 45 healthy children were selected as control group. The mild group、moderate to severe group and control group were evaluated with the Chinese Version Wechsler Intelligence Scale for Children(C - WISC)and Eysenck Personality Questionnaire(EPQ). Results Compared with the control group,there was no statistical difference in full scale intelligence quotient (FIQ)、verbal scale intelligence quotient( VIQ)、performance scale intelligence quotient( PIQ),subtests of C - WISC and the unbalance between VIQ and PIQ incidence rate in mild group(P > 0. 05),but there was statistically significant difference in full scale intelligence quotient(FIQ)、verbal scale intelligence quotient(VIQ)、performance scale intelligence quotient(PIQ)between moderate to severe group and control group(P 0. 05),compared with the control group,the score of psychoticism and neuroticism of the moderate to severe group was higher,however,the score of introversion - ex - traversion was lower,and the difference was statistical significant (P 0.05);中重度组与对照组相比,总智商(FIQ)、言语智商(VIQ)、操作智商(PIQ)差异有统计学意义(P 0.05);中重度组与对照组相比,精神质维度评分高,内外向维度评分低,神经质维度评分高,差异有统计学意义(P <0.05)。结论中重度持续性变应性鼻炎儿童智商水平普遍偏低,患儿智力结构损害以知识、领悟、词汇为代表的反映言语理解因子和以算术、数字广度、编码为代表的反映记忆/注意因子方面为主,智力结构发展不平衡;患儿人格特质以情绪不稳、敏感、孤僻等抑郁质倾向为主。

  1. 儿童变应性鼻炎吸入性和食入性变应原比较%Inhalation versus food allergens in children with allergic rhinitis

    Institute of Scientific and Technical Information of China (English)

    李卡凡; 邝立

    2014-01-01

    目的 探讨佛山地区儿童变应性鼻炎(AR)患者吸入性和食入性变应原的种类和分布情况.方法 选取300例近2年门诊儿童AR患者进行吸入性和食入性变应原皮肤点刺试验,分析比较佛山地区AR患者变应原分布特点.结果 300例儿童患者中,吸入组变应原SPT阳性反应243例(81.00%),变应原排列前位的为屋尘螨、粉尘螨、热带螨、德国小蠊、狗毛;食入组中SPT阳性反应105例(35.00%),变应原排列依次为螃蟹、虾、花生、桃子.结论 佛山地区AR患者的主要变应原是尘螨、蟑螂及海鲜类食入性变应原.%Objective To investigate the distribution of inhalation and food allergens in children with allergic rhinitis in Fosha.Methods 300 children were detected by skin prick test in the past two years and then analyzed the distribution of allergens.Results In the inhalation group,243 of 300 cases (81.00%) got positive reaction; the top allergens were house dust mite,farina mite,tropical mite,blattella germanica,and dog hair.In the food group,the ratio of positive reaction was 35.00% (105/300); the top common allergens were crab,shrimp,peanut,and peach.Conclusions The main allergens of children with allergic rhinitis in Foshan include dust mites,cockroaches,and seafood.

  2. Characteristics of aeroallergens of children with allergic rhinitis in Foshan%佛山地区儿童变应性鼻炎患者吸入性变应原特点分析

    Institute of Scientific and Technical Information of China (English)

    于青青; 王跃建; 唐隽; 刘悦胜; 刘美华; 马新苗

    2016-01-01

    Objective To investigate the distribution of aeroallergens in children with allergic rhinitis (AR) in Foshan city and to analyze the relevant factors.Methods 562 children with AR treated at our outpatient department from September,2012 to September,2015 underwent skin prick tests (SPT) with allergopharma skin prick kit,which included 11 kinds of standardized common aeroallergens.The positive rate of variety of allergens was calculated.Their gender,age,family history,and histories of asthma and eczema were analyzed.Results The total positive rate of aeroallergens was 82.56% (464/562).The positive rates of dermatophagoides pteronyssinus (80.64%),dermatophagoides farina (78.66%),and tropical mites (59.31%) were the top three and the positive rates of dog hair (15.36%),cat hair (12.63%),and Blattella germanica (12.32%) came next.Among the positive patients,16 cases (3.30%) were allergic to only one aeroallergen,39(8.02%) to two,and 431 (88.68%)to three or more than three.The positive rate of SPT was different in three different age groups and the highest one was that of the 10-14 years old group (90.18%),that of the 7-10 years old group (87.57%) came next,and that of the 3-7 years old group (79.73%) was the lowest,but with no statistical differences between each two groups (x2=2.452,P>0.05).There was statistical difference in the positive rate of SPT between the female group and the male group (x2=7.195,P<0.05).The positive rate correlated with family history and histories of eczema and asthma.Conclusions The main aeroallergens in children with allergic rhinitis in Foshan city tested by SPT are dermatophagoides pteronyssinus,dermatophagoides farina,and tropical mites.The positive rate of aeroallergens correlates with the sex and age of children.The positive rate of children with family history and the histories of asthma and eczema is much higher than that of the control group.Early skin prick test is helpful for the early diagnosis and

  3. Trichuris suis ova therapy for allergic rhinitis does not affect allergen-specific cytokine responses despite a parasite-specific cytokine response

    DEFF Research Database (Denmark)

    Bourke, C.D.; Mutapi, F.; Nausch, N.;

    2012-01-01

    Parasitic helminths have been shown to reduce inflammation in most experimental models of allergic disease, and this effect is mediated via cytokine responses. However, in humans, the effects of controlled helminth infection on cytokine responses during allergy have not been studied....

  4. Effect of Desloratadine Citrate Disodium Injections on Ovalbumin-induced Allergic Rhinitis in Rats%枸地氯雷他定注射液对大鼠过敏性鼻炎的影响

    Institute of Scientific and Technical Information of China (English)

    揭琼; 袁馨; 陈美灵; 吴玉林

    2015-01-01

    Objective: To study the effect of desloratadine citrate disodium injections (DLC) on ovalbumin-induced allergic rhinitis in rats, including the rhinitis symptoms, PGD2 and LTC4 levels and inflammatory cell infiltration in nasal lavage fluid (NLF). Methods: Ovalbumin-induced allergic rhinitis male SD rats were randomly divided in five groups: model group, DLC low, medium and high dose groups, and chlorphenamine maleate injectlon (CHM) group as positive group. In addition, the normal rats were also recorded. From the 22nd day of being modeled, rats of the model and normal groups were given iv saline, the DLC low, medium and high dose groups were given DLC at 0.3, 0.6 and 1.2 mg·kg-1, CHM group were given CHM at 0.6 mg·kg-1, all the iv treatments were once a day for five days. Rats were topically sensitized by instilling ovalbumin solution into the bilateral nasal cavities on alternate days. Symptoms of rhinitis were observed continuously for 30 min at the last time for administration and topically sensitization, taking the scoring method to record the symptoms of rhinitis. Two hours after the intranasal challenge, NLF was collected, PGD2 and LTC4 levels and inflammatory cellular infiltration were evaluated, respectively. Results and Conclusion: DLC significantly attenuated ovalbumin-induced rhinitis symptoms and caused a significant reduction in PGD2 and LTC4 levels and inflammatory cellular infiltration.%目的:研究枸地氯雷他定注射液对卵白蛋白(OVA)致大鼠过敏性鼻炎的鼻部症状及鼻腔灌洗液PGD2、LTC4含量和炎症细胞浸润的影响。方法:采用OVA建立大鼠过敏性鼻炎模型,将造模成功的SD雄性大鼠随机分成5组:模型组、枸地氯雷他定注射液(简称枸地)低、中、高剂量组,阳性药马来酸氯苯那敏注射液(扑尔敏)组。另随机取正常大鼠设正常组。造模第22天,模型组和正常组静注生理盐水;枸地低、中、高剂量组分别静注0.3、0

  5. Study of clinical immunotherapy in children with allergic asthma and rhinitis%过敏性哮喘和鼻炎患儿的临床免疫治疗研究

    Institute of Scientific and Technical Information of China (English)

    杭杲; 刘春霞

    2014-01-01

    目的:探讨过敏性哮喘和鼻炎患儿的特异性免疫治疗的临床应用。方法采用体外特异性过敏原检测系统对儿童医院门诊患儿进行血清过敏原特异性 lgE(SlgE)抗体和总 lgE 进行检测,对尘螨过敏患儿进行分组治疗,免疫治疗组采用粉尘螨滴剂舌下脱敏治疗,对照组按普通药物抗过敏治疗,治疗6个月、12个月给予临床控制指标评分,同时观察患儿血清中 SIgE 的改变。结果218例过敏患儿吸入性过敏114例(52.4%),食入性过敏101例(46.3%)。98例尘螨过敏患儿占总过敏者和吸入性过敏者的44.95%和85.96%。免疫治疗组与对照组比较差异有统计学意义(P <0.05);脱敏治疗患儿 SIgE 阳性率有所下降,但差异无统计学意义(P >0.05)。结论218例过敏患儿的特异性过敏原检测中尘螨过敏者最多;舌下特异性免疫治疗过敏性哮喘和鼻炎效果显著。%Objective To investigate the clinical application of specific allergen immunotherapy (AIT)for the children with al-lergic asthma and rhinitis.Methods The in vitro specific allergen test system was adopted to detect allergen specific IgE and total IgE in children outpatients of the Children's Hospital.The children patients with dust mite allergy were divided into groups for con-ducting therapy.The immunotherapy group adopted the Dermatophagoides farinae drops for hypoglossis desensitization therapy, while the control group was performed the anti-allergic therapy by the common drugs.The clinical control indicator scores were per-formed after 6-months and 12-month therapy and at the same time the change of serum specific LgE was observed.Results Among 218 cases of allergy,114 cases(52.4%)were inhalation allergy and 101 cases (46.3%)were food allergy.98 cases of dust mite al-lergy accounted for 44.95% of the total allergy and 85.96% of the inhalation allergy.The difference in the curative effects

  6. 成都地区过敏性鼻炎患者过敏原的检测分析%Detection and analysis of allergens in allergic rhinitis patients in Chengdu

    Institute of Scientific and Technical Information of China (English)

    蒋锐明; 范敏; 谢亚柳; 袁洛花; 许琴

    2013-01-01

    目的 检测成都地区过敏性鼻炎(AR)患者血清中的过敏原情况,为临床诊断和治疗过敏性鼻炎提供实验室依据.方法 过敏性鼻炎患者88例及同期就诊的非过敏性鼻炎患者30例,采用酶免疫斑点法,检测患者血清中的吸入性和食入性过敏原共20项.结果 吸入性过敏原前3位为:屋尘螨/粉尘螨组合(65.9%)、屋尘(43.2%)狗上皮(9.1%);食入性过敏原前3位为:虾和海鱼组合(13.6%)、艾蒿(11.4%)、黄豆(10.2%).30例阴性对照仅有1例检测出阳性过敏原为虾和海鱼.结论 屋尘螨/粉尘螨和虾/海鱼分别是导致成都地区AR最主要的吸入性和食入性过敏原,有意识地避免接触这些过敏原及进行特异性的免疫治疗对防治过敏性鼻炎具有积极意义.%Objective To detect allergen in serum of patients with allergic rhinitis (AR) for diagnosis and treatment.Methods Sera from 88 AR patients and 30 non-allergic rhinitis controls were collected and detected for 20 kinds of allergen by using enzyme-linked immunospot assay.Results In Chengdu city,the positve rates arrangement of top 3 of inhalant allergens are house dust mite/dermatophagoides farinae (65.9%),house dust (43.2%) and dog epithelium (9.1%),respectively and of ingested allergens are shrimp/marine fish (13.6%),artemisia argyi (11.4%) and soybean (10.2%),respectively.Only 1 of 30 controls is allergic to shrimp and marine fish.Conclusion House dust mite/dermatophagoides farinae and shrimp/marine fish are the uppermost inhalant and ingested allergens recpectively which induced AR in Chengdu city.Dection of allergen is meaningful for patients to prevent suffering from AR disease by avoiding touching these allergens consciously,and it is important for clinicians to perform specific immunotherapy on AR patients.

  7. The effects of subcutaneous allergen immunotherapy by Alutard SQ allergy vaccination in management of perennial allergic rhinitis%标准化屋尘螨疫苗特异性免疫治疗常年性变应性鼻炎的疗效观察

    Institute of Scientific and Technical Information of China (English)

    符微; 林霞; 蔡飞; 王刚; 邓慧林; 黎箐; 王小娟

    2012-01-01

    目的:了解标准化屋尘螨疫苗特异性免疫治疗常年性变应性鼻炎的疗效.方法:对38例变应性鼻炎患者用标准化屋尘螨疫苗特异性免疫治疗3年或3年以上,免疫前后进行症状和体征评分.结果:38例中,显效21例,有效7例,无效10例,总有效率达73.68%.结论:标准化屋尘螨疫苗特异性免疫治疗变应性鼻炎疗效明显.%Objective: To study the effects of subcutaneous allergen immunotherapy by Alutard SQ allergy vaccination in management of perennial allergic rhinitis. Method:Thirty-eight cases of the perennial allergic rhinitis received the subcutaneous allergen immunotherapy by Alutard SQ allergy vaccination for 3 years or more than 3 years. The clinical symptoms and signs were compared before and after treatment. Result:Good result were obtained in 21 of 38 cases, 7 cases effective, and 10 cases ineffective. Total effective rate was 73. 68%. Conclusion: The subcutaneous allergen immunotherapy by Alutard SQ allergy vaccination was very effective for the perennial allergen rhinitis.

  8. Effect of Desloratadine in Treatment of Allergic Rhinitis%地氯雷他定治疗过敏性鼻炎的疗效分析

    Institute of Scientific and Technical Information of China (English)

    崔佳菲

    2016-01-01

    Objective Desloratadine effect in treatment of al ergic rhinitis is to be studied. Methods Chose 73 patients of al ergic rhinitis who were treated in hospital from October 2014 to October 2015 and separated them into two groups at random,39 patients in study group were given desloratadine medication treatment,while another 34 patients in control group were given placebo medication treatment,and then compared treatment effects and medication safety between two groups. Results Patients’treatment efficacy in study group was 92.31%,while treatment efficacy in control group was 82.35%,thus,treatment efficacy was much higher in study group and such a differential had statistic value(P<0.05). Besides,side-effect incidence in study group was 2.6%and it was up to 11.8%in control group. Thus,side-effect incidence in control group was quite higher than that in study group (P<0.05). Conclusion Desloratadine medication is quite effective in treatment of al ergic rhinitis,it is conducive to relieving patients’symptoms quickly with low side-effect incidence but high medication safety.%目的:探究过敏性鼻炎患者采用地氯雷他定治疗的方法和效果。方法选取2014年10月~2015年10月收支的73例过敏性鼻炎患者进行治疗,随机分组,实验组39例患者采用地氯雷他定治疗,对照组34例患者给予安慰剂的之力啊,比较患者的疗效和安全性。结果实验组患者治疗有效率为92.31%,对照组治疗有效率为82.35%。实验组患者得到更加显著的治疗效果,差异有统计学意义(P<0.05)。且实验组不良反应发生率为2.6%,对照组不良反应发生率为11.8%,对照组患者的不良反应率高于对照组(P<0.05)。结论过敏性鼻炎患者采用地氯雷他定治疗,身体不适的症状在短时间内得到缓解,不良反应较小,安全性高。

  9. Paediatric rhinitis: position paper of the European Academy of Allergy and Clinical Immunology.

    Science.gov (United States)

    Roberts, G; Xatzipsalti, M; Borrego, L M; Custovic, A; Halken, S; Hellings, P W; Papadopoulos, N G; Rotiroti, G; Scadding, G; Timmermans, F; Valovirta, E

    2013-09-01

    Rhinitis is a common problem in childhood and adolescence and impacts negatively on physical, social and psychological well-being. This position paper, prepared by the European Academy of Allergy and Clinical Immunology Taskforce on Rhinitis in Children, aims to provide evidence-based recommendations for the diagnosis and therapy of paediatric rhinitis. Rhinitis is characterized by at least two nasal symptoms: rhinorrhoea, blockage, sneezing or itching. It is classified as allergic rhinitis, infectious rhinitis and nonallergic, noninfectious rhinitis. Similar symptoms may occur with other conditions such as adenoidal hypertrophy, septal deviation and nasal polyps. Examination by anterior rhinoscopy and allergy tests may help to substantiate a diagnosis of allergic rhinitis. Avoidance of relevant allergens may be helpful for allergic rhinitis (AR). Oral and intranasal antihistamines and nasal corticosteroids are both appropriate for first-line AR treatment although the latter are more effective. Once-daily forms of corticosteroids are preferred given their improved safety profile. Potentially useful add-on therapies for AR include oral leukotriene receptor antagonists, short bursts of a nasal decongestant, saline douches and nasal anticholinergics. Allergen-specific immunotherapy is helpful in IgE-mediated AR and may prevent the progression of allergic disease. There are still a number of areas that need to be clarified in the management of rhinitis in children and adolescents.

  10. 共刺激分子OX40/OX40L在小鼠变应性鼻炎发病机制中的作用%Effect of the costimulatory pathway OX40/OX40L on pathogenesis of allergic rhinitis in mice

    Institute of Scientific and Technical Information of China (English)

    李伟; 甘敏; 刘尚耀; 朱凤华; 杜明; 赵建东

    2011-01-01

    目的 探讨OX40/OX40L在小鼠变应性鼻炎发病机制中的可能作用.方法 精选30只清洁级小白鼠,随机分成对照组、模型组、干预组.通过免疫组织化学方法 测定对照组和模型组小鼠鼻黏膜中OX40的表达,同时应用ILISA法测定各组中IL-4、IL-10、IFN-γ的水平.结果 OX40在变应性鼻炎小鼠鼻黏膜上皮细胞、腺体细胞、血管内皮细胞、CD4T细胞中均呈现高表达,OX40主要表达于细胞膜、细胞浆,在对照组中极少表达(P<0.05).ILISA法测定IL-4、IL-10、IFN-γ在对照组与模型组间差异有统计学意义(P<0.05),模型组和干预组相比差异有统计学意义(P<0.05).结论 OX40/OX40L在变应性鼻炎小鼠发病机制中起重要作用.%Objective To evaluate the role of another costimulatory pathway OX40/OX40 ligand(L) in pathogenesis of allergic rhinitis in mice. Methods 30 mice were divided into three groups: the control group, the allergic rhinitis group, and the OX40LmAb interfere group. Immunohistochemistry was used to examine expression of OX40 in the first two groups. IL-4, IL-10 and IFN-γ in the peripheral blood were analyzed by ELISA. Results OX40 showed a strong expression in the epithelium, glandular epithelium cells, vascular endotheliocytes and CD4 + T cells. OX40 was mainly expressed in cytomembrance and cytoplasm, while OX40 was a stained a little in the control group. There was a statistically significant deviation between the allergic rhinitis and control groups ( P <0.05). Compared with the control group, the allergic rhinitis group had higher IL-4 and IL-10 levels and lower IFN-γlevel in peripheral blood (P <0.05). Compared with the allergic rhinitis group, the OX40LmAb interfere group had lower IL-4 level and higher IFN-γlevel in peripheral blood(P <0.05). Conclusion OX40/OX40L plays an important role in pathogenesis of allergic rhinitis in mice.

  11. 变应原疫苗免疫治疗对过敏性支气管哮喘合并鼻炎的疗效分析%Effect of allergen immunotherapy with standardized vaccine in patients with allergic asthma and rhinitis

    Institute of Scientific and Technical Information of China (English)

    孙立英; 郭胤仕; 王菁兰; 王群; 王怡玮; 许以平

    2011-01-01

    目的 评估标准化变应原疫苗免疫治疗(allergen immunotherapy,AIT)对过敏性哮喘合并鼻炎患者的近期疗效.方法设计调查问卷,对我院门诊接受标准化变应原疫苗-安脱达(Alutard(R)SQ)AIT治疗的39例过敏性哮喘合并鼻炎患者进行问卷调查,应用哮喘控制水平分级和哮喘控制测试(ACT)评分评价哮喘的疾病控制水平,应用鼻炎病情评分(RCT)评价过敏性鼻炎的控制情况.结果39例患者治疗前后的哮喘控制水平分级(Z=-7.235,P<0.05)、ACT评分(t=16.533,P<0.05)、RCT评分(t=16.650,P<0.05),情绪(x2=34.873,P<0.05)等均有较大程度的改善.结论标准化AIT治疗能明显改善过敏性哮喘合并鼻炎患者的临床症状.%Objective We sought to assess the effect of allergen immunotherapy (AIT) with Alutard? SQ in patients with allergic asthma and rhinitis. Methods Designed the questionnaire and surveyed 39 patients with allergic asthma and rhinitis accepting AIT with Alutard? SQ allergen extract so that we can know their situation before and after accepting AIT. We used levels of asthma control and Asthma Control Test(ACT)to evaluate their levels of asthma control, and used Rhinitis condition score (RCT) to evaluated their rhinitis control. Results 39 subjects completed the survey, and the results showed: AIT resulted in a significant improvement in levels of asthma control( Z = - 7. 235, P <0. 05), ACT (t =16.533, P <0. 05), RCT (t =16.650, P <0. 05) and mood(x2= 34. 873, P <0. 05). Conclusions AIT with Alutard? SQ significantly improved symptoms of the patients with allergic asthma and rhinitis.

  12. 雷公藤甲素对变应性鼻炎大鼠模型Fas表达的影响及机制研究%Mechanism and effects of triptolide on Fas of rats with allergic rhinitis

    Institute of Scientific and Technical Information of China (English)

    姚淋尹; 耿曼英

    2011-01-01

    Objective This experiment investigated the effects of triptolide about Fas in nasal mucosa of rats allergic rhinitis models, discussed the possible mechanism of triptolide's therapeutic effect on allergic rhinitis and compared with glucocorticosteroids, in order to provide the evidence of applying TP to clinics. Methods Totally 40 healthy SD rats were divided into four groups randomly (n = 10). They were OVA(ovalbumin) group, TP( triptolide ) group, DM(dexmethasone) group and SC( sodium chloride) group. OVA was applied on rats orderly going through two phases: basic sensitization and stimulation. TP, DM and SC group were applied on the other groups respectively before 30 minutes in phase of stimulation. Nasal mucosa was separated from nasal cavity. IH (Immunohistochemistry) was used to determine the expression of Fas in nasal mueosa. The numbers of each sample were calculated under microscope and expressed as ± s, all data were analysed by statistic software SPSS 13. O: F test( one factor analysis of variance) and LSD( the least significant difference). Results The positive expressing signals of Fas were located in the part of glands, epithelials, endothelials of vessel, vascular smooth muscle and inflammation cells. Fas expression had significant difference compared with other three groups in OVA group or SC group ( P <0.01 ); And no significant difference had been seen between TP and DM groups( P >0.05). Conclusions TP can promote expression of Fas in AR model established by OVA. TP has no significant difference with DM. TP is worthy of being further studied as a promising drug in clinical therapy for AR.%目的 探讨变应性鼻炎(AR)大鼠鼻黏膜Fas的表达和雷公藤甲素对他们的干预作用,为雷公藤甲素治疗变应性鼻炎提供初步理论依据.方法 选健康SD大鼠加只,雌雄不限,随机分为卵清蛋白(OVA)致敏组,雷公藤(TP)处理组,地寒米松(DM)处理组和生理盐水(SC)对照组,每组10只,用卵清蛋白腹

  13. Establishment of Aats Allergic Rhinitis and Asthma Syndrome Model and Evaluation%过敏性鼻炎-哮喘综合征大鼠模型的建立与评价

    Institute of Scientific and Technical Information of China (English)

    史锁芳; 周奎龙

    2014-01-01

    Objective:To establish a rat model of allergic rhinitis and asthma syndrome and evaluate its effect .Methods:Clean level 20 healthy male SD rats , were randomly divided into control group and model group , 14 days after the use of intraperitoneal injection of ovalbumin, continuous nasal drip with ovalbumin 7 days, starting from 15th, the model group rats in the airtight vessel within (home-made 50 cm ×30 cm ×20 cm transparent plastic box ) with cover , give 2%OVA atomized inhalation solution , build model;In the con-trol group with normal saline instead .Results:The model group after antigen stimulate the mouth breathing , abdominal moved , irrita-bility, restlessness, shaking, hair, nose, sneezing, very oral and ear purple , water quantity increased obviously , listlessness, eat less, unresponsive, activity significantly reduced or prone motionless , the colour yellow curly, such as asthma acute attack.Total num-ber of white blood cells in BALF ( bronchoalveolar lavage ) and classification of eosinophil increased obviously .Nose and a small bron-chus and lung tissue pathology slice see accompanying around blood vessels more inflammatory cells , numerous eosinophils cells infil-trating .Conclusion:The model of allergic rhinitis and asthma syndrome is established by the way in this study , which is comparable to the physiopathologic characteristics of human asthma ., the successful molding method has certain popularization value .%目的:建立一种大鼠过敏性鼻炎-哮喘综合征的模型并评价其效果。方法:清洁级健康雄性SD大鼠20只,随机分为对照组和模型组,运用卵白蛋白腹腔注射14天后,用卵白蛋白连续鼻部滴注7天,从第15日开始,将模型组大鼠置于密闭器皿内(自制的50 cm ×30 cm ×20 cm透明带盖塑料盒),给予2%OVA溶液进行雾化吸入,建立模型;对照组以生理盐水代替。结果:模型组经抗原激发后张口喘息,腹部翕动,易激惹,躁动

  14. 青岛地区变应性鼻炎患者合并哮喘的流行病学调查研究%Epidemiological Investigation of Allergic Rhinitis Patients with Asthma in Qingdao Area

    Institute of Scientific and Technical Information of China (English)

    高荣莉; 张念凯; 丁见; 臧延伟; 闫舒; 刘婷婷; 刘赞刚; 宫相贵; 周晓彬; 李娜

    2012-01-01

    目的:调查青岛地区变应性鼻炎患者合并哮喘的患病率及相关因素.方法:设计“青岛地区变应性鼻炎问卷调查表”.采用多阶段抽样及整群抽样的方法,调查青岛地区常住(5年及5年以上)居民,年龄在5-70岁,均无高血压、糖尿病、风湿性疾病及精神障碍性疾病的居民.共调查人数为2052人:调查分三个阶段:问卷调查阶段、根据问卷结果筛选AR可疑对象、对AR可疑对象进行专科检查及变应原皮肤点刺试验以确诊.对结果进行统计学处理.结果:发放问卷总数为2400份,有效问卷为2052份,有效率为85.5%,青岛地区5-70岁居民AR患者248例,其中20例合并支气管哮喘,AR患者合并哮喘的患病率为8.06%,其中男7.14%,女9.26%,男女AR患者合并哮喘的患病率差异无统计学意义(X2=0.36 P>0.05).结论:青岛地区变应性鼻炎患者合并哮喘的患病率为8.06%,初步了解青岛地区人群中变应性鼻炎合并哮喘的现状,为临床医生对其综合治疗并制定合理有效的治疗方案提供理论基础.%Objective:To investigate the morbidity of allergic rhinitis patients with asthma and correlative factors in Qingdao area.Methods:A questionnaire survey on AR in Qingdao area was designed.Two-stage sampling and cluster sampling methods were applied to the mental healthy permanent residence,excluding hypertension,diabetes mellitus and rheumatic disease,aged from 5-70 years old in Qingdao area including seven district and five cities.This investigation had three stages:questionnaire survey,screening of suspected AR patients according to the results of questionnaire,then suspects of AR were identified by the diagnose through specific examination of professional doctors and Allergen skin tests.Results:2052 questionnaires were available.The effective rate was 85.5%.There were 248 cases of AR,including 20 cases with asthma.The prevalence rate of AR patients with asthma in residents aged from 5

  15. Prevalence of allergens for Changsha patients with allergic rhinitis%长沙地区变应性鼻炎患者的变应原分布特点及结果分析

    Institute of Scientific and Technical Information of China (English)

    吕云霞; 谢志海; 赵素萍; 章华; 刘永珍; 陈香; 蒋卫红

    2011-01-01

    目的:通过对长沙地区变应性鼻炎患者进行过敏原检测及分析,筛查本地区常见过敏原,绘制本地区变应性鼻炎患者的变应原分布图,为合理防治变应性鼻炎提供统计学依据.方法:对1437例疑似变应性鼻炎患者进行皮肤点刺试验,测定致敏变应原,并进行统计学分析.结果:1437例疑似变应性鼻炎患者中898例(62.49%)有阳性反应,898例阳性患者中吸入性变应原阳性率依次为粉尘螨883例(98.33%)、屋尘螨849例(94.54%)、真菌Ⅱ 173例(19.27%)和杂草165例(18.37%);食入组变应原以小虾318例(35.41%)为主;儿童期、青少年期和成年期点刺阳性患者中2种以上变应原呈阳性的比例依次为8.57%、18.04%、19.15%.结论:在长沙地区,导致变应性鼻炎的吸入性变应原中,屋尘螨、粉尘螨占据绝对的主导地位,应作为长沙地区的重点变应原开展变应性鼻炎的防治工作,尤其重视儿童变应性鼻炎的治疗.%Objective:To investigate the allergens in patients with allergic rhinitis,to find common allergens of Changsha and to provide statistic basis for a reasonable prevention and treatment. Method: The allergens in 1437 patients with allergic rhinitis in Changsha were detected by skin prick test. Result: Eight hundred and ninty eight (62.49 %)of 1 437 cases presented positive reaction. Among positive cases in inhalation group, the most common allergen was flour mite (98.33%), then were house dust mite (94. 54%), mycetes Ⅱ (19. 27%) and weed (18.37%). Shrimp(35.41%) was thc most common allergens in food group. △nd in childhood, adolescence and a dulthood prick positive cases, the ratio of more than 2 positive allergens were about 8. 57,18.04 %, 19. 15%.Conclusion:The study shows that the f1our mite and house dust mite are the most common allergens in Changsha.

  16. Clinical research on the serum serum levels of vitamin D in the children with allergic rhinitis%血清维生素D水平与儿童过敏性鼻炎的相关性研究

    Institute of Scientific and Technical Information of China (English)

    吕翔

    2015-01-01

    目的:探讨儿童过敏性鼻炎与血清维生素D水平的相关性。方法选择2013年4月—2014年4月我院儿科门诊体检5岁~10岁儿童60例,其中过敏性鼻炎患儿30例作为试验组,在门诊体检健康儿童30例作为对照组,分别使用串联质谱仪检测其血清维生素D水平。结果试验组儿童总维生素D测定水平为(22.88±1.78)ng/mL,其中维生素D3测定水平(21.12±2.24)ng/mL,维生素D2测定水平(3.69±3.03)ng/mL;对照组儿童总维生素D测定水平为(31.88±4.54)ng/mL,其中维生素D3测定水平(29.18±2.44)ng/mL,维生素D2测定水平(3.86±4.09)ng/mL。2组维生素D3及总维生素D测定水平比较差异均存在统计学意义(P<0.05)。结论过敏性鼻炎儿童患者的血清维生素D水平与正常儿童相比明显偏低,而且以血清维生素D3水平偏低为主。%ObjectiveTo research the relationship between serum level of vitamin D and allergic rhinitis. Methods100 children aged from 5 to 10 years old were divided into the experimental group and the control group, each group had 50 cases.Tandem mass spectrometry was used to detect the serum levdls of vitamin D.ResultsTotal vitamin D level of control group was(22.88±1.78)ng/mL. vitamin D3 level was(21.12±2.24)ng/ml,and vitamin D2 level was(3.69±3.03)ng/ml.Total vitamin D level of experimental group was(31.88±4.54)ng/mL.vitamin D3 level was(29.18±2.44)ng/mL,and vitamin D2 level was(3.86±4.09)ng/mL.There were significant differences of total vitamin D level and vitamin D3 level between the two groups(P<0.05).ConclusionThe level of total vitamin D in allergic rhinitis children is lower than that of normal children,with lower level of vitamin D3 primarily.

  17. Clinical research on the serum levels of vitamin D in the children with allergic rhinitis%过敏性鼻炎儿童血清维生素D水平的临床研究

    Institute of Scientific and Technical Information of China (English)

    周宁; 曹梅馨; 黎冬梅; 黄斯凡

    2012-01-01

    Objective To research the relationship between serum level of vitamin D and allergic rhinitis. Methods 100 children aged from 2 to 6 years old were divided into the experimental group and the control group, each group had 50 cases. Tandem mass spectrometry was used to detect the serum levels of vitamin D. Results Total vitamin D level of control group was (32.87+4.67) ng/mL, vitamin D2 level was (3.84±4.21) ng/mL and vitamin D3 level was (29.96+2.52) ng/mL. Total vitamin D level of experimental group was (23.00±2.00) ng/mL, vitamin D2 level was (3.62±3.04) ng/mL and vitamin D3 level was (20.38+2.32) ng/mL. There were significant differences of total vitamin D level and vitamin D3 level between the two groups (P < 0.05). Conclusion The level of total vitamin D in allergic rhinitis children is lower than that of normal children, with lower level of vitamin D3 primarily.%目的 探讨血清维生素D水平与过敏性鼻炎的相关性.方法 选择海珠区妇幼保健院2~6岁儿童100例,其中健康儿童50例为对照组,患过敏性鼻炎儿童50例为实验组,分别使用串联质谱仪检测其血清维生素D水平.结果对照组总维生素D水平为(32.87±4.67)ng/mL,其中维生素D2水平为(3.84±4.21)ng/mL,维生素D3水平为(29.96±2.52)ng/mL;实验组总维生素D水平(23.00±2.00)ng/mL,其中维生素D2水平(3.62±3.04)ng/mL,维生素D3水平(20.38±2.32)ng/mL.两组总维生素D及维生素D3水平比较差异均存在统计学意义(均P < 0.05).结论 过敏性鼻炎儿童血清维生素D水平比正常儿童偏低,且以维生素D3水平偏低为主.

  18. 枸地氯雷他定治疗过敏性鼻炎疗效观察%Efficacy of Desloratadine Citrate Disodium in the Treatment of Allergic Rhinitis

    Institute of Scientific and Technical Information of China (English)

    俞静

    2015-01-01

    Objective:To observe the clinical effect and safety of desloratadine citrate disodium in the treatment of allergic rhinitis ( AR) . Methods:Totally 80 patients were randomly divided into the control group and the observation group with 40 ones in each. There was no difference in gender, age, duration of allergic rhinitis, classification of serological specificity IgE between the two groups (P>0. 05). The observation group was treated with desloratadine citrate disodium tablets 8. 8mg, po, qd. The control group was given loratadine 10mg, po, qd. The treatment course was 12 days. All the patients were not given corticosteroids and other antihistamines. The clinical symptoms and signs integral, curative effect and adverse drug reactions during the treatment were observed. Results: In the observation group, 23 cases were markedly effective, 13 cases were effective, 3 cases were ineffective, one case didn’ t finish the study, and the total effective rate was 92. 30%. In the control group, the above index was 10 cases, 18 cases, 10 cases, 2 cases and 73. 68%, respectively. There was statistically significant difference in the total effective rate between the two groups (P0.05),观察组予以枸地氯雷他定片8.8 mg,po,qd,连续服用12 d。对照组予以氯雷他定10 mg,po, qd,连续服用12 d。所有观察患者均不使用皮质类固醇及其他抗组胺药物。观察两组患者治疗前后症状及体征积分、临床疗效及药品不良反应。结果:观察组显效23例,有效13例,无效3例,脱失1例,总有效率92.30%;对照组显效10例,有效18例,无效10例,脱失2例,总有效率73.68%;两组总有效率比较,差异有统计学意义(P<0.05)。观察组治疗后各项症状体征积分与对照组相比有明显降低,差异有统计学意义(P<0.05)。观察组药品不良反应发生率明显少于对照组。结论:枸地氯雷他定片治疗AR临床疗效优于氯雷他定,安全性好。

  19. 变应性鼻炎患者3292例变应原谱变化分析%Analysis of allergen variation for 3292 patients with allergic rhinitis

    Institute of Scientific and Technical Information of China (English)

    彭晓林; 张金梅; 王丽生; 时文杰; 孙沛湧; 张玉庚; 林鹏

    2013-01-01

    Objective To investigate the variation of common allergens in patients with allergic rhinitis in recent 4 years in Tianjin First Center Hospital.Methods The medical records of skin prick test on 3292 patients with allergic rhinitis between 2009 and 2012 were restrospectively analyzed.The changing trend of various allergens in 4 years and distribution differences were compared.The differences of the top 5 allergens in under age group,adult group and different gender group were further analyzed by SPSS 19.0 software.Results The positive rate of dermatophagoides farinae was increasing year by year,from 45.1% in 2009 to 66.3% in 2012,and the positive rate of dermatophagoides pteronyssinus increased from 42.0% in 2009 to 58.6% in 2012,the difference was statistically significant (x2 value was 68.70,41.55,all P <0.01).The positive rate of dermatophagoides farinae and dermatophagoides pteronyssinus in adult group and male group showed significant upward trend year by year (x2 value was 75.85,69.93,274.25,42.62,all P <0.01),but not in adult group and female group.The positive rate of quinoa,mugwort and humulus scandens decreased year by year between 2009 and 2011 (x2 value was 22.08,11.64,203.19,all P <0.01),but increased again in 2012 (x2 value was 21.55,29.38,12.40,all P < 0.01).Conclusions There is a tendency of change of allergens in patients with AR.This phenominon may be helpful for doctors to choose the type of skin prick liquid.%目的 了解天津市第一中心医院近4年来变应性鼻炎(allergic rhinitis,AR)患者变应原谱的变化情况.方法 回顾性分析2009-2012年确诊为AR的3292例患者皮肤点刺试验结果,研究各变应原阳性率4年来的变化趋势,并进一步分析前5位变应原在未成年人组、成年人组以及不同性别组的变化情况,以SPSS 19.0软件对数据进行统计学分析.结果 粉尘螨、屋尘螨变应原阳性率呈逐年增高趋势,分别由2009年的45.1%、42.0%上升至2012

  20. Allergic rhinitis and its impact on asthma control and pulmonary function%变应性鼻炎对哮喘患者临床控制及肺通气功能的影响

    Institute of Scientific and Technical Information of China (English)

    张丽; 胡红; 陈雷; 曹璐; 刘巧维; 牛晓婷

    2012-01-01

    Objective To determine the impact of allergic rhinitis on asthma clinical control and lung function. Methods Sixty-three patients with asthma alone or patients with asthma combined with allergic rhinitis ( 36 males and 27 females, mean age: 48.6 ±16. 1 years ) were divided into asthma group( n =32) and asthma combined with allergic rhinitis ( AR ) group( n =31 ) at Chinese PLA general hospital. The Asthma Control Test ( ACT ) score, the Asthma Control Questionnaire ( ACQ ) score, rescue use of salbutamol agonist and percent predicted FEV, ( FEV, % ), percent predicted PEF ( PEF% ) were evaluated respectively between asthma alone group and asthma combined with AR group. Results The patients in asthma combined with AR group had a significantly( P < 0.05 ) lower ACT score ( 16.3 ±5.6) than those with asthma alone ( 19. 0 ±4. 7 ); whereas the ACQ score ( 2. 1 ± 1. 3 ) in patients with asthma combined with AR was significantly higher than those ( 1.4 ± 1. 1 ) with asthma alone( P <0.05 ). The need for the salbutamol-agonist as a rescue medication 4 ( 0,12 ) in patients with asthma combined with AR was significantly( P <0.05 ) higher than those 0( 0,5 ) with asthma alone. The FEV,% ( 64.7 ±23. 1 )% in patients with asthma combined with AR was significantly( P < 0. 05 ) lower than those ( 77.7 ±21.7 )% with asthma alone, and the PEF% ( 65. 8 ±22. 0 )% in the patients with asthma combined with AR was significantly( P <0.05 ) lower than those (79.4 ±26. 3 )% with asthma alone. Conclusion The patients with asthma combined with AR experienced more poor clinical control and severe asthmatic symptoms, and more need for salbutamol agonist as a rescue medication, and decreased in pulmonary function.%目的 探讨变应性鼻炎对支气管哮喘(简称哮喘)患者临床控制及肺通气功能的影响.方法 收集2010年5月-2011年7月解放军总医院呼吸科及耳鼻咽喉头颈外科门诊就诊的63例哮喘和哮喘合并变应性鼻炎患者,将其分为2

  1. 常州地区过敏性鼻炎儿童吸入性过敏原分析%Analysis of inhaled allergens in children with allergic rhinitis in Changzhou area

    Institute of Scientific and Technical Information of China (English)

    许小朋; 史梅; 史伟峰

    2014-01-01

    目的:分析常州地区过敏性鼻炎患儿吸入性过敏原检测结果及不同年龄组过敏原分布情况。方法采用德国敏筛过敏原检侧系统(Allergy Screen)测定473例0~12岁过敏性鼻炎患儿血清中过敏原特异性 IgE 抗体水平。根据年龄分为婴幼儿组(0~3岁)、学龄前儿童(4~6岁)和学龄儿童(7~12岁),并比较不同年龄组过敏原阳性率及变化趋势。结果473例患儿过敏原阳性340例(71.9%),前三位过敏原分别是户尘螨(55.6%)、混合真菌(25.8%)和屋尘(18.8%),随年龄增长阳性率均呈升高趋势。其中户尘螨(χ2=21.061,P =0.000)、屋尘(χ2=15.111,P =0.000)和猫狗毛皮屑(χ2=7.597,P =0.022)组间分布比较差异有统计学意义。单一过敏原阳性率最高(38.5%),第二位为双重过敏原阳性(23.7%)。单一过敏原阳性前三位与各类过敏原总体阳性排序相同。最常见双重过敏原是户尘螨+屋尘组合,多重过敏原阳性率组间分布差异有统计学意义(χ2=13.399,P =0.001)。结论常州地区过敏性鼻炎患儿吸入性过敏原以户尘螨、混合真菌和屋尘为主,阳性率随年龄增长呈上升趋势,不同年龄组过敏原构成有差异,单一过敏原阳性最常见,其次为双重过敏原阳性。%Objective To analyze the results of inhaled allergens detection in children with allergic rhinitis(AR)in Changzhou ar-ea and the distribution situation of allergens in different age groups.Methods The levels of serum allergen specific IgE antibodies in 473 children cases(aged 1-12 years)of allergic rhinitis(AR)were detected by the Allergy Screen allergen screen system.The children cases were divided into the infants group(0-3 years old),preschool children(4-6 years old)and school age children(7 -12 years old)according to age.The allergen positive rates and the change tendency were compared among

  2. 鼻舒适片联合枸地氯雷他定治疗过敏性鼻炎的临床研究%Clinical study on Bishushi Tablets combined with desloratadine citrate disodium in treatment of allergic rhinitis

    Institute of Scientific and Technical Information of China (English)

    陈阳静; 李宏慧; 赵瑞敏; 赵谦

    2016-01-01

    目的:探讨鼻舒适片联合枸地氯雷他定治疗过敏性鼻炎的临床疗效。方法选取2015年1月—2016年1月西安交通大学第一附属医院接受治疗的过敏性鼻炎患者138例,随机分为对照组和治疗组,每组各69例。对照组口服枸地氯雷他定胶囊,1粒/次,1次/d。治疗组在对照组的治疗基础上口服鼻舒适片,5片/次,3次/d。两组均连续治疗12 d。观察两组的临床疗效,同时比较两组治疗前后症状积分、白三烯 B4(LTB4)、IL-4、IL-10、IL-12、转化生长因子α(TGF-α)、γ-干扰素(IFN-γ)、IgE 的变化情况。结果治疗后,对照组和治疗组的总有效率分别为85.51%、95.65%,两组比较差异具有统计学意义(P<0.05)。治疗后,两组患者症状(包括鼻塞、鼻痒、喷嚏、流涕)评分、总分、IL-4、IL-10、TGF-α、LTB4、IgE 水平均显著降低,IL-12、IFN-γ水平显著升高,同组治疗前后差异有统计学意义(P<0.05);且治疗组这些观察指标的改善程度优于对照组,两组比较差异有统计学意义(P<0.05)。结论鼻舒适片联合枸地氯雷他定治疗过敏性鼻炎具有较好的临床疗效,可改善患者的临床症状,改善各检测因子水平,具有一定的临床推广应用价值。%Objective To explore the clinical efficacy of Bishushi Tablets combined with desloratadine citrate disodium in treatment of allergic rhinitis. Methods Patients (138 cases) with allergic rhinitis in the First Affiliated Hospital of Xi’an Jiaotong University from January 2015 to January 2016 were randomly divided into control and treatment groups, and each group had 69 cases. The patients in the control group were po administered with Desloratadine Citrate Disodium Capsules, 1 grain/time, once daily. The patients in the treatment group were po administered with Bishushi Tablets on the basis of the control group, 5 tablets/time, three times daily. The

  3. Analysis of efficacy and safety of standardized dust mites allergen vaccine in treatment of allergic rhinitis%标准化尘螨变应原治疗变应性鼻炎的疗效及安全性分析

    Institute of Scientific and Technical Information of China (English)

    桂晓钟; 纪东; 程静; 赵军; 王林; 蒋传亚

    2012-01-01

    目的 观察分析标准化尘螨变应原皮下注射治疗常年性变应性鼻炎的疗效及安全性.方法 对175 例尘螨过敏的变应性鼻炎患者进行标准化尘螨变应原皮下注射治疗,比较接受免疫治疗前与剂量累加阶段、剂量维持阶段的鼻部症状评分、体征评分和不良反应情况,分析评价特异性免疫治疗的疗效及安全性.结果 175例尘螨过敏的变应性鼻炎患者的鼻部症状与治疗前相比有明显减轻,差异有统计学意义(P﹤0.05);剂量累加阶段和剂量维持阶段的总有效率分别为84.57%和95.43%,单一尘螨过敏较以尘螨过敏为主的多种过敏原病例疗效较好,单一尘螨过敏显效的占全部病例的78.38%;多种过敏原过敏显效的占全部病例的40.38%.本组病例均未出现严重不良反应.结论 对尘螨引起的常年性变应性鼻炎进行规范化标准化变应原特异性免疫皮下注射治疗,是一种有效、安全和持久的对因治疗方法,并可有效控制哮喘症状.%Objective To observe and analyse the therapeutic effects and the safety of standard subcutaneous immuno - theraphy on the patients with perennial allergic rhinitis. Methods One hundred and seventy - five patients with allergic rhinitis caused by house - dust mites were selected. Clinical efficacy was evaluated by symptom and sign score after two stages of specific immunotherapy and compared with pre - treatment scores. Results The main symptoms of allergic rhinitis were significantly alleviated in those treated with standardized dust mites compared with those untreated. The difference was statistically significant ( P < 0.05 ). The effective rates were 84. 57% after the first phases of the SIT and 95. 43% after the second phases. Clinical efficacy on the house - dust mite allergic rhinitis patients was better than multi - allergen rhinitis patients. No serious complications or bad reaction were found in the treatment process. The treatment efficacy

  4. The Treatment of Allergic Respiratory Disease During Pregnancy.

    Science.gov (United States)

    Namazy, Jai; Schatz, M

    2016-01-01

    Pregnancy may be complicated by new-onset or preexisting asthma and allergic rhinitis.This article reviews the recognition and management of asthma and allergic rhinitis during pregnancy, paying close attention to the general principles of allergy and use of asthma medication during pregnancy. Both allergic rhinitis and asthma can adversely affect both maternal quality of life and, in the case of maternal asthma, perinatal outcomes. Optimal management is thus important for both mother and baby. This article reviews the safety of asthma and allergy medications commonly used during pregnancy.

  5. Clinical Study on Allergic Rhinitis (AR)Treated by "Shao′s Five-needling"and Modified Guomin Jian (Allergy Decoction)in Switzerland%“邵氏五针法”配合加味过敏煎治疗变应性鼻炎临床研究

    Institute of Scientific and Technical Information of China (English)

    田开宇; 陈强

    2015-01-01

    Objective:To observe on allergic rhinitis (AR)treated by acupuncture and modified Guomin Jian.Methods:9 1 cases of AR were treated by acupuncture and herbs for 6 weeks,the overall symptoms were scored with visual analogue scale (VAS)before and after treatment course.The average scores were compared and analyzed by paired T-test.Results:Data comparison shows significant difference (P66%.Conclusion:Joint use of acupuncture and modified Guomin Jian is markedly effective for allergic rhinitis (AR).%目的:观察针灸配合加味过敏煎治疗变应性鼻炎的临床疗效。方法:针灸配合加味过敏煎对91例变应性鼻炎瑞士患者治疗6周,应用视觉模拟评分法(visual analogue scale,VAS)对变应性鼻炎总体症状进行VAS评分,并对治疗前后VAS评分均数比较。结果:治疗前后VAS评分比较有显著性差异(P<0.05),疗效指标n>66%。结论:针灸配合加味过敏煎治疗变应性鼻炎有显著疗效。

  6. 变应性鼻炎与昆明气传花粉及气象条件的关系%Relationship among allergic rhinitis, regional pollens and meteorological conditions in Kunming area

    Institute of Scientific and Technical Information of China (English)

    程晟; 阮标; 余咏梅; 浦吉存

    2015-01-01

    Objective To evaluate the species,quantity and diffusionof allergenic pollens as well as the relationship among allergic rhinitis (AR),pollen species and meteorological conditions in Kunming area.Methods The exposure film was used to investigate the species of airborne pollen,the total number of these pollens during December 2009 to November 2010 by means of gravitational sedimentation,at the same time,AR patients were registered.The species of allergic pollen in Kunming area during the same period,and the statistic analysis was made with the meteorological elements,using the correlation analysis methods of Excel for data analysis.Results From December 2009 to November 2010,a total of 60 exposure films of pollen species was found,including 26 147 pollens.The annual airborne pollen showed two scattering peak,respectively:February to April and September to October;the number of advantage pollen was 17 species.The number of year-round drifting pollen was 13 species while 2 species showed two peaks on spring and autumn.There was another 26 new species added to the results of 2009-2010,compared with1987-1989,while the original 12 species were not seen.The drifting peak was the same.The number of allergen intradermal tests (AIT) positive AR patients was positively correlated with 16 pollen species,respectively,oleaceae,alnus nepalensis,walnut,palm,pigweed,fennel,Amaranthaceae,artemisia,rosa,Albizia julibrissin Durazz,gramineae,castor,Fraxinus L,populus,Morus alba L,hemp humulus,(r value were 0.689 7,0.550 1,0.742 1,0.755 2,0.771 2,0.663 3,0.556 1,0.568 3,0.659 8,0.607 4,0.834 7,0.664 3,0.745 9,0.634 7,0.718 3,0.777 2,all P < 0.05).The population of AIT positive AR patients was positively correlated with average temperature,average wind speed and other meteorological factors (r values were 0.552 0,0.883 5,both P < 0.05),and was negatively correlated with average relative humidity (r =-0.714 7,P <0.05).Conclusions Kunming had a large number of airborne pollen species

  7. Out-of-season recollection of drug use for seasonal IgE-mediated rhinitis

    DEFF Research Database (Denmark)

    Bodtger, Uffe; Malling, Hans-Jørgen; Poulsen, Lars K.

    2005-01-01

    The history of seasonal, IgE-mediated (allergic) rhinitis is often obtained postseasonally as a retrospective assessment. It is not known whether recollected drug use is representative for the in-seasonal medication history....

  8. Co-Administration of Chenopodium Album Allergens and CpG Oligodeoxy-nucleotides Effects on Peripheral Blood Mononuclear Cells of Patients with Allergic Rhinitis Treated with Intranasal Corticosteroids

    Directory of Open Access Journals (Sweden)

    Shokrollah Farrokhi

    2011-06-01

    Full Text Available Allergic Rhinitis (AR is one of the most common chronic diseases in the developed countries. This study was performed to investigate the effect of CpG-ODN in alteration of T-helper (Th1/Th2 balance of patients with AR treated with intranasal corticosteroids (INCs and antihistamines. Peripheral blood mononuclear cells (PBMCs of 20 patients with AR were isolated before and after 45 days therapy.Cytokine production (IL-4, IL-10, IL-13, IFN-γ and specific Ch.a IgE in response to CpG co- administration  of  natural  chenopodium  album  (CpG/Ch.a  or  recombinant  Ch.a  (CpG/rCh.a allergen were investigated in supernatants.of cultured PBMCs using ELISA Intracellular IL-10 was also assessed in CD4+ cells using flow cytometry. Significant increase in production of IFN-γ and IL-10 and decrease in production of IL-4 were found in supernatants of cultured PBMCs activated with CPG/ch.a and CPG/rch.a. of both CpG/Ch.a and CpG/rCh.a compared to allergens alone, before and after therapy.After therapy, IFN-γ production with CpG/Ch.a was significantly increased in comparison with before (237 vs. 44 pg/ml, p=0.001. IFN-γ and IL-10 production with CpG/rCh.a was significantly increased after therapy compared to before (407.6 vs. 109 pg/ml, p=0.01 for IFN-γ; 171.7 vs. 52.6 pg/ml, p=0.008  for  IL-10,  whilst  IL-4  was  significantly decreased (2.1  vs.  5.8  pg/ml,  p=0.02. Intracellular IL-10 expression was also significantly increased in response to either CpG/Ch.a or CpG/rCh.a that showed intracellular assay could be more sensitive than ELISA. Also, treatment with intranasal corticosteroids and antihistamines could enhance this CpG effect, in vitro.

  9. Clinical economy investigation on combined allergic rhinitis and asthma syndrome%过敏性鼻炎-哮喘综合征的临床经济学研究

    Institute of Scientific and Technical Information of China (English)

    李明华; 田涛; 刘颖慧; 张迎俊

    2009-01-01

    目的 明确过敏性鼻炎-哮喘综合征(combined allergic rhinitis and asthma syndrome,CARAS)这一新的医学诊断术语.从临床经济学角度出发,对经鼻吸入糖皮质激素对CARAS联合治疗与传统的采用鼻喷雾剂和口喷雾剂分别治疗的成本/效果比(C/E)进行研究比较.方法 哮喘门诊中随机选择CARAS患者74例,随机分为两组.其中一组为联合治疗组,采用经鼻吸入糖皮质激素喷雾剂进行治疗;另一组为传统治疗组,采用鼻喷雾剂和口喷雾剂分别进行治疗,疗程3个月.分别计算两组治疗的总费用(C),治疗后鼻部症状改善总评分(E1)、胸部症状改善总评分(E2)和PEFR增加值(E3),分别计算联合治疗组和传统治疗组的C/E1,C/E2和C/E3.结果 C/E1,联合组为8. 194,传统组为17. 499;C/E2,联合组为9. 001,传统组为15. 432;C/E3,联合组为8. 489,传统组为15. 867.结论 联合治疗组和传统治疗组在临床疗效基本相同的情况下,联合治疗组3个指标的C/E都远远低于传统治疗组的C/E,联合治疗这一新的治疗方式更具有临床经济学意义.

  10. Treatment of combined allergic rhinitis and asthma syndrome by nasal inhalation of budesonide%经鼻吸入布地奈德治疗过敏性鼻炎-哮喘综合征

    Institute of Scientific and Technical Information of China (English)

    刘颖慧; 付蔷; 张迎俊; 李明华

    2009-01-01

    目的 最近世界变态反应组织提出了过敏性鼻炎-哮喘综合征(combined allergic rhinitis and asthma syndrome,CARAS)这一新的诊断术语.同时指出上、下呼吸道疾病需要进行联合诊断和联合治疗.采用了鼻-口两用雾化器(spacer),分别经口或经鼻吸入糖皮质激素治疗CARAS患者,以评价经鼻吸入糖皮质激素在防治CARAS的价值.方法 采用鼻-口两用雾化器(商品名:吸保)吸入布地奈德气雾剂治疗86例CARAS患者,随机将患者分为经口吸入组和经鼻吸入组,同时观察了两组治疗前后的鼻部症状记分、胸部症状记分、肺功能和气道反应性.结果 鼻吸组与口吸组均可显著改善胸部症状、肺通气功能,降低气道高反应性.治疗前后差异有统计学意义(P<0.01),两组间比较差异无统计学意义,但在改善鼻部症状记分方面鼻吸组明显优于口吸组(P<0.01).结论 与口腔吸入比较,经鼻吸入给予布地奈德气雾剂是一种既可控制过敏性鼻炎,又可防治哮喘的治疗方法,应在伴有过敏性鼻炎的哮喘和CARAS患者的防治中推荐使用.

  11. Clinical economy investigation on combined allergic rhinitis and asthma syndrome%过敏性鼻炎-哮喘综合征的临床经济学研究

    Institute of Scientific and Technical Information of China (English)

    李明华; 田涛; 刘颖慧; 张迎俊

    2009-01-01

    目的 明确过敏性鼻炎-哮喘综合征(combined allergic rhinitis and asthma syndrome,CARAS)这一新的医学诊断术语.从临床经济学角度出发,对经鼻吸入糖皮质激素对CARAS联合治疗与传统的采用鼻喷雾剂和口喷雾剂分别治疗的成本/效果比(C/E)进行研究比较.方法 哮喘门诊中随机选择CARAS患者74例,随机分为两组.其中一组为联合治疗组,采用经鼻吸入糖皮质激素喷雾剂进行治疗;另一组为传统治疗组,采用鼻喷雾剂和口喷雾剂分别进行治疗,疗程3个月.分别计算两组治疗的总费用(C),治疗后鼻部症状改善总评分(E1)、胸部症状改善总评分(E2)和PEFR增加值(E3),分别计算联合治疗组和传统治疗组的C/E1,C/E2和C/E3.结果 C/E1,联合组为8.194,传统组为17.499;C/E2,联合组为9.001,传统组为15.432;C/E3,联合组为8.489,传统组为15.867.结论 联合治疗组和传统治疗组在临床疗效基本相同的情况下,联合治疗组3个指标的C/E都远远低于传统治疗组的C/E,联合治疗这一新的治疗方式更具有临床经济学意义.

  12. 特异性免疫治疗对儿童过敏性鼻炎-哮喘综合征的效果观察%Effect of Specific Immunity in Treatment of Children with Allergic Rhinitis Combined with Asthma

    Institute of Scientific and Technical Information of China (English)

    王淑玉; 郑一博; 吕朝霞

    2016-01-01

    目的 探讨特异性免疫治疗对过敏性鼻炎-哮喘综合征(combined allergic rhinitis and asthma syndrome,CARAS)儿童的临床效果和肺功能改善情况.方法 选择2014年2月-2015年2月就诊的CARAS 85例.按治疗方法分为观察组40例和对照组45例.对照组给予吸入糖皮质激素治疗,观察组在对照组基础上给予特异性免疫治疗.观察两组哮喘控制测试(C-ACT)、过敏性鼻炎症状评分及肺功能变化情况.结果 治疗后12个月观察组C-ACT评分高于对照组,治疗9、12个月观察组鼻炎症状评分低于对照组(P<0.05).观察组治疗9、12个月第1秒用力呼气量、用力呼出50%肺活量的呼气流速、用力呼出75%肺活量的呼气流速、最大呼气中期流量较对照组升高,呼吸总阻抗、气道总阻力、周边弹性阻力绝对值较对照组降低(P<0.05,P<0.01).结论 特异性免疫治疗联合吸入糖皮质激素治疗CARAS效果优于单纯吸入糖皮质激素,能显著改善小气道功能.

  13. 低温等离子消融治疗持续性变应性鼻炎回顾分析%Retrospective analysis of low-temperature plasma ablation therapy on persistent allergic rhinitis

    Institute of Scientific and Technical Information of China (English)

    刘智献; 李晓晖

    2012-01-01

    目的 探讨低温等离子消融及YAG激光联合鼻中隔矫正术治疗持续性变应性鼻炎(PAR)的疗效,寻求治疗PAR的辅助手术方法.方法 随访随机分组治疗后3年的患者,其中低温等离子消融组127例,YAG激光组118例.应用视觉模拟量表(VAS)对患者鼻塞、流鼻水、喷嚏、鼻痒、眼痒等症状进行术前和术后3年评分,比较两组治疗前后和两组之间疗效.结果 低温等离子消融组有效率87.4%,YAG激光组有效率为66.1%,差异有统计学意义(x2=15.74,P<0.01).两组术后VAS评分差异均有统计学意义(t=21.24、20.56,均P<0.01).结论 低温等离子消融治疗PAR明显优于YAG激光,可作为治疗PAR辅助方法之一,且安全性高.%Objective To compare the effect of low-temperature plasma ablation and YAG laser treatment on persistent allergic rhinitis(PAR) after septoplasty and to seek adjunct surgical procedures to tackle PAR.Methods Follow-up was performed three years after randomized grouping on PAR patients ( Low-temperature plasma ablation group 127 cases and YAG laser group 1 18 cases).Visual Analog Scale (VAS) was used to evaluate symptoms,such as nasal congestion,running nose,sneezing,nasal itching,eye itching etc preoperatively and postoperatively in order to compare the treatment effectiveness and intergroup difference.Results The efficacy rate of Low-temperature plasma ablation group was 87.4%,and YAG laser group was 66.1%.The difference was statistically significant( x2 =15.74,P < 0.01 ).The VAS scores for postoperative symptom relief in both groups were significantly different ( t =21.24,20.56,all P < 0.0 1 ).Conclusion As an adjunct treatment approach,low-temperature plasma ablation was superior to YAG laser in the treatment of PAR with preferable safety.

  14. Association between the Interaction of Key Genes Involved in Effector T-Cell Pathways and Susceptibility to Develop allergic Rhinitis: A Population-Based Case-Control Association Study.

    Directory of Open Access Journals (Sweden)

    Yuan Zhang

    Full Text Available Evidence suggests that interaction between key genes mediating signaling and transcriptional networks involving effector T-cell responses may influence an individual's susceptibility to develop allergic rhinitis(AR.The aim of this study was todetermine whether specific interactions between key genes involved in effector T-cell pathways are associated with an individual's susceptibility to develop AR in Han Chinese subjects.A cohort of 489 patients with AR and 421 healthy controls was enrolled from the Han Chinese population in Beijing, China. AR was established by questionnaire and clinical examination, and peripheral blood was drawn from all subjects for DNA extraction. A total of 96 single nucleotide polymorphisms (SNPs in 26 reprehensive candidate genes involved in T helper 1 (Th1, Th2, Th17, Th9 and T regulatory cell pathways were selected from the International Haplotype Mappingdatabase for Han Chinese in Beijing (CHB population, and IlluminaGoldenGate assay was conducted for SNP genotyping. The PLINK software package was used to perform statistical analyses.Simple SNP-phenotype association analysis using logistic regression showed SNP rs8193036 in IL17A gene, rs2569254 in IL-12 and rs1898413 in RORα weresignificantlyassociatedwith AR.Simple SNP-phenotype association analysis with genetic models demonstrated thatrs2569254 in IL-12, rs1031508 in STAT4, and rs3741809 in IL-26 were likely to be recessive, rs8193036 in IL17A allelic, rs897200in STAT4 genotypic, and rs1898413 in RORα dominant. Epistasis analyses exhibited that 83 SNPs in 23 genes were significantly interactive; of which 59 interactions/SNP pairs demonstrated OR values higher than 2 or lower than 0.5, and 12 interactions/SNP pairs OR values higher than 4 or lower than 0.25. STAT3, RORα and IL-26, involved in Th17 pathway,were the mostfrequentlyinteractive genes.This study suggests that interactions between several SNPs in key genes involved in effector T-cell pathways are

  15. 中医药治疗变应性鼻炎临床研究的思考与展望%Thinking and look forward to clinical study of allergic rhinitis by treatment of traditional Chinese medicine

    Institute of Scientific and Technical Information of China (English)

    张晓阳; 李颖; 连增林

    2009-01-01

    变应性鼻炎(AR)是一种由IgE介导的,针对环境过敏原的鼻黏膜炎症反应性疾病,临床主要表现为鼻痒、喷嚏、流涕、鼻塞等.中医认为古病"鼻鼽"包括了AR.对比AR的临床表现特点和中医风邪致病特点及风病临床表现特点,可以看出AR应属中医风病范畴.近10年的中医临床研究文献显示,治疗AR处方中出现最多的药物是风药(每方均有).文中针对近十年中医临床研究中存在的3方面问题,探讨今后研究应关注的5个问题,为中医治疗AR的临床与实验研究提供借鉴.%Allergic rhinitis (AR) is one kind of nose mucous membrane inflammation reactiveness disease , which is mediated by IgE for the environment sensitizin. The major clinical symptoms are:nose itch , the sneeze , nasal discharge, nasal obstruction and so on. It is thought that the acient disease named " Bi Qiu" has included AR. By comparing the AR clinical manifestation characteristic with trditional Chinese medicine (TCM) " Feng/wind" induced disease characteristic and the "Feng/wind" disease clinical manifestation characteristic, we can know that AR should belong to the " Feng/wind" disease category of TCM. It is shown that the " Feng/ wind" medicine is the most windly appeared in AR treatment formulas of TCM clinical research data (in each formular) in the past 10 years. To aim directly at three knids of problem in TCM clinical research, we discussed five problems which should pay close attention to the feature research, therefor to provide a mirror for AR clinical and experimental studies by TCM.

  16. 特异性免疫治疗对慢性鼻窦炎伴变应性鼻炎患者鼻内镜手术效果的影响%Effect of specific immunotherapy on outcomes after endoscopic sinus surgery for chronic rhinosinusitis with allergic rhinitis

    Institute of Scientific and Technical Information of China (English)

    陈金湘; 赵青; 周宁霞

    2011-01-01

    目的 探讨特异性免疫治疗对慢性鼻窦炎(CRS)伴变应性鼻炎患者功能性内镜鼻窦手术(FESS)效果的影响.方法 将确诊为CRS伴常年性变应性鼻炎的57例患者按照尘螨过敏与否分成两组,尘螨过敏者为治疗Ⅰ组,FESS术后采用皮下免疫治疗;非尘螨过敏者为治疗Ⅱ组,单纯行FESS.分别对两组患者术前、术后6个月、术后1年的症状及体征进行评分并对比,采用鼻腔鼻窦结局测试-20 (SNOT-20)量表及Lund-Kennedy鼻内镜评分法.结果 两组患者术后6个月和1年的SNOT-20及Lund-Kennedy评分较术前均有明显改善(P<0.01),治疗Ⅰ组患者的疗效优于治疗Ⅱ组且组间差异有统计学意义(P<0.05).结论 特异性免疫治疗可改善CRS伴变应性鼻炎患者的手术效果.%Objective To investigate the effect of specific immunotherapy on outcomes after functional endoscopic sinus surgery (FESS) for chronic rhinosinusitis (CRS) with allergic rhinitis. Method Fifty-seven CRS patients accompanied with perennial allergic rhinitis were divided into two groups according to the results of allergen skin prick test. Those who were allergic to dust mites, the treatment group I, were treated with subcutaneous immunotherapy after FESS, others were treatment group II and treated with FESS merely. Before and 6, 12 months after FESS, the nasal symptoms and signs of all patients were evaluated by sino-nasal outcome test-20 (SNOT-20) and Lund-Kennedy endoscopic scores, and compared with each other. Results Compared to the scores before FESS, the SNOT-20 and Lund-Kennedy scores of two groups are significantly improved in 6 months and one year after FESS (P<0.01). Significantly better curative effects were obtained in the treatment group I when compared with the treatment group Ⅱ (F<0.05). Conclusion Specific immunotherapy may improve the surgical outcomes in CRS patients with allergic rhinitis.

  17. Anthropogenic Climate Change and Allergic Diseases

    Directory of Open Access Journals (Sweden)

    Hueiwang Anna Jeng

    2012-02-01

    Full Text Available Climate change is expected to have an impact on various aspects of health, including mucosal areas involved in allergic inflammatory disorders that include asthma, allergic rhinitis, allergic conjunctivitis and anaphylaxis. The evidence that links climate change to the exacerbation and the development of allergic disease is increasing and appears to be linked to changes in pollen seasons (duration, onset and intensity and changes in allergen content of plants and their pollen as it relates to increased sensitization, allergenicity and exacerbations of allergic airway disease. This has significant implications for air quality and for the global food supply.

  18. Clinical economy investigation on combined allergic rhinitis and asthma syndrome%过敏性鼻炎-哮喘综合征的临床经济学研究

    Institute of Scientific and Technical Information of China (English)

    李明华; 田涛; 刘颖慧; 张迎俊

    2009-01-01

    Objective To define the new medical diagnostic term, which combines allergic rhinitis and asthma syndrome(CARAS). The cost/effectiveness ratio(C/E) value is interpreted and compared from clinical economy perspective on two different administrations in term of combined intranasal corticosteroids and traditional inhale corticosteroids (ICS) nasal and oral separately for treating CARAS. Methods 74 CARAS cases were selected from asthma clinic, then divided into two groups randomly, one group treated with combined ICS by nasal, another with traditional ICS by nasal and oral inhalation separately, the therapeutic course was 3 months. The total cost of two groups was calculated respectively, the result was (C) ,the nasal symptom total improved scores was (E1) and the chest symptom total improved scores was (E2) ,PEFR improvement was (E3). The combined treatment group and traditional group C/E as C/E1, C/E2 and C/E3 were figured out. Results The nasal symptom improvement C/E was C/E1,the combined group was 8. 194, the traditional group was 17. 499, the chest symptom improvement C/E was C/E2, the comhined group was 9. 001, the traditional group was 15. 432, PEFR improvement C/E was C/E3 the combined group was 8. 489, the traditional group was 15. 867. Conclusions Almost same clinical outcomes are achieved by combined treatment group and traditional group, but three indicators of C/E of combined group are much more lower than those of traditional group, which demonstrates that the new approach of combined treatment is meaningful for clinical economy.%目的 明确过敏性鼻炎-哮喘综合征(combined allergic rhinitis and asthma syndrome,CARAS)这一新的医学诊断术语.从临床经济学角度出发,对经鼻吸入糖皮质激素对CARAS联合治疗与传统的采用鼻喷雾剂和口喷雾剂分别治疗的成本/效果比(C/E)进行研究比较.方法 哮喘门诊中随机选择CARAS患者74例,随机分为两组.其中一组为联合治疗组,采用经鼻吸入

  19. Distribution of allergens in patients with allergic rhinitis in Hebei villagers and Tianjin citizens%河北地区村民与天津市民变应性鼻炎变应原谱比较

    Institute of Scientific and Technical Information of China (English)

    王泽海; 林文森; 王丽; 王小奇; 陈洁; 张振富; 于金珍

    2012-01-01

    目的 通过对变应性鼻炎( allergic rhinitis,AR)流行病学调查分析,获得河北地区生活村民(简称河北村民)与天津市生活市民(简称天津市民)以及其中AR确诊患者的变应原分布情况.方法 自2007年4月至2010年5月,通过随机整群和多级抽样,抽取河北村民与天津市民,进行直接面访调查和血清特异性IgE( specific IgE,sIgE)检测,应用SPSS 13.0软件对变应原分布数据进行统计学分析.结果 调查对象共计1524例.其中,河北村民1024例、天津市民500例,血清sIgE检测阳性率分别为27.2% (279/1024)和21.2% (106/500),差异有统计学意义(x2=7.13,P<0.01);AR患病率分别为9.2% (94/1024)和9.0% (45/500),差异无统计学意义(x2=0.01,P>0.05).狗上皮、猫上皮是河北农村地区AR的首要变应原,其次为粉尘螨、屋尘螨、桦木花粉(桦木)、牧草花粉(牧草);粉尘螨、屋尘螨是天津市区AR的首要变应原,其次为狗上皮、桦木、猫上皮、牧草.河北村民与天津市民AR变应原存在明显差异的变应原种类为:屋尘螨、粉尘螨和狗上皮(x2值分别为11.36、9.14、5.28,P值均<0.05).狗上皮变应原AR致病率河北村民较天津市民高,屋尘螨和粉尘螨变应原AR患病率天津市民较河北村民高.结论 变应原在AR患病中起重要作用,变应原存在地域和城乡差异.%Objective To investigate the epidemiology of allergic rhinitis(AR) and the distribution of allergens in villagers who lived in Hebei Province( Hebei villagers) and the citizens who lived in the city of Tianjin (Tianjin citizens).Methods From April 2007 to May 2010,face to face investigation and serum specific IgE (sIgE) examination were conducted among Hebei villagers and Tianjin citizens by randomly multi-stage and cluster sampling,and the results were analyzed. Results A total of 1524 cases were investigated,among them,1024 cases in Hebei and 500 cases in Tianjin,the prevalence of the sIgE test was

  20. Psychological characteristics in patients with allergic rhinitis and its associated factors analysis%变应性鼻炎患者的心理学特点及影响因素分析

    Institute of Scientific and Technical Information of China (English)

    锡琳; 韩德民; 吕晓飞; 张罗

    2009-01-01

    Objective To investigate the psychological characteristics of patients with allergic rhinitis(AR)and its associated factors.Methods Three hundred and seventy-seven patients with AR were evaluated by the Symptom Checklist-90(SCL-90).The results were compared with a standard,obtained from healthy Chinese population,including factors of gender,age,educational level,medical history of AR,presence of complications,type of allergenic sensitizations and nasal symptoms(using logistic regression analysis).Results An abnormal psychological state was found in 10% of AR patients,13% with deutohealthy,and remaining 77% of AR patients were completely healthy.The SCL-90 scores of the 377 patients were significantly higher than those of the normal standard population,including symptoms of somatization,compulsion,anxiety,rivalry and psychosis(t equals 7.128,3.943,2.777,6.423,7.507,respectively,all P<0.01).Male patients had worse psychological state than femals,especially in the aspects of compulsion,depression,anxiety,crankiness and psychosis(t equals respectively 2.680,1.977,2.539,2.107,2.844,all P<0.05).The SCL-90 scores of compulsion and horror were respectively different in different AR case history(F equals respectively 2.379,2.255,all P<0.05).AR complicated with asthma and eczema was the important factors that influenced patient's psychological status including compulsion,interpersonal sensitivity,depression,crankiness and psychosis(t equals respectively 6.835,8.914,7.254,13.358,6.030,all P<0.01).There were no statistical differences in different ages,AR types,educational level,allergen types(all P>0.05).Snuffle,sneeze and snivel had no influence on patient's SCL-90 scores(all P>0.05).Itchy nose was a major symptom that affect on AR patients' SCL-90 scores of depression(standard regression b=0.126,t=2.076,P<0.05).Conclusions AR patients' psychological status was worse than that of the healthy adults.%目的 观察变应性鼻炎(allergic rhinitis,AR)患者的

  1. Asma e rinite alérgica como expressão de uma única doença: um paradigma em construção Asthma and allergic rhinitis as symptoms of the same disease: a paradigm under construction

    Directory of Open Access Journals (Sweden)

    Paulo Augusto Moreira Camargos

    2002-12-01

    êuticas integradas para estas afecções.Objective: to describe current ideas about the relation between upper and lower respiratory tract and to review the epidemiological, immunological, and pathological aspects that support the paradigm of united airways disease. Sources: literature review using the Medline, MD Consult, HighWire, Medscape and Lilacs databases. We used allergic rhinitis and asthma as keywords, and searched articles published in the past 20 years. Summary of the findings: epidemiological evidence includes prevalence of allergic rhinitis in asthmatic patients and vice-versa, results of cross-sectional studies, bronchial hyperresponsiveness in patients with allergic rhinitis, importance of genetic and environmental factors, and the age of onset of atopic disease. Morphological and physiological aspects show structural differences between the nasal and bronchial mucosa, and the mechanisms that could explain the effect of rhinitis on asthma. Immunological aspects including the participation of bone marrow in the production of inflammatory cells and allergic reactions after allergen challenge are the same in allergic rhinitis and asthma. Finally, the results of the therapy for allergic rhinitis in bronchial hyperresponsiveness and in clinical and functional control of asthma are also reported. Conclusions: epidemiological evidence and immunological and pathological aspects suggest that there is a relation between allergic rhinitis and asthma. The paradigm of united airways disease suggests the implementation of an integrated therapeutic approach.

  2. 盐酸氮卓斯汀鼻喷剂联合地氯雷他定治疗过敏性鼻炎40例%Azelastine Hydrochloride Nasal Spray Combined with Desloratadine for Treating Allergic Rhinitis in 40 Cases

    Institute of Scientific and Technical Information of China (English)

    王明婧

    2015-01-01

    Objective To investigate the clinical effect of azelastine hydrochloride nasal sPray combined with desloratadine in the treatment of allergic rhinitis. Methods 80 cases of allergic rhinitis Patients were divided into two grouPs according to the random number table method,the control grouP were treated with azelastine hydrochloride nasal sPray,the observation grouP were given azelastine hydrochloride nasal sPray combined with desloratadine. The clinical effect of the two grouPs were observed and comPared after treatment. Results After treatment,the total effiective rate of the observation grouP (97. 50%) was significantly higher than that of the control grouP (70. 00%),with significant difference ( P < 0. 05); the incidence rate of comPlication,such as bronchial asthma, sinusitis,nasal PolyPs,middle ear inflammation and allergic of conjunctival inflammation of the observation grouP (5. 00% ) was significantly lower than that of the control grouP(32. 50%),with significant difference( P < 0. 05);the recurrence rate of allergic rhinitis in the observation(0)was significantly lower than that of the control grouP(27. 50%),with significant difference( P < 0. 05). Conclusion Azelastine hydrochloride nasal sPray combined with desloratadine in the treatment of allergic rhinitis has raPid effect, high safety,can effectively alleviate the clinical symPtoms with good clinical effect.%目的:观察盐酸氮卓斯汀鼻喷剂联合地氯雷他定治疗过敏性鼻炎的临床疗效。方法采用随机数字表法将医院收治的80例过敏性鼻炎患者分为两组,对照组给予盐酸氮卓斯汀鼻喷剂治疗,观察组则采用盐酸氮卓斯汀鼻喷剂联合地氯雷他定口服治疗。结果治疗后,观察组总有效率为97.50%,明显高于对照组的70.00%( P<0.05);观察组治疗期间支气管哮喘、鼻窦炎、鼻息肉、中耳炎及变应性结膜炎等并发症的发生率为5.00%,明显低于对照组的32.50%( P<0.05)

  3. 低温等离子射频治疗阻塞性睡眠呼吸暂停低通气综合征合并变应性鼻炎%Clinical Analysis of Low-Temperature Plasma Radio Frequency Treatment For Osahs Complicated With Allergic Rhinitis

    Institute of Scientific and Technical Information of China (English)

    黄红星; 杨立; 唐梓轩; 赵之栋

    2011-01-01

    Objective To observe the clinical effect of treatment by low-temperature plasma radio frequency on obstructive sleep apnea-hypopnea syndrome (OSAHS) complicated with allergic rhinitis. Methods A total of 42 patients with OSAHS complicated with allergic rhinitis between January 2010 and May 2010 were chosen. All of the patients were treated by low-temperature plasma radio frequency nerve block, concha nasalis inferior ablation and other operations such as nasal septal construction. The nerve terminals of sphenopalatine nerve and anterior ethmoid nerve were blocked by ablatioa Epworth sleepiness scale (ESS) and visual analogue scale (VAS) were used to estimate the curative effects. Results The results of ESS and VAS were consistent with gaussian distribution. There were statistical significant difference between the scores of pre-and post-operation (P<0. 05). Conclusion The low-temperature plasma radio frequency treatment for OSAHS complicated with allergic rhinitis is easy,safe and efficient.%目的 观察低温等离子射频治疗阻塞性睡眠呼吸暂停低通气综合征(obstructive sleep apnea-hypopnea syndrome,USAHS)合并变应性鼻炎的疗效.方法 对2010年1-5月收治的42例OSANS合并变应性鼻炎患者,采用低温等离子射频双下鼻甲减容、鼻腔内蝶腭神经及筛前神经末梢阻滞,并配合鼻中隔成形等手术.使用Epworth嗜睡评分量表(epworth sleepiness scale,ESS)和视觉模拟评分法(visual analogue scale,VAS)对治疗前及治疗3个月后的总体感受评分.结果 ESS评分与VAS评分均符合正态分布,手术前、后ESS评分[(14.22±4.21)分,(6.78±4.12)分]与VAS评分[(8.34±2.72)分,(3.96±1.02)分」差异有统计学意义(P<0.05).结论 低温等离子射频治疗OSAHS合并变应性鼻炎疗效较好.

  4. Effect of treatment of allergic rhinitis and asthma syndrome by inhaling and nasal spray corticosteroids%口鼻吸入丙酸氟替卡松对过敏性鼻炎-哮喘综合症患者的影响

    Institute of Scientific and Technical Information of China (English)

    林士军; 王桂杰; 刘玉春; 徐继庆; 陈兰春; 李观强

    2011-01-01

    Objective To observe the clinical effect of treatment of allergic rhinitis and asthma syndrome(CARAS) by different ways of inhaling corticosteroids. Methods Totally 55 cases of patients suffered from allergic rhinitis and asthma syndrome were randomly divided into two groups. Nasal spray group: 27 cases were treated with fluticasones propionate nasal spray 100μg (2 puffs) a.m. and 150μg (3 puffs) p.m. into each nostril twice daily. Inhaling group: 28 cases were treated with fluticasones propionate inhaling 250μ g (2 puffs) twice daily for 12 weeks, respectively. The symptom scores of rhinitis, asthma, quality of life and pulmonary function were examined before and after treatment. Results The symptom scores of rhinitis , ACT and QOL after treatment in nasal spay groups and inhaling groups were significantly improved (P < 0. 05 ), the scores of rhinitis in nasal spay groups than that in inhaling groups were significantly decreased ( P < 0. 05 ), the scores of ACT, QOL and pulmonary function in inhaling groups than that in nasal spay groups were significantly increased (P < 0. 05). Conclusions The symptoms of rhinitis and asthma, quality of life on CARAS in two groups by two ways of inhaling fluticasones propionate are greatly improved, however, it is not best ways and is no satisfaction that nasal spay or inhaling fluticasones propionate single on CARAS.%目的 探讨口吸及鼻吸激素对过敏性鼻炎-哮喘综合症(CARAS)患者临床症状及生存质量的影响.方法 55例过敏性鼻炎-哮喘综合症患者被随机分为两组,鼻吸组27例,给予丙酸氟替卡松鼻喷雾剂,早上每个鼻孔各2次,晚上每个鼻孔各3次,鼻腔吸入,每喷50μg;口吸组28例,给予丙酸氟替卡松吸入气雾剂,早上吸入2次,晚上吸入2次,经口吸入,每吸125μg.两组每日给药剂量均为500μg,分别于治疗前及治疗12周后统计患者鼻炎症状积分,哮喘控制测试评分,哮喘生存质量评分及肺功能.结果 两组

  5. Treatment of perennial rhinitis with 2% solution of sodium cromoglycate.

    Science.gov (United States)

    Lobaton, P; Seranno, V; Rubio, N; Gomez, D

    1975-08-01

    This trial has demonstrated that S.C.G. is significantly better than placebo and therefore that a 2% solution of S.C.G. is effective in the treatment of perennial rhinitis. It would appear that better results can be obtained in patients who have a demonstrable allergic aetiology with a nasal eosinophilia.

  6. Clinical study on treatment of sensitive isolate homemade cream combined with montelukast sodium in prevention and treatment of allergic rhinitis%自制治敏隔离膏联合孟鲁司特钠治疗过敏性鼻炎的临床研究

    Institute of Scientific and Technical Information of China (English)

    贺荣莉; 欧仁兵; 高雅; 杨芳; 李刚; 付蓉

    2015-01-01

    Objective To explore the safety and effectiveness of treatment of sensitive self isolation agent combined with montelukast sodium in prevention and treatment of allergic rhinitis, a new way to search for the effective prevention and treatment of allergic rhinitis. Method 122 cases of children with allergic rhinitis in children methods selection standard, were randomly divided into two groups, treatment group 62 cases, using the self-made isolation agent applied daily to treat allergic nasal 1~3 times per night, oral montelukast sodium 4~5mg a. The control group of 60 cases, Fluticasone Propionate Nasal Spray every morning and evening of 1, per oral ketotifen 0.5~1mg. Two groups all take 1 months for a course of treatment. The changes were observed in the two groups during the treatment, the symptoms of rhinitis symptoms score, drug daily integral, recurrence rate and adverse reaction of index.Results In 1 months of treatment, the efficacy of the two groups were not significant (P > 0.05), the control group symptoms improved time was shorter in the treatment group (P < 0.01); but the 6 and 12 months after the treatment group the recurrence rate is low (P < 0.01), the long-term curative effect is better than that of the control group; the treatment group no adverse reaction while in the control group the incidence of adverse reactions was 51.7%.Conclusions Treatment of allergic isolation agent in combination with montelukast treatment of children allergic rhinitis curative effect, good safety, and less recurrence, opened up a new way of prevention and treatment of allergic rhinitis, is worth the clinical promotion.%目的:探索自制治敏隔离膏联合孟鲁司特钠治疗过敏性鼻炎的安全性、有效性,旨在寻找有效的治疗过敏性鼻炎的新途径。方法:择符合标准的小儿过敏性鼻炎患儿122例,随机分为两组,治疗组62例,采用自制治敏隔离膏每日涂鼻腔1~3次,每晚口服孟鲁司特钠4~5m g

  7. 江苏省6个城市儿童变应性鼻炎流行病学调查%Epidemiological survey of pediatric allergic rhinitis in six cities of Jiangsu Province

    Institute of Scientific and Technical Information of China (English)

    林旸; 张大为; 陈仁杰

    2011-01-01

    目的 在获取江苏省6个城市6~7岁和13~14岁儿童变应性鼻炎患病率调查问卷的基础上,分析变应性鼻炎与遗传和环境因素的关系.方法 2010年1~12月,在江苏省南京、扬州、南通、徐州、苏州和无锡6个城市随即各抽取2所小学,对其中6~7岁和13~14岁儿童进行变应性鼻炎的问卷调查,了解其家族史,同时获取各城市的空气状况和空气污染指标,分析变应性鼻炎患病率与遗传及空气污染的关系.结果 实际调查问卷2000份,应答1989份(99.5%),有效问卷1980份(99.0%).6~7岁儿童变应性鼻炎患病率为14.9% (145/972),13~14岁儿童患病率为13.0% (131/1008).变应性鼻炎患儿中有家族史者占25.7% (71/276).变应性鼻炎患病率与相应城市空气中二氧化硫浓度呈正相关(R2=0.704,P<0.05).结论 江苏省6个城市的儿童变应性鼻炎患病率为13.9%,空气中二氧化硫浓度对变应性鼻炎发病可能有影响.%Objective To analyze the relationship between the genetic-environmental factors and allergic rhinitis (AR) on the basis of questionnaire survey of AR prevalence in 6 to 7 and 13 to 14 years old children in the six cities of Jiangsu Province. Method A questionnaire survey on prevalence of pediatric AR and related factors was performed among primary school children, aged 6 to 7 and 13 to 14, of 12 schools in Nanjing, Yangzhou, Nantong, Xuzhou, Suzhou and Wuxi of Jiangsu Province by random cluster sampling. The relationship between the genetic-environmental factors and AR was discussed while air condition and air pollution indicators in 6 cities were collected. Results A number of 1989 (99.5%) subjects answered their questionnaires and 1980 (99.0%) were available among all 2000 questionnaires. The prevalence of AR in children aged 6 to 7 was 14.9% (145/972) and that of children aged 13 to 14 was 13.0% (131/1008). The ratio of AR children with family history was 25.7% (71/276). The prevalence of AR

  8. Budesonide inhalation by nose in treating 40 patients with combined allergic rhinitis and asthma syndrome%经鼻吸入布地奈德治疗过敏性鼻炎-哮喘综合征40例

    Institute of Scientific and Technical Information of China (English)

    左扬松

    2012-01-01

    AIM To explore the effect and safety of budesonide inhalation by nose on combined allergic rhinitis and asthma syndrome (CARAS) . METHODS Eighty-two patients with CARAS were randomly divided into two groups. All patients were treated by atomization pots. The patients in the nose group (n = 40) received budesonide aerosol by nose-suction nozzle, while the others in the mouth group (n = 42) received budesonide aerosol by mouth-suction nozzle. The doses of the two groups were the same and the courses were both 8 weeks. The symptoms scorings, lung function (FEV1, PEF), levels of serum total IgE and eosinophil absolute values were observed before and after the treatment. RESULTS The symptoms scorings of nasal and thorax, the levels of IgE, and the eosinophil absolute values in both groups decreased obviously after the treatment (P 0.05) . The levels of FEV1 and PEF increased significantly in both groups, and those in the nose group were higher ( P < 0.01) . There was no severe adverse reaction in the two groups. CONCLUSION Budesonide inhalation by nose in treating CARAS can obviously improve symptoms and lung functions, reduce serum total IgE level, with few adverse reaction. Budesonide inhalation by nose is superior to inhalation by mouth.%目的 探讨经鼻吸入布地奈德治疗过敏性鼻炎-哮喘综合征(CARAS)的疗效及安全性.方法 82例CARAS急性发作期患者,随机分为2组,均采用口-鼻两用雾化罐.经鼻组(n=40)和经口组(n=42)分别经鼻和经口吸入布地奈德气雾剂,均每次1吸200 μg,早晚各1次,连续治疗8 wk.观察治疗前后症状评分、第一秒用力呼气容积(FEV1)、呼气峰流量(PEF)、血清总IgE、嗜酸粒细胞(EOS)绝对值的变化.结果 治疗后2组鼻部及胸部症状评分、血清总IgE水平、EOS绝对值均下降(P<0.01),经鼻组症状评分、总IgE水平低于经口组(P< 0.05或P<0.01),2组EOS绝对值无显著差异(P>0.05).2组FEV1、PEF水平均升高(P<0.01),经鼻组FEV1

  9. 上海宝山地区儿童变应性鼻炎患病率调查%Self-reported prevalence of pediatrics allergic rhinitis in Baoshan district

    Institute of Scientific and Technical Information of China (English)

    鲍爱春; 龚齐; 章如新; 朱静静; 支纪治; 刘燕萍

    2011-01-01

    目的 调查上海市宝山区7~12岁儿童变应性鼻炎自报患病率并分析其相关危险因素.方法 2010年3~6月,选择宝山区5所小学-~五年级(7~12岁)学生为研究对象,设计"宝山区儿童变应性鼻炎问卷调查表",进行流行病学调查.对结果进行统计学处理.结果 发放问卷总数为3046份,回收2464份,应答率80.9%,有效问卷2313份.宝山区7~12岁儿童变应性鼻炎自诉现患率为23.9%(553/2313),其中男26.1%(314/1203),女21.5%(239/1110),有统计学意义(X=6.627,P<0.01).自报患病率随年龄增长而上升.在变应性鼻炎的危险因素中,被动吸烟、家养宠物、居住环境、湿疹史,个人过敏史、家族过敏史可能与变应性鼻炎有一定相关性.结论 宝山区7~12岁儿童变应性鼻炎自报现患率为23.9%.初步了解宝山区变应性鼻炎流行病现状,为上海变应性鼻炎防治提供参考.%Objective To investigate the self-reported prevalence of pediatric allergic rhinitis(AR)sufferers and analyze its related risk factors in Baoshan district, Shanghai city. Methods The pupils in Baoshan district of shanghai from 7 to 12 years old from March to June were included in the study. A questionnaire survey on AR was designed for the study. The data were performed statistical analysis.Results Totally 2464 were returned in 3046 questionnaires,the response rate was 80.9 %. 2313 questionnaires were available. The selfreported prevalence of AR was 23.9% (558/2313), male was 26.1%(314/1203),female was 21.5 %(239/1110, there were significant difference in then.The self-reported prevalence of AR was increasing as children age. Passive smoking favor animal, living environment,history of eczema,personal and family allergen history might be related to prevalence of AR. Conclusion The self-reported prevalence of AR in children aged from 7 to 12 in Baoshan is 23.9 %. This survey proveides a first-hand data on epidemic features of children with AR in Baoshan

  10. Curative Effect of Unite Yupingfeng in Allergic Rhinitis Patients%联合玉屏风颗粒治疗变应性鼻炎的疗效观察

    Institute of Scientific and Technical Information of China (English)

    杨立新; 赵伍西; 周宁

    2013-01-01

    目的:研究联合玉屏风颗粒治疗变应性鼻炎(Allergic rhinitis ,AR)的疗效及对AR患者外周血白介素-4(Inter-leukin ,IL-4)和γ-干扰素(Interferon ,IFN-γ)的影响。方法:选择我院耳鼻喉科门诊2010年4月-2013年4月AR患者58例,随机分为治疗组与研究组,研究组在治疗组常规使用抗组胺药、抗白三烯药、鼻用或口服糖皮质激素治疗基础上加用玉屏风颗粒。同时选择健康体检者29例为对照组进行对照研究。治疗前及治疗后1个月、3个月、6个月测定外周血IL-4和IFN-γ的浓度,并观察临床症状及体征。结果:治疗组与研究组在治疗前及治疗期间体征评分比较无明显差异(P>0.05),IL-4和IFN-γ水平比较无明显差异(P>0.05)、治疗期间症状评分及疗效两组比较有差异(P<0.05)。停药后3个月两组在症状及体征评分、疗效、IL-4和IFN-γ的水平均有差异(P<0.05)。结论:联合玉屏风颗粒治疗AR可提高疗效,对AR患者的免疫状态有恢复作用且作用长久。%Objective :To investigate the curative effect of unite Yupingfeng in AR patients and effect on peripheral blood IL-4 and IFN-γin AR patients .Methods :58 AR patients were chosen in outpatients service of Otorhinolaryngolo-gy from April 2010 to April 2013 .58 AR patients were divided into treatment group and research group in random . Treatment group were treated with drug of antihistamine ,antileukotriene ,intranasal or oral corticosteroids ,Research group were treated with Yupingfeng particle in addition .29 Healthy controls were chosen .Peripheral blood concentra-tion of IL-4 and IFN-γwere measured before treatment and one month ,three months ,six months after treatment .Clini-cal symptoms and physical signs were observed .Results:Grade of physical signs weren’t different before treatment pe-riod and in treatment period between treatment group and research group (P>0

  11. 变应性鼻炎患者伴发食物变应原致敏的特异性抗体检测分析%Detection and analysis of specific antibodies of food allergens in patients with allergic rhinitis

    Institute of Scientific and Technical Information of China (English)

    王俊阁; 陈钢; 俞琳琳; 李婉英; 盖建青; 闫新宇; 吴慧莉

    2016-01-01

    [ABSTRACT]OBJECTIVETo investigate the relationship between food allergen specific IgE, IgG and allergic rhinitis, and to explore the significance of food allergen in the diagnosis and prevention of allergic rhinitis.METHODSTen kinds of food specific IgE were detected by Western blot and 14 kinds of food specific IgG were detected by ELISA in 2860 allergic rhinitis patients. The positive results of specific IgE and specific IgG were retrospectively analyzed.RESULTSThere was no difference in positive rate of allergen in patients with different gender. Total positive rate of food specific IgE was 68.5%. The specific IgE positive rate of crab was 31.5%, shrimp 27.6%, milk 21.3%, fish assemblages 19.2%, freshwater fish assemblages 18.3% and soybean 17.2%. With the growth of age, the specific IgE positive rate of peanut increased, but eggs decreased. The total positive rate of food allergen specific IgG was 81.5%. The specific IgG positive rate of egg was 59.4%, milk 38.2%, codfish 32.6%, soybean 22.8%, rice 19% and shrimp 12.7%. With the growth of age, the specific IgG positive rate of crab increased. Specific IgE and IgG of soybean, milk, crab, shrimp and fish were correlated well.CONCLUSIONThe detection of specific food allergen antibodies is helpful for the diagnosis of allergic rhinitis.%目的:研究食物变应原特异性IgE(specific IgE,sIgE)、sIgG与变应性鼻炎的关系,探讨食物变应原在变应性鼻炎诊断和预防中的意义。方法对2860例变应性鼻炎患者采用免疫印迹法检测10种食物sIgE和ELISA法检测14种食物sIgG阳性结果进行回顾性分析。结果变应原阳性率在不同性别患者间无差别。食物sIgE总阳性率为68.5%,依次为螃蟹(31.5%)、虾(27.6%)、牛奶(21.3%)、海鱼组合(19.2%)、淡水鱼组合(18.3%)、大豆(17.2%),其中花生随年龄增长,阳性率增加,鸡蛋则降低。食物变应原sIgG总阳性率81.5%,以鸡蛋(59.4%

  12. The clinical study on seasonal rhythm of melatonin and nitric oxide of patients with allergic rhinitis%变应性鼻炎患者血清褪黑素、一氧化氮水平的季节测定及临床意义

    Institute of Scientific and Technical Information of China (English)

    张波; 郭燕冰; 许继宗; 王普艳; 李洁; 司英奎

    2015-01-01

    目的:探讨变应性鼻炎患者血清褪黑素及一氧化氮( nitric oxide,NO)水平的季节变化及临床意义。方法选择符合变应性鼻炎标准的成年患者41例,其中男21例、女20例。采取自身对照的方法,分别在春分、夏至、秋分、冬至4个节气的前后各1个月进行血清褪黑素、NO水平的检测。结果血清褪黑素水平秋冬季节有较高表达,秋春、冬春、秋夏、冬夏对比差异有显著性(P<0.01);血清NO水平在冬季有较高表达,冬春对比差异有显著性(P<0.01),冬夏对比差异有显著性(P<0.01)。血清褪黑素、NO在春、夏、秋三季的水平变化有显著的相关性(春季r分别为0.518、0.518,P<0.01;夏季r分别为0.485、0.485,P<0.01;秋季r分别为0.437、0.437,P<0.01)。结论血清褪黑素、NO水平季节变化的表达,进一步验证了中医“天人相应”的理论,在变应性鼻炎发病过程中起到较重要的作用,对临床的预防及诊治有较大的参考价值。%Objective To assess whether the levels of serum melatonin and nitric oxide ( NO) correlate with reasons in allergic rhinitis patients. Method 41 allergic rhinitis patients were selected which included male 21 cases;female 20 cases. Self-control method was taken and the levels of MT and NO were measured which obtained all serum sam-ples in one month near to Vernal Equinox, Summer Solstice, Autumn Equinox and Winter Solstice. Result The lev-els of melatonin were much higher in winter and autumn than those in spring and summer; the levels of NO were much higher in winter than those in spring and summer. Whether in spring, summer and autumn the levels of me-latonin and NO have significant correlations (in spring the r was 0. 518,0. 518 respectively, P<0. 01; in summer the r was 0. 485,0. 485 respectively, P<0. 01; in autumn the r was 0. 437,0. 437 respectively, P<0. 01). Conclusion The seasonal rhythm expression of melatonin and NO verified the Chinese medicine theory of

  13. 芪柴煎剂对变应性鼻炎大鼠血清IL-4,IFN-γ影响的实验研究%Effect of Qi Chai decoction on serum IL-4, IFN-γlevel in allergic rhinitis rats

    Institute of Scientific and Technical Information of China (English)

    胥彪; 胡文健

    2015-01-01

    Objective: To study the influence of Qi Chai decoction on serum IL-4, IFN-γ level of allergic rhinitis model of rats so as to explore its role and efficacy in treating allergic rhinitis. Methods:Rats with allergic rhinitis were made by ovalbumin as sensitizing agent. 40 healthy adult SD rats were randomly divided into five groups(8 rats each):normal control group low-dose and high dose Qi Chai decoction groups,loratadine group, and model control group. Corresponding mjodel control given for 14 consecutive days in each group. Then the serum IL-4 and IFN-γ contents were tested by ELISA. Results: Compared with model control group,the serum IL-4 levels of low dose and high dose Qi Chai decoction groups and desloratadine group were significantly lower, and there were significant differences (P<0.05), and IL-4 level of low dose Qi Chai decoction group was higher than that of high dose group (P< 0.05). Compared with model control group, the serum IFN-γ level of low dose and high dose Qi Chai decoction groups, and the desloratadine group were significantly higher (P< 0.05). Compared with high dose group, the serum IFN-γ level of low dose Qi Chai decoction group and loratadine group were significantly lower (P< 0.05). Conclusion: The Qi Chai decoction can down-regulate the serum IL-4 levels and up-regulate the serum IFN-γlevels of the rats with allergic rhinitis.%目的::研究芪柴煎剂(自拟方)对变应性鼻炎大鼠模型血清IL-4、IFN-γ的影响,探讨其对变应性鼻炎大鼠的作用疗效。方法:应用卵清蛋白将实验大鼠制作成变应性鼻炎模型,随机分为正常对照组(A组)、芪柴煎剂低剂量组(B组)、高剂量组(C组)、地氯雷他定组(D组)、模型对照组(E组)各8只。连续14 d分别给予对应的药物,A组、E组以蒸馏水替代。用双抗体夹心ELISA法检测血清IL-4、IFN-γ的含量。结果:各实验组血清IL-4含量较模型对照组明显偏低,差异均有统计学意义(P<0.05)

  14. [Work-related rhinitis - Is it always an occupational disease?

    Science.gov (United States)

    Salski, Witold; Wiszniewska, Marta; Salska, Agata; Tymoszuk, Diana; Walusiak-Skorupa, Jolanta

    2016-12-22

    Rhinitis is a chronic inflammatory disease of the upper respiratory tract, characterized by a high prevalence and a complex pathogenesis. Work-related rhinitis (WRR) can be divided into occupational rhinitis (OR) and work-exacerbated rhinitis (WER). It is not only considered as a disease entity but also in the context of medical certification as the allergic disease associated with occupational exposure. Epidemiology of work-related rhinitis has been found to vary depending on the occupation and specific exposure, on the other hand the prevalence data may be underestimated due to the lack of uniform diagnostic criteria. This paper reviews the issues comprising the pathogenesis, epidemiology, diagnosis and treatment of patients with work-related rhinitis. It also discusses the significance of the disease in occupational medicine, particularly in terms of preventive worker care, general principles of good practice in primary and secondary WRR prevention and the necessary directions of changes in medical certification in the cases of occupational rhinitis. Med Pr 2016;67(6):801-815.

  15. 药物和聚焦超声治疗变应性鼻炎的随机对照研究%Comparison of therapeutic effects between focused ultrasound under nasal endoscope and conventional drug therapy in treatment of allergic rhinitis-a prospective randomized trial

    Institute of Scientific and Technical Information of China (English)

    温蓓; 何刚

    2012-01-01

    目的 探讨药物和聚焦超声治疗中-重度持续性变应性鼻炎(allergic rhinitis,AR)的临床疗效及安全性.方法 100例中-重度持续性AR根据随机分配方案(完全随机设计),按1:1比例随机分配到药物组和聚焦超声组,每组各50例.药物组予鼻用皮质类固醇布地奈德鼻喷剂,以及抗组胺药氯雷他定,治疗4周;聚焦超声组使用CZB型超声波鼻炎治疗仪进行治疗.治疗结束后随访6个月进行疗效和安全性评估.结果 药物组显效率24%,有效率36%,无效率40%,总有效率为60%;聚焦超声组显效率38%,有效率50%,无效率12%,总有效率为88%.两组总有效率差异有统计学意义(P<0.05).术后患者均未出现并发症.结论 鼻内镜下采用聚焦超声治疗中-重度持续性AR具有操作简单、创伤小等优点,安全性高,近期效果优于药物组.%Objective To investigate the therapeulic effect and safely of focused ultrasound in treatment of allergic rhinitis under nasal endoscope. Methods One hundred patients with allergic rhinilis were enrolled in the study. They were randomly divided into to the ultrasound therapy and conventional drug therapy groups,50 in each. The Budesonide Nasal Spray and toraladine were used in the conventional drug therapy group for four weeks. The CZB ultrasound therapeulic system was used in the ultrasound therapeulic group under nasal endoscope. The therapeutic efficiency was evaluated by clinical symptoms controlled counting-scores according to the 2004 Chinese Lanzhou principle of treatment and recommendation program for allergic rhinitis. Results All the patients were followed-up al least 6 months. In the conventional drug therapy group,the excellent effective rate,effective rate,ineffective rate,and the total effective rate were 24% ,36% ,40% and 60% ,respectively. However,in the CZB ultrasound therapeulic group there rates were 38% ,50% ,12% and 88% ,respeetively. The excellent effective rate and effective rate were

  16. 231 Pattern of Positive Sensitization in Patient with Asthma and Rhinitis to 3600 MSNM (La Paz, Bolivia)

    OpenAIRE

    Moncada Alcon, Abel Marcelo; Rios Mora, Roxana Ivon

    2012-01-01

    Background In the high altitude exists very few studies about allergies, we seek to give to know our sensitization in population with breathing problems (asthma and Allergic Rhinitis). Methods They were carried out allergy tests to 94 patients between 6 and 13 years with breathing symptoms predominantly allergic rhinitis and asthma. They were carried out allergy tests to foods like peanut, wheat, almond, tomato, milk, fish, soya, nuts, corn egg, chocolate, dog epithelia, cat, rabbit, feathers...

  17. Effect of treatment on combined allergic rhinitis and asthma syndrome by different ways of inhaling corticosteroids%激素不同吸入方法对过敏性鼻炎-哮喘综合症患者临床症状及生存质量的影响

    Institute of Scientific and Technical Information of China (English)

    林士军; 王桂杰; 刘玉春; 徐继庆; 李观强; 陈兰春

    2012-01-01

    Objective To observe the clinical effect of treatment of combined allergic rhinitis and asthma syndrome (CAR AS) by different ways of inhaling corticosteroids. Methods Totally 90 cases of patients suffered from combined allergic rhinitis and asthma syndrome were randomly divided into three groups. Nasal spray group: 30 cases were treated with fluticasones propionate nasal spray 100 |xg (2 puffs) a. m. and 150 μg(3 puffs) p. m. into each nostril twice daily. Inhaling group: 30 cases were treated with fluticasones propionate inhaling 250 μg(2 puffs) twice daily. Combined group: 30 cases were treated with fluticasones propionate nasal spay-inhaling combined administration for 12 weeks, respectively. The symptom scores of rhinitis, asthma, quality of life and pulmonary function were examined before and after treatment. Results The symptom scores of rhinitis after the treatment in the nasal spay groups and the nasal spay-inhaling combined groups were significant decreases (P 0.05). The scores of ACT, QOL and pulmonary function in the three groups were significant improvement (P < 0.05) compared with nasal spay groups. The inhaling groups and nasal spay-inhaling combined groups, had significant increases (P <0. 05). The pulmonary function except ACT and QOL was not significant improvement in the nasal spay-inhaling combined groups compared with inhaling groups. Conclusions It is best of all ways that nasal spay-inhaling combined fluticasones propionate can control symptom of rhinitis, and improve control asthma level and quality of life on CARAS.%目的 探讨激素不同吸入方法对CARAS患者临床症状及生存质量的影响.方法 90例CARAS患者被随机分为鼻吸组、口吸组及联合组,分别于治疗前后统计患者鼻炎症状积分,ACT、QOL评分及肺功能指标.结果 鼻吸组和联合组治疗后鼻炎症状评分明显减少(P<0.05),口吸组也有减少,但无统计学意义(P>0.05).口吸组、联合组比鼻吸组治疗后ACT、QOL

  18. Website updates

    Data.gov (United States)

    National Aeronautics and Space Administration — Updates to Website: (Please add new items at the top of this description with the date of the website change) May 9, 2012: Uploaded experimental data in matlab...

  19. 血清IgE与免疫球蛋白游离轻链在变应性鼻炎中的表达及意义%The expression and significance of serum IgE and immunoglobulin free light chain in allergic rhinitis

    Institute of Scientific and Technical Information of China (English)

    梁红英; 陈玉辉; 谭晓光

    2016-01-01

    目的:探讨血清 IgE 与免疫球蛋白游离轻链在变应性鼻炎中的表达及意义。方法分析2013年1月至2014年12月接受治疗的变应性鼻炎患者的临床资料,设为观察组。同时选取同时期行体检的健康人群作为对照组。观察比较两组对象血清中白介素(IL)-4、IL -9、IL -17、IgE、免疫球蛋白游离轻链、κFLC、λFLC 水平。分析观察组患者IgE 与 IL -4、IL -9、IL -17的相关性和 IgE 与λFLC、κFLC 水平的相关性。结果观察组患者血清中 IL -4、IL -9、IL -17与 IgE 水平显著高于对照组,差异具有统计学意义( P ﹤0.05);采用 Pearson 相关性检验分析观察组患者血清中 IgE与 IL -4、IL -17水平的相关性,观察组患者 IgE 与 IL -4( r =0.576,P ﹤0.001)及 IL -17( r =0.584,P ﹤0.001)呈现显著正相关;观察组患者血清中κFLC、λFLC 水平显著高于对照组,差异具有统计学意义( P ﹤0.05);观察组患者血清IgE 与λFLC( r =0.653,P ﹤0.001)、κFLC( r =0.625,P ﹤0.001)水平呈现显著正相关。结论变应性鼻炎患者 IgE与 IL -4及 IL -17呈现显著正相关,血清中 IgE 与免疫球蛋白游离轻链水平亦呈现正相关关系,血清中 IgE 和免疫球蛋白游离轻链含量水平对变应性鼻炎的诊断具有一定的临床价值。significant positive correlation with IgE in patients with allergic rhinitis,serum level of IgE also has positive correlation with levels of free light chain immunoglobulin,serum levels of IgE and free light chain immunoglobulin have certain clinical significance in the diagnosis of allergic rhinitis.%Objective To explore the expression and significance of serum IgE and immunoglobulin free light chain in allergic rhinitis. Methods The clinical data of patients with allergic rhinitis for treatment in this hospital during January 2013 to December 2014 were selected as observation group. At the same time

  20. Effects of dust mite allergen-specific immunotherapy on prevention and cure in children with asthma and allergic rhinitis and the reasons of symptom exacerbation during specific immunotherapy.%粉尘螨特异性免疫治疗变应性哮喘合并鼻炎疗效评价及治疗期间病情反复原因分析

    Institute of Scientific and Technical Information of China (English)

    谭永强; 鲍一笑; 沈瑾; 叶桂云; 陈柳

    2012-01-01

    Objective To evaluate the effects of dust mite allergen-specific immunotherapy combined with standardized management on prevention and cure in children with asthma and allergic rhinitis and analyze the reasons of the asthma and allergic rhinitis symptom exacerbation during specific immunotherapy. Methods One hundred and two children with established diagnosis of allergic asthma and allergic rhinitis to dust mite were enrolled in this study from january 2006 to december 2010, of whom 78 children received the treatment with specific immunotherapy (SIT) combined with standardized management for 2 to 4 year (as the test group) and the other 24 served as the control group with inhaled corticosteroids according to Global Initiative for Asthma (GINA) and Allergic Rhinitis and its Impact on Asthma (ARIA) in the same time. At the beginning, 6 months, 1 year, 2 years of the treament and 1 year after the treament,the clinical symptom and acute episode, pulmonery function (Peak Expiratory Flow, PEF) and Chinese children asthma control test (Ch-CACT) of the asthmatic children, symptem scores and Visual Analogue Scale( VAS) of allergic rhinitis were analyzed, while respiratory tract infection of all the patients were recorded at the second year and after 1 year of the treatment. The reasons of the asthma and allergic rhinitis symptom exacerbation during dust mite allergen-specific immunotherapy were analyzed. The data were analyzed by SPSS15.0. Results Compared with control group, the frequency of acute episode, the frequency of respiratory tract infection in test group were significantly decreased at the 2 years of the treament and 1 year after the treament. The PEFof asthmasic children were obviously improved in the test group at the 2 years of the treament and 1 year after the treament and the Ch-CACT were more higher in the test group than the control group at 1 year after the treament. Compared with control group, the symptem scores and VAS of allergic rhinitis were

  1. Clinical Experience of Small Qinglong Decoction in the Treatment of 36 Cases with Allergic Rhinitis%小青龙虚化汤治疗过敏性鼻炎36例

    Institute of Scientific and Technical Information of China (English)

    张爱宁

    2015-01-01

    Objective To observe the curative ef ect of virtual Decoction in the treatment of al ergic rhinitis with smal dragon.Methods Using virtual smal Qinglong Decoction in the treatment of 36 cases of al ergic rhinitis.Results 28 cases were cured,7 cases improved,1 cases inef ective,the total ef iciency of 97.2%.Conclusion The curative ef ect of deficiency cold type of smal Qinglong Decoction in the treatment of al ergic rhinitis virtual exact.%目的观察小青龙虚化汤治疗过敏性鼻炎的疗效。方法采用小青龙虚化汤治疗过敏性鼻炎36例。结果痊愈28例,好转7例,无效1例,总有效率97.2%。结论小青龙虚化汤治疗过敏性鼻炎之虚寒型疗效确切。

  2. Improvement of Modeling Method for Allergic Rhinitis Model in Guinea Pigs by Ovalbumin%经卵清蛋白致敏过敏性鼻炎模型豚鼠造模方法探讨

    Institute of Scientific and Technical Information of China (English)

    王朋; 谭程; 张佳佳; 耿国燕; 王蓬文; 任映; 赵吉平

    2012-01-01

    Objective To improve the modeling method for allergic rhinitis model in guinea pigs by ovalbumin(OVA). Methods AR mode! Animals, allergen, allergens route, doses of allergenie drugs and evaluation method are based on published literature. Healthy guinea pigs were stimulated to AR by OVA. If the successful rate of models in AR guinea pigs were lower or instable, doses of OVA were added to 1.5 times and 2 times respectively in the control group. Results Despite of the fact that the duration of local irritation was extended in the first modeling, the rate of successful AR model was 12.5% (2/16). In the process of modeling, most of the guinea pigs did not have laryngeal edema, lower respiratory and systemic allergies. One female from the 1.5 times group and one male from the 2 times group had total symptom scores > 5, the rest two did not meet the standard. The rate of successful AR model was 50% (2/4). All of the four guinea pigs had a history of nasal congestion, and one male in the 2 times group suffered from nasal inflammation after the fourth local irritation and breathing difficulties after the sixth time. Conclusion Whether the model of AR is successful or not may be related to drug dose, drug concentration, body weight of guinea pigs and animal gender. When the doses are increased to 1.5 times and 2 times, it takes less time to meet the successful AR model standard, and the model stability is better. Significant adverse reactions caused by increased dose were not observed. Therefore, increased dose should be considered in AR guinea pigs modeling in the future.%目的 对经卵清蛋白(OVA)致敏过敏性鼻炎模型豚鼠造模方法进行改进.方法 AR模型动物、过敏原、致敏方式、致敏药物剂量及成模评价方法均参考有关文献进行.选择健康豚鼠经OVA致敏制作过敏性鼻炎模型.若成模率低或模型不稳定,进行造模方法的改进,即选用空白对照组分别以原剂量的1.5倍和2倍进行造模.结果 本

  3. 白三烯受体拮抗剂孟鲁司特治疗变应性鼻炎的荟萃分析%Meta-analysis of leukotriene receptor antagonist montelukast in the treatment of allergic rhinitis

    Institute of Scientific and Technical Information of China (English)

    陆忆; 殷敏; 程雷

    2014-01-01

    鲁司特或氯雷他定.%Objective To evaluate the treatment outcomes of leukotriene receptor antagonists (LTRA) as monotherapy or combined with the second-generation oral H1-histamines in the treatment of allergic rhinitis (AR),and to provide a basis for optimizing clinical therapeutic strategies.Methods PubMed,EMBASE,CBMdisc and CJFD databases,retrieving randomized controlled trials (RCTs) of AR therapy literatures were searched.Based on the literature inclusion and exclusion criteria,the related literatures were selected and the quality was evaluated by using the Jadad scale.Meta-analysis was performed by Stata 12.1 software.For continuous outcomes,the weighted mean difference (WMD) and its 95% confidence intervals (CI) were calculated.The forest plots were drawn.The treatment outcomes included daytime nasal symptom scores (DNSS),nighttime symptom scores (NSS),composite symptom scores (CSS),daytime eye symptom scores (DESS),and the rhinoconjunctivitis quality of life questionnaire (RQLQ) were used to evaluate the therapeutic effects of LTRA on seasonal and perennial AR.Results Eleven of clinical RCTs including 14 809 cases of AR patients,aged 15 to 85 years old,were available for Meta-analysis.Montelukast,a drug of LTRA,was primarily evaluated in the study.The results of Metaanalysis showed:(1) Compared with the placebo,montelukast statistically significantly reduced the DNSS,NSS,CSS,and RQLQ scores in patients with seasonal and perennial AR,as well as the DESS in patients with seasonal AR.(2) There were no statistical differences in the improvement of the CSS,DESS,and RQLQ scores in patients with seasonal AR after the treatment by montelukast compared with loratadine,a secondgeneration oral H1-histamine.(3) Montelukast statistically significantly reduced the NSS,but not DNSS,in patients with seasonal AR compared with loratadine.(4) The combination therapy of montelukast and loratadine statistically significantly improved the CSS compared with either montelukast or loratadine monotherapy

  4. AB042. Allergy Working Group Update: the burden and management of rhinitis and rhinosinusitis in UK primary care

    Science.gov (United States)

    Fokkens, Wytske; Nibber, Anjan; Chisholm, Alison; Hellings, Peter; Skinner, Derek; Price, David

    2016-01-01

    Background Rhinitis and rhinosinusitis are diseases of the upper airways with a high prevalence and when they are chronic with a high quality of life burden on patients and costs for society. To date, data on the primary care burden of rhinitis and rhinosinusitis are limited as is knowledge of how primary care physicians currently manage these patients. This study aims to quantify the burden of CRS and characterize related management approaches in UK primary care. Methods Patients with diagnostic codes for rhinitis and rhinosinusitis were identified within the UK’s Optimum Patient Care Research Database (OPCRD), a respiratory enriched primary care database. Consultations over a 5-year period (latest for each patient) code for rhinitis and rhinosinusitis symptoms resulting in prescriptions for antibiotics, oral steroids and/or antihistamines were identified. Diagnostic codes were used to further categorize patients into acute/chronic rhinitis/rhinosinusitis and allergic/non allergic chronic rhinitis subgroups. Prescribed therapies were categorized as: antibiotics (all); steroids (oral, injectable, nasal) and antihistamines, nasal spray and eye drops and mapped across rhinitis/rhinosinusitis and allergic/non-allergic patient subgroups. Results A total of 685,429 patients were identified with rhinitis and rhinosinusitis diagnostic codes. Of these patients: 80,900 (5%) had a diagnostic code for acute rhinitis (common cold); 176,353 (26%) for acute rhinosinusitis; 65,610 (10%) for chronic rhinosinusitis; 306,030 (45%) for chronic allergic rhinitis; 4,747 (1%) for chronic non-allergic rhinitis and 51,790 (8%) undefined chronic rhinitis. A total of 1,664,068 consultations for rhinitis and rhinosinusitis symptoms were identified, of which 185,730 (27%) resulted in an antibiotic prescription, 5,597 (0.8%) in an oral steroid prescription and 1,898 (0.3%) in an antibiotic and oral steroid prescription. Drug prescribing varied markedly across diagnostic subgroups with

  5. Effects of house dust mite sublingual immunotherapy in children with allergic rhinitis and asthma%不同疗程舌下含服粉尘螨滴剂治疗螨过敏变应性鼻炎伴哮喘患儿的疗效观察

    Institute of Scientific and Technical Information of China (English)

    陈实; 曾霞; 王灵; 陈冰; 陈丽丽; 吴少皎; 廖锋; 冯小伟

    2015-01-01

    Objective To evaluate the efficacy of SLIT with Dermatophagoides farinae drops in children with allergic rhinitis and allergic asthma according to its different duration.Methods The efficacy of Dermatophagoides farinae SLIT in 100 children (aged 3-14 yr) with allergic rhinitis and allergic asthma induced by house dust mites was retrospectively analyzed.All children were treated with Dermatophagoides farinae drops for 4 years and followed-up at the interval of 3 months.Total nasal symptom scores (TNSS),total rhinitis symptomatic medication scores (TRMS),daytime asthma symptom scores (DASS),nighttime asthma symptom scores (NASS),total asthma symptomatic medication scores (TAMS),visual analog scale scores (VAS) and lung function were assessed during follow-up visit.SPSS 20.0 software was used for data analysis.Results After 2 years' SLIT,compared with 1-year duration,besides NASS (0.00 [0.00;0.00],0.00[0.00;0.00];Z =1.811;P >0.05),TNSS (2.00[1.00;2.00],0.00[0.00;0.00];Z =7.021,P<0.01),TRMS (2.00[2.00;2.00],0.00[0.00;0.00];Z=8.855;P<0.01),VAS scores (3.00[2.00;4.00],1.00[0.00;1.00];Z =4.494,P<0.01),DASS (1.00[0.00;1.00];0.00[0.00;0.00];Z =4.383,P <0.01) and TAMS (0.00[0.00;1.00],0.00[0.00;0.00];Z =8.944;P < 0.01) all showed significant improvement.After 3-year duration,compared with 2-year duration,VAS scores (1.00 [0.00;1.00],0.00 [0.00;0.00];Z =3.645,P < 0.05) in patients were significantly decreased.Other results showed no significant difference.The comparison of efficacy between 3 and 4-year duration showed no significant difference in global clinical outcomes (all P > 0.05).Conclusions Patients receiving 2 year' SLIT achieve more clinical benefits than those who receiving 1-year duration.The higher efficacy of 3-year duration compared with 2-year duration is supported by a significant improvement in VAS.Besides,the comparison between 3 and 4-year duration shows no significant difference in global clinical outcomes.Therefore,3 years' duration is

  6. Analysis of total and specific IgE in serum of carvota mitis pollen-induced allergic rhinitis patients%鱼尾葵花粉过敏的变应性鼻炎患者中血清总IgE及特异性IgE结果的分析

    Institute of Scientific and Technical Information of China (English)

    姚敏; 孟光

    2013-01-01

    Objective:Exploring the relationship between total and specific IgE in serum and allergen skin test of carvota mitis pollen-induced allergic rhinitis patients. Method; Four hundred and twenty-nine carvota mitis pollen-induced allergic rhinitis patients and 243 healthy control subjects were recruited. The experimental group carried out skin tests, and pollen-specific IgE were also examined by BSA-ELISA method. Total IgE in serum of all of the subjects were determined by ELISA. Result;The positive rate of the total IgE level of the patients were much higher than those of the controls(66. 2% vs. 15. 6% ,P<0. 01). No statistically significance was found between the positivity of skin test and serum specific IgE of the experimental group(χ2 =0. 7588,P>0. 05). The difference between serum-specific IgE and total IgE was statistically significant(χ2 = 50. 639, P<0. 01). There was no statistical significance of specific IgE and the total IgE in serum between long term residents in Haikou and Hainan Tourisms (P>0. 05). Conclusion; Allergen skin test and carvota mitis pollen-specific IgE are two effective methods for the diagnosis of carvota mitis pollen-induced allergic rhinitis . The detection of total IgE in serum of carvota mitis pollen-induced allergic rhinitis provides a reference value for diagnosis. The relationship between concentration of IgE in serum of the carvota mitis pollen-induced allergic rhinitis and allergen contact duration is waiting for further study.%目的:探讨鱼尾葵花粉过敏的变应性鼻炎(AR)患者中血清总IgE、特异性IgE和变应原皮肤试验之间的关系.方法:选择429例对鱼尾葵花粉过敏的AR患者为实验组,243例健康体检者为对照组.实验组进行皮肤试验和特异性IgE水平检测,鱼尾葵花粉特异性IgE采用BSA-ELISA法;所有个体均检测血清总IgE水平.结果:实验组血清总IgE的阳性率明显高于对照组的阳性率(分别为66.2%和15.6%,P<0.01)

  7. Diagnosis and management of rhinitis: complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology. American Academy of Allergy, Asthma, and Immunology.

    Science.gov (United States)

    Dykewicz, M S; Fineman, S; Skoner, D P; Nicklas, R; Lee, R; Blessing-Moore, J; Li, J T; Bernstein, I L; Berger, W; Spector, S; Schuller, D

    1998-11-01

    This document contains complete guidelines for diagnosis and management of rhinitis developed by the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology, representing the American Academy of Allergy, Asthma and Immunology, the American College of Allergy, Asthma and Immunology and the Joint Council on Allergy, Asthma and Immunology. The guidelines are comprehensive and begin with statements on clinical characteristics and diagnosis of different forms of rhinitis (allergic, non-allergic, occupational rhinitis, hormonal rhinitis [pregnancy and hypothyroidism], drug-induced rhinitis, rhinitis from food ingestion), and other conditions that may be confused with rhinitis. Recommendations on patient evaluation discuss appropriate use of history, physical examination, and diagnostic testing, as well as unproven or inappropriate techniques that should not be used. Parameters on management include use of environmental control measures, pharmacologic therapy including recently introduced therapies and allergen immunotherapy. Because of the risks to patients and society from sedation and performance impairment caused by first generation antihistamines, second generation antihistamines that reduce or eliminate these side effects should usually be considered before first generation antihistamines for the treatment of allergic rhinitis. The document emphasizes the importance of rhinitis management for comorbid conditions (asthma, sinusitis, otitis media). Guidelines are also presented on special considerations in patients subsets (children, the elderly, pregnancy, athletes and patients with rhinitis medicamentosa); and when consultation with an allergist-immunologist should be considered.

  8. Current and future biomarkers in allergic asthma.

    Science.gov (United States)

    Zissler, U M; Esser-von Bieren, J; Jakwerth, C A; Chaker, A M; Schmidt-Weber, C B

    2016-04-01

    Diagnosis early in life, sensitization, asthma endotypes, monitoring of disease and treatment progression are key motivations for the exploration of biomarkers for allergic rhinitis and allergic asthma. The number of genes related to allergic rhinitis and allergic asthma increases steadily; however, prognostic genes have not yet entered clinical application. We hypothesize that the combination of multiple genes may generate biomarkers with prognostic potential. The current review attempts to group more than 161 different potential biomarkers involved in respiratory inflammation to pave the way for future classifiers. The potential biomarkers are categorized into either epithelial or infiltrate-derived or mixed origin, epithelial biomarkers. Furthermore, surface markers were grouped into cell-type-specific categories. The current literature provides multiple biomarkers for potential asthma endotypes that are related to T-cell phenotypes such as Th1, Th2, Th9, Th17, Th22 and Tregs and their lead cytokines. Eosinophilic and neutrophilic asthma endotypes are also classified by epithelium-derived CCL-26 and osteopontin, respectively. There are currently about 20 epithelium-derived biomarkers exclusively derived from epithelium, which are likely to innovate biomarker panels as they are easy to sample. This article systematically reviews and categorizes genes and collects current evidence that may promote these biomarkers to become part of allergic rhinitis or allergic asthma classifiers with high prognostic value.

  9. Futura study: evaluation of efficacy and safety of rupatadine fumarate in the treatment of persistent allergic rhinitis Estudo futura: avaliação da eficácia e segurança do fumarato de rupatadina no tratamento da rinite alérgica persistente

    Directory of Open Access Journals (Sweden)

    Olavo de Godoy Mion

    2009-10-01

    Full Text Available Allergic rhinitis affects 10-30% of the population, negatively impacting one's quality of life and productivity. It has been associated with sinusitis, otitis media, sleep disorders, and asthma. Rupatadine is a second generation antihistamine with increased affinity to histamine receptor H1; it is also a potent PAF (platelet-activating factor antagonist. It starts acting quite quickly, offers long lasting effect, and reduces the chronic effects of rhinitis. AIM: this study aims to assess the efficacy and safety of rupatadine in the treatment of persistent allergic rhinitis. MATERIALS AND METHOD: this is a multi-centric open prospective study. This study included 241 patients from 13 centers in Brazil and was held between October of 2004 and August of 2005. Signs and symptoms of rhinitis and tolerance to medication were analyzed after one and two weeks of treatment. RESULTS: reduction on general scores from 8.65 to 3.21 on week 2 (pA rinite alérgica acomete 10 a 30% da população, interferindo na qualidade de vida e na capacidade produtiva. Está associada à sinusite, otite, roncopatias e asma. A Rupatadina é um anti-histamínico de segunda geração, com elevada afinidade ao receptor histamínico H1 e potente inibição do fator ativador plaquetário (PAF. Tem rápido início de ação, longa duração e reduz os efeitos crônicos da rinite. OBJETIVO: Avaliar a eficácia e segurança da rupatadina no tratamento da rinite alérgica persistente. MATERIAL E MÉTODO: Estudo multicêntrico, aberto, prospectivo. Foram selecionados 241 pacientes em 13 centros no Brasil durante o período de outubro de 2004 a agosto de 2005. Foram analisados os sinais e sintomas da rinite e a tolerabilidade após 1 e 2 semanas. RESULTADOS: Redução do escore geral de 8,65 para 3,21 na semana 2 (p<0,001. Todos os sinais e sintomas melhoraram significativamente, e no primeiro dia de tratamento (p<0,001, com exceção da obstrução e secreção nasal, a partir do

  10. 舌下含服粉尘螨滴剂对小儿过敏性鼻炎伴腺样体肥大的疗效%Specific Sublingual Immunotherapy with Dermatophagoides Farinae Drops for Allergic Rhinitis Complicated by Adenoid Hypertrophy in Children

    Institute of Scientific and Technical Information of China (English)

    吕显林; 岳耀光; 张永强; 朱绪亮; 张俊; 郭军; 黄丽芳; 梁仕才

    2015-01-01

    ABSTRACT:Objective To investigate the curative effects of specific sublingual immunotherapy with Dermatophagoides farinae drops on allergic rhinitis complicated by adenoid hypertrophy in children.Methods Ninety children with allergic rhinitis and adenoid hypertrophy randomly re-ceived sublingual immunotherapy with Dermatophagoides farinae drops(group A,n=30),conven-tional treatment with anti-allergic drugs(group B,n=30),or their combination(group C,n=30). Nasal symptoms(nasal congestion,nasal itching,sneezing,runny nose,etc.)and snoring symp-toms(labored breathing,waking up repeatedly,snoring,mouth breathing,etc.)were evaluated u-sing the visual analogue scale(VAS)before and after treatment for 6 months.The maximum thickness of adenoid/anterior-posterior diameter of nasopharyngeal air space (A/N)ratio was measured by X-ray absorptiometry and computed tomography.Results Before treatment,there were no significant differences among the three groups in VAS scores of nasal symptoms and sno-ring symptoms,as well as in A/N ratio(P >0.05).After treatment for 6 months,VAS scores of nasal symptoms and snoring symptoms and A/N ratio obviously reduced in all the three groups (P 0.05).Compared with group B,VAS scores of snoring symp-toms and A/N ratio increased in group A but decreased in group C(P <0.05).Conclusion There is a close relationship between allergic rhinitis and adenoid hypertrophy in children.Specific sub-lingual immunotherapy not only improves nasal allergic symptoms,but also relieves snoring symptoms through reducing adenoid volume.Therefore,specific sublingual immunotherapy pro-vides a new method for non-surgical treatment of allergic rhinitis complicated by adenoid hyper-trophy.%目的:探讨儿童过敏性鼻炎伴腺样体肥大患儿采用舌下含服粉尘螨滴剂治疗的疗效。方法将90例过敏性鼻炎合并腺样体肥大的患儿按随机数字表法分为 A、B、C 3组,每组30例。A 组给予舌下含服粉尘螨滴剂治疗;B 组

  11. 过敏性鼻炎-哮喘综合征7种治疗方法的成本-效果分析%The Cost-Effectiveness Analysis of Seven Kinds of Treatment of Allergic Rhinitis-Asthma Syndrome

    Institute of Scientific and Technical Information of China (English)

    雷国强; 谢士茂; 陈木娟; 白玉; 李冬影; 陈桂红

    2015-01-01

    目的:从药物经济学的角度探讨过敏性鼻炎-哮喘综合征(CARAS)治疗方法的成本-效果,从而合理选择治疗药物。方法将280例CARAS患者根据药物应用的不同随机分成糖皮质激素组(A组)、抗组胺组(B组)、白三烯受体拮抗剂(C组)、抗-IgE单克隆抗体组(D组)、转移因子组(E组)、糖皮质激素+转移因子组(F组)、糖皮质激素+抗-IgE单克隆抗体组(G组),分别应用相应的药物治疗。结果 D,E,F组与G组的有效率均高于A,B,C组( P<0.05);C,D,F组与G组的成本明显高于A,B,E组( P<0.05);A,B组与E组的 C/ E值明显少于其他组( P<0.05)。结论糖皮质激素法、抗组胺法与转移因子法是治疗CARAS的最佳治疗方法。%Objective To investigate the cost effective theraPy for allergic rhinitis- asthma syndrome,from the Point of view of Pharma-ceutical economics,to choose the reasonable treatment of drug. Methods 280 cases of allergic rhinitis-astlma syndrome Patients were equally divided into glucocorticoid grouP(A),the anti histamine grouP(B),leukotriene recePtor antagonist grouP(C),anti-IgE monoclonal antibody grouP(D),transfer factor grouP(E),glucocorticoid add transfer factor grouP (F) and glucocorticoid add anti-IgE monoclonal antibody grouP(G) dePending on the drug aPPlication resPectively,each with aPProPriate medication. Results The effective rates of grouP D,E,F and G were higher than grouP A,B,C( P < 0. 05);the cost of grouP C,D,F and G were significantly higher than grouP A,B,E( P < 0. 05),the C/ E values of grouP A,B and E were significantly less than the other grouPs( P < 0. 05). Conclusion The method of glucocorticoid law,the anti histamine and the transfer factor are the best treatment for treating allergic rhinitis-asthma syndrome.

  12. 玉屏风颗粒联合地氯雷他定治疗过敏性鼻炎50例疗效观察%Efficacy of Yupingfeng particles comebined with loratadine in treatment of allergic rhinitis of 50 cases

    Institute of Scientific and Technical Information of China (English)

    王海英; 慈军

    2014-01-01

    Objective To investigate the effect of Yupingfeng particles joint desloratadine in treatment of allergic rhinitis. Methods From January 2010 to January 2013 in our hospital, 100 patients with allergic rhinitis according to the methods were randomly divided into study group and control group, 50 patients in the control group was given lo-ratadine tablets each an oral, once a day, once every 14 days. treatment group combined Yupingfeng particles,each bag, blunt, 3 times a day, once every 14 days. Total efficiency and sneezing, nasal congestion , runny nose, itchy nose symp-toms relief time, the recurrence rate after one month, two months of two groups were compared. Results The total effec-tive rate of the study group was 96.0% ,was significantly higher than the symptoms (P <0.05), and sneezing, nasal con-gestion, runny nose and nasal itching of study group were relieved more significantly than the control group (P <0.05). Study patients were followed up 1 month recurrence rate after two months and were significantly lower than the control group (6.7% vs 27.5%, 15.6% vs 37.5%, P <0.05). Conclusion Yupingfeng particles jointly loratadine integrative cura-tive in treatment of allergic rhinitis can significantly improve clinical symptoms, and no significant adverse reactions, should be popularized and applied.%目的:探讨玉屏风颗粒联合地氯雷他定治疗过敏性鼻炎的临床疗效。方法选择2010年1月~2013年1月我院住院治疗的过敏性鼻炎患者100例,根据治疗方法不同随机分为研究组和对照组各50例,对照组予氯雷他定片每次1片口服,每日1次,连用14 d。治疗组同时联合玉屏风颗粒每次1袋冲服,每日3次,连用14 d。比较两组患者治疗后的总有效率及两组患者的喷嚏、鼻塞、流涕、鼻痒的临床症状的缓解时间及随访1个月、2个月后的复发率。结果研究组的总有效率达96.0%,显著高于对照组(P<0.05),且研究组患者的喷嚏

  13. Investigation of the effect of Loratadine associated with physiological seawater nasal wash spray in the treat-ment of children with allergic rhinitis%氯雷他定联用生理性海水喷雾洗鼻液治疗儿童变应性鼻炎84例临床研究

    Institute of Scientific and Technical Information of China (English)

    潘彧

    2014-01-01

    Objective To investigate the clinical efficacy and safety of loratadine associated with physiological seawater nasal wash spray in the treatment of children with allergic rhinitis. Method 84 children with allergic rhinitis were randomly divided into observation group and control group,42 cases in each group. All children were given oral loratadine,and children in the observation group was treated with physiological seawater nasal wash spray for four weeks,the clinical efficacy and adverse drug reactions were observed. Results The to-tal symptom score in the two groups decreased significantly after treatment than before treatment(t=5. 863,4. 318,P<0. 01),total symp-tom score in the observation group(4. 21 ±0. 62)was significantly lower than that in the control group(t=4. 117,P<0. 05). The teffi-ciency(45. 2%)and total efficiency(92. 9%)in the observation group were better than that in the control group(χ2 =4. 266,10. 182, P<0. 05). Conclusion Loratadine associated with physiological seawater nasal wash spray in the treatment of children with allergic rhinitis is safe and effective,and suitable for clinical application.%目的:探讨氯雷他定联用生理性海水喷雾洗鼻液治疗儿童变应性鼻炎的临床疗效及安全性。方法:将84例儿童变应性鼻炎患儿随机分成观察组和对照组,每组42例,两组均给予氯雷他定口服治疗,观察组加用生理性海水喷雾洗鼻液喷鼻治疗,两组疗程均为4周,观察两组患儿临床疗效及药物不良反应。结果:两组患儿治疗后症状总评分均较治疗前显著降低(t=5.863,4.318,P<0.01),观察组症状总评分(4.21±0.62)明显低于对照组(t=4.117,P<0.05)。观察组显效率(45.2%)、总有效率(92.9%)明显优于对照组(χ2=4.266,10.182,P<0.05)。结论:氯雷他定联用生理性海水喷雾洗鼻液治疗儿童变应性鼻炎安全、有效,适合临床推广应用。

  14. 氮卓斯汀鼻喷剂联合地氯雷他定治疗过敏性鼻炎的随机对照研究%A Randomized Controlled Study of Azelastine Nasal Spray Combined with Desloratadine in the Treatment of Allergic Rhinitis

    Institute of Scientific and Technical Information of China (English)

    欧阳绍基; 姚榕威; 徐学江; 蔡琴芳; 谢凤梅; 胡全福; 王小刚

    2015-01-01

    Objective:To investigate the effects and safety of azelastine nasal spray combined with desloratadine for the treatment of allergic rhinitis.Method:174 cases of allergic rhinitis in our hospital were selected from January 2012 to September 2014 and were randomly divided into research group and control group,87 cases in each group.The control group was treated with azelastine nasal spray,the research group was treated with azelastine nasal spray combined with desloratadine.The total effective rate,symptom scores before and after treatment and adverse reactions rate were compared.Result:The total effective rate of research group was 93.1%,which was higher than 80.5% of control group,the difference was statistically significant(P0.05);after treatment,the symptom scores of research group was better than control group,the difference was statistically significant (P0.05).Conclusion:Azelastine nasal spray combined with desloratadine in the treatment of allergic rhinitis has exact effect.It can effectively relieve clinical symptoms without serious adverse reactions.It’s worthy of clinical widely used.%目的:探讨氮卓斯汀鼻喷剂联合地氯雷他定治疗过敏性鼻炎的临床疗效和安全性。方法:选取2012年1月-2014年9月本院收治的174例过敏性鼻炎患者作为研究对象,采用随机数字表法将所选患者分为研究组和对照组,每组各87例。对照组患者使用氮卓斯汀鼻喷剂治疗,研究组患者在对照组基础上使用地氯雷他定治疗。综合比较两组患者治疗总有效率、治疗前后各证候积分及不良反应发生率的差异。结果:研究组患者治疗总有效率为93.1%,高于对照组的80.5%,两组比较差异有统计学意义(P0.05),研究组治疗后各项证候积分均优于对照组,两组比较差异有统计学意义(P0.05)。结论:氮卓斯汀鼻喷剂联合地氯雷他定治疗过敏性鼻炎效果确切,对过敏性鼻炎相关症状有显著疗

  15. Website Optimization

    CERN Document Server

    King, Andrew

    2008-01-01

    Remember when an optimized website was one that merely didn't take all day to appear? Times have changed. Today, website optimization can spell the difference between enterprise success and failure, and it takes a lot more know-how to achieve success. This book is a compr